CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: nefazodone
Accession: CHEBI:7494
browse the term
Definition: A N-alkylpiperazine that has formula C25H32ClN5O2.
Synonyms: exact_synonym: 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
related_synonym: 1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one; Formula=C25H32ClN5O2; InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3; InChIKey=VRBKIVRKKCLPHA-UHFFFAOYSA-N; SMILES=CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1; nefazodona; nefazodonum
xref: Beilstein:4728403; CAS:83366-66-9; DrugBank:DB01149; Drug_Central:1890; KEGG:C07256; KEGG:D08257; LINCS:LSM-4031
xref_mesh: MESH:C051752
xref: Patent:US4338317; Wikipedia:Nefazodone
G
A1cf
APOBEC1 complementation factor
increases expression
EXP
nefazodone results in increased expression of A1CF mRNA
CTD
PMID:24136188
NCBI chr 1:229,736,037...229,823,499
Ensembl chr 1:239,149,493...239,236,817
G
Aadac
arylacetamide deacetylase
decreases expression
EXP
nefazodone results in decreased expression of AADAC mRNA
CTD
PMID:24136188
NCBI chr 2:146,293,449...146,351,061
Ensembl chr 2:146,313,279...146,324,525
G
Aadat
aminoadipate aminotransferase
decreases expression
EXP
nefazodone results in decreased expression of AADAT mRNA
CTD
PMID:24136188
NCBI chr16:34,520,236...34,566,388
Ensembl chr16:34,520,238...34,566,540
G
Aamp
angio-associated, migratory cell protein
increases expression
EXP
nefazodone results in increased expression of AAMP mRNA
CTD
PMID:24136188
NCBI chr 9:83,312,519...83,318,325
Ensembl chr 9:83,312,519...83,318,325
G
Aasdhppt
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
increases expression
EXP
nefazodone results in increased expression of AASDHPPT mRNA
CTD
PMID:24136188
NCBI chr 8:9,731,592...9,748,934
Ensembl chr 8:9,738,172...9,748,953
G
Abat
4-aminobutyrate aminotransferase
decreases expression
EXP
nefazodone results in decreased expression of ABAT mRNA
CTD
PMID:24136188
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474
G
Abca3
ATP binding cassette subfamily A member 3
decreases expression
EXP
nefazodone results in decreased expression of ABCA3 mRNA
CTD
PMID:24136188
NCBI chr10:13,886,948...13,944,286
Ensembl chr10:13,887,083...13,944,285
G
Abca8a
ATP-binding cassette, subfamily A (ABC1), member 8a
decreases expression
EXP
nefazodone results in decreased expression of ABCA8A mRNA
CTD
PMID:24136188
NCBI chr10:95,002,334...95,072,315
Ensembl chr10:95,501,798...95,571,873
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity decreases expression
ISO EXP
nefazodone inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] nefazodone results in decreased activity of ABCB11 protein nefazodone results in decreased expression of ABCB11 mRNA
CTD
PMID:16410371 PMID:20829430 PMID:22646477 PMID:23956101 PMID:24014644 PMID:24136188 PMID:28437613 More...
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
G
Abcb4
ATP binding cassette subfamily B member 4
increases expression decreases activity multiple interactions
EXP ISO
nefazodone results in increased expression of ABCB4 mRNA nefazodone results in decreased activity of ABCB4 protein [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of ABCB4 mRNA
CTD
PMID:24136188 PMID:28437613 PMID:33819548
NCBI chr 4:26,106,895...26,164,440
G
Abcb6
ATP binding cassette subfamily B member 6
increases expression
EXP
nefazodone results in increased expression of ABCB6 mRNA
CTD
PMID:24136188
NCBI chr 9:84,117,222...84,125,939
Ensembl chr 9:84,117,220...84,125,526
G
Abcc3
ATP binding cassette subfamily C member 3
increases expression multiple interactions decreases expression
EXP ISO
nefazodone results in increased expression of ABCC3 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ABCC3 mRNA nefazodone results in decreased expression of ABCC3 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
G
Abcc4
ATP binding cassette subfamily C member 4
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ABCC4 mRNA nefazodone results in increased expression of ABCC4 mRNA
CTD
PMID:32152650
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
G
Abcc6
ATP binding cassette subfamily C member 6
decreases expression
EXP
nefazodone results in decreased expression of ABCC6 mRNA
CTD
PMID:24136188
NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895
G
Abce1
ATP binding cassette subfamily E member 1
increases expression
EXP
nefazodone results in increased expression of ABCE1 mRNA
CTD
PMID:24136188
NCBI chr19:45,109,880...45,134,819
Ensembl chr19:45,109,906...45,134,819
G
Abcf3
ATP binding cassette subfamily F member 3
increases expression
EXP
nefazodone results in increased expression of ABCF3 mRNA
CTD
PMID:24136188
NCBI chr11:93,844,863...93,856,595
Ensembl chr11:93,844,363...93,856,595
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of ABCG2 mRNA
CTD
PMID:33819548
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
G
Abcg3l2
ATP-binding cassette, subfamily G (WHITE), member 3-like 2
decreases expression
EXP
nefazodone results in decreased expression of ABCG3L2 mRNA
CTD
PMID:24136188
NCBI chr14:4,493,259...4,538,264
Ensembl chr14:4,798,053...4,838,117
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of ABCG5 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ABCG5 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376
G
Abcg8
ATP binding cassette subfamily G member 8
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of ABCG8 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ABCG8 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:15,698,448...15,717,730
G
Abhd1
abhydrolase domain containing 1
decreases expression
EXP
nefazodone results in decreased expression of ABHD1 mRNA
CTD
PMID:24136188
NCBI chr 6:31,142,476...31,147,464
Ensembl chr 6:31,142,476...31,147,464
G
Abhd2
abhydrolase domain containing 2, acylglycerol lipase
decreases expression
EXP
nefazodone results in decreased expression of ABHD2 mRNA
CTD
PMID:24136188
NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:142,626,732...142,712,674
G
Abhd4
abhydrolase domain containing 4, N-acyl phospholipase B
increases expression
EXP
nefazodone results in increased expression of ABHD4 mRNA
CTD
PMID:24136188
NCBI chr15:31,674,090...31,686,051
Ensembl chr15:31,674,143...31,687,007
G
Ablim3
actin binding LIM protein family, member 3
increases expression
EXP
nefazodone results in increased expression of ABLIM3 mRNA
CTD
PMID:24136188
NCBI chr18:57,527,917...57,646,936
Ensembl chr18:57,527,917...57,646,710
G
Abtb1
ankyrin repeat and BTB domain containing 1
increases expression
EXP
nefazodone results in increased expression of ABTB1 mRNA
CTD
PMID:24136188
NCBI chr 4:121,299,302...121,305,667
Ensembl chr 4:122,856,564...122,862,789
G
Acaa1a
acetyl-CoA acyltransferase 1A
increases expression
EXP
nefazodone results in increased expression of ACAA1 mRNA
CTD
PMID:24136188
NCBI chr 8:127,956,126...127,966,348
Ensembl chr 8:127,956,129...127,966,241
G
Acaa2
acetyl-CoA acyltransferase 2
increases expression
EXP
nefazodone results in increased expression of ACAA2 mRNA
CTD
PMID:24136188
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
G
Acaca
acetyl-CoA carboxylase alpha
decreases expression
EXP
nefazodone results in decreased expression of ACACA mRNA
CTD
PMID:24136188
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
G
Acad11
acyl-CoA dehydrogenase family, member 11
increases expression
EXP
nefazodone results in increased expression of ACAD11 mRNA
CTD
PMID:24136188
NCBI chr 8:113,560,142...113,625,346
Ensembl chr 8:113,560,196...113,625,352
G
Acly
ATP citrate lyase
decreases expression
EXP
nefazodone results in decreased expression of ACLY mRNA
CTD
PMID:24136188
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631
G
Aco1
aconitase 1
increases expression
EXP
nefazodone results in increased expression of ACO1 mRNA
CTD
PMID:24136188
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600
G
Aco2
aconitase 2
increases expression
EXP
nefazodone results in increased expression of ACO2 mRNA
CTD
PMID:24136188
NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892
G
Acot12
acyl-CoA thioesterase 12
increases expression
EXP
nefazodone results in increased expression of ACOT12 mRNA
CTD
PMID:24136188
NCBI chr 2:24,721,648...24,763,686
Ensembl chr 2:24,721,910...24,765,298
G
Acot13
acyl-CoA thioesterase 13
decreases expression
EXP
nefazodone results in decreased expression of ACOT13 mRNA
CTD
PMID:24136188
NCBI chr17:40,668,404...40,680,876
Ensembl chr17:40,668,316...40,680,876
G
Acot2
acyl-CoA thioesterase 2
increases expression
EXP
nefazodone results in increased expression of ACOT2 mRNA
CTD
PMID:24136188
NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:109,342,646...109,350,502
G
Acot7
acyl-CoA thioesterase 7
increases expression
EXP
nefazodone results in increased expression of ACOT7 mRNA
CTD
PMID:24136188
NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:167,968,895...168,062,033
G
Acot8
acyl-CoA thioesterase 8
increases expression
EXP
nefazodone results in increased expression of ACOT8 mRNA
CTD
PMID:24136188
NCBI chr 3:173,950,530...173,962,188
Ensembl chr 3:173,950,531...173,962,570
G
Acox1
acyl-CoA oxidase 1
increases expression
EXP
nefazodone results in increased expression of ACOX1 mRNA
CTD
PMID:24136188
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
G
Acox3
acyl-CoA oxidase 3, pristanoyl
decreases expression
EXP
nefazodone results in decreased expression of ACOX3 mRNA
CTD
PMID:24136188
NCBI chr14:79,358,604...79,405,160
Ensembl chr14:79,302,042...79,400,881
G
Acp1
acid phosphatase 1
increases expression
EXP
nefazodone results in increased expression of ACP1 mRNA
CTD
PMID:24136188
NCBI chr 6:53,233,937...53,249,576
Ensembl chr 6:53,233,948...53,251,959
G
Acp2
acid phosphatase 2, lysosomal
decreases expression
EXP
nefazodone results in decreased expression of ACP2 mRNA
CTD
PMID:24136188
NCBI chr 3:97,630,654...97,642,601
Ensembl chr 3:97,631,326...97,642,565
G
Acsf2
acyl-CoA synthetase family member 2
decreases expression
EXP
nefazodone results in decreased expression of ACSF2 mRNA
CTD
PMID:24136188
NCBI chr10:80,001,389...80,043,796
Ensembl chr10:80,001,389...80,045,050
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of ACSL1 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ACSL1 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023
G
Acsl4
acyl-CoA synthetase long-chain family member 4
increases expression
EXP
nefazodone results in increased expression of ACSL4 mRNA
CTD
PMID:24136188
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
G
Acsl5
acyl-CoA synthetase long-chain family member 5
decreases expression
EXP
nefazodone results in decreased expression of ACSL5 mRNA
CTD
PMID:24136188
NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943
G
Acsm2
acyl-CoA synthetase medium-chain family member 2
increases expression
EXP
nefazodone results in increased expression of ACSM2A mRNA
CTD
PMID:24136188
NCBI chr 1:183,347,705...183,386,453
Ensembl chr 1:183,347,705...183,386,453
G
Acss2
acyl-CoA synthetase short-chain family member 2
decreases expression
EXP
nefazodone results in decreased expression of ACSS2 mRNA
CTD
PMID:24136188
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830
G
Actr3
actin related protein 3
increases expression
EXP
nefazodone results in increased expression of ACTR3 mRNA
CTD
PMID:24136188
NCBI chr13:39,353,413...39,396,509
Ensembl chr13:39,353,079...39,396,711
G
Adamts7
ADAM metallopeptidase with thrombospondin type 1 motif, 7
decreases expression
EXP
nefazodone results in decreased expression of ADAMTS7 mRNA
CTD
PMID:24136188
NCBI chr 8:99,584,529...99,624,132
Ensembl chr 8:99,584,529...99,624,132
G
Adap2
ArfGAP with dual PH domains 2
decreases expression
EXP
nefazodone results in decreased expression of ADAP2 mRNA
CTD
PMID:24136188
NCBI chr10:65,635,891...65,665,019
Ensembl chr10:65,622,434...65,664,022
G
Adck5
aarF domain containing kinase 5
increases expression
EXP
nefazodone results in increased expression of ADCK5 mRNA
CTD
PMID:24136188
NCBI chr 7:110,182,275...110,200,088
Ensembl chr 7:110,181,981...110,200,088
G
Add1
adducin 1
increases expression
EXP
nefazodone results in increased expression of ADD1 mRNA
CTD
PMID:24136188
NCBI chr14:80,333,242...80,401,641
Ensembl chr14:80,333,244...80,391,732
G
Adgrg1
adhesion G protein-coupled receptor G1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of ADGRG1 mRNA
CTD
PMID:33819548
NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124
G
Adgrl2
adhesion G protein-coupled receptor L2
decreases expression
EXP
nefazodone results in decreased expression of ADGRL2 mRNA
CTD
PMID:24136188
NCBI chr 2:240,356,176...240,987,246
Ensembl chr 2:240,356,177...240,855,933
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ADH1C mRNA
CTD
PMID:33819548
NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of ADH4 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ADH4 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:229,622,095...229,641,879
G
Adh6
alcohol dehydrogenase 6 (class V)
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ADH6 mRNA
CTD
PMID:33819548
NCBI chr 2:229,576,612...229,608,359
Ensembl chr 2:229,576,636...229,607,914
G
Adhfe1
alcohol dehydrogenase, iron containing, 1
decreases expression
EXP
nefazodone results in decreased expression of ADHFE1 mRNA
CTD
PMID:24136188
NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:14,488,788...14,515,835
G
Adprm
ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent
increases expression
EXP
nefazodone results in increased expression of ADPRM mRNA
CTD
PMID:24136188
NCBI chr10:51,732,073...51,744,635
Ensembl chr10:52,230,233...52,243,569
G
Adprs
ADP-ribosylserine hydrolase
increases expression
EXP
nefazodone results in increased expression of ADPRS mRNA
CTD
PMID:24136188
NCBI chr 5:143,898,542...143,903,816
Ensembl chr 5:143,898,542...143,903,816
G
Adra1b
adrenoceptor alpha 1B
decreases expression
EXP
nefazodone results in decreased expression of ADRA1B mRNA
CTD
PMID:24136188
NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347
G
Adrm1
ADRM1 26S proteasome ubiquitin receptor
increases expression
EXP
nefazodone results in increased expression of ADRM1 mRNA
CTD
PMID:24136188
NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:187,642,654...187,648,483
G
Adsl
adenylosuccinate lyase
increases expression
EXP
nefazodone results in increased expression of ADSL mRNA
CTD
PMID:24136188
NCBI chr 7:114,359,440...114,383,618
Ensembl chr 7:114,359,440...114,384,872
G
Afg3l2
AFG3 like matrix AAA peptidase subunit 2
increases expression
EXP
nefazodone results in increased expression of AFG3L2 mRNA
CTD
PMID:24136188
NCBI chr18:63,224,163...63,269,000
Ensembl chr18:63,224,163...63,269,000
G
Afm
afamin
decreases expression
EXP
nefazodone results in decreased expression of AFM mRNA
CTD
PMID:24136188
NCBI chr14:17,815,194...17,848,042
Ensembl chr14:17,815,194...17,848,039
G
Agxt2
alanine-glyoxylate aminotransferase 2
decreases expression
EXP
nefazodone results in decreased expression of AGXT2 mRNA
CTD
PMID:24136188
NCBI chr 2:61,063,416...61,104,828
Ensembl chr 2:61,063,419...61,105,090
G
Ahcyl1
adenosylhomocysteinase-like 1
increases expression
EXP
nefazodone results in increased expression of AHCYL1 mRNA
CTD
PMID:24136188
NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:197,982,344...198,033,930
G
Ahsa1
activator of Hsp90 ATPase activity 1
increases expression
EXP
nefazodone results in increased expression of AHSA1 mRNA
CTD
PMID:24136188
NCBI chr 6:112,644,287...112,652,290
Ensembl chr 6:112,644,479...112,655,595
G
Aig1
androgen-induced 1
increases expression
EXP
nefazodone results in increased expression of AIG1 mRNA
CTD
PMID:24136188
NCBI chr 1:9,866,546...10,089,454
Ensembl chr 1:9,866,548...10,089,155
G
Aimp1
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
increases expression
EXP
nefazodone results in increased expression of AIMP1 mRNA
CTD
PMID:24136188
NCBI chr 2:223,825,930...223,849,477
Ensembl chr 2:223,825,931...223,849,994
G
Aimp2
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
increases expression
EXP
nefazodone results in increased expression of AIMP2 mRNA
CTD
PMID:24136188
NCBI chr12:15,814,854...15,824,432
Ensembl chr12:15,814,878...15,824,431
G
Aip
aryl-hydrocarbon receptor-interacting protein
increases expression
EXP
nefazodone results in increased expression of AIP mRNA
CTD
PMID:24136188
NCBI chr 1:210,837,473...210,848,691
Ensembl chr 1:210,836,755...210,848,634
G
Ak3
adenylate kinase 3
increases expression
EXP
nefazodone results in increased expression of AK3 mRNA
CTD
PMID:24136188
NCBI chr 1:236,151,012...236,178,689
Ensembl chr 1:236,151,012...236,178,183
G
Ak4
adenylate kinase 4
decreases expression
EXP
nefazodone results in decreased expression of AK4 mRNA
CTD
PMID:24136188
NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401
G
Akap8l
A-kinase anchoring protein 8 like
decreases expression
EXP
nefazodone results in decreased expression of AKAP8L mRNA
CTD
PMID:24136188
NCBI chr 7:11,983,215...12,012,843
Ensembl chr 7:11,982,721...12,012,811
G
Akr1a1
aldo-keto reductase family 1 member A1
increases expression
EXP
nefazodone results in increased expression of AKR1A1 mRNA
CTD
PMID:24136188
NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases expression
EXP
nefazodone results in decreased expression of AKR1C1 mRNA
CTD
PMID:24136188
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247
G
Akr1c14
aldo-keto reductase family 1, member C14
increases expression
EXP
nefazodone results in increased expression of AKR1C14 mRNA
CTD
PMID:24136188
NCBI chr17:71,066,197...71,083,184
Ensembl chr17:71,066,200...71,083,157
G
Akr1d1
aldo-keto reductase family 1, member D1
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of AKR1D1 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of AKR1D1 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540
G
Akr7a2
aldo-keto reductase family 7, member A2
increases expression
EXP
nefazodone results in increased expression of AKR7A2 mRNA
CTD
PMID:24136188
NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109
G
Akr7a3
aldo-keto reductase family 7 member A3
increases expression decreases expression multiple interactions
EXP ISO
nefazodone results in increased expression of AKR7A3 mRNA nefazodone results in decreased expression of AKR7A3 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153
G
Akt1s1
AKT1 substrate 1
increases expression
EXP
nefazodone results in increased expression of AKT1S1 mRNA
CTD
PMID:24136188
NCBI chr 1:104,469,823...104,476,168
Ensembl chr 1:104,469,803...104,476,167
G
Alas1
5'-aminolevulinate synthase 1
increases expression
EXP
nefazodone results in increased expression of ALAS1 mRNA
CTD
PMID:24136188
NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:115,755,238...115,768,642
G
Alb
albumin
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ALB mRNA
CTD
PMID:33819548
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
EXP
nefazodone results in increased expression of ALDH1A1 mRNA
CTD
PMID:24136188
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
G
Aldh1a7
aldehyde dehydrogenase family 1, subfamily A7
increases expression
EXP
nefazodone results in increased expression of ALDH1A7 mRNA
CTD
PMID:24136188
NCBI chr 1:227,627,977...227,667,877
Ensembl chr 1:227,627,448...227,672,523
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
decreases expression
EXP
nefazodone results in decreased expression of ALDH1B1 mRNA
CTD
PMID:24136188
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
increases expression
EXP
nefazodone results in increased expression of ALDH1L1 mRNA
CTD
PMID:24136188
NCBI chr 4:124,617,182...124,663,674
Ensembl chr 4:124,617,217...124,664,704
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
increases expression
EXP
nefazodone results in increased expression of ALDH3A2 mRNA
CTD
PMID:24136188
NCBI chr10:46,427,789...46,448,449
Ensembl chr10:46,407,993...46,448,648
G
Aldoa
aldolase, fructose-bisphosphate A
increases expression
EXP
nefazodone results in increased expression of ALDOA mRNA
CTD
PMID:24136188
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
G
Alg12
ALG12, alpha-1,6-mannosyltransferase
increases expression
EXP
nefazodone results in increased expression of ALG12 mRNA
CTD
PMID:24136188
NCBI chr 7:121,774,796...121,789,175
Ensembl chr 7:121,768,234...121,788,983
G
Alg3
ALG3, alpha-1,3- mannosyltransferase
increases expression
EXP
nefazodone results in increased expression of ALG3 mRNA
CTD
PMID:24136188
NCBI chr11:80,300,487...80,306,014
Ensembl chr11:93,804,891...93,812,060
G
Alkbh7
alkB homolog 7
increases expression
EXP
nefazodone results in increased expression of ALKBH7 mRNA
CTD
PMID:24136188
NCBI chr 9:1,925,896...1,928,048
Ensembl chr 9:1,925,743...1,928,048
G
Alpp
alkaline phosphatase, placental
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ALPP mRNA
CTD
PMID:33819548
NCBI chr 9:95,213,763...95,216,509
Ensembl chr 9:95,213,374...95,219,451
G
Amd1
adenosylmethionine decarboxylase 1
increases expression
EXP
nefazodone results in increased expression of AMD1 mRNA
CTD
PMID:24136188
NCBI chr20:45,250,289...45,324,939
Ensembl chr20:45,250,289...45,265,982
G
Ammecr1l
AMMECR1 like
decreases expression
EXP
nefazodone results in decreased expression of AMMECR1L mRNA
CTD
PMID:24136188
NCBI chr18:23,661,649...23,685,391
Ensembl chr18:23,661,341...23,685,649
G
Ampd3
adenosine monophosphate deaminase 3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of AMPD3 mRNA
CTD
PMID:33819548
NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608
G
Amt
aminomethyltransferase
increases expression
EXP
nefazodone results in increased expression of AMT mRNA
CTD
PMID:24136188
NCBI chr 8:117,859,700...117,866,692
Ensembl chr 8:117,860,345...117,866,803
G
Amy1
amylase alpha 1
decreases expression
EXP
nefazodone results in decreased expression of AMY1A mRNA
CTD
PMID:24136188
NCBI chr 2:204,071,101...204,085,910
Ensembl chr 2:204,071,098...204,086,239
G
Ang
angiogenin
decreases expression
EXP
nefazodone results in decreased expression of ANG mRNA
CTD
PMID:24136188
NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106
G
Angptl3
angiopoietin-like 3
decreases expression
EXP
nefazodone results in decreased expression of ANGPTL3 mRNA
CTD
PMID:24136188
NCBI chr 5:118,818,494...118,825,531
Ensembl chr 5:118,818,499...118,826,444
G
Angptl4
angiopoietin-like 4
decreases expression
EXP
nefazodone results in decreased expression of ANGPTL4 mRNA
CTD
PMID:24136188
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681
G
Ankh
ANKH inorganic pyrophosphate transport regulator
decreases expression
EXP
nefazodone results in decreased expression of ANKH mRNA
CTD
PMID:24136188
NCBI chr 2:79,883,350...80,011,222
Ensembl chr 2:79,883,544...80,011,699
G
Ankrd13c
ankyrin repeat domain 13C
decreases expression
EXP
nefazodone results in decreased expression of ANKRD13C mRNA
CTD
PMID:24136188
NCBI chr 2:249,679,752...249,729,272
Ensembl chr 2:249,681,872...249,729,272
G
Anks4b
ankyrin repeat and sterile alpha motif domain containing 4B
decreases expression
EXP
nefazodone results in decreased expression of ANKS4B mRNA
CTD
PMID:24136188
NCBI chr 1:183,934,528...183,989,127
Ensembl chr 1:183,978,769...183,989,122
G
Ano10
anoctamin 10
increases expression
EXP
nefazodone results in increased expression of ANO10 mRNA
CTD
PMID:24136188
NCBI chr 8:130,719,177...130,838,243
Ensembl chr 8:130,718,755...130,877,636
G
Anp32a
acidic nuclear phosphoprotein 32 family member A
decreases expression
EXP
nefazodone results in decreased expression of ANP32A mRNA
CTD
PMID:24136188
NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:71,724,531...71,760,922
G
Anp32b
acidic nuclear phosphoprotein 32 family member B
increases expression
EXP
nefazodone results in increased expression of ANP32B mRNA
CTD
PMID:24136188
NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:65,538,535...65,561,437
G
Anp32e
acidic nuclear phosphoprotein 32 family member E
increases expression
EXP
nefazodone results in increased expression of ANP32E mRNA
CTD
PMID:24136188
NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986
G
Anpep
alanyl aminopeptidase, membrane
decreases expression
EXP
nefazodone results in decreased expression of ANPEP mRNA
CTD
PMID:24136188
NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101
G
Antxr2
ANTXR cell adhesion molecule 2
decreases expression
EXP
nefazodone results in decreased expression of ANTXR2 mRNA
CTD
PMID:24136188
NCBI chr14:11,845,774...11,986,166
Ensembl chr14:11,845,700...11,986,168
G
Anxa3
annexin A3
decreases expression
EXP
nefazodone results in decreased expression of ANXA3 mRNA
CTD
PMID:24136188
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
G
Anxa5
annexin A5
decreases expression
EXP
nefazodone results in decreased expression of ANXA5 mRNA
CTD
PMID:24136188
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
G
Anxa7
annexin A7
increases expression
EXP
nefazodone results in increased expression of ANXA7 mRNA
CTD
PMID:24136188
NCBI chr15:3,869,180...3,897,827
Ensembl chr15:3,870,974...3,898,891
G
Aox1
aldehyde oxidase 1
increases expression decreases expression multiple interactions
EXP ISO
nefazodone results in increased expression of AOX1 mRNA nefazodone results in decreased expression of AOX1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980
G
Ap1m1
adaptor related protein complex 1 subunit mu 1
increases expression
EXP
nefazodone results in increased expression of AP1M1 mRNA
CTD
PMID:24136188
NCBI chr16:17,620,910...17,636,431
Ensembl chr16:17,616,187...17,636,462
G
Ap2m1
adaptor related protein complex 2 subunit mu 1
increases expression
EXP
nefazodone results in increased expression of AP2M1 mRNA
CTD
PMID:24136188
NCBI chr11:93,859,690...93,868,600
Ensembl chr11:93,859,690...93,868,480
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
increases expression
EXP
nefazodone results in increased expression of APEX1 mRNA
CTD
PMID:24136188
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
G
Api5
apoptosis inhibitor 5
increases expression
EXP
nefazodone results in increased expression of API5 mRNA
CTD
PMID:24136188
NCBI chr 3:100,833,417...100,858,580
Ensembl chr 3:100,833,417...100,858,580
G
Aplp2
amyloid beta precursor like protein 2
decreases expression
EXP
nefazodone results in decreased expression of APLP2 mRNA
CTD
PMID:24136188
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031
G
Apmap
adipocyte plasma membrane associated protein
decreases expression
EXP
nefazodone results in decreased expression of APMAP mRNA
CTD
PMID:24136188
NCBI chr 3:159,869,451...159,897,727
Ensembl chr 3:159,869,451...159,897,726
G
Apoa1
apolipoprotein A1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of APOA1 mRNA
CTD
PMID:33819548
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729
G
Apoa4
apolipoprotein A4
decreases expression
EXP
nefazodone results in decreased expression of APOA4 mRNA
CTD
PMID:24136188
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164
G
Apoa5
apolipoprotein A5
decreases expression
EXP
nefazodone results in decreased expression of APOA5 mRNA
CTD
PMID:24136188
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:55,456,899...55,460,507
G
Apol2
apolipoprotein L2
decreases expression
EXP
nefazodone results in decreased expression of APOL3 mRNA
CTD
PMID:24136188
NCBI chr 7:111,211,944...111,219,209
Ensembl chr 7:111,211,893...111,217,223
G
Apol9a-Apol7a
Apol9a-Apol7a readthrough
decreases expression
EXP
nefazodone results in decreased expression of APOL7B mRNA
CTD
PMID:24136188
NCBI chr 7:109,118,559...109,149,798
Ensembl chr 7:111,011,645...111,017,084
G
Apom
apolipoprotein M
decreases expression
EXP
nefazodone results in decreased expression of APOM mRNA
CTD
PMID:24136188
NCBI chr20:3,695,618...3,698,218
Ensembl chr20:3,692,737...3,698,218
G
Aqp8
aquaporin 8
increases expression
EXP
nefazodone results in increased expression of AQP8 mRNA
CTD
PMID:24136188
NCBI chr 1:187,424,314...187,430,243
Ensembl chr 1:187,424,417...187,430,242
G
Arcn1
archain 1
increases expression
EXP
nefazodone results in increased expression of ARCN1 mRNA
CTD
PMID:24136188
NCBI chr 8:53,954,401...53,979,005
Ensembl chr 8:53,954,404...53,979,005
G
Arf1
ARF GTPase 1
increases expression
EXP
nefazodone results in increased expression of ARF1 mRNA
CTD
PMID:24136188
NCBI chr10:44,497,543...44,513,994
G
Arf6
ARF GTPase 6
increases expression
EXP
nefazodone results in increased expression of ARF6 mRNA
CTD
PMID:24136188
NCBI chr 6:93,589,777...93,590,925
Ensembl chr 6:93,569,234...93,610,536
G
Arfip2
ARF interacting protein 2
decreases expression
EXP
nefazodone results in decreased expression of ARFIP2 mRNA
CTD
PMID:24136188
NCBI chr 1:169,387,484...169,392,290
Ensembl chr 1:169,387,485...169,392,166
G
Arg1
arginase 1
increases expression
EXP
nefazodone results in increased expression of ARG1 mRNA
CTD
PMID:24136188
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
G
Arhgef19
Rho guanine nucleotide exchange factor 19
decreases expression
EXP
nefazodone results in decreased expression of ARHGEF19 mRNA
CTD
PMID:24136188
NCBI chr 5:153,536,038...153,554,203
Ensembl chr 5:158,818,932...158,837,196
G
Arid1a
AT-rich interaction domain 1A
decreases expression
EXP
nefazodone results in decreased expression of ARID1A mRNA
CTD
PMID:24136188
NCBI chr 5:151,192,014...151,269,291
Ensembl chr 5:151,192,014...151,265,386
G
Arl4a
ARF like GTPase 4A
increases expression
EXP
nefazodone results in increased expression of ARL4A mRNA
CTD
PMID:24136188
NCBI chr 6:62,809,287...62,811,297
Ensembl chr 6:62,804,548...62,820,760
G
Arl5a
ARF like GTPase 5A
increases expression
EXP
nefazodone results in increased expression of ARL5A mRNA
CTD
PMID:24136188
NCBI chr 3:57,287,599...57,312,488
Ensembl chr 3:57,289,846...57,312,488
G
Arl6ip1
ARL6 interacting reticulophagy regulator 1
decreases expression
EXP
nefazodone results in decreased expression of ARL6IP1 mRNA
CTD
PMID:24136188
NCBI chr 1:181,864,717...181,874,232
Ensembl chr 1:181,864,746...181,874,232
G
Arl6ip4
ARF like GTPase 6 interacting protein 4
increases expression
EXP
nefazodone results in increased expression of ARL6IP4 mRNA
CTD
PMID:24136188
NCBI chr12:38,140,566...38,142,711
Ensembl chr12:38,140,550...38,142,724
G
Arpc5l
actin related protein 2/3 complex, subunit 5-like
increases expression
EXP
nefazodone results in increased expression of ARPC5L mRNA
CTD
PMID:24136188
NCBI chr 3:43,169,518...43,177,224
Ensembl chr 3:43,169,462...43,177,240 Ensembl chr 9:43,169,462...43,177,240
G
Arpin
actin-related protein 2/3 complex inhibitor
increases expression
EXP
nefazodone results in increased expression of ARPIN mRNA
CTD
PMID:24136188
NCBI chr 1:143,273,590...143,282,426
Ensembl chr 1:143,273,590...143,282,532
G
Arpp19
cAMP-regulated phosphoprotein 19
increases expression
EXP
nefazodone results in increased expression of ARPP19 mRNA
CTD
PMID:24136188
NCBI chr 8:84,660,166...84,683,012
Ensembl chr 8:119,691,942...119,692,385 Ensembl chr 8:119,691,942...119,692,385
G
Arsa
arylsulfatase A
decreases expression
EXP
nefazodone results in decreased expression of ARSA mRNA
CTD
PMID:24136188
NCBI chr 7:122,422,971...122,426,971
Ensembl chr 7:122,422,982...122,428,401
G
Asap2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
decreases expression
EXP
nefazodone results in decreased expression of ASAP2 mRNA
CTD
PMID:24136188
NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:46,386,605...46,549,669
G
Asf1a
anti-silencing function 1A histone chaperone
increases expression
EXP
nefazodone results in increased expression of ASF1A mRNA
CTD
PMID:24136188
NCBI chr20:33,436,632...33,451,478
Ensembl chr20:33,436,707...33,449,639
G
Ash1l
ASH1 like histone lysine methyltransferase
decreases expression
EXP
nefazodone results in decreased expression of ASH1L mRNA
CTD
PMID:24136188
NCBI chr 2:176,644,393...176,780,848
Ensembl chr 2:176,644,924...176,780,847
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
nefazodone results in increased expression of ASNS mRNA
CTD
PMID:24136188
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
G
Asnsd1
asparagine synthetase domain containing 1
increases expression
EXP
nefazodone results in increased expression of ASNSD1 mRNA
CTD
PMID:24136188
NCBI chr 9:55,618,799...55,631,064
Ensembl chr 9:55,618,799...55,631,064
G
Aspg
asparaginase
decreases expression
EXP
nefazodone results in decreased expression of ASPG mRNA
CTD
PMID:24136188
NCBI chr 6:136,997,832...137,017,417
Ensembl chr 6:136,998,023...137,017,417
G
Atf1
activating transcription factor 1
increases expression
EXP
nefazodone results in increased expression of ATF1 mRNA
CTD
PMID:24136188
NCBI chr 7:133,240,774...133,283,488
Ensembl chr 7:133,241,197...133,283,485
G
Atf4
activating transcription factor 4
multiple interactions increases expression
ISO
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [nefazodone results in increased expression of ATF4 protein]; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF4 mRNA nefazodone results in increased expression of ATF4 mRNA; nefazodone results in increased expression of ATF4 protein
CTD
PMID:27613715 PMID:32152650
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
G
Atf5
activating transcription factor 5
increases expression
EXP
nefazodone results in increased expression of ATF5 mRNA
CTD
PMID:24136188
NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183
G
Atf6
activating transcription factor 6
increases expression multiple interactions
ISO
nefazodone results in increased expression of ATF6 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA
CTD
PMID:32152650
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
G
Atg7
autophagy related 7
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA nefazodone results in increased expression of ATG7 mRNA
CTD
PMID:32152650
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:149,391,390...149,598,319
G
Atg9a
autophagy related 9A
decreases expression
EXP
nefazodone results in decreased expression of ATG9A mRNA
CTD
PMID:24136188
NCBI chr 9:84,126,071...84,136,723
Ensembl chr 9:84,126,071...84,136,666
G
Atic
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
increases expression
EXP
nefazodone results in increased expression of ATIC mRNA
CTD
PMID:24136188
NCBI chr 9:80,614,311...80,634,360
Ensembl chr 9:80,614,283...80,635,756
G
Atl2
atlastin GTPase 2
increases expression
EXP
nefazodone results in increased expression of ATL2 mRNA
CTD
PMID:24136188
NCBI chr 6:20,891,220...20,932,644
Ensembl chr 6:20,891,227...20,933,320
G
Atl3
atlastin GTPase 3
increases expression
EXP
nefazodone results in increased expression of ATL3 mRNA
CTD
PMID:24136188
NCBI chr 1:214,110,127...214,151,098
Ensembl chr 1:214,109,702...214,152,510
G
Atoh8
atonal bHLH transcription factor 8
decreases expression
EXP
nefazodone results in decreased expression of ATOH8 mRNA
CTD
PMID:24136188
NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379
G
Atosa
atos homolog A
decreases expression
EXP
nefazodone results in decreased expression of ATOSA mRNA
CTD
PMID:24136188
NCBI chr 8:84,575,360...84,653,103
Ensembl chr 8:84,575,370...84,653,091
G
Atp11a
ATPase phospholipid transporting 11A
decreases expression
EXP
nefazodone results in decreased expression of ATP11A mRNA
CTD
PMID:24136188
NCBI chr16:83,359,884...83,469,807
Ensembl chr16:83,359,884...83,469,767
G
Atp5f1d
ATP synthase F1 subunit delta
increases expression
EXP
nefazodone results in increased expression of ATP5F1D mRNA
CTD
PMID:24136188
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583
G
Atp5if1
ATP synthase inhibitory factor subunit 1
increases expression
EXP
nefazodone results in increased expression of ATP5IF1 mRNA
CTD
PMID:24136188
NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677
G
Atp5mc1
ATP synthase membrane subunit c locus 1
increases expression
EXP
nefazodone results in increased expression of ATP5MC1 mRNA
CTD
PMID:24136188
NCBI chr10:81,520,762...81,523,735
Ensembl chr10:81,520,765...81,523,363
G
Atp5pd
ATP synthase peripheral stalk subunit d
increases expression
EXP
nefazodone results in increased expression of ATP5PD mRNA
CTD
PMID:24136188
NCBI chr10:101,156,673...101,161,926
Ensembl chr10:101,156,673...101,162,954
G
Atp6ap2
ATPase H+ transporting accessory protein 2
increases expression
EXP
nefazodone results in increased expression of ATP6AP2 mRNA
CTD
PMID:24136188
NCBI chr X:12,856,708...12,883,670
Ensembl chr X:12,855,859...12,905,875
G
Atp6v0b
ATPase H+ transporting V0 subunit B
increases expression
EXP
nefazodone results in increased expression of ATP6V0B mRNA
CTD
PMID:24136188
NCBI chr 5:136,708,823...136,710,339
Ensembl chr 5:136,708,823...136,716,828
G
Atp6v0e1
ATPase H+ transporting V0 subunit e1
increases expression
EXP
nefazodone results in increased expression of ATP6V0E1 mRNA
CTD
PMID:24136188
NCBI chr10:16,984,084...17,007,156
Ensembl chr10:16,984,084...17,028,858
G
Atp6v1a
ATPase H+ transporting V1 subunit A
increases expression
EXP
nefazodone results in increased expression of ATP6V1A mRNA
CTD
PMID:24136188
NCBI chr11:70,066,800...70,120,603
Ensembl chr11:70,035,134...70,120,603
G
Atp6v1b2
ATPase H+ transporting V1 subunit B2
increases expression
EXP
nefazodone results in increased expression of ATP6V1B2 mRNA
CTD
PMID:24136188
NCBI chr16:25,384,254...25,408,388
Ensembl chr16:25,384,257...25,408,839
G
Atp6v1c1
ATPase H+ transporting V1 subunit C1
increases expression
EXP
nefazodone results in increased expression of ATP6V1C1 mRNA
CTD
PMID:24136188
NCBI chr 7:71,719,326...71,757,191
Ensembl chr 7:71,719,404...71,757,184
G
Atp6v1d
ATPase H+ transporting V1 subunit D
increases expression
EXP
nefazodone results in increased expression of ATP6V1D mRNA
CTD
PMID:24136188
NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:103,389,783...103,405,346
G
Atp6v1e1
ATPase H+ transporting V1 subunit E1
increases expression
EXP
nefazodone results in increased expression of ATP6V1E1 mRNA
CTD
PMID:24136188
NCBI chr 4:155,694,534...155,716,660
Ensembl chr 4:155,694,534...155,716,678
G
Atp6v1f
ATPase H+ transporting V1 subunit F
increases expression
EXP
nefazodone results in increased expression of ATP6V1F mRNA
CTD
PMID:24136188
NCBI chr 4:59,033,020...59,035,980
G
Atp6v1g1
ATPase H+ transporting V1 subunit G1
increases expression
EXP
nefazodone results in increased expression of ATP6V1G1 mRNA
CTD
PMID:24136188
NCBI chr 5:81,976,959...81,983,139
Ensembl chr 5:81,977,015...81,985,930
G
Atp6v1h
ATPase H+ transporting V1 subunit H
increases expression
EXP
nefazodone results in increased expression of ATP6V1H mRNA
CTD
PMID:24136188
NCBI chr 5:19,176,849...19,282,516
Ensembl chr 5:19,176,849...19,282,516
G
Atpsckmt
ATP synthase c subunit lysine N-methyltransferase
increases expression
EXP
nefazodone results in increased expression of ATPSCKMT mRNA
CTD
PMID:24136188
NCBI chr 2:84,313,991...84,329,195
Ensembl chr 2:84,313,921...84,329,194
G
Atr
ATR serine/threonine kinase
decreases expression
ISO
nefazodone results in decreased expression of ATR mRNA
CTD
PMID:27288927
NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:105,306,305...105,403,718
G
Atrn
attractin
decreases expression
EXP
nefazodone results in decreased expression of ATRN mRNA
CTD
PMID:24136188
NCBI chr 3:138,563,271...138,697,360
Ensembl chr 3:138,563,312...138,697,360
G
Auh
AU RNA binding methylglutaconyl-CoA hydratase
increases expression
EXP
nefazodone results in increased expression of AUH mRNA
CTD
PMID:24136188
NCBI chr17:12,481,396...12,576,748
Ensembl chr17:12,481,416...12,602,587
G
Aup1
AUP1, lipid droplet regulating VLDL assembly factor
increases expression
EXP
nefazodone results in increased expression of AUP1 mRNA
CTD
PMID:24136188
NCBI chr 4:117,118,035...117,121,063
Ensembl chr 4:117,117,999...117,121,061
G
Avpr1a
arginine vasopressin receptor 1A
decreases expression
EXP
nefazodone results in decreased expression of AVPR1A mRNA
CTD
PMID:24136188
NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837
G
Azi2
5-azacytidine induced 2
increases expression
EXP
nefazodone results in increased expression of AZI2 mRNA
CTD
PMID:24136188
NCBI chr 8:126,651,268...126,674,795
Ensembl chr 8:126,651,206...126,676,182
G
Azin1
antizyme inhibitor 1
increases expression
EXP
nefazodone results in increased expression of AZIN1 mRNA
CTD
PMID:24136188
NCBI chr 7:71,539,711...71,566,515
Ensembl chr 7:71,539,711...71,566,515
G
B2m
beta-2 microglobulin
decreases expression
EXP
nefazodone results in decreased expression of B2M mRNA
CTD
PMID:24136188
NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356
G
Baat
bile acid CoA:amino acid N-acyltransferase
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of BAAT mRNA
CTD
PMID:33819548
NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:68,646,203...68,656,181
G
Bag3
BAG cochaperone 3
increases expression
EXP
nefazodone results in increased expression of BAG3 mRNA
CTD
PMID:24136188
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
G
Baiap2l1
BAR/IMD domain containing adaptor protein 2 like 1
increases expression
EXP
nefazodone results in increased expression of BAIAP2L1 mRNA
CTD
PMID:24136188
NCBI chr12:15,364,090...15,453,602
Ensembl chr12:15,364,109...15,453,605
G
Banf1
barrier to autointegration nuclear assembly factor 1
increases expression
EXP
nefazodone results in increased expression of BANF1 mRNA
CTD
PMID:24136188
NCBI chr 1:212,101,523...212,103,568
Ensembl chr 1:212,101,523...212,103,552
G
Bbc3
Bcl-2 binding component 3
increases expression
ISO
nefazodone results in increased expression of BBC3 mRNA
CTD
PMID:27288927
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666
G
Bbox1
gamma-butyrobetaine hydroxylase 1
decreases expression
EXP
nefazodone results in decreased expression of BBOX1 mRNA
CTD
PMID:24136188
NCBI chr 3:117,277,226...117,326,383
Ensembl chr 3:117,277,226...117,326,064
G
Bcap29
B-cell receptor-associated protein 29
increases expression
EXP
nefazodone results in increased expression of BCAP29 mRNA
CTD
PMID:24136188
NCBI chr 6:53,910,209...53,950,206
Ensembl chr 6:53,910,216...53,949,963
G
Bckdk
branched chain ketoacid dehydrogenase kinase
decreases expression
EXP
nefazodone results in decreased expression of BCKDK mRNA
CTD
PMID:24136188
NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:191,946,471...191,953,453
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of BCL2L1 mRNA
CTD
PMID:33819548
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
G
Bcl6
BCL6, transcription repressor
increases expression
EXP
nefazodone results in increased expression of BCL6 mRNA
CTD
PMID:24136188
NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047
G
Bcs1l
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone
increases expression
EXP
nefazodone results in increased expression of BCS1L mRNA
CTD
PMID:24136188
NCBI chr 9:83,614,045...83,618,052
Ensembl chr 9:83,613,975...83,618,257
G
Bet1
Bet1 golgi vesicular membrane trafficking protein
increases expression
EXP
nefazodone results in increased expression of BET1 mRNA
CTD
PMID:24136188
NCBI chr 4:33,070,892...33,081,162
Ensembl chr 4:33,070,891...33,081,164
G
Bgn
biglycan
decreases expression
EXP
nefazodone results in decreased expression of BGN mRNA
CTD
PMID:24136188
NCBI chr X:156,348,633...156,360,797
Ensembl chr X:156,348,615...156,360,799
G
Bhmt
betaine-homocysteine S-methyltransferase
decreases expression
EXP
nefazodone results in decreased expression of BHMT mRNA
CTD
PMID:24136188
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715
G
Bltp3b
bridge-like lipid transfer protein family member 3B
increases expression
EXP
nefazodone results in increased expression of BLTP3B mRNA
CTD
PMID:24136188
NCBI chr 7:26,068,948...26,149,033
Ensembl chr 7:26,068,955...26,149,083
G
Blvrb
biliverdin reductase B
increases expression
EXP
nefazodone results in increased expression of BLVRB mRNA
CTD
PMID:24136188
NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225
G
Bmp1
bone morphogenetic protein 1
decreases expression
EXP
nefazodone results in decreased expression of BMP1 mRNA
CTD
PMID:24136188
NCBI chr15:51,961,310...52,005,597
Ensembl chr15:51,961,310...52,005,485
G
Bmp6
bone morphogenetic protein 6
increases expression
ISO
nefazodone results in increased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261
G
Bnip3
BCL2 interacting protein 3
increases expression
EXP
nefazodone results in increased expression of BNIP3 mRNA
CTD
PMID:24136188
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
G
Bnip3l
BCL2 interacting protein 3 like
increases expression
EXP
nefazodone results in increased expression of BNIP3L mRNA
CTD
PMID:24136188
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282
G
Bola3
bolA family member 3
increases expression
EXP
nefazodone results in increased expression of BOLA3 mRNA
CTD
PMID:24136188
NCBI chr 4:117,411,044...117,420,491
Ensembl chr 4:117,410,680...117,420,491
G
Bop1
BOP1 ribosomal biogenesis factor
increases expression
EXP
nefazodone results in increased expression of BOP1 mRNA
CTD
PMID:24136188
NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529
G
Bpnt1
3'(2'), 5'-bisphosphate nucleotidase 1
increases expression
EXP
nefazodone results in increased expression of BPNT1 mRNA
CTD
PMID:24136188
NCBI chr13:99,397,127...99,425,056
Ensembl chr13:99,400,115...99,425,053
G
Bpnt2
3'(2'), 5'-bisphosphate nucleotidase 2
increases expression
EXP
nefazodone results in increased expression of BPNT2 mRNA
CTD
PMID:24136188
NCBI chr 5:22,573,241...22,600,126
Ensembl chr 5:22,570,165...22,600,126
G
Brd10
bromodomain containing 10
decreases expression
EXP
nefazodone results in decreased expression of BRD10 mRNA
CTD
PMID:24136188
NCBI chr 1:227,490,983...227,572,246
Ensembl chr 1:236,904,520...236,983,923
G
Brd3
bromodomain containing 3
decreases expression
EXP
nefazodone results in decreased expression of BRD3 mRNA
CTD
PMID:24136188
NCBI chr 3:31,173,332...31,227,749
Ensembl chr 3:31,173,332...31,227,629
G
Brix1
biogenesis of ribosomes BRX1
increases expression
EXP
nefazodone results in increased expression of BRIX1 mRNA
CTD
PMID:24136188
NCBI chr 2:59,450,608...59,461,486
Ensembl chr 2:61,177,771...61,188,647
G
Brk1
BRICK1 subunit of SCAR/WAVE actin nucleating complex
increases expression
EXP
nefazodone results in increased expression of BRK1 mRNA
CTD
PMID:24136188
NCBI chr 4:148,306,436...148,321,668
Ensembl chr 4:148,306,398...148,321,984
G
Btbd1
BTB domain containing 1
decreases expression
EXP
nefazodone results in decreased expression of BTBD1 mRNA
CTD
PMID:24136188
NCBI chr 1:145,143,806...145,183,653
Ensembl chr 1:145,143,808...145,181,197
G
Btf3
basic transcription factor 3
increases expression
EXP
nefazodone results in increased expression of BTF3 mRNA
CTD
PMID:24136188
NCBI chr 2:31,394,010...31,401,138
Ensembl chr 2:31,394,011...31,401,125 Ensembl chr13:31,394,011...31,401,125
G
Btg1
BTG anti-proliferation factor 1
decreases expression
EXP
nefazodone results in decreased expression of BTG1 mRNA
CTD
PMID:24136188
NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406
G
Bub3
BUB3 mitotic checkpoint protein
increases expression
EXP
nefazodone results in increased expression of BUB3 mRNA
CTD
PMID:24136188
NCBI chr 1:195,760,532...195,771,140
Ensembl chr 1:195,758,105...195,791,028
G
Bysl
bystin-like
increases expression
EXP
nefazodone results in increased expression of BYSL mRNA
CTD
PMID:24136188
NCBI chr 9:20,880,341...20,890,092
Ensembl chr 9:20,880,026...20,890,900
G
Bzw1
basic leucine zipper and W2 domains 1
increases expression
EXP
nefazodone results in increased expression of BZW1 mRNA
CTD
PMID:24136188
NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:67,424,866...67,439,684
G
C10h17orf58
similar to human chromosome 17 open reading frame 58
increases expression
EXP
nefazodone results in increased expression of C10H17ORF58 mRNA
CTD
PMID:24136188
NCBI chr10:92,472,779...92,477,330
Ensembl chr10:92,471,934...92,477,330
G
C10h5orf15
similar to human chromosome 5 open reading frame 15
increases expression
EXP
nefazodone results in increased expression of C10H5ORF15 mRNA
CTD
PMID:24136188
NCBI chr10:37,064,889...37,077,493
Ensembl chr10:37,064,728...37,077,493
G
C13h1orf115
similar to human chromosome 1 open reading frame 115
decreases expression
EXP
nefazodone results in decreased expression of C13H1ORF115 mRNA
CTD
PMID:24136188
NCBI chr13:98,953,841...98,963,577
Ensembl chr13:98,953,843...98,963,810
G
C18h18orf32
similar to human chromosome 18 open reading frame 32
increases expression
EXP
nefazodone results in increased expression of C18H18ORF32 mRNA
CTD
PMID:24136188
NCBI chr18:68,586,278...68,594,851
Ensembl chr18:70,861,435...70,869,983
G
C1galt1c1
C1GALT1-specific chaperone 1
increases expression
EXP
nefazodone results in increased expression of C1GALT1C1 mRNA
CTD
PMID:24136188
NCBI chr X:122,243,736...122,248,217
Ensembl chr X:122,234,454...122,248,422
G
C1qbp
complement C1q binding protein
increases expression
EXP
nefazodone results in increased expression of C1QBP mRNA
CTD
PMID:24136188
NCBI chr10:56,198,534...56,203,185
Ensembl chr10:56,198,540...56,203,235
G
C1r
complement C1r
decreases expression
EXP
nefazodone results in decreased expression of C1R mRNA
CTD
PMID:24136188
NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714
G
C1s
complement C1s
decreases expression
EXP
nefazodone results in decreased expression of C1S mRNA
CTD
PMID:24136188
NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736
G
C2
complement C2
decreases expression
EXP
nefazodone results in decreased expression of C2 mRNA
CTD
PMID:24136188
NCBI chr20:3,944,722...3,975,006
Ensembl chr20:3,955,776...3,981,740
G
C20h6orf89
similar to human chromosome 6 open reading frame 89
increases expression
EXP
nefazodone results in increased expression of C20H6ORF89 mRNA
CTD
PMID:24136188
NCBI chr20:7,322,483...7,362,054
Ensembl chr20:7,324,129...7,363,666
G
C4b
complement C4B
decreases expression
EXP
nefazodone results in decreased expression of C4B mRNA
CTD
PMID:24136188
NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,201,961...4,216,289
G
C5
complement C5
decreases expression
EXP
nefazodone results in decreased expression of C5 mRNA
CTD
PMID:24136188
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468
G
C5h1orf210
similar to human chromosome 1 open reading frame 210
decreases expression
EXP
nefazodone results in decreased expression of C5H1ORF210 mRNA
CTD
PMID:24136188
NCBI chr 5:137,334,142...137,337,300
Ensembl chr 5:137,334,142...137,337,300
G
C6
complement C6
decreases expression
EXP
nefazodone results in decreased expression of C6 mRNA
CTD
PMID:24136188
NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:55,573,653...55,649,120
G
C8a
complement C8 alpha chain
decreases expression
EXP
nefazodone results in decreased expression of C8A mRNA
CTD
PMID:24136188
NCBI chr 5:124,812,131...124,866,631
Ensembl chr 5:124,812,131...124,866,710
G
C8b
complement C8 beta chain
decreases expression
EXP
nefazodone results in decreased expression of C8B mRNA
CTD
PMID:24136188
NCBI chr 5:124,763,974...124,801,522
Ensembl chr 5:124,761,790...124,801,516
G
C8h11orf54
similar to human chromosome 11 open reading frame 54
increases expression
EXP
nefazodone results in increased expression of C8H11ORF54 mRNA
CTD
PMID:24136188
NCBI chr 8:20,405,240...20,427,811
Ensembl chr 8:20,405,241...20,427,811
G
C8h11orf65
similar to human chromosome 11 open reading frame 65
increases expression
EXP
nefazodone results in increased expression of C8H11ORF65 mRNA
CTD
PMID:24136188
NCBI chr 8:62,692,123...62,720,951
Ensembl chr 8:62,692,568...62,720,946
G
C9
complement C9
decreases expression
EXP
nefazodone results in decreased expression of C9 mRNA
CTD
PMID:24136188
NCBI chr 2:57,300,510...57,348,759
Ensembl chr 2:57,300,427...57,348,752
G
C9h2orf69
similar to human chromosome 2 open reading frame 69
increases expression
EXP
nefazodone results in increased expression of C9H2ORF69 mRNA
CTD
PMID:24136188
NCBI chr 9:66,444,084...66,452,720
Ensembl chr 9:66,444,112...66,453,983
G
Ca3
carbonic anhydrase 3
decreases expression
EXP
nefazodone results in decreased expression of CAR3 mRNA
CTD
PMID:24136188
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524
G
Ca8
carbonic anhydrase 8
decreases expression
EXP
nefazodone results in decreased expression of CAR8 mRNA
CTD
PMID:24136188
NCBI chr 5:26,102,767...26,199,819
Ensembl chr 5:26,102,813...26,199,796
G
Cab39
calcium binding protein 39
increases expression
EXP
nefazodone results in increased expression of CAB39 mRNA
CTD
PMID:24136188
NCBI chr 9:93,911,099...93,972,542
Ensembl chr 9:93,911,054...93,972,542
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
affects activity
ISO
nefazodone affects the activity of CACNA1C protein
CTD
PMID:26821276
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762
G
Cacna2d1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CACNA2D1 mRNA
CTD
PMID:33819548
NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:19,905,764...20,330,147
G
Cacul1
CDK2-associated, cullin domain 1
increases expression
EXP
nefazodone results in increased expression of CACUL1 mRNA
CTD
PMID:24136188
NCBI chr 1:259,666,335...259,726,249
Ensembl chr 1:269,652,356...269,712,112
G
Cacybp
calcyclin binding protein
increases expression
EXP
nefazodone results in increased expression of CACYBP mRNA
CTD
PMID:24136188
NCBI chr13:74,970,917...74,981,298
Ensembl chr13:74,970,923...74,981,505
G
Cald1
caldesmon 1
decreases expression
EXP
nefazodone results in decreased expression of CALD1 mRNA
CTD
PMID:24136188
NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085
G
Calm2
calmodulin 2
decreases expression
EXP
nefazodone results in decreased expression of CALM2 mRNA
CTD
PMID:24136188
NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657 Ensembl chr 6:64,519,554...64,520,657
G
Caprin1
cell cycle associated protein 1
increases expression
EXP
nefazodone results in increased expression of CAPRIN1 mRNA
CTD
PMID:24136188
NCBI chr 3:110,606,489...110,685,408
Ensembl chr 3:110,606,489...110,685,562
G
Carhsp1
calcium regulated heat stable protein 1
decreases expression
EXP
nefazodone results in decreased expression of CARHSP1 mRNA
CTD
PMID:24136188
NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770
G
Casp3
caspase 3
multiple interactions increases expression increases activity
ISO EXP
Palmitic Acid promotes the reaction [nefazodone results in increased activity of CASP3 protein] nefazodone results in increased expression of CASP3 mRNA
CTD
PMID:22700542 PMID:24136188 PMID:27288927
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp7
caspase 7
increases activity multiple interactions
ISO
nefazodone results in increased activity of CASP7 protein Palmitic Acid promotes the reaction [nefazodone results in increased activity of CASP7 protein]
CTD
PMID:22700542
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
G
Casp9
caspase 9
increases activity
ISO
nefazodone results in increased activity of CASP9 protein
CTD
PMID:27288927
Ensembl chr 5:159,391,188...159,409,648
G
Cat
catalase
decreases expression multiple interactions
ISO
nefazodone results in decreased expression of CAT mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CAT mRNA
CTD
PMID:32152650
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Cavin3
caveolae associated protein 3
increases expression
EXP
nefazodone results in increased expression of CAVIN3 mRNA
CTD
PMID:24136188
NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:169,238,384...169,239,981
G
Cbr1
carbonyl reductase 1
multiple interactions increases expression
ISO EXP
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA nefazodone results in increased expression of CBR1 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104 Ensembl chr11:46,378,411...46,381,104
G
Cbr4
carbonyl reductase 4
increases expression
EXP
nefazodone results in increased expression of CBR4 mRNA
CTD
PMID:24136188
NCBI chr16:33,625,734...33,695,067
Ensembl chr16:33,617,399...33,656,832
G
Cbx3
chromobox 3
increases expression
EXP
nefazodone results in increased expression of CBX3 mRNA
CTD
PMID:24136188
NCBI chr 4:81,876,155...81,889,912
Ensembl chr 4:81,876,649...81,889,911
G
Ccdc107
coiled-coil domain containing 107
decreases expression
EXP
nefazodone results in decreased expression of CCDC107 mRNA
CTD
PMID:24136188
NCBI chr 5:62,545,273...62,548,711
Ensembl chr 5:62,544,714...62,548,709
G
Ccdc47
coiled-coil domain containing 47
increases expression
EXP
nefazodone results in increased expression of CCDC47 mRNA
CTD
PMID:24136188
NCBI chr10:91,630,101...91,648,626
Ensembl chr10:91,630,106...91,648,626
G
Ccdc6
coiled-coil domain containing 6
increases expression
EXP
nefazodone results in increased expression of CCDC6 mRNA
CTD
PMID:24136188
NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,431,243...18,527,227
G
Ccdc80
coiled-coil domain containing 80
decreases expression
EXP
nefazodone results in decreased expression of CCDC80 mRNA
CTD
PMID:24136188
NCBI chr11:69,191,188...69,224,844
Ensembl chr11:69,191,189...69,224,844
G
Ccl9
C-C motif chemokine ligand 9
decreases expression
EXP
nefazodone results in decreased expression of CCL6 mRNA; nefazodone results in decreased expression of CCL9 mRNA
CTD
PMID:24136188
NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877
G
Ccnl1
cyclin L1
decreases expression
EXP
nefazodone results in decreased expression of CCNL1 mRNA
CTD
PMID:24136188
NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468
G
Ccnl2
cyclin L2
decreases expression
EXP
nefazodone results in decreased expression of CCNL2 mRNA
CTD
PMID:24136188
NCBI chr 5:171,698,951...171,711,037
Ensembl chr 5:171,699,689...171,711,231
G
Ccr2
C-C motif chemokine receptor 2
increases expression multiple interactions
ISO
nefazodone results in increased expression of CCR2 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of CCR2 mRNA
CTD
PMID:32152650
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
G
Ccs
copper chaperone for superoxide dismutase
increases expression
EXP
nefazodone results in increased expression of CCS mRNA
CTD
PMID:24136188
NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:211,542,701...211,564,260
G
Cct2
chaperonin containing TCP1 subunit 2
increases expression
EXP
nefazodone results in increased expression of CCT2 mRNA
CTD
PMID:24136188
NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977
G
Cct3
chaperonin containing TCP1 subunit 3
increases expression
EXP
nefazodone results in increased expression of CCT3 mRNA
CTD
PMID:24136188
NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:176,063,526...176,089,925
G
Cct4
chaperonin containing TCP1 subunit 4
increases expression
EXP
nefazodone results in increased expression of CCT4 mRNA
CTD
PMID:24136188
NCBI chr14:101,193,057...101,205,935
Ensembl chr14:101,192,772...101,205,770
G
Cct5
chaperonin containing TCP1 subunit 5
increases expression
EXP
nefazodone results in increased expression of CCT5 mRNA
CTD
PMID:24136188
NCBI chr 2:84,302,621...84,313,773
Ensembl chr 2:84,302,623...84,313,779
G
Cct6a
chaperonin containing TCP1 subunit 6A
increases expression
EXP
nefazodone results in increased expression of CCT6A mRNA
CTD
PMID:24136188
NCBI chr12:32,508,842...32,519,072
Ensembl chr12:32,508,675...32,519,119
G
Cct7
chaperonin containing TCP1 subunit 7
increases expression
EXP
nefazodone results in increased expression of CCT7 mRNA
CTD
PMID:24136188
NCBI chr 4:119,546,730...119,563,973
Ensembl chr 4:119,546,730...119,563,973
G
Cct8
chaperonin containing TCP1 subunit 8
increases expression
EXP
nefazodone results in increased expression of CCT8 mRNA
CTD
PMID:24136188
NCBI chr11:40,196,619...40,208,328
Ensembl chr11:40,196,619...40,208,328
G
Cd14
CD14 molecule
increases expression
EXP
nefazodone results in increased expression of CD14 mRNA
CTD
PMID:24136188
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
G
Cd164
CD164 molecule
decreases expression
EXP
nefazodone results in decreased expression of CD164 mRNA
CTD
PMID:24136188
NCBI chr20:46,606,439...46,618,015
Ensembl chr20:46,606,107...46,638,649
G
Cd302
CD302 molecule
decreases expression
EXP
nefazodone results in decreased expression of CD302 mRNA
CTD
PMID:24136188
NCBI chr 3:65,131,017...65,164,737
Ensembl chr 3:65,113,102...65,164,737
G
Cd5l
Cd5 molecule-like
decreases expression
EXP
nefazodone results in decreased expression of CD5L mRNA
CTD
PMID:24136188
NCBI chr 2:175,088,915...175,099,928
Ensembl chr 2:175,088,884...175,099,926
G
Cd74
CD74 molecule
decreases expression
EXP
nefazodone results in decreased expression of CD74 mRNA
CTD
PMID:24136188
NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410
G
Cd81
Cd81 molecule
decreases expression
EXP
nefazodone results in decreased expression of CD81 mRNA
CTD
PMID:24136188
NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092
G
Cd82
Cd82 molecule
decreases expression
EXP
nefazodone results in decreased expression of CD82 mRNA
CTD
PMID:24136188
NCBI chr 3:99,842,748...99,887,298
Ensembl chr 3:99,842,757...99,886,744
G
Cdc40
cell division cycle 40
increases expression
EXP
nefazodone results in increased expression of CDC40 mRNA
CTD
PMID:24136188
NCBI chr20:45,855,739...45,908,239
Ensembl chr20:45,855,739...45,907,978
G
Cdc73
cell division cycle 73
increases expression
EXP
nefazodone results in increased expression of CDC73 mRNA
CTD
PMID:24136188
NCBI chr13:57,897,924...58,000,031
Ensembl chr13:57,883,983...57,999,978
G
Cdh2
cadherin 2
decreases expression
EXP
nefazodone results in decreased expression of CDH2 mRNA
CTD
PMID:24136188
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
G
Cdk4
cyclin-dependent kinase 4
increases expression
EXP
nefazodone results in increased expression of CDK4 mRNA
CTD
PMID:24136188
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
G
Cdk7
cyclin-dependent kinase 7
increases expression
EXP
nefazodone results in increased expression of CDK7 mRNA
CTD
PMID:24136188
NCBI chr 2:33,574,623...33,599,485
Ensembl chr 2:33,574,623...33,599,485
G
Cdo1
cysteine dioxygenase type 1
decreases expression
EXP
nefazodone results in decreased expression of CDO1 mRNA
CTD
PMID:24136188
NCBI chr18:41,619,076...41,633,719
Ensembl chr18:41,619,070...41,633,891
G
Ceacam1
CEA cell adhesion molecule 1
decreases expression
EXP
nefazodone results in decreased expression of CEACAM1 mRNA
CTD
PMID:24136188
NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798
G
Cela1
chymotrypsin like elastase 1
decreases expression
EXP
nefazodone results in decreased expression of CELA1 mRNA
CTD
PMID:24136188
NCBI chr 7:133,651,939...133,665,136
Ensembl chr 7:133,651,941...133,665,061
G
Cenpv
centromere protein V
increases expression
EXP
nefazodone results in increased expression of CENPV mRNA
CTD
PMID:24136188
NCBI chr10:47,713,778...47,746,800
Ensembl chr10:47,713,778...47,727,679
G
Cep170
centrosomal protein 170
decreases expression
EXP
nefazodone results in decreased expression of CEP170 mRNA
CTD
PMID:24136188
NCBI chr13:91,201,808...91,285,990
Ensembl chr13:91,201,808...91,285,990
G
Ces1e
carboxylesterase 1E
increases expression
EXP
nefazodone results in increased expression of CES1E mRNA
CTD
PMID:24136188
NCBI chr19:13,833,154...13,869,627
Ensembl chr19:30,006,153...30,042,626
G
Ces2h
carboxylesterase 2H
increases expression
EXP
nefazodone results in increased expression of CES2 mRNA
CTD
PMID:24136188
NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752
G
Cfap20
cilia and flagella associated protein 20
increases expression
EXP
nefazodone results in increased expression of CFAP20 mRNA
CTD
PMID:24136188
NCBI chr19:9,614,265...9,628,612
Ensembl chr19:9,614,721...9,628,612
G
Cfap298
cilia and flagella associated protein 298
increases expression
EXP
nefazodone results in increased expression of CFAP298 mRNA
CTD
PMID:24136188
NCBI chr11:43,667,996...43,678,049
Ensembl chr11:43,668,014...43,677,382
G
Cfb
complement factor B
decreases expression
EXP
nefazodone results in decreased expression of CFB mRNA
CTD
PMID:24136188
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740
G
Cfh
complement factor H
decreases expression
EXP
nefazodone results in decreased expression of CFH mRNA
CTD
PMID:24136188
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532
G
Cfhr1
complement factor H-related 1
decreases expression
EXP
nefazodone results in decreased expression of CFHR1 mRNA
CTD
PMID:24136188
NCBI chr13:53,946,298...53,961,282
Ensembl chr13:53,919,927...53,961,303
G
Cgn
cingulin
decreases expression
EXP
nefazodone results in decreased expression of CGN mRNA
CTD
PMID:24136188
NCBI chr 2:184,997,425...185,024,785
Ensembl chr 2:184,997,425...185,023,635
G
Cgnl1
cingulin-like 1
decreases expression
EXP
nefazodone results in decreased expression of CGNL1 mRNA
CTD
PMID:24136188
NCBI chr 8:81,154,169...81,305,598
Ensembl chr 8:81,140,091...81,305,747
G
Cgrrf1
cell growth regulator with ring finger domain 1
increases expression
EXP
nefazodone results in increased expression of CGRRF1 mRNA
CTD
PMID:24136188
NCBI chr15:22,560,902...22,588,815
Ensembl chr15:22,568,332...22,588,811
G
Chac2
ChaC glutathione specific gamma-glutamylcyclotransferase 2
decreases expression
EXP
nefazodone results in decreased expression of CHAC2 mRNA
CTD
PMID:24136188
NCBI chr14:108,921,669...108,929,215
Ensembl chr14:108,921,341...108,929,469
G
Chchd10
coiled-coil-helix-coiled-coil-helix domain containing 10
increases expression
EXP
nefazodone results in increased expression of CHCHD10 mRNA
CTD
PMID:24136188
NCBI chr20:12,725,274...12,730,295
Ensembl chr20:12,725,277...12,745,677
G
Chchd2
coiled-coil-helix-coiled-coil-helix domain containing 2
increases expression
EXP
nefazodone results in increased expression of CHCHD2 mRNA
CTD
PMID:24136188
NCBI chr12:32,464,847...32,470,871
Ensembl chr12:32,464,824...32,470,871
G
Chchd5
coiled-coil-helix-coiled-coil-helix domain containing 5
increases expression
EXP
nefazodone results in increased expression of CHCHD5 mRNA
CTD
PMID:24136188
NCBI chr 3:116,361,845...116,372,238
Ensembl chr 3:136,815,048...136,821,914
G
Chchd6
coiled-coil-helix-coiled-coil-helix domain containing 6
increases expression
EXP
nefazodone results in increased expression of CHCHD6 mRNA
CTD
PMID:24136188
NCBI chr 4:123,360,729...123,581,429
Ensembl chr 4:123,349,187...123,581,421
G
Chi3l1
chitinase 3 like 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CHI3L1 mRNA
CTD
PMID:33819548
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825
G
Chka
choline kinase alpha
decreases expression
EXP
nefazodone results in decreased expression of CHKA mRNA
CTD
PMID:24136188
NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752
G
Chmp4c
charged multivesicular body protein 4C
increases expression
EXP
nefazodone results in increased expression of CHMP4C mRNA
CTD
PMID:24136188
NCBI chr 2:93,299,152...93,336,075
Ensembl chr 2:93,299,157...93,360,850
G
Chordc1
cysteine and histidine rich domain containing 1
increases expression
EXP
nefazodone results in increased expression of CHORDC1 mRNA
CTD
PMID:24136188
NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696
G
Chpf2
chondroitin polymerizing factor 2
increases expression
EXP
nefazodone results in increased expression of CHPF2 mRNA
CTD
PMID:24136188
NCBI chr 4:11,470,917...11,479,096
Ensembl chr 4:11,472,908...11,478,370
G
Chpt1
choline phosphotransferase 1
increases expression
EXP
nefazodone results in increased expression of CHPT1 mRNA
CTD
PMID:24136188
NCBI chr 7:24,753,880...24,802,529
Ensembl chr 7:24,750,343...24,802,521
G
Chrac1
chromatin accessibility complex subunit 1
increases expression
EXP
nefazodone results in increased expression of CHRAC1 mRNA
CTD
PMID:24136188
NCBI chr 7:106,901,841...106,905,441
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
increases expression
EXP
nefazodone results in increased expression of CHUK mRNA
CTD
PMID:24136188
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273
G
Churc1
churchill domain containing 1
increases expression
EXP
nefazodone results in increased expression of CHURC1 mRNA
CTD
PMID:24136188
NCBI chr 6:101,203,778...101,218,364
Ensembl chr 6:101,203,841...101,237,748
G
Ciao2a
cytosolic iron-sulfur assembly component 2A
increases expression
EXP
nefazodone results in increased expression of CIAO2A mRNA
CTD
PMID:24136188
NCBI chr 8:75,565,620...75,577,542
Ensembl chr 8:75,565,567...75,577,541
G
Ciapin1
cytokine induced apoptosis inhibitor 1
increases expression
EXP
nefazodone results in increased expression of CIAPIN1 mRNA
CTD
PMID:24136188
NCBI chr19:10,185,955...10,199,120
Ensembl chr19:10,182,088...10,201,495
G
Cidea
cell death-inducing DFFA-like effector a
increases expression
EXP
nefazodone results in increased expression of CIDEA mRNA
CTD
PMID:24136188
NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382
G
Cidec
cell death-inducing DFFA-like effector c
decreases expression
EXP
nefazodone results in decreased expression of CIDEC mRNA
CTD
PMID:24136188
NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:148,124,925...148,137,806
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
decreases expression
EXP
nefazodone results in decreased expression of CITED2 mRNA
CTD
PMID:24136188
NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782
G
Cks1b
CDC28 protein kinase regulatory subunit 1B
increases expression
EXP
nefazodone results in increased expression of CKS1B mRNA
CTD
PMID:24136188
NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression
EXP
nefazodone results in decreased expression of CKS2 mRNA
CTD
PMID:24136188
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
G
Clcn3
chloride voltage-gated channel 3
increases expression
EXP
nefazodone results in increased expression of CLCN3 mRNA
CTD
PMID:24136188
NCBI chr16:34,138,004...34,210,984
Ensembl chr16:34,137,952...34,210,984
G
Clcn4
chloride voltage-gated channel 4
decreases expression
EXP
nefazodone results in decreased expression of CLCN4 mRNA
CTD
PMID:24136188
NCBI chr X:27,290,769...27,356,967
Ensembl chr X:27,290,868...27,356,939
G
Cldnd1
claudin domain containing 1
increases expression
EXP
nefazodone results in increased expression of CLDND1 mRNA
CTD
PMID:24136188
NCBI chr11:55,352,321...55,358,779
Ensembl chr11:55,352,321...55,358,907
G
Clec4f
C-type lectin domain family 4, member F
decreases expression
EXP
nefazodone results in decreased expression of CLEC4F mRNA
CTD
PMID:24136188
NCBI chr 4:117,686,686...117,696,407
Ensembl chr 4:117,686,686...117,696,438
G
Clip1
CAP-GLY domain containing linker protein 1
increases expression
EXP
nefazodone results in increased expression of CLIP1 mRNA
CTD
PMID:24136188
NCBI chr12:38,571,533...38,678,779
Ensembl chr12:38,571,834...38,678,779
G
Clpp
caseinolytic mitochondrial matrix peptidase proteolytic subunit
increases expression
EXP
nefazodone results in increased expression of CLPP mRNA
CTD
PMID:24136188
NCBI chr 9:1,917,305...1,924,706
Ensembl chr 9:1,918,682...1,924,705
G
Cltb
clathrin, light chain B
increases expression
EXP
nefazodone results in increased expression of CLTB mRNA
CTD
PMID:24136188
NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,006,656...10,024,915
G
Cltc
clathrin heavy chain
increases expression
EXP
nefazodone results in increased expression of CLTC mRNA
CTD
PMID:24136188
NCBI chr10:72,014,984...72,073,308
Ensembl chr10:72,014,986...72,070,691
G
Cmas
cytidine monophosphate N-acetylneuraminic acid synthetase
increases expression
EXP
nefazodone results in increased expression of CMAS mRNA
CTD
PMID:24136188
NCBI chr 4:177,449,801...177,468,117
Ensembl chr 4:177,449,732...177,476,291
G
Cmbl
carboxymethylenebutenolidase homolog
increases expression
EXP
nefazodone results in increased expression of CMBL mRNA
CTD
PMID:24136188
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:84,242,512...84,301,880
G
Cmtm6
CKLF-like MARVEL transmembrane domain containing 6
decreases expression
EXP
nefazodone results in decreased expression of CMTM6 mRNA
CTD
PMID:24136188
NCBI chr 8:123,301,131...123,319,230
Ensembl chr 8:123,300,918...123,319,230
G
Cmtm8
CKLF-like MARVEL transmembrane domain containing 8
increases expression
EXP
nefazodone results in increased expression of CMTM8 mRNA
CTD
PMID:24136188
NCBI chr 8:123,360,168...123,425,291
Ensembl chr 8:123,360,170...123,425,276
G
Cnot11
CCR4-NOT transcription complex, subunit 11
increases expression
EXP
nefazodone results in increased expression of CNOT11 mRNA
CTD
PMID:24136188
NCBI chr 9:41,814,923...41,824,626
Ensembl chr 9:49,309,518...49,321,771
G
Coa3
cytochrome C oxidase assembly factor 3
increases expression
EXP
nefazodone results in increased expression of COA3 mRNA
CTD
PMID:24136188
NCBI chr10:86,220,192...86,221,173
Ensembl chr10:86,720,456...86,721,440
G
Coa5
cytochrome C oxidase assembly factor 5
increases expression
EXP
nefazodone results in increased expression of COA5 mRNA
CTD
PMID:24136188
NCBI chr 9:47,147,267...47,160,724
Ensembl chr 9:47,147,267...47,160,672
G
Coasy
Coenzyme A synthase
increases expression
EXP
nefazodone results in increased expression of COASY mRNA
CTD
PMID:24136188
NCBI chr10:86,514,850...86,519,130
Ensembl chr10:86,514,874...86,519,130
G
Cog6
component of oligomeric golgi complex 6
increases expression
EXP
nefazodone results in increased expression of COG6 mRNA
CTD
PMID:24136188
NCBI chr 2:137,062,127...137,099,176
Ensembl chr 2:139,211,678...139,249,737
G
Col14a1
collagen type XIV alpha 1 chain
decreases expression
EXP
nefazodone results in decreased expression of COL14A1 mRNA
CTD
PMID:24136188
NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:88,611,828...88,826,938
G
Col18a1
collagen type XVIII alpha 1 chain
decreases expression
EXP
nefazodone results in decreased expression of COL18A1 mRNA
CTD
PMID:24136188
NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112
G
Col1a2
collagen type I alpha 2 chain
decreases expression
EXP
nefazodone results in decreased expression of COL1A2 mRNA
CTD
PMID:24136188
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
G
Col3a1
collagen type III alpha 1 chain
decreases expression
EXP
nefazodone results in decreased expression of COL3A1 mRNA
CTD
PMID:24136188
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
G
Col6a1
collagen type VI alpha 1 chain
decreases expression
EXP
nefazodone results in decreased expression of COL6A1 mRNA
CTD
PMID:24136188
NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107
G
Commd5
COMM domain containing 5
increases expression
EXP
nefazodone results in increased expression of COMMD5 mRNA
CTD
PMID:24136188
NCBI chr 7:110,502,492...110,503,916
Ensembl chr 7:110,479,403...110,505,897
G
Comtd1
catechol-O-methyltransferase domain containing 1
increases expression
EXP
nefazodone results in increased expression of COMTD1 mRNA
CTD
PMID:24136188
NCBI chr15:2,509,121...2,512,232
Ensembl chr15:2,509,032...2,512,232
G
Cope
COPI coat complex subunit epsilon
increases expression
EXP
nefazodone results in increased expression of COPE mRNA
CTD
PMID:24136188
NCBI chr16:19,148,832...19,159,052
Ensembl chr16:19,148,832...19,159,212
G
Cops4
COP9 signalosome subunit 4
increases expression
EXP
nefazodone results in increased expression of COPS4 mRNA
CTD
PMID:24136188
NCBI chr14:9,078,579...9,108,788
Ensembl chr14:9,382,900...9,413,107
G
Cops5
COP9 signalosome subunit 5
increases expression
EXP
nefazodone results in increased expression of COPS5 mRNA
CTD
PMID:24136188
NCBI chr 5:13,975,198...13,993,391
Ensembl chr 5:13,975,052...13,993,387
G
Cops7a
COP9 signalosome subunit 7A
increases expression
EXP
nefazodone results in increased expression of COPS7A mRNA
CTD
PMID:24136188
NCBI chr 4:159,452,878...159,478,878
Ensembl chr 4:159,452,897...159,460,315
G
Coq10a
coenzyme Q10A
decreases expression
EXP
nefazodone results in decreased expression of COQ10A mRNA
CTD
PMID:24136188
NCBI chr 7:1,376,591...1,387,694
Ensembl chr 7:1,376,591...1,382,722
G
Coq6
coenzyme Q6 monooxygenase
increases expression
EXP
nefazodone results in increased expression of COQ6 mRNA
CTD
PMID:24136188
NCBI chr 6:109,738,934...109,750,315
Ensembl chr 6:109,738,951...109,750,310
G
Coq8a
coenzyme Q8A
decreases expression
EXP
nefazodone results in decreased expression of COQ8A mRNA
CTD
PMID:24136188
NCBI chr13:94,436,680...94,465,535
Ensembl chr13:94,436,546...94,463,378
G
Coro1c
coronin 1C
decreases expression
EXP
nefazodone results in decreased expression of CORO1C mRNA
CTD
PMID:24136188
NCBI chr12:48,373,573...48,445,718
Ensembl chr12:48,373,597...48,445,716
G
Cox14
cytochrome c oxidase assembly factor COX14
increases expression
EXP
nefazodone results in increased expression of COX14 mRNA
CTD
PMID:24136188
NCBI chr 7:132,731,069...132,733,159
Ensembl chr 7:132,731,069...132,733,159
G
Cox19
cytochrome c oxidase assembly factor COX19
increases expression
EXP
nefazodone results in increased expression of COX19 mRNA
CTD
PMID:24136188
NCBI chr12:20,417,389...20,426,868
Ensembl chr12:20,417,341...20,426,868
G
Cp
ceruloplasmin
decreases expression
EXP
nefazodone results in decreased expression of CP mRNA
CTD
PMID:24136188
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
G
Cpb2
carboxypeptidase B2
decreases expression
EXP
nefazodone results in decreased expression of CPB2 mRNA
CTD
PMID:24136188
NCBI chr15:56,967,128...57,015,964
Ensembl chr15:56,966,839...57,015,962
G
Cpox
coproporphyrinogen oxidase
increases expression
EXP
nefazodone results in increased expression of CPOX mRNA
CTD
PMID:24136188
NCBI chr11:55,405,778...55,415,761
Ensembl chr11:55,405,784...55,415,761
G
Cpq
carboxypeptidase Q
decreases expression
EXP
nefazodone results in decreased expression of PGCP mRNA
CTD
PMID:24136188
NCBI chr 7:66,148,973...66,719,189
Ensembl chr 7:66,149,377...66,716,137
G
Cps1
carbamoyl-phosphate synthase 1
decreases expression
EXP
nefazodone results in decreased expression of CPS1 mRNA
CTD
PMID:24136188
NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:76,000,754...76,186,734
G
Cpsf3
cleavage and polyadenylation specific factor 3
increases expression
EXP
nefazodone results in increased expression of CPSF3 mRNA
CTD
PMID:24136188
NCBI chr 6:46,564,855...46,592,776
Ensembl chr 6:46,564,735...46,594,136
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression
EXP
nefazodone results in increased expression of CPT1A mRNA
CTD
PMID:24136188
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
G
Cpt2
carnitine palmitoyltransferase 2
increases expression
EXP
nefazodone results in increased expression of CPT2 mRNA
CTD
PMID:24136188
NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818
G
Crat
carnitine O-acetyltransferase
increases expression
EXP
nefazodone results in increased expression of CRAT mRNA
CTD
PMID:24136188
NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:34,073,506...34,087,099
G
Creb3
cAMP responsive element binding protein 3
increases expression
EXP
nefazodone results in increased expression of CREB3 mRNA
CTD
PMID:24136188
NCBI chr 5:62,613,652...62,619,019
Ensembl chr 5:62,613,638...62,619,500
G
Creb3l3
cAMP responsive element binding protein 3-like 3
increases expression
EXP
nefazodone results in increased expression of CREB3L3 mRNA
CTD
PMID:24136188
NCBI chr 7:9,273,320...9,281,755
Ensembl chr 7:9,273,338...9,281,778
G
Creg1
cellular repressor of E1A-stimulated genes 1
increases expression
EXP
nefazodone results in increased expression of CREG1 mRNA
CTD
PMID:24136188
NCBI chr13:80,552,779...80,565,272
Ensembl chr13:80,549,933...80,565,272
G
Creld1
cysteine-rich with EGF-like domains 1
increases expression
EXP
nefazodone results in increased expression of CRELD1 mRNA
CTD
PMID:24136188
NCBI chr 4:148,187,510...148,197,120
Ensembl chr 4:148,187,265...148,197,116
G
Crem
cAMP responsive element modulator
decreases expression
EXP
nefazodone results in decreased expression of CREM mRNA
CTD
PMID:24136188
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160
G
Crip2
cysteine-rich protein 2
decreases expression
EXP
nefazodone results in decreased expression of CRIP2 mRNA
CTD
PMID:24136188
NCBI chr 6:138,042,175...138,047,121
Ensembl chr 6:138,041,906...138,047,120
G
Crot
carnitine O-octanoyltransferase
decreases expression
EXP
nefazodone results in decreased expression of CROT mRNA
CTD
PMID:24136188
NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:26,052,516...26,088,064
G
Cry1
cryptochrome circadian regulator 1
decreases expression
EXP
nefazodone results in decreased expression of CRY1 mRNA
CTD
PMID:24136188
NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822
G
Crybg2
crystallin beta-gamma domain containing 2
decreases expression
EXP
nefazodone results in decreased expression of CRYBG2 mRNA
CTD
PMID:24136188
NCBI chr 5:151,570,154...151,602,164
Ensembl chr 5:151,570,540...151,602,163
G
Cryl1
crystallin, lambda 1
increases expression
EXP
nefazodone results in increased expression of CRYL1 mRNA
CTD
PMID:24136188
NCBI chr15:35,542,628...35,661,563
Ensembl chr15:35,542,628...35,661,563
G
Cse1l
chromosome segregation 1 like
increases expression
EXP
nefazodone results in increased expression of CSE1L mRNA
CTD
PMID:24136188
NCBI chr 3:176,060,183...176,097,909
Ensembl chr 3:176,060,215...176,108,734
G
Csf1
colony stimulating factor 1
decreases expression increases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of CSF1 mRNA nefazodone results in increased expression of CSF1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of CSF1 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468
G
Csf1r
colony stimulating factor 1 receptor
decreases expression
EXP
nefazodone results in decreased expression of CSF1R mRNA
CTD
PMID:24136188
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806
G
Csrp1
cysteine and glycine-rich protein 1
decreases expression
EXP
nefazodone results in decreased expression of CSRP1 mRNA
CTD
PMID:24136188
NCBI chr13:49,709,928...49,731,141
Ensembl chr13:49,709,914...49,731,139
G
Cth
cystathionine gamma-lyase
decreases expression
EXP
nefazodone results in decreased expression of CTH mRNA
CTD
PMID:24136188
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066
G
Ctsc
cathepsin C
decreases expression
EXP
nefazodone results in decreased expression of CTSC mRNA
CTD
PMID:24136188
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082
G
Ctsd
cathepsin D
increases expression
EXP
nefazodone results in increased expression of CTSD mRNA
CTD
PMID:24136188
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821
G
Ctsh
cathepsin H
decreases expression
EXP
nefazodone results in decreased expression of CTSH mRNA
CTD
PMID:24136188
NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181
G
Ctsl
cathepsin L
increases expression
EXP
nefazodone results in increased expression of CTSL mRNA
CTD
PMID:24136188
NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113
G
Cttn
cortactin
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of CTTN mRNA
CTD
PMID:33819548
NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:209,029,048...209,058,211
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
EXP
nefazodone results in decreased expression of CXCL12 mRNA
CTD
PMID:24136188
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
G
Cxxc5
CXXC finger protein 5
decreases expression
EXP
nefazodone results in decreased expression of CXXC5 mRNA
CTD
PMID:24136188
NCBI chr18:27,701,650...27,732,633
Ensembl chr18:27,701,188...27,732,635
G
Cyb5a
cytochrome b5 type A
increases expression
EXP
nefazodone results in increased expression of CYB5A mRNA
CTD
PMID:24136188
NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094 Ensembl chr18:14,453,966...14,455,094
G
Cybb
cytochrome b-245 beta chain
decreases expression
EXP
nefazodone results in decreased expression of CYBB mRNA
CTD
PMID:24136188
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
G
Cyld
CYLD lysine 63 deubiquitinase
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of CYLD mRNA nefazodone results in increased expression of CYLD mRNA
CTD
PMID:32152650
NCBI chr19:34,487,491...34,547,311
Ensembl chr19:34,488,583...34,547,118
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression decreases activity
EXP ISO
nefazodone results in increased expression of CYP1A1 mRNA nefazodone results in decreased activity of CYP1A1 protein
CTD
PMID:24136188 PMID:33814510
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of CYP1A2 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CYP1A2 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
nefazodone results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
G
Cyp20a1
cytochrome P450, family 20, subfamily a, polypeptide 1
increases expression
EXP
nefazodone results in increased expression of CYP20A1 mRNA
CTD
PMID:24136188
NCBI chr 9:69,249,841...69,299,146
Ensembl chr 9:69,249,844...69,299,291
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CYP27A1 mRNA
CTD
PMID:33819548
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
G
Cyp2b12
cytochrome P450, family 2, subfamily b, polypeptide 12
increases expression
EXP
nefazodone results in increased expression of CYP2B12 mRNA
CTD
PMID:24136188
NCBI chr 1:91,135,294...91,147,094
Ensembl chr 1:91,135,294...91,208,159
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
decreases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of CYP2B3 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA nefazodone results in decreased expression of CYP2B6 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr 1:90,780,468...90,859,852
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CYP2C18 mRNA
CTD
PMID:33819548
NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853
G
Cyp2c13
cytochrome P450, family 2, subfamily c, polypeptide 13
decreases expression
EXP
nefazodone results in decreased expression of CYP2C13 mRNA
CTD
PMID:24136188
NCBI chr 1:248,706,787...248,787,239
Ensembl chr 1:248,706,788...248,787,210
G
Cyp2c22
cytochrome P450, family 2, subfamily c, polypeptide 22
decreases expression
EXP
nefazodone results in decreased expression of CYP2C22 mRNA
CTD
PMID:24136188
NCBI chr 1:248,941,143...248,980,767
Ensembl chr 1:248,904,062...248,971,182
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CYP2C19 mRNA
CTD
PMID:33819548
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases expression
EXP
nefazodone results in increased expression of CYP2E1 mRNA
CTD
PMID:24136188
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
G
Cyp2j3
cytochrome P450, family 2, subfamily j, polypeptide 3
decreases expression
EXP
nefazodone results in decreased expression of CYP2J3 mRNA
CTD
PMID:24136188
NCBI chr 5:116,335,755...116,360,677
Ensembl chr 5:116,335,755...116,360,499
G
Cyp2t1
cytochrome P450, family 2, subfamily t, polypeptide 1
decreases expression
EXP
nefazodone results in decreased expression of CYP2T1 mRNA
CTD
PMID:24136188
NCBI chr 1:91,573,923...91,579,215
Ensembl chr 1:91,574,572...91,579,215
G
Cyp3a18
cytochrome P450, family 3, subfamily a, polypeptide 18
increases expression
EXP
nefazodone results in increased expression of CYP3A18 mRNA
CTD
PMID:24136188
NCBI chr12:13,994,312...14,044,185
Ensembl chr12:13,994,311...14,045,788
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases expression increases response to substance multiple interactions increases hydroxylation
ISO
nefazodone results in decreased expression of CYP3A4 mRNA CYP3A4 protein results in increased susceptibility to nefazodone [CYP3A4 protein results in increased hydroxylation of nefazodone] which results in increased abundance of hydroxynefazodone; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP3A4 mRNA; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased hydroxylation of nefazodone]; nefazodone inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased activity of Haloperidol]
CTD
PMID:12584149 PMID:21540358 PMID:27485346 PMID:32152650
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions increases expression
ISO EXP
nefazodone inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] nefazodone results in increased expression of CYP3A9 mRNA
CTD
PMID:12584149 PMID:24136188
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
increases expression
EXP
nefazodone results in increased expression of CYP4A1 mRNA
CTD
PMID:24136188
NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
increases expression
EXP
nefazodone results in increased expression of CYP4A3 mRNA
CTD
PMID:24136188
NCBI chr 5:134,334,396...134,352,268
Ensembl chr 5:134,334,701...134,352,236
G
Cyp4f1
cytochrome P450, family 4, subfamily f, polypeptide 1
decreases expression
EXP
nefazodone results in decreased expression of CYP4F1 mRNA
CTD
PMID:24136188
NCBI chr 7:12,661,357...12,672,952
Ensembl chr 7:12,661,359...12,672,612
G
Cyp4f6
cytochrome P450, family 4, subfamily f, polypeptide 6
decreases expression
EXP
nefazodone results in decreased expression of CYP4F6 mRNA
CTD
PMID:24136188
NCBI chr 7:12,680,799...12,708,378
Ensembl chr 7:12,680,806...12,708,402
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions decreases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA nefazodone results in decreased expression of CYP7A1 mRNA
CTD
PMID:32152650
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CYP7B1 mRNA
CTD
PMID:33819548
NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of CYP8B1 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CYP8B1 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
G
Daam1
dishevelled associated activator of morphogenesis 1
decreases expression
EXP
nefazodone results in decreased expression of DAAM1 mRNA
CTD
PMID:24136188
NCBI chr 6:96,125,521...96,286,049
Ensembl chr 6:96,125,621...96,286,049
G
Dag1
dystroglycan 1
decreases expression
EXP
nefazodone results in decreased expression of DAG1 mRNA
CTD
PMID:24136188
NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:117,769,517...117,782,199
G
Dao
D-amino-acid oxidase
increases expression
EXP
nefazodone results in increased expression of DAO mRNA
CTD
PMID:24136188
NCBI chr12:48,252,900...48,275,964
Ensembl chr12:48,252,902...48,273,300
G
Dars1
aspartyl-tRNA synthetase 1
increases expression
EXP
nefazodone results in increased expression of DARS1 mRNA
CTD
PMID:24136188
NCBI chr13:42,410,351...42,465,467
Ensembl chr13:42,379,162...42,465,467
G
Dcaf11
DDB1 and CUL4 associated factor 11
increases expression
EXP
nefazodone results in increased expression of DCAF11 mRNA
CTD
PMID:24136188
NCBI chr15:33,015,370...33,027,407
Ensembl chr15:33,016,762...33,027,672
G
Dcaf13
DDB1 and CUL4 associated factor 13
increases expression
EXP
nefazodone results in increased expression of DCAF13 mRNA
CTD
PMID:24136188
NCBI chr 7:72,045,828...72,081,039
Ensembl chr 7:72,045,872...72,083,629
G
Ddc
dopa decarboxylase
decreases expression
EXP
nefazodone results in decreased expression of DDC mRNA
CTD
PMID:24136188
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
G
Ddhd1
DDHD domain containing 1
decreases expression
EXP
nefazodone results in decreased expression of DDHD1 mRNA
CTD
PMID:24136188
NCBI chr15:21,304,053...21,370,608
Ensembl chr15:21,303,826...21,370,608
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
ISO
nefazodone results in increased expression of DDIT3 mRNA; nefazodone results in increased expression of DDIT3 protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [nefazodone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [nefazodone results in increased expression of DDIT3 protein]; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DDIT3 mRNA
CTD
PMID:24136188 PMID:27613715 PMID:32152650
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
G
Ddx17
DEAD-box helicase 17
decreases expression
EXP
nefazodone results in decreased expression of DDX17 mRNA
CTD
PMID:24136188
NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:112,971,523...112,989,747
G
Ddx21
DExD-box helicase 21
increases expression
EXP
nefazodone results in increased expression of DDX21 mRNA
CTD
PMID:24136188
NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238
G
Ddx39a
DExD-box helicase 39A
increases expression
EXP
nefazodone results in increased expression of DDX39A mRNA
CTD
PMID:24136188
NCBI chr19:41,323,465...41,331,413
Ensembl chr19:41,322,836...41,332,306
G
Ddx56
DEAD-box helicase 56
increases expression
EXP
nefazodone results in increased expression of DDX56 mRNA
CTD
PMID:24136188
NCBI chr14:85,325,942...85,336,262
Ensembl chr14:85,325,942...85,336,262
G
Decr1
2,4-dienoyl-CoA reductase 1
increases expression
EXP
nefazodone results in increased expression of DECR1 mRNA
CTD
PMID:24136188
NCBI chr 5:34,208,195...34,236,074
Ensembl chr 5:34,208,195...34,236,033
G
Decr2
2,4-dienoyl-CoA reductase 2
increases expression
EXP
nefazodone results in increased expression of DECR2 mRNA
CTD
PMID:24136188
NCBI chr10:15,609,389...15,617,779
Ensembl chr10:15,611,092...15,617,397
G
Degs1
delta(4)-desaturase, sphingolipid 1
increases expression
EXP
nefazodone results in increased expression of DEGS1 mRNA
CTD
PMID:24136188
NCBI chr13:96,478,645...96,485,302
Ensembl chr13:96,478,646...96,485,302
G
Dennd4c
DENN domain containing 4C
increases expression
EXP
nefazodone results in increased expression of DENND4C mRNA
CTD
PMID:24136188
NCBI chr 5:101,272,298...101,369,529
Ensembl chr 5:106,318,281...106,415,489
G
Desi1
desumoylating isopeptidase 1
increases expression
EXP
nefazodone results in increased expression of DESI1 mRNA
CTD
PMID:24136188
NCBI chr 7:115,401,613...115,422,974
Ensembl chr 7:115,401,624...115,423,172
G
Desi2
desumoylating isopeptidase 2
increases expression
EXP
nefazodone results in increased expression of DESI2 mRNA
CTD
PMID:24136188
NCBI chr13:92,493,765...92,543,307
Ensembl chr13:92,493,989...92,564,981
G
Dexi
Dexi homolog
decreases expression
EXP
nefazodone results in decreased expression of DEXI mRNA
CTD
PMID:24136188
NCBI chr10:5,126,021...5,138,746
Ensembl chr10:5,632,961...5,645,648
G
Dgat1
diacylglycerol O-acyltransferase 1
increases expression
EXP
nefazodone results in increased expression of DGAT1 mRNA
CTD
PMID:24136188
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016
G
Dgka
diacylglycerol kinase, alpha
decreases expression
EXP
nefazodone results in decreased expression of DGKA mRNA
CTD
PMID:24136188
NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,733,248...1,759,569
G
Dgkz
diacylglycerol kinase zeta
decreases expression
EXP
nefazodone results in decreased expression of DGKZ mRNA
CTD
PMID:24136188
NCBI chr 3:98,359,804...98,401,847
Ensembl chr 3:98,359,804...98,401,951
G
Dhdds
dehydrodolichyl diphosphate synthase subunit
increases expression
EXP
nefazodone results in increased expression of DHDDS mRNA
CTD
PMID:24136188
NCBI chr 5:151,482,139...151,508,248
Ensembl chr 5:151,481,429...151,508,129
G
Dhrs4
dehydrogenase/reductase 4
increases expression
EXP
nefazodone results in increased expression of DHRS4 mRNA
CTD
PMID:24136188
NCBI chr15:32,924,482...32,948,103
Ensembl chr15:32,936,522...32,948,101
G
Dhtkd1
dehydrogenase E1 and transketolase domain containing 1
decreases expression
EXP
nefazodone results in decreased expression of DHTKD1 mRNA
CTD
PMID:24136188
NCBI chr17:77,242,512...77,316,074
Ensembl chr17:77,264,514...77,316,071
G
Dhx15
DEAH-box helicase 15
increases expression
EXP
nefazodone results in increased expression of DHX15 mRNA
CTD
PMID:24136188
NCBI chr14:62,999,886...63,037,829
Ensembl chr14:62,999,877...63,037,828
G
Diablo
diablo, IAP-binding mitochondrial protein
increases expression
EXP
nefazodone results in increased expression of DIABLO mRNA
CTD
PMID:24136188
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265
G
Dlc1
DLC1 Rho GTPase activating protein
decreases expression
EXP
nefazodone results in decreased expression of DLC1 mRNA
CTD
PMID:24136188
NCBI chr16:61,954,177...62,374,819
Ensembl chr16:61,995,001...62,374,819
G
Dmgdh
dimethylglycine dehydrogenase
decreases expression
EXP
nefazodone results in decreased expression of DMGDH mRNA
CTD
PMID:24136188
NCBI chr 2:26,647,540...26,722,496
Ensembl chr 2:26,647,565...26,723,071
G
Dnaaf9
dynein axonemal assembly factor 9
decreases expression
EXP
nefazodone results in decreased expression of DNAAF9 mRNA
CTD
PMID:24136188
NCBI chr 3:117,918,047...118,052,641
Ensembl chr 3:138,372,531...138,505,695
G
Dnaja1
DnaJ heat shock protein family (Hsp40) member A1
increases expression
EXP
nefazodone results in increased expression of DNAJA1 mRNA
CTD
PMID:24136188
NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160
G
Dnaja2
DnaJ heat shock protein family (Hsp40) member A2
increases expression
EXP
nefazodone results in increased expression of DNAJA2 mRNA
CTD
PMID:24136188
NCBI chr19:37,671,019...37,689,163
Ensembl chr19:37,670,945...37,690,120
G
Dnaja3
DnaJ heat shock protein family (Hsp40) member A3
increases expression
EXP
nefazodone results in increased expression of DNAJA3 mRNA
CTD
PMID:24136188
NCBI chr10:11,361,168...11,386,599
Ensembl chr10:11,361,168...11,386,599
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of DNAJB1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416
G
Dnajb11
DnaJ heat shock protein family (Hsp40) member B11
multiple interactions
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB11 mRNA
CTD
PMID:32152650
NCBI chr11:91,656,334...91,672,800
Ensembl chr11:91,656,335...91,672,800
G
Dnajb12
DnaJ heat shock protein family (Hsp40) member B12
increases expression
EXP
nefazodone results in increased expression of DNAJB12 mRNA
CTD
PMID:24136188
NCBI chr20:28,371,180...28,389,390
Ensembl chr20:28,371,199...28,389,389
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of DNAJB9 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of DNAJB9 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB9 mRNA
CTD
PMID:24136188 PMID:32152650 PMID:33819548
NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344
G
Dnajc1
DnaJ heat shock protein family (Hsp40) member C1
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC1 mRNA nefazodone results in increased expression of DNAJC1 mRNA
CTD
PMID:32152650
NCBI chr17:80,955,209...81,112,025
Ensembl chr17:85,863,651...86,020,432
G
Dnajc10
DnaJ heat shock protein family (Hsp40) member C10
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC10 mRNA nefazodone results in increased expression of DNAJC10 mRNA
CTD
PMID:32152650
NCBI chr 3:85,636,890...85,679,620
Ensembl chr 3:85,639,589...85,689,368
G
Dnajc12
DnaJ heat shock protein family (Hsp40) member C12
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of DNAJC12 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of DNAJC12 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr20:25,245,475...25,266,238
Ensembl chr20:25,222,298...25,266,251
G
Dnajc15
DnaJ heat shock protein family (Hsp40) member C15
increases expression
EXP
nefazodone results in increased expression of DNAJC15 mRNA
CTD
PMID:24136188
NCBI chr15:59,594,314...59,658,862
Ensembl chr15:59,594,314...59,658,987
G
Dnajc18
DnaJ heat shock protein family (Hsp40) member C18
multiple interactions
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC18 mRNA
CTD
PMID:32152650
NCBI chr18:27,543,438...27,577,535
Ensembl chr18:27,543,438...27,577,535
G
Dnajc19
DnaJ heat shock protein family (Hsp40) member C19
decreases expression multiple interactions
ISO
nefazodone results in decreased expression of DNAJC19 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC19 mRNA
CTD
PMID:32152650
NCBI chr 2:118,851,497...118,875,813
Ensembl chr 2:118,869,413...118,873,781
G
Dnajc21
DnaJ heat shock protein family (Hsp40) member C21
multiple interactions decreases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC21 mRNA nefazodone results in decreased expression of DNAJC21 mRNA
CTD
PMID:32152650
NCBI chr 2:61,146,669...61,173,908
Ensembl chr 2:61,145,142...61,174,126
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
multiple interactions
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC3 mRNA
CTD
PMID:32152650
NCBI chr15:102,432,667...102,475,643
Ensembl chr15:102,432,663...102,475,643
G
Dnajc6
DnaJ heat shock protein family (Hsp40) member C6
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC6 mRNA nefazodone results in increased expression of DNAJC6 mRNA
CTD
PMID:32152650
NCBI chr 5:121,232,532...121,398,775
Ensembl chr 5:121,235,425...121,398,775
G
Dnlz
DNL-type zinc finger
increases expression
EXP
nefazodone results in increased expression of DNLZ mRNA
CTD
PMID:24136188
NCBI chr 3:29,568,041...29,569,937
Ensembl chr 3:29,568,041...29,569,996
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
increases expression
EXP
nefazodone results in increased expression of DNPH1 mRNA
CTD
PMID:24136188
NCBI chr 9:21,978,894...21,981,631
Ensembl chr 9:21,978,894...21,981,631
G
Dnttip1
deoxynucleotidyltransferase, terminal, interacting protein 1
increases expression
EXP
nefazodone results in increased expression of DNTTIP1 mRNA
CTD
PMID:24136188
NCBI chr 3:173,901,070...173,924,742
Ensembl chr 3:173,900,945...173,925,098
G
Dock9
dedicator of cytokinesis 9
increases expression
EXP
nefazodone results in increased expression of DOCK9 mRNA
CTD
PMID:24136188
NCBI chr15:105,018,341...105,289,799
Ensembl chr15:105,024,912...105,289,799
G
Dohh
deoxyhypusine hydroxylase
increases expression
EXP
nefazodone results in increased expression of DOHH mRNA
CTD
PMID:24136188
NCBI chr 7:8,972,202...8,977,025
Ensembl chr 7:8,972,202...8,977,025
G
Dph3
diphthamide biosynthesis 3
increases expression
EXP
nefazodone results in increased expression of DPH3 mRNA
CTD
PMID:24136188
NCBI chr16:7,294,580...7,299,996
Ensembl chr16:7,294,580...7,299,996
G
Dpm1
dolichyl-phosphate mannosyltransferase subunit 1, catalytic
increases expression
EXP
nefazodone results in increased expression of DPM1 mRNA
CTD
PMID:24136188
NCBI chr 3:177,338,855...177,358,398
Ensembl chr 3:177,338,855...177,358,412
G
Dpy19l1
dpy-19 like C-mannosyltransferase 1
decreases expression
EXP
nefazodone results in decreased expression of DPY19L1 mRNA
CTD
PMID:24136188
NCBI chr 8:31,209,025...31,297,485
Ensembl chr 8:31,209,025...31,297,518
G
Dpy30
dpy-30 histone methyltransferase complex regulatory subunit
increases expression
EXP
nefazodone results in increased expression of DPY30 mRNA
CTD
PMID:24136188
NCBI chr 6:26,872,812...26,893,580
Ensembl chr 6:26,872,732...26,894,930
G
Dpys
dihydropyrimidinase
decreases expression
EXP
nefazodone results in decreased expression of DPYS mRNA
CTD
PMID:24136188
NCBI chr 7:72,707,566...72,814,183
Ensembl chr 7:72,721,048...72,814,142
G
Dr1
down-regulator of transcription 1
increases expression
EXP
nefazodone results in increased expression of DR1 mRNA
CTD
PMID:24136188
NCBI chr14:1,603,203...1,614,556
Ensembl chr14:1,603,204...1,614,556
G
Dsc2
desmocollin 2
increases expression
EXP
nefazodone results in increased expression of DSC2 mRNA
CTD
PMID:24136188
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466
G
Dstn
destrin, actin depolymerizing factor
increases expression
EXP
nefazodone results in increased expression of DSTN mRNA
CTD
PMID:24136188
NCBI chr 3:151,737,711...151,764,752
Ensembl chr 3:151,737,849...151,764,769
G
Dtd1
D-aminoacyl-tRNA deacylase 1
increases expression
EXP
nefazodone results in increased expression of DTD1 mRNA
CTD
PMID:24136188
NCBI chr 3:131,995,870...132,158,646
Ensembl chr 3:152,452,620...152,486,304
G
Dut
deoxyuridine triphosphatase
increases expression
EXP
nefazodone results in increased expression of DUT mRNA
CTD
PMID:24136188
NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956
G
Dync1h1
dynein cytoplasmic 1 heavy chain 1
increases expression
EXP
nefazodone results in increased expression of DYNC1H1 mRNA
CTD
PMID:24136188
NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116
G
Dynll2
dynein light chain LC8-type 2
increases expression
EXP
nefazodone results in increased expression of DYNLL2 mRNA
CTD
PMID:24136188
NCBI chr10:73,264,260...73,283,042
Ensembl chr10:73,264,261...73,272,285
G
Dynlt3
dynein light chain Tctex-type 3
decreases expression
EXP
nefazodone results in decreased expression of DYNLT3 mRNA
CTD
PMID:24136188
NCBI chr X:16,000,425...16,009,632
Ensembl chr X:16,000,395...16,009,627
G
Ebna1bp2
EBNA1 binding protein 2
increases expression
EXP
nefazodone results in increased expression of EBNA1BP2 mRNA
CTD
PMID:24136188
NCBI chr 5:137,433,534...137,438,100
Ensembl chr 5:137,433,226...137,438,637
G
Ebp
EBP, cholestenol delta-isomerase
decreases expression
EXP
nefazodone results in decreased expression of EBP mRNA
CTD
PMID:24136188
NCBI chr X:16,971,372...16,977,782
Ensembl chr X:16,971,405...16,977,781
G
Ebpl
EBP like
increases expression
EXP
nefazodone results in increased expression of EBPL mRNA
CTD
PMID:24136188
NCBI chr15:39,684,140...39,707,537
Ensembl chr15:39,684,140...39,707,537
G
Ech1
enoyl-CoA hydratase 1
increases expression
EXP
nefazodone results in increased expression of ECH1 mRNA
CTD
PMID:24136188
NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440
G
Echdc1
ethylmalonyl-CoA decarboxylase 1
decreases expression
EXP
nefazodone results in decreased expression of ECHDC1 mRNA
CTD
PMID:24136188
NCBI chr 1:30,304,968...30,355,957
Ensembl chr 1:30,304,971...30,337,208
G
Eci1
enoyl-CoA delta isomerase 1
increases expression
EXP
nefazodone results in increased expression of ECI1 mRNA
CTD
PMID:24136188
NCBI chr10:13,961,250...13,974,595
Ensembl chr10:13,961,218...13,974,773
G
Ecm1
extracellular matrix protein 1
decreases expression
EXP
nefazodone results in decreased expression of ECM1 mRNA
CTD
PMID:24136188
NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:185,976,440...185,981,606
G
Ecpas
Ecm29 proteasome adaptor and scaffold
increases expression
EXP
nefazodone results in increased expression of ECPAS mRNA
CTD
PMID:24136188
NCBI chr 5:78,398,449...78,509,077
Ensembl chr 5:78,398,718...78,512,908
G
Ecsit
ECSIT signaling integrator
increases expression
EXP
nefazodone results in increased expression of ECSIT mRNA
CTD
PMID:24136188
NCBI chr 8:28,881,594...28,894,443
Ensembl chr 8:28,881,594...28,894,397
G
Eef1b2
eukaryotic translation elongation factor 1 beta 2
increases expression
EXP
nefazodone results in increased expression of EEF1B2 mRNA
CTD
PMID:24136188
NCBI chr 9:72,074,091...72,076,591
Ensembl chr 9:72,073,802...72,076,589
G
Eef1d
eukaryotic translation elongation factor 1 delta
increases expression
EXP
nefazodone results in increased expression of EEF1D mRNA
CTD
PMID:24136188
NCBI chr 7:109,462,645...109,478,021
Ensembl chr 7:109,462,646...109,489,531
G
Eef1e1
eukaryotic translation elongation factor 1 epsilon 1
increases expression
EXP
nefazodone results in increased expression of EEF1E1 mRNA
CTD
PMID:24136188
NCBI chr17:26,354,247...26,364,953
Ensembl chr17:26,354,228...26,370,687
G
Efna1
ephrin A1
decreases expression
EXP
nefazodone results in decreased expression of EFNA1 mRNA
CTD
PMID:24136188
NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726
G
Egf
epidermal growth factor
decreases expression
EXP
nefazodone results in decreased expression of EGF mRNA
CTD
PMID:24136188
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
G
Egfr
epidermal growth factor receptor
decreases expression
EXP
nefazodone results in decreased expression of EGFR mRNA
CTD
PMID:24136188
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
G
Ehbp1
EH domain binding protein 1
decreases expression
EXP
nefazodone results in decreased expression of EHBP1 mRNA
CTD
PMID:24136188
NCBI chr14:100,294,585...100,581,764
Ensembl chr14:100,294,585...100,546,579
G
Eif1a
eukaryotic translation initiation factor 1A
increases expression
EXP
nefazodone results in increased expression of EIF1A mRNA
CTD
PMID:24136188
NCBI chr18:39,325,695...39,338,043
Ensembl chr18:41,503,180...41,549,696
G
Eif1ad
eukaryotic translation initiation factor 1A domain containing
increases expression
EXP
nefazodone results in increased expression of EIF1AD mRNA
CTD
PMID:24136188
NCBI chr 1:212,103,715...212,109,015
Ensembl chr 1:212,103,892...212,109,017
G
Eif2a
eukaryotic translation initiation factor 2A
multiple interactions increases expression
ISO
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [nefazodone results in increased expression of EIF2A protein modified form]
CTD
PMID:27613715
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201
G
Eif2ak1
eukaryotic translation initiation factor 2 alpha kinase 1
decreases expression
EXP
nefazodone results in decreased expression of EIF2AK1 mRNA
CTD
PMID:24136188
NCBI chr12:15,824,431...15,858,266
Ensembl chr12:15,825,124...15,858,281
G
Eif2b5
eukaryotic translation initiation factor 2B subunit epsilon
increases expression
EXP
nefazodone results in increased expression of EIF2B5 mRNA
CTD
PMID:24136188
NCBI chr11:93,898,814...93,909,431
Ensembl chr11:93,898,814...93,908,800
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases expression
EXP
nefazodone results in increased expression of EIF2S1 mRNA
CTD
PMID:24136188
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
G
Eif2s2
eukaryotic translation initiation factor 2 subunit beta
increases expression
EXP
nefazodone results in increased expression of EIF2S2 mRNA
CTD
PMID:24136188
NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570
G
Eif2s3
eukaryotic translation initiation factor 2 subunit gamma
increases expression
EXP
nefazodone results in increased expression of EIF2S3X mRNA
CTD
PMID:24136188
NCBI chr X:62,910,292...62,933,936
Ensembl chr X:62,910,293...62,934,489
G
Eif3b
eukaryotic translation initiation factor 3, subunit B
increases expression
EXP
nefazodone results in increased expression of EIF3B mRNA
CTD
PMID:24136188
NCBI chr12:19,310,308...19,334,768
Ensembl chr12:19,310,311...19,334,939
G
Eif3c
eukaryotic translation initiation factor 3, subunit C
increases expression
EXP
nefazodone results in increased expression of EIF3C mRNA
CTD
PMID:24136188
NCBI chr 1:190,565,183...190,583,067
Ensembl chr 1:190,565,184...190,583,067
G
Eif3e
eukaryotic translation initiation factor 3 subunit E
increases expression
EXP
nefazodone results in increased expression of EIF3E mRNA
CTD
PMID:24136188
NCBI chr 7:76,224,567...76,257,346
Ensembl chr 7:76,224,568...76,257,785
G
Eif3g
eukaryotic translation initiation factor 3, subunit G
increases expression
EXP
nefazodone results in increased expression of EIF3G mRNA
CTD
PMID:24136188
NCBI chr 8:27,705,914...27,709,946
Ensembl chr 8:27,705,915...27,709,987
G
Eif3i
eukaryotic translation initiation factor 3, subunit I
increases expression
EXP
nefazodone results in increased expression of EIF3I mRNA
CTD
PMID:24136188
NCBI chr 5:147,219,457...147,226,910
Ensembl chr 5:147,219,366...147,241,232
G
Eif3l
eukaryotic translation initiation factor 3, subunit L
increases expression
EXP
nefazodone results in increased expression of EIF3L mRNA
CTD
PMID:24136188
NCBI chr 7:112,522,222...112,544,063
Ensembl chr 7:112,507,831...112,544,062
G
Eif3m
eukaryotic translation initiation factor 3, subunit M
increases expression
EXP
nefazodone results in increased expression of EIF3M mRNA
CTD
PMID:24136188
NCBI chr 3:111,879,589...111,897,193
Ensembl chr 3:111,870,925...111,897,193
G
Eif4a1
eukaryotic translation initiation factor 4A1
increases expression
EXP
nefazodone results in increased expression of EIF4A1 mRNA
CTD
PMID:24136188
NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602
G
Eif4e
eukaryotic translation initiation factor 4E
increases expression
EXP
nefazodone results in increased expression of EIF4E mRNA
CTD
PMID:24136188
NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
increases expression
EXP
nefazodone results in increased expression of EIF4EBP1 mRNA
CTD
PMID:24136188
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
G
Eif4ebp2
eukaryotic translation initiation factor 4E binding protein 2
increases expression
EXP
nefazodone results in increased expression of EIF4EBP2 mRNA
CTD
PMID:24136188
NCBI chr20:29,922,260...29,942,922
Ensembl chr20:29,922,260...29,942,922
G
Eif4g1
eukaryotic translation initiation factor 4 gamma 1
increases expression
EXP
nefazodone results in increased expression of EIF4G1 mRNA
CTD
PMID:24136188
NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367
G
Eif5
eukaryotic translation initiation factor 5
increases expression
EXP
nefazodone results in increased expression of EIF5 mRNA
CTD
PMID:24136188
NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:136,407,440...136,418,821
G
Eif5a
eukaryotic translation initiation factor 5A
increases expression
EXP
nefazodone results in increased expression of EIF5A mRNA
CTD
PMID:24136188
NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330
G
Eif6
eukaryotic translation initiation factor 6
increases expression
EXP
nefazodone results in increased expression of EIF6 mRNA
CTD
PMID:24136188
NCBI chr 3:164,785,162...164,791,410
Ensembl chr 3:164,785,163...164,791,525
G
Elac2
elaC ribonuclease Z 2
increases expression
EXP
nefazodone results in increased expression of ELAC2 mRNA
CTD
PMID:24136188
NCBI chr10:50,131,449...50,154,755
Ensembl chr10:50,131,521...50,155,069
G
Elavl1
ELAV like RNA binding protein 1
increases expression
EXP
nefazodone results in increased expression of ELAVL1 mRNA
CTD
PMID:24136188
NCBI chr12:7,441,699...7,482,625
Ensembl chr12:7,441,699...7,482,631
G
Eloc
elongin C
increases expression
EXP
nefazodone results in increased expression of ELOC mRNA
CTD
PMID:24136188
NCBI chr 5:7,444,769...7,461,187
Ensembl chr 5:7,445,018...7,464,128 Ensembl chr20:7,445,018...7,464,128
G
Elovl2
ELOVL fatty acid elongase 2
increases expression
EXP
nefazodone results in increased expression of ELOVL2 mRNA
CTD
PMID:24136188
NCBI chr17:23,750,350...23,790,601
Ensembl chr17:23,750,350...23,790,601
G
Elovl5
ELOVL fatty acid elongase 5
decreases expression
EXP
nefazodone results in decreased expression of ELOVL5 mRNA
CTD
PMID:24136188
NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616
G
Elp2
elongator acetyltransferase complex subunit 2
increases expression
EXP
nefazodone results in increased expression of ELP2 mRNA
CTD
PMID:24136188
NCBI chr18:15,885,940...15,921,564
Ensembl chr18:16,160,671...16,196,414
G
Emc1
ER membrane protein complex subunit 1
increases expression
EXP
nefazodone results in increased expression of EMC1 mRNA
CTD
PMID:24136188
NCBI chr 5:156,891,773...156,917,092
Ensembl chr 5:156,891,773...156,917,092
G
Emc10
ER membrane protein complex subunit 10
increases expression
EXP
nefazodone results in increased expression of EMC10 mRNA
CTD
PMID:24136188
NCBI chr 1:104,119,040...104,125,409
Ensembl chr 1:104,119,040...104,125,368
G
Emc6
ER membrane protein complex subunit 6
increases expression
EXP
nefazodone results in increased expression of EMC6 mRNA
CTD
PMID:24136188
NCBI chr10:57,794,072...57,795,671
Ensembl chr10:58,292,470...58,298,885
G
Emc7
ER membrane protein complex subunit 7
increases expression
EXP
nefazodone results in increased expression of EMC7 mRNA
CTD
PMID:24136188
NCBI chr 3:119,714,617...119,728,748
Ensembl chr 3:119,718,357...119,730,486
G
Emc8
ER membrane protein complex subunit 8
increases expression
EXP
nefazodone results in increased expression of EMC8 mRNA
CTD
PMID:24136188
NCBI chr19:65,620,365...65,630,328
Ensembl chr19:65,620,375...65,630,235
G
Emilin1
elastin microfibril interfacer 1
decreases expression
EXP
nefazodone results in decreased expression of EMILIN1 mRNA
CTD
PMID:24136188
NCBI chr 6:31,175,919...31,183,657
Ensembl chr 6:31,175,919...31,183,657
G
Eml4
EMAP like 4
decreases expression
EXP
nefazodone results in decreased expression of EML4 mRNA
CTD
PMID:24136188
NCBI chr 6:16,972,054...17,087,365
Ensembl chr 6:16,972,075...17,087,439
G
Enc1
ectodermal-neural cortex 1
multiple interactions decreases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA nefazodone results in decreased expression of ENC1 mRNA
CTD
PMID:32152650
NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
decreases expression
EXP
nefazodone results in decreased expression of ENPP1 mRNA
CTD
PMID:24136188
NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044
G
Entpd4
ectonucleoside triphosphate diphosphohydrolase 4
increases expression
EXP
nefazodone results in increased expression of ENTPD4 mRNA
CTD
PMID:24136188
NCBI chr15:51,040,665...51,068,450
Ensembl chr15:51,040,673...51,068,441
G
Entpd5
ectonucleoside triphosphate diphosphohydrolase 5
increases expression
EXP
nefazodone results in increased expression of ENTPD5 mRNA
CTD
PMID:24136188
NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:109,753,204...109,786,495
G
Entr1
endosome associated trafficking regulator 1
increases expression
EXP
nefazodone results in increased expression of ENTR1 mRNA
CTD
PMID:24136188
NCBI chr 3:29,599,059...29,605,780
Ensembl chr 3:29,599,059...29,605,898
G
Epb41
erythrocyte membrane protein band 4.1
increases expression
EXP
nefazodone results in increased expression of EPB41 mRNA
CTD
PMID:24136188
NCBI chr 5:149,394,080...149,548,178
Ensembl chr 5:149,394,096...149,543,540
G
Epb41l4b
erythrocyte membrane protein band 4.1 like 4B
decreases expression
EXP
nefazodone results in decreased expression of EPB41L4B mRNA
CTD
PMID:24136188
NCBI chr 5:76,486,886...76,647,752
Ensembl chr 5:76,486,902...76,647,752
G
Ephx1
epoxide hydrolase 1
increases expression multiple interactions decreases expression
EXP ISO
nefazodone results in increased expression of EPHX1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of EPHX1 mRNA nefazodone results in decreased expression of EPHX1 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
increases expression
EXP
nefazodone results in increased expression of EPRS1 mRNA
CTD
PMID:24136188
NCBI chr13:99,431,955...99,503,510
Ensembl chr13:99,433,130...99,503,509
G
Ereg
epiregulin
increases expression
ISO
nefazodone results in increased expression of EREG mRNA
CTD
PMID:32816093
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260
G
Eri3
ERI1 exoribonuclease family member 3
increases expression
EXP
nefazodone results in increased expression of ERI3 mRNA
CTD
PMID:24136188
NCBI chr 5:131,016,146...131,143,347
Ensembl chr 5:136,252,683...136,379,815
G
Erlin1
ER lipid raft associated 1
increases expression
EXP
nefazodone results in increased expression of ERLIN1 mRNA
CTD
PMID:24136188
NCBI chr 1:252,870,356...252,905,681
Ensembl chr 1:252,870,356...252,905,947
G
Ermp1
endoplasmic reticulum metallopeptidase 1
increases expression
EXP
nefazodone results in increased expression of ERMP1 mRNA
CTD
PMID:24136188
NCBI chr 1:236,801,459...236,835,656
Ensembl chr 1:236,801,466...236,839,197
G
Errfi1
ERBB receptor feedback inhibitor 1
decreases expression
EXP
nefazodone results in decreased expression of ERRFI1 mRNA
CTD
PMID:24136188
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432
G
Esd
esterase D
increases expression
EXP
nefazodone results in increased expression of ESD mRNA
CTD
PMID:24136188
NCBI chr15:56,453,082...56,472,582
Ensembl chr15:56,453,044...56,473,508
G
Etf1
eukaryotic translation termination factor 1
increases expression
EXP
nefazodone results in increased expression of ETF1 mRNA
CTD
PMID:24136188
NCBI chr18:26,776,518...26,804,857
Ensembl chr18:26,777,858...26,804,613
G
Ethe1
ETHE1, persulfide dioxygenase
decreases expression
EXP
nefazodone results in decreased expression of ETHE1 mRNA
CTD
PMID:24136188
NCBI chr 1:89,311,948...89,327,000
Ensembl chr 1:89,311,934...89,326,998
G
Etnk1
ethanolamine kinase 1
increases expression
EXP
nefazodone results in increased expression of ETNK1 mRNA
CTD
PMID:24136188
NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:177,856,960...177,924,721
G
Exosc4
exosome component 4
increases expression
EXP
nefazodone results in increased expression of EXOSC4 mRNA
CTD
PMID:24136188
NCBI chr 7:109,928,491...109,931,233
Ensembl chr 7:109,928,498...109,931,820
G
Exosc5
exosome component 5
increases expression
EXP
nefazodone results in increased expression of EXOSC5 mRNA
CTD
PMID:24136188
NCBI chr 1:90,295,495...90,305,047
Ensembl chr 1:90,293,797...90,305,046
G
Exosc7
exosome component 7
increases expression
EXP
nefazodone results in increased expression of EXOSC7 mRNA
CTD
PMID:24136188
NCBI chr 8:122,773,607...122,798,943
Ensembl chr 8:131,651,050...131,696,825
G
F10
coagulation factor X
decreases expression
EXP
nefazodone results in decreased expression of F10 mRNA
CTD
PMID:24136188
NCBI chr16:83,170,973...83,190,280
Ensembl chr16:83,170,977...83,190,280
G
Faah
fatty acid amide hydrolase
decreases expression
EXP
nefazodone results in decreased expression of FAAH mRNA
CTD
PMID:24136188
NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:134,716,545...134,735,396
G
Fabp5
fatty acid binding protein 5
decreases expression
EXP
nefazodone results in decreased expression of FABP5 mRNA
CTD
PMID:24136188
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127
G
Fabp7
fatty acid binding protein 7
decreases expression
EXP
nefazodone results in decreased expression of FABP7 mRNA
CTD
PMID:24136188
NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,669,601...37,675,907
G
Fads1
fatty acid desaturase 1
decreases expression
EXP
nefazodone results in decreased expression of FADS1 mRNA
CTD
PMID:24136188
NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615
G
Fads2
fatty acid desaturase 2
decreases expression
EXP
nefazodone results in decreased expression of FADS2 mRNA
CTD
PMID:24136188
NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066
G
Faf1
Fas associated factor 1
increases expression
EXP
nefazodone results in increased expression of FAF1 mRNA
CTD
PMID:24136188
NCBI chr 5:129,654,677...130,018,604
Ensembl chr 5:129,654,445...130,020,516
G
Fam117b
family with sequence similarity 117, member B
decreases expression
EXP
nefazodone results in decreased expression of FAM117B mRNA
CTD
PMID:24136188
NCBI chr 9:68,834,334...68,902,543
Ensembl chr 9:68,834,354...68,902,543
G
Fam136a
family with sequence similarity 136, member A
increases expression
EXP
nefazodone results in increased expression of FAM136A mRNA
CTD
PMID:24136188
NCBI chr 4:120,362,563...120,368,479
Ensembl chr 4:120,362,561...120,368,479
G
Fam193b
family with sequence similarity 193, member B
decreases expression
EXP
nefazodone results in decreased expression of FAM193B mRNA
CTD
PMID:24136188
NCBI chr17:9,066,818...9,099,511
Ensembl chr17:9,071,795...9,104,656
G
Fam3a
FAM3 metabolism regulating signaling molecule A
increases expression
EXP
nefazodone results in increased expression of FAM3A mRNA
CTD
PMID:24136188
NCBI chr X:157,317,993...157,326,640
Ensembl chr X:157,317,990...157,326,612
G
Fam89a
family with sequence similarity 89, member A
decreases expression
EXP
nefazodone results in decreased expression of FAM89A mRNA
CTD
PMID:24136188
NCBI chr19:69,607,391...69,620,019
Ensembl chr19:69,607,391...69,620,019
G
Fam91a1
family with sequence similarity 91, member A1
increases expression
EXP
nefazodone results in increased expression of FAM91A1 mRNA
CTD
PMID:24136188
NCBI chr 7:89,969,558...90,007,546
Ensembl chr 7:91,859,062...91,898,195
G
Farsb
phenylalanyl-tRNA synthetase subunit beta
increases expression
EXP
nefazodone results in increased expression of FARSB mRNA
CTD
PMID:24136188
NCBI chr 9:87,336,321...87,395,546
Ensembl chr 9:87,336,326...87,395,505
G
Fasn
fatty acid synthase
decreases expression
EXP
nefazodone results in decreased expression of FASN mRNA
CTD
PMID:24136188
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
G
Fbl
fibrillarin
increases expression
EXP
nefazodone results in increased expression of FBL mRNA
CTD
PMID:24136188
NCBI chr 1:92,597,407...92,606,507
Ensembl chr 1:92,597,258...92,606,506
G
Fbxo21
F-box protein 21
increases expression
EXP
nefazodone results in increased expression of FBXO21 mRNA
CTD
PMID:24136188
NCBI chr12:44,231,918...44,266,035
Ensembl chr12:44,231,923...44,266,035
G
Fbxo31
F-box protein 31
increases expression
EXP
nefazodone results in increased expression of FBXO31 mRNA
CTD
PMID:24136188
NCBI chr19:66,533,437...66,564,674
Ensembl chr19:66,533,437...66,564,674
G
Fbxo4
F-box protein 4
increases expression
EXP
nefazodone results in increased expression of FBXO4 mRNA
CTD
PMID:24136188
NCBI chr 2:54,902,394...54,915,388
Ensembl chr 2:54,902,394...54,915,388
G
Fbxo7
F-box protein 7
increases expression
EXP
nefazodone results in increased expression of FBXO7 mRNA
CTD
PMID:24136188
NCBI chr 7:19,696,951...19,725,180
Ensembl chr 7:19,696,961...19,725,180
G
Fcgr2a
Fc gamma receptor 2A
decreases expression
EXP
nefazodone results in decreased expression of FCGR2A mRNA
CTD
PMID:24136188
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394 Ensembl chr13:85,855,437...85,864,394
G
Fcna
ficolin A
decreases expression
EXP
nefazodone results in decreased expression of FCNA mRNA
CTD
PMID:24136188
NCBI chr 3:28,844,036...28,847,441
Ensembl chr 3:28,844,039...28,847,237
G
Fdx1
ferredoxin 1
increases expression
EXP
nefazodone results in increased expression of FDX1 mRNA
CTD
PMID:24136188
NCBI chr 8:61,164,839...61,183,645
Ensembl chr 8:61,164,839...61,183,583
G
Fech
ferrochelatase
increases expression
EXP
nefazodone results in increased expression of FECH mRNA
CTD
PMID:24136188
NCBI chr18:60,215,325...60,248,525
Ensembl chr18:60,215,325...60,249,546
G
Fga
fibrinogen alpha chain
decreases expression
EXP
nefazodone results in decreased expression of FGA mRNA
CTD
PMID:24136188
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577
G
Fgb
fibrinogen beta chain
decreases expression
EXP
nefazodone results in decreased expression of FGB mRNA
CTD
PMID:24136188
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434
G
Fgf21
fibroblast growth factor 21
increases expression
EXP
nefazodone results in increased expression of FGF21 mRNA
CTD
PMID:24136188
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056
G
Fgfr2
fibroblast growth factor receptor 2
decreases expression
EXP
nefazodone results in decreased expression of FGFR2 mRNA
CTD
PMID:24136188
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
G
Fgg
fibrinogen gamma chain
decreases expression
EXP
nefazodone results in decreased expression of FGG mRNA
CTD
PMID:24136188
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170
G
Fggy
FGGY carbohydrate kinase domain containing
decreases expression
EXP
nefazodone results in decreased expression of FGGY mRNA
CTD
PMID:24136188
NCBI chr 5:115,514,573...115,901,713
Ensembl chr 5:115,472,211...115,901,714
G
Fgl1
fibrinogen-like 1
decreases expression
EXP
nefazodone results in decreased expression of FGL1 mRNA
CTD
PMID:24136188
NCBI chr16:57,824,127...57,854,413
Ensembl chr16:57,824,200...57,854,429
G
Fkbp11
FKBP prolyl isomerase 11
increases expression
EXP
nefazodone results in increased expression of FKBP11 mRNA
CTD
PMID:24136188
NCBI chr 7:131,750,828...131,757,784
Ensembl chr 7:131,750,672...131,770,123
G
Fkbp1a
FKBP prolyl isomerase 1A
increases expression
EXP
nefazodone results in increased expression of FKBP1A mRNA
CTD
PMID:24136188
NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:160,500,726...160,524,233
G
Fkbp3
FKBP prolyl isomerase 3
increases expression
EXP
nefazodone results in increased expression of FKBP3 mRNA
CTD
PMID:24136188
NCBI chr 6:88,850,137...88,862,542
Ensembl chr 6:88,843,879...88,863,447
G
Fkbp5
FKBP prolyl isomerase 5
decreases expression multiple interactions
ISO
nefazodone results in decreased expression of FKBP5 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA
CTD
PMID:32152650
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118
G
Flcn
folliculin
increases expression
EXP
nefazodone results in increased expression of FLCN mRNA
CTD
PMID:24136188
NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309
G
Flot1
flotillin 1
decreases expression
EXP
nefazodone results in decreased expression of FLOT1 mRNA
CTD
PMID:24136188
NCBI chr20:2,922,662...2,932,906
Ensembl chr20:2,922,655...2,932,771
G
Flywch1
FLYWCH-type zinc finger 1
increases expression
EXP
nefazodone results in increased expression of FLYWCH1 mRNA
CTD
PMID:24136188
NCBI chr10:13,279,232...13,298,955
Ensembl chr10:13,279,232...13,298,925
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression multiple interactions
ISO
nefazodone results in decreased expression of FMO1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FMO1 mRNA
CTD
PMID:32152650
NCBI chr13:77,715,405...77,747,666
Ensembl chr13:77,715,402...77,747,874
G
Fn1
fibronectin 1
decreases expression
EXP
nefazodone results in decreased expression of FN1 mRNA
CTD
PMID:24136188
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
G
Fndc3b
fibronectin type III domain containing 3B
increases expression
EXP
nefazodone results in increased expression of FNDC3B mRNA
CTD
PMID:24136188
NCBI chr 2:112,240,108...112,546,113
Ensembl chr 2:112,243,202...112,546,306
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
nefazodone results in increased expression of FOS mRNA
CTD
PMID:27288927
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of FOSL1 mRNA nefazodone results in increased expression of FOSL1 mRNA
CTD
PMID:32152650
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391
G
Foxa2
forkhead box A2
decreases expression
EXP
nefazodone results in decreased expression of FOXA2 mRNA
CTD
PMID:24136188
NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757
G
Foxn3
forkhead box N3
decreases expression
EXP
nefazodone results in decreased expression of FOXN3 mRNA
CTD
PMID:24136188
NCBI chr 6:124,191,695...124,572,070
Ensembl chr 6:124,195,701...124,572,040
G
Foxo3
forkhead box O3
increases expression
ISO
nefazodone results in increased expression of FOXO3 mRNA
CTD
PMID:27288927
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
G
Fstl1
follistatin-like 1
decreases expression
EXP
nefazodone results in decreased expression of FSTL1 mRNA
CTD
PMID:24136188
NCBI chr11:76,400,870...76,454,053
Ensembl chr11:76,391,315...76,455,126
G
Ftcd
formimidoyltransferase cyclodeaminase
increases expression
EXP
nefazodone results in increased expression of FTCD mRNA
CTD
PMID:24136188
NCBI chr20:12,054,710...12,068,219
Ensembl chr20:12,054,711...12,068,237
G
Ftl1
ferritin light chain 1
increases expression
EXP
nefazodone results in increased expression of FTL1 mRNA
CTD
PMID:24136188
NCBI chr 1:105,072,858...105,074,705
Ensembl chr X:45,399,355...45,399,915 Ensembl chr 2:45,399,355...45,399,915 Ensembl chr 1:45,399,355...45,399,915
G
Fus
Fus RNA binding protein
decreases expression
EXP
nefazodone results in decreased expression of FUS mRNA
CTD
PMID:24136188
NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884
G
Fxr1
FMR1 autosomal homolog 1
increases expression
EXP
nefazodone results in increased expression of FXR1 mRNA
CTD
PMID:24136188
NCBI chr 2:118,812,287...118,865,813
Ensembl chr 2:118,811,980...118,867,027
G
Fzd1
frizzled class receptor 1
decreases expression
EXP
nefazodone results in decreased expression of FZD1 mRNA
CTD
PMID:24136188
NCBI chr 4:30,265,074...30,269,472
Ensembl chr 4:30,247,228...30,833,176
G
Fzd8
frizzled class receptor 8
decreases expression
EXP
nefazodone results in decreased expression of FZD8 mRNA
CTD
PMID:24136188
NCBI chr17:62,007,849...62,015,485
Ensembl chr17:62,007,627...62,015,961
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
nefazodone results in decreased expression of G6PC1 mRNA
CTD
PMID:24136188
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
G
Gaa
alpha glucosidase
increases expression
EXP
nefazodone results in increased expression of GAA mRNA
CTD
PMID:24136188
NCBI chr10:105,028,106...105,045,365
Ensembl chr10:105,028,307...105,045,366
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
EXP
nefazodone results in increased expression of GADD45A mRNA
CTD
PMID:24136188
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
G
Galk1
galactokinase 1
increases expression
EXP
nefazodone results in increased expression of GALK1 mRNA
CTD
PMID:24136188
NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258
G
Galm
galactose mutarotase
decreases expression
EXP
nefazodone results in decreased expression of GALM mRNA
CTD
PMID:24136188
NCBI chr 6:20,589,775...20,641,516
Ensembl chr 6:20,589,776...20,644,417
G
Gars1
glycyl-tRNA synthetase 1
increases expression
EXP
nefazodone results in increased expression of GARS1 mRNA
CTD
PMID:24136188
NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876
G
Gas5
growth arrest specific 5
increases expression
EXP
nefazodone results in increased expression of GAS5 mRNA
CTD
PMID:24136188
NCBI chr13:75,836,963...75,840,284
G
Gas6
growth arrest specific 6
decreases expression
EXP
nefazodone results in decreased expression of GAS6 mRNA
CTD
PMID:24136188
NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088
G
Gc
GC, vitamin D binding protein
decreases expression
EXP
nefazodone results in decreased expression of GC mRNA
CTD
PMID:24136188
NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,916,246...18,951,673
G
Gcat
glycine C-acetyltransferase
decreases expression
EXP
nefazodone results in decreased expression of GCAT mRNA
CTD
PMID:24136188
NCBI chr 7:112,475,572...112,481,920
Ensembl chr 7:112,475,496...112,482,664
G
Gch1
GTP cyclohydrolase 1
increases expression
EXP
nefazodone results in increased expression of GCH1 mRNA
CTD
PMID:24136188
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
G
Gck
glucokinase
decreases expression
EXP
nefazodone results in decreased expression of GCK mRNA
CTD
PMID:24136188
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
G
Gckr
glucokinase regulator
decreases expression
EXP
nefazodone results in decreased expression of GCKR mRNA
CTD
PMID:24136188
NCBI chr 6:30,765,071...30,795,627
Ensembl chr 6:30,765,075...30,795,627
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
EXP
nefazodone results in increased expression of GCLC mRNA
CTD
PMID:24136188
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
EXP
nefazodone results in increased expression of GCLM mRNA
CTD
PMID:24136188
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
G
Gda
guanine deaminase
increases expression
EXP
nefazodone results in increased expression of GDA mRNA
CTD
PMID:24136188
NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:228,333,364...228,409,348
G
Gde1
glycerophosphodiester phosphodiesterase 1
increases expression
EXP
nefazodone results in increased expression of GDE1 mRNA
CTD
PMID:24136188
NCBI chr 1:182,451,182...182,466,569
Ensembl chr 1:182,451,184...182,466,772
G
Gemin6
gem (nuclear organelle) associated protein 6
increases expression
EXP
nefazodone results in increased expression of GEMIN6 mRNA
CTD
PMID:24136188
NCBI chr 6:20,538,325...20,542,867
Ensembl chr 6:20,538,325...20,542,852
G
Get4
guided entry of tail-anchored proteins factor 4
increases expression
EXP
nefazodone results in increased expression of GET4 mRNA
CTD
PMID:24136188
NCBI chr12:20,490,861...20,508,096
Ensembl chr12:20,490,861...20,555,240
G
Ggh
gamma-glutamyl hydrolase
increases expression
EXP
nefazodone results in increased expression of GGH mRNA
CTD
PMID:24136188
NCBI chr 5:38,326,747...38,349,655
Ensembl chr 5:38,326,594...38,349,647
G
Ggt1
gamma-glutamyltransferase 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of GGT1 mRNA
CTD
PMID:33819548
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050
G
Ghitm
growth hormone inducible transmembrane protein
increases expression
EXP
nefazodone results in increased expression of GHITM mRNA
CTD
PMID:24136188
NCBI chr16:12,907,062...12,918,149
Ensembl chr16:12,905,806...12,918,123
G
Ghr
growth hormone receptor
decreases expression
EXP
nefazodone results in decreased expression of GHR mRNA
CTD
PMID:24136188
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331
G
Gjb1
gap junction protein, beta 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of GJB1 mRNA
CTD
PMID:33819548
NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843
G
Gjb2
gap junction protein, beta 2
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of GJB2 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of GJB2 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877
G
Gk
glycerol kinase
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of GK mRNA
CTD
PMID:33819548
NCBI chr X:54,106,708...54,189,940
Ensembl chr X:54,112,214...54,196,701
G
Gldc
glycine decarboxylase
decreases expression
EXP
nefazodone results in decreased expression of GLDC mRNA
CTD
PMID:24136188
NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:237,296,753...237,375,604
G
Glrx
glutaredoxin
increases expression
EXP
nefazodone results in increased expression of GLRX mRNA
CTD
PMID:24136188
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543
G
Glrx2
glutaredoxin 2
increases expression
EXP
nefazodone results in increased expression of GLRX2 mRNA
CTD
PMID:24136188
NCBI chr13:58,032,199...58,055,061
Ensembl chr13:58,032,401...58,043,150
G
Glrx3
glutaredoxin 3
increases expression
EXP
nefazodone results in increased expression of GLRX3 mRNA
CTD
PMID:24136188
NCBI chr 1:201,671,410...201,701,722
Ensembl chr 1:201,671,481...201,701,717
G
Glrx5
glutaredoxin 5
increases expression
EXP
nefazodone results in increased expression of GLRX5 mRNA
CTD
PMID:24136188
NCBI chr 6:129,752,902...129,763,278
Ensembl chr 6:129,752,840...129,763,278
G
Gls2
glutaminase 2
decreases expression
EXP
nefazodone results in decreased expression of GLS2 mRNA
CTD
PMID:24136188
NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:1,201,838...1,218,013
G
Glud1
glutamate dehydrogenase 1
decreases expression
EXP
nefazodone results in decreased expression of GLUD1 mRNA
CTD
PMID:24136188
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210
G
Glul
glutamate-ammonia ligase
decreases expression
EXP
nefazodone results in decreased expression of GLUL mRNA
CTD
PMID:24136188
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
G
Glyatl2
glycine-N-acyltransferase-like 2
increases expression
EXP
nefazodone results in increased expression of GLYATL2 mRNA
CTD
PMID:24136188
NCBI chr 1:209,807,488...209,840,480
Ensembl chr 1:219,232,103...219,266,322
G
Gm2a
ganglioside GM2 activator
decreases expression
EXP
nefazodone results in decreased expression of GM2A mRNA
CTD
PMID:24136188
NCBI chr10:39,719,919...39,732,452
Ensembl chr10:39,719,938...39,732,451
G
Gmps
guanine monophosphate synthase
increases expression
EXP
nefazodone results in increased expression of GMPS mRNA
CTD
PMID:24136188
NCBI chr 2:150,587,824...150,641,564
Ensembl chr 2:150,587,854...150,648,986
G
Gnai2
G protein subunit alpha i2
decreases expression
EXP
nefazodone results in decreased expression of GNAI2 mRNA
CTD
PMID:24136188
NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622
G
Gnai3
G protein subunit alpha i3
increases expression
EXP
nefazodone results in increased expression of GNAI3 mRNA
CTD
PMID:24136188
NCBI chr 2:198,430,920...198,468,874
G
Gnas
GNAS complex locus
decreases expression
EXP
nefazodone results in decreased expression of GNAS mRNA
CTD
PMID:24136188
NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536
G
Gne
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
decreases expression
EXP
nefazodone results in decreased expression of GNE mRNA
CTD
PMID:24136188
NCBI chr 5:63,062,953...63,103,320
Ensembl chr 5:63,062,850...63,103,251
G
Gnl3
G protein nucleolar 3
increases expression
EXP
nefazodone results in increased expression of GNL3 mRNA
CTD
PMID:24136188
NCBI chr16:6,213,844...6,220,029
Ensembl chr16:6,213,871...6,219,845
G
Gnl3l
G protein nucleolar 3 like
increases expression
EXP
nefazodone results in increased expression of GNL3L mRNA
CTD
PMID:24136188
NCBI chr X:23,404,324...23,437,501
Ensembl chr X:23,404,324...23,439,315
G
Gnmt
glycine N-methyltransferase
decreases expression
EXP
nefazodone results in decreased expression of GNMT mRNA
CTD
PMID:24136188
NCBI chr 9:21,752,235...21,756,368
Ensembl chr 9:21,752,266...21,755,692
G
Gns
glucosamine (N-acetyl)-6-sulfatase
decreases expression
EXP
nefazodone results in decreased expression of GNS mRNA
CTD
PMID:24136188
NCBI chr 7:58,774,625...58,808,650
Ensembl chr 7:58,774,625...58,808,650
G
Golph3
golgi phosphoprotein 3
increases expression
EXP
nefazodone results in increased expression of GOLPH3 mRNA
CTD
PMID:24136188
NCBI chr 2:63,072,610...63,103,091
Ensembl chr 2:63,074,256...63,113,577
G
Golt1a
golgi transport 1A
increases expression
EXP
nefazodone results in increased expression of GOLT1A mRNA
CTD
PMID:24136188
NCBI chr13:44,760,356...44,773,123
Ensembl chr13:47,322,002...47,325,175
G
Gopc
golgi associated PDZ and coiled-coil motif containing
increases expression
EXP
nefazodone results in increased expression of GOPC mRNA
CTD
PMID:24136188
NCBI chr20:32,270,314...32,319,635
Ensembl chr20:32,270,314...32,319,611
G
Got1
glutamic-oxaloacetic transaminase 1
decreases expression
EXP
nefazodone results in decreased expression of GOT1 mRNA
CTD
PMID:24136188
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
G
Gpat4
glycerol-3-phosphate acyltransferase 4
increases expression
EXP
nefazodone results in increased expression of GPAT4 mRNA
CTD
PMID:24136188
NCBI chr16:75,515,935...75,555,431
Ensembl chr16:75,521,640...75,557,847
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
increases expression
EXP
nefazodone results in increased expression of GPD1 mRNA
CTD
PMID:24136188
NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368
G
Gpi
glucose-6-phosphate isomerase
increases expression
EXP
nefazodone results in increased expression of GPI mRNA
CTD
PMID:24136188
NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:95,965,396...95,993,261
G
Gpld1
glycosylphosphatidylinositol specific phospholipase D1
decreases expression
EXP
nefazodone results in decreased expression of GPLD1 mRNA
CTD
PMID:24136188
NCBI chr17:40,512,659...40,560,483
Ensembl chr17:40,512,660...40,554,975
G
Gprc5b
G protein-coupled receptor, class C, group 5, member B
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of GPRC5B mRNA
CTD
PMID:33819548
NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:182,748,247...182,772,757
G
Gpx1
glutathione peroxidase 1
decreases expression
EXP
nefazodone results in decreased expression of GPX1 mRNA
CTD
PMID:24136188
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
G
Gpx2
glutathione peroxidase 2
decreases expression multiple interactions
ISO
nefazodone results in decreased expression of GPX2 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of GPX2 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA
CTD
PMID:32152650 PMID:33819548
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
G
Gpx4
glutathione peroxidase 4
increases expression
EXP
nefazodone results in increased expression of GPX4 mRNA
CTD
PMID:24136188
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
G
Gramd2b
GRAM domain containing 2B
increases expression
EXP
nefazodone results in increased expression of GRAMD2B mRNA
CTD
PMID:24136188
NCBI chr18:52,082,128...52,180,056
Ensembl chr18:52,082,029...52,180,054
G
Grina
glutamate ionotropic receptor NMDA type subunit associated protein 1
increases expression
EXP
nefazodone results in increased expression of GRINA mRNA
CTD
PMID:24136188
NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:109,843,196...109,846,042
G
Grwd1
glutamate-rich WD repeat containing 1
increases expression
EXP
nefazodone results in increased expression of GRWD1 mRNA
CTD
PMID:24136188
NCBI chr 1:105,437,708...105,443,410
Ensembl chr 1:105,437,709...105,443,825
G
Gsr
glutathione-disulfide reductase
increases expression
EXP
nefazodone results in increased expression of GSR mRNA
CTD
PMID:24136188
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
G
Gss
glutathione synthetase
increases expression
EXP
nefazodone results in increased expression of GSS mRNA
CTD
PMID:24136188
NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306
G
Gsta1
glutathione S-transferase alpha 1
multiple interactions decreases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTA1 mRNA nefazodone results in decreased expression of GSTA1 mRNA
CTD
PMID:32152650
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528
G
Gsta2
glutathione S-transferase alpha 2
increases expression
EXP
nefazodone results in increased expression of GSTA2 mRNA
CTD
PMID:24136188
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092
G
Gsta3
glutathione S-transferase alpha 3
increases expression
EXP
nefazodone results in increased expression of GSTA3 mRNA
CTD
PMID:24136188
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:31,154,989...31,180,654
G
Gsta4
glutathione S-transferase alpha 4
increases expression
EXP
nefazodone results in increased expression of GSTA4 mRNA
CTD
PMID:24136188
NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488
G
Gstm1
glutathione S-transferase mu 1
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of GSTM1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM1 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
G
Gstm2
glutathione S-transferase mu 2
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of GSTM2 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr 2:198,312,179...198,316,962
G
Gstm4
glutathione S-transferase mu 4
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of GSTM4 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM4 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr 2:198,356,114...198,373,487
Ensembl chr 2:198,358,744...198,373,638
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP
nefazodone results in increased expression of GSTP1 mRNA
CTD
PMID:24136188
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
G
Gstp3
glutathione S-transferase pi 3
decreases expression
EXP
nefazodone results in decreased expression of GSTP3 mRNA
CTD
PMID:24136188
NCBI chr 1:210,785,151...210,787,705
Ensembl chr 1:210,785,151...210,787,684
G
Gstt3
glutathione S-transferase, theta 3
increases expression
EXP
nefazodone results in increased expression of GSTT3 mRNA
CTD
PMID:24136188
NCBI chr20:12,873,618...12,881,974
Ensembl chr20:12,874,374...12,881,973
G
Gtf2b
general transcription factor IIB
increases expression
EXP
nefazodone results in increased expression of GTF2B mRNA
CTD
PMID:24136188
NCBI chr 2:234,427,734...234,446,043
Ensembl chr 2:234,427,637...234,446,049
G
Gtf2h1
general transcription factor IIH subunit 1
increases expression
EXP
nefazodone results in increased expression of GTF2H1 mRNA
CTD
PMID:24136188
NCBI chr 1:106,457,692...106,485,729
Ensembl chr 1:106,457,394...106,485,727
G
Gtf3a
general transcription factor III A
increases expression
EXP
nefazodone results in increased expression of GTF3A mRNA
CTD
PMID:24136188
NCBI chr12:13,250,643...13,258,587
Ensembl chr12:13,250,644...13,258,587
G
Gucy1b2
guanylate cyclase 1 soluble subunit beta 2
decreases expression
EXP
nefazodone results in decreased expression of GUCY1B2 mRNA
CTD
PMID:24136188
NCBI chr15:40,774,907...40,845,463
Ensembl chr15:40,774,906...40,845,463
G
Gulo
gulonolactone (L-) oxidase
decreases expression
EXP
nefazodone results in decreased expression of GULO mRNA
CTD
PMID:24136188
NCBI chr15:40,205,677...40,227,766
Ensembl chr15:44,381,214...44,403,422
G
Gusb
glucuronidase, beta
decreases expression
EXP
nefazodone results in decreased expression of GUSB mRNA
CTD
PMID:24136188
NCBI chr12:32,337,281...32,350,838
Ensembl chr12:32,334,075...32,363,024
G
H1f0
H1.0 linker histone
decreases expression
EXP
nefazodone results in decreased expression of H1F0 mRNA
CTD
PMID:24136188
NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006
G
H2az2
H2A.Z variant histone 2
decreases expression
EXP
nefazodone results in decreased expression of H2AZ2 mRNA
CTD
PMID:24136188
NCBI chr14:85,507,228...85,526,166
Ensembl chr14:85,507,228...85,526,207 Ensembl chr16:85,507,228...85,526,207
G
H3f3b
H3.3 histone B
increases expression
EXP
nefazodone results in increased expression of H3F3B mRNA
CTD
PMID:24136188
NCBI chr10:101,755,404...101,764,616
Ensembl chr10:101,755,404...101,757,636
G
Hacd3
3-hydroxyacyl-CoA dehydratase 3
increases expression
EXP
nefazodone results in increased expression of HACD3 mRNA
CTD
PMID:24136188
NCBI chr 8:74,396,441...74,433,700
Ensembl chr 8:74,396,442...74,433,700
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
increases expression
EXP
nefazodone results in increased expression of HADHA mRNA
CTD
PMID:24136188
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
increases expression
EXP
nefazodone results in increased expression of HADHB mRNA
CTD
PMID:24136188
NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:31,873,404...31,907,835
G
Hagh
hydroxyacyl glutathione hydrolase
decreases expression
EXP
nefazodone results in decreased expression of HAGH mRNA
CTD
PMID:24136188
NCBI chr10:14,379,400...14,394,046
Ensembl chr10:14,382,410...14,394,043
G
Hal
histidine ammonia lyase
decreases expression
EXP
nefazodone results in decreased expression of HAL mRNA
CTD
PMID:24136188
NCBI chr 7:29,894,495...29,924,744
Ensembl chr 7:29,893,855...29,924,744
G
Hamp
hepcidin antimicrobial peptide
decreases expression
EXP
nefazodone results in decreased expression of HAMP mRNA
CTD
PMID:24136188
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
G
Hao1
hydroxyacid oxidase 1
decreases expression
EXP
nefazodone results in decreased expression of HAO1 mRNA
CTD
PMID:24136188
NCBI chr 3:142,102,873...142,281,527
Ensembl chr 3:142,224,612...142,281,494
G
Hao2
hydroxyacid oxidase 2
decreases expression
EXP
nefazodone results in decreased expression of HAO2 mRNA
CTD
PMID:24136188
NCBI chr 2:188,888,848...188,921,567
Ensembl chr 2:188,889,212...188,913,133
G
Hars1
histidyl-tRNA synthetase 1
increases expression
EXP
nefazodone results in increased expression of HARS1 mRNA
CTD
PMID:24136188
NCBI chr18:28,655,669...28,672,712
Ensembl chr18:28,655,671...28,672,712
G
Hba-a1
hemoglobin alpha, adult chain 1
decreases expression
EXP
nefazodone results in decreased expression of HBA-A1 mRNA
CTD
PMID:24136188
NCBI chr10:15,841,724...15,842,580
Ensembl chr10:15,841,763...15,842,603
G
Hba-a2
hemoglobin alpha, adult chain 2
decreases expression
EXP
nefazodone results in decreased expression of HBA1 mRNA
CTD
PMID:24136188
NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141
G
Hdac2
histone deacetylase 2
decreases expression
EXP
nefazodone results in decreased expression of HDAC2 mRNA
CTD
PMID:24136188
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:42,102,861...42,126,311
G
Hdac6
histone deacetylase 6
increases expression
EXP
nefazodone results in increased expression of HDAC6 mRNA
CTD
PMID:24136188
NCBI chr X:17,222,538...17,244,373
Ensembl chr X:17,222,856...17,244,370
G
Hdgf
heparin binding growth factor
increases expression
EXP
nefazodone results in increased expression of HDGF mRNA
CTD
PMID:24136188
NCBI chr 2:175,668,290...175,677,614
Ensembl chr 2:175,668,324...175,677,225
G
Helz2
helicase with zinc finger 2
decreases expression
EXP
nefazodone results in decreased expression of HELZ2 mRNA
CTD
PMID:24136188
NCBI chr 3:188,716,370...188,730,776
Ensembl chr 3:188,716,370...188,730,716
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of HERPUD1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HERPUD1 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
G
Hes6
hes family bHLH transcription factor 6
decreases expression
EXP
nefazodone results in decreased expression of HES6 mRNA
CTD
PMID:24136188
NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:99,449,371...99,451,096
G
Hexa
hexosaminidase subunit alpha
decreases expression
EXP
nefazodone results in decreased expression of HEXA mRNA
CTD
PMID:24136188
NCBI chr 8:68,832,524...68,857,462
Ensembl chr 8:68,809,615...68,859,560
G
Hexim1
HEXIM P-TEFb complex subunit 1
decreases expression
EXP
nefazodone results in decreased expression of HEXIM1 mRNA
CTD
PMID:24136188
NCBI chr10:88,562,889...88,565,001
Ensembl chr10:88,560,519...88,580,000
G
Hfe
homeostatic iron regulator
increases expression
EXP
nefazodone results in increased expression of HFE mRNA
CTD
PMID:24136188
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,841,252...41,851,208
G
Hgd
homogentisate 1, 2-dioxygenase
decreases expression
EXP
nefazodone results in decreased expression of HGD mRNA
CTD
PMID:24136188
NCBI chr11:76,592,202...76,643,776
Ensembl chr11:76,592,204...76,643,767
G
Hgf
hepatocyte growth factor
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of HGF mRNA
CTD
PMID:33819548
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
G
Hgs
hepatocyte growth factor-regulated tyrosine kinase substrate
increases expression
EXP
nefazodone results in increased expression of HGS mRNA
CTD
PMID:24136188
NCBI chr10:106,237,988...106,256,174
Ensembl chr10:106,237,824...106,256,174
G
Hhex
hematopoietically expressed homeobox
decreases expression
EXP
nefazodone results in decreased expression of HHEX mRNA
CTD
PMID:24136188
NCBI chr 1:244,602,945...244,608,532
Ensembl chr 1:244,602,825...244,608,604
G
Hibch
3-hydroxyisobutyryl-CoA hydrolase
increases expression
EXP
nefazodone results in increased expression of HIBCH mRNA
CTD
PMID:24136188
NCBI chr 9:56,082,082...56,161,796
Ensembl chr 9:56,082,091...56,161,886
G
Higd1a
HIG1 hypoxia inducible domain family, member 1A
increases expression
EXP
nefazodone results in increased expression of HIGD1A mRNA
CTD
PMID:24136188
NCBI chr 8:130,391,658...130,400,888
Ensembl chr 8:130,391,661...130,400,888
G
Hikeshi
heat shock protein nuclear import factor hikeshi
increases expression
EXP
nefazodone results in increased expression of HIKESHI mRNA
CTD
PMID:24136188
NCBI chr 1:153,237,948...153,261,856
Ensembl chr 1:153,237,948...153,261,911
G
Hint2
histidine triad nucleotide binding protein 2
increases expression
EXP
nefazodone results in increased expression of HINT2 mRNA
CTD
PMID:24136188
NCBI chr 5:62,700,383...62,702,638
Ensembl chr 5:62,700,384...62,702,915
G
Hist1h4b
histone cluster 1 H4 family member B
decreases expression
EXP
nefazodone results in decreased expression of HIST1H4B mRNA
CTD
PMID:24136188
NCBI chr17:47,176,246...47,180,690
Ensembl chr17:41,797,152...41,806,539 Ensembl chr17:41,797,152...41,806,539 Ensembl chr17:41,797,152...41,806,539 Ensembl chr 4:41,797,152...41,806,539
G
Hlcs
holocarboxylase synthetase
increases expression
EXP
nefazodone results in increased expression of HLCS mRNA
CTD
PMID:24136188
NCBI chr11:46,925,491...47,123,111
Ensembl chr11:46,925,491...47,105,082
G
Hmbs
hydroxymethylbilane synthase
increases expression
EXP
nefazodone results in increased expression of HMBS mRNA
CTD
PMID:24136188
NCBI chr 8:53,570,364...53,577,758
Ensembl chr 8:53,570,364...53,577,802
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
EXP
nefazodone results in increased expression of HMGCR mRNA
CTD
PMID:24136188
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
decreases expression
EXP
nefazodone results in decreased expression of HMGCS1 mRNA
CTD
PMID:24136188
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802
G
Hmgn1
high mobility group nucleosome binding domain 1
increases expression
EXP
nefazodone results in increased expression of HMGN1 mRNA
CTD
PMID:24136188
NCBI chr11:48,891,813...48,897,732
Ensembl chr11:48,891,814...48,897,771
G
Hmox1
heme oxygenase 1
increases expression
EXP
nefazodone results in increased expression of HMOX1 mRNA
CTD
PMID:24136188
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
decreases expression
EXP
nefazodone results in decreased expression of HNRNPA2B1 mRNA
CTD
PMID:24136188
NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
increases expression
EXP
nefazodone results in increased expression of HNRNPAB mRNA
CTD
PMID:24136188
NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307
G
Hnrnpf
heterogeneous nuclear ribonucleoprotein F
increases expression
EXP
nefazodone results in increased expression of HNRNPF mRNA
CTD
PMID:24136188
NCBI chr 4:152,755,668...152,776,867
Ensembl chr 4:152,722,617...152,815,769
G
Hoga1
4-hydroxy-2-oxoglutarate aldolase 1
decreases expression
EXP
nefazodone results in decreased expression of HOGA1 mRNA
CTD
PMID:24136188
NCBI chr 1:250,806,430...250,833,544
Ensembl chr 1:250,806,255...250,833,869
G
Homer1
homer scaffold protein 1
increases expression
EXP
nefazodone results in increased expression of HOMER1 mRNA
CTD
PMID:24136188
NCBI chr 2:26,279,012...26,388,279
Ensembl chr 2:26,278,105...26,381,657
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
increases expression
EXP
nefazodone results in increased expression of HPRT1 mRNA
CTD
PMID:24136188
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712
G
Hpx
hemopexin
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of HPX mRNA
CTD
PMID:33819548
NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:169,344,583...169,352,156
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
increases expression
EXP
nefazodone results in increased expression of HSD17B4 mRNA
CTD
PMID:24136188
NCBI chr18:45,515,427...45,604,467
Ensembl chr18:45,515,373...45,604,467
G
Hsd17b6
hydroxysteroid (17-beta) dehydrogenase 6
decreases expression
EXP
nefazodone results in decreased expression of HSD17B6 mRNA
CTD
PMID:24136188
NCBI chr 7:831,407...850,950
Ensembl chr 7:831,421...850,873
G
Hsd3b5
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5
decreases expression
EXP
nefazodone results in decreased expression of HSD3B5 mRNA
CTD
PMID:24136188
NCBI chr 2:188,697,669...188,717,141
Ensembl chr 2:188,697,670...188,709,118
G
Hsdl2
hydroxysteroid dehydrogenase like 2
increases expression
EXP
nefazodone results in increased expression of HSDL2 mRNA
CTD
PMID:24136188
NCBI chr 5:79,238,881...79,274,051
Ensembl chr 5:79,212,525...79,274,798
G
Hsf2
heat shock transcription factor 2
increases expression
EXP
nefazodone results in increased expression of HSF2 mRNA
CTD
PMID:24136188
NCBI chr20:37,366,301...37,393,922
Ensembl chr20:37,366,279...37,401,022
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
EXP
nefazodone results in increased expression of HSP90AA1 mRNA
CTD
PMID:24136188
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
increases expression
EXP
nefazodone results in increased expression of HSP90AB1 mRNA
CTD
PMID:24136188
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPA5 mRNA nefazodone results in increased expression of HSPA5 mRNA
CTD
PMID:32152650
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
G
Hspa8
heat shock protein family A (Hsp70) member 8
increases expression
EXP
nefazodone results in increased expression of HSPA8 mRNA
CTD
PMID:24136188
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
G
Hspa9
heat shock protein family A (Hsp70) member 9
increases expression
EXP
nefazodone results in increased expression of HSPA9 mRNA
CTD
PMID:24136188
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
G
Hspb1
heat shock protein family B (small) member 1
increases expression
EXP
nefazodone results in increased expression of HSPB1 mRNA
CTD
PMID:24136188
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
G
Hspb8
heat shock protein family B (small) member 8
increases expression
EXP
nefazodone results in increased expression of HSPB8 mRNA
CTD
PMID:24136188
NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937
G
Hspbp1
HSPA (Hsp70) binding protein 1
increases expression
EXP
nefazodone results in increased expression of HSPBP1 mRNA
CTD
PMID:24136188
NCBI chr 1:78,194,067...78,217,836
Ensembl chr 1:78,189,305...78,217,835
G
Hspd1
heat shock protein family D (Hsp60) member 1
increases expression
EXP
nefazodone results in increased expression of HSPD1 mRNA
CTD
PMID:24136188
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
G
Hspe1
heat shock protein family E (Hsp10) member 1
increases expression
EXP
nefazodone results in increased expression of HSPE1 mRNA
CTD
PMID:24136188
NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
EXP
nefazodone results in increased expression of HSPH1 mRNA
CTD
PMID:24136188
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891
G
Htatip2
HIV-1 Tat interactive protein 2
increases expression
EXP
nefazodone results in increased expression of HTATIP2 mRNA
CTD
PMID:24136188
NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:108,605,811...108,624,815
G
Htr1a
5-hydroxytryptamine receptor 1A
affects binding
ISO
nefazodone binds to HTR1A protein
CTD
PMID:7855217
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:38,427,083...38,540,760
G
Htr2c
5-hydroxytryptamine receptor 2C
affects binding
ISO
nefazodone binds to HTR2C protein
CTD
PMID:18083778
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324
G
Htra1
HtrA serine peptidase 1
decreases expression
EXP
nefazodone results in decreased expression of HTRA1 mRNA
CTD
PMID:24136188
NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:194,927,687...194,977,620
G
Hyal3
hyaluronidase 3
decreases expression
EXP
nefazodone results in decreased expression of HYAL3 mRNA
CTD
PMID:24136188
NCBI chr 8:117,133,028...117,138,663
Ensembl chr 8:117,132,649...117,139,289
G
Hycc2
hyccin PI4KA lipid kinase complex subunit 2
increases expression
EXP
nefazodone results in increased expression of HYCC2 mRNA
CTD
PMID:24136188
NCBI chr 9:67,551,064...67,623,353
Ensembl chr 9:67,551,064...67,587,186
G
Iars1
isoleucyl-tRNA synthetase 1
increases expression
EXP
nefazodone results in increased expression of IARS1 mRNA
CTD
PMID:24136188
NCBI chr17:15,147,357...15,193,716
Ensembl chr17:15,147,357...15,193,652
G
Iars2
isoleucyl-tRNA synthetase 2, mitochondrial
increases expression
EXP
nefazodone results in increased expression of IARS2 mRNA
CTD
PMID:24136188
NCBI chr13:99,363,035...99,397,068
Ensembl chr13:99,362,696...99,397,068
G
Iba57
iron-sulfur cluster assembly factor IBA57
increases expression
EXP
nefazodone results in increased expression of IBA57 mRNA
CTD
PMID:24136188
NCBI chr10:44,441,579...44,450,368
Ensembl chr10:44,441,579...44,450,368
G
Icam1
intercellular adhesion molecule 1
decreases expression
EXP
nefazodone results in decreased expression of ICAM1 mRNA
CTD
PMID:24136188
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Id4
inhibitor of DNA binding 4
decreases expression
EXP
nefazodone results in decreased expression of ID4 mRNA
CTD
PMID:24136188
NCBI chr17:16,595,724...16,598,293
Ensembl chr17:16,595,724...16,598,492
G
Ide
insulin degrading enzyme
increases expression
EXP
nefazodone results in increased expression of IDE mRNA
CTD
PMID:24136188
NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
increases expression
EXP
nefazodone results in increased expression of IDH1 mRNA
CTD
PMID:24136188
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555
G
Ier3
immediate early response 3
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of IER3 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IER3 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377
G
Ifi27
interferon, alpha-inducible protein 27
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IFI27 mRNA
CTD
PMID:33819548
NCBI chr 6:128,355,312...128,361,783
Ensembl chr 6:128,355,079...128,361,781
G
Ifi35
interferon-induced protein 35
increases expression
EXP
nefazodone results in increased expression of IFI35 mRNA
CTD
PMID:24136188
NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,887,122...86,889,750
G
Ifitm1
interferon induced transmembrane protein 1
decreases expression
EXP
nefazodone results in decreased expression of IFITM1 mRNA
CTD
PMID:24136188
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776
G
Ifng
interferon gamma
multiple interactions
ISO EXP
[IFNG protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to nefazodone
CTD
PMID:19362101
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Ifrd1
interferon-related developmental regulator 1
increases expression
EXP
nefazodone results in increased expression of IFRD1 mRNA
CTD
PMID:24136188
NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131
G
Ifrd2
interferon-related developmental regulator 2
increases expression
EXP
nefazodone results in increased expression of IFRD2 mRNA
CTD
PMID:24136188
NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836
G
Igf1
insulin-like growth factor 1
decreases expression
EXP
nefazodone results in decreased expression of IGF1 mRNA
CTD
PMID:24136188
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
decreases expression
EXP
nefazodone results in decreased expression of IGFALS mRNA
CTD
PMID:24136188
NCBI chr10:14,397,076...14,408,439
Ensembl chr10:14,403,399...14,407,138
G
Igfbp1
insulin-like growth factor binding protein 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IGFBP1 mRNA
CTD
PMID:33819548
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344
G
Igfbp3
insulin-like growth factor binding protein 3
decreases expression
EXP
nefazodone results in decreased expression of IGFBP3 mRNA
CTD
PMID:24136188
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
G
Igfbp4
insulin-like growth factor binding protein 4
decreases expression
EXP
nefazodone results in decreased expression of IGFBP4 mRNA
CTD
PMID:24136188
NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473
G
Igfbp7
insulin-like growth factor binding protein 7
decreases expression
EXP
nefazodone results in decreased expression of IGFBP7 mRNA
CTD
PMID:24136188
NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620
G
Igsf11
immunoglobulin superfamily, member 11
increases expression
EXP
nefazodone results in increased expression of IGSF11 mRNA
CTD
PMID:24136188
NCBI chr11:75,238,706...75,389,748
Ensembl chr11:75,236,545...75,390,425
G
Igsf5
immunoglobulin superfamily, member 5
decreases expression
EXP
nefazodone results in decreased expression of IGSF5 mRNA
CTD
PMID:24136188
NCBI chr11:35,686,513...35,729,396
Ensembl chr11:49,156,341...49,210,603
G
Igtp
interferon gamma induced GTPase
decreases expression
EXP
nefazodone results in decreased expression of IGTP mRNA
CTD
PMID:24136188
NCBI chr10:42,875,047...42,882,866
Ensembl chr10:42,876,790...42,882,858
G
Il13ra1
interleukin 13 receptor subunit alpha 1
increases expression
EXP
nefazodone results in increased expression of IL13RA1 mRNA
CTD
PMID:24136188
NCBI chr X:120,213,670...120,294,777
Ensembl chr X:120,214,075...120,274,461
G
Il17ra
interleukin 17 receptor A
decreases expression
EXP
nefazodone results in decreased expression of IL17RA mRNA
CTD
PMID:24136188
NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:155,339,400...155,362,382
G
Il1a
interleukin 1 alpha
multiple interactions decreases expression
EXP ISO
[IFNG protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to nefazodone nefazodone results in decreased expression of IL1A mRNA
CTD
PMID:19362101 PMID:32816093
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
G
Il1b
interleukin 1 beta
decreases expression
ISO
nefazodone results in decreased expression of IL1B mRNA
CTD
PMID:32816093
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il24
interleukin 24
increases expression
ISO
nefazodone results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760
G
Il33
interleukin 33
decreases expression
EXP
nefazodone results in decreased expression of IL33 mRNA
CTD
PMID:24136188
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901
G
Imp3
IMP U3 small nucleolar ribonucleoprotein 3
increases expression
EXP
nefazodone results in increased expression of IMP3 mRNA
CTD
PMID:24136188
NCBI chr 8:66,235,498...66,236,386
G
Imp4
IMP U3 small nucleolar ribonucleoprotein 4
increases expression
EXP
nefazodone results in increased expression of IMP4 mRNA
CTD
PMID:24136188
NCBI chr 9:44,150,029...44,155,167
Ensembl chr 9:44,150,337...44,157,751
G
Impdh2
inosine monophosphate dehydrogenase 2
increases expression
EXP
nefazodone results in increased expression of IMPDH2 mRNA
CTD
PMID:24136188
NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873
G
Inhba
inhibin subunit beta A
decreases expression
EXP
nefazodone results in decreased expression of INHBA mRNA
CTD
PMID:24136188
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
G
Inhbc
inhibin subunit beta C
decreases expression
EXP
nefazodone results in decreased expression of INHBC mRNA
CTD
PMID:24136188
NCBI chr 7:65,069,450...65,082,919
Ensembl chr 7:65,069,451...65,082,919
G
Inmt
indolethylamine N-methyltransferase
increases expression
EXP
nefazodone results in increased expression of INMT mRNA
CTD
PMID:24136188
NCBI chr 4:85,648,459...85,652,755
Ensembl chr 4:85,648,459...85,652,755
G
Insig1
insulin induced gene 1
decreases expression
EXP
nefazodone results in decreased expression of INSIG1 mRNA
CTD
PMID:24136188
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
G
Insig2
insulin induced gene 2
increases expression
EXP
nefazodone results in increased expression of INSIG2 mRNA
CTD
PMID:24136188
NCBI chr13:35,025,160...35,052,937
Ensembl chr13:35,025,164...35,047,658
G
Ipmk
inositol polyphosphate multikinase
decreases expression
EXP
nefazodone results in decreased expression of IPMK mRNA
CTD
PMID:24136188
NCBI chr20:17,216,151...17,250,826
Ensembl chr20:17,216,151...17,250,757
G
Ipo4
importin 4
increases expression
EXP
nefazodone results in increased expression of IPO4 mRNA
CTD
PMID:24136188
NCBI chr15:33,087,321...33,097,241
Ensembl chr15:33,087,321...33,097,241
G
Ipo5
importin 5
increases expression
EXP
nefazodone results in increased expression of IPO5 mRNA
CTD
PMID:24136188
NCBI chr15:104,397,626...104,447,985
Ensembl chr15:104,397,276...104,447,985
G
Ipo7
importin 7
increases expression
EXP
nefazodone results in increased expression of IPO7 mRNA
CTD
PMID:24136188
NCBI chr 1:173,497,472...173,537,707
Ensembl chr 1:173,497,503...173,536,778
G
Irak1
interleukin-1 receptor-associated kinase 1
increases expression
EXP
nefazodone results in increased expression of IRAK1 mRNA
CTD
PMID:24136188
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:156,920,081...156,929,825
G
Ireb2
iron responsive element binding protein 2
increases expression
EXP
nefazodone results in increased expression of IREB2 mRNA
CTD
PMID:24136188
NCBI chr 8:64,124,152...64,207,702
Ensembl chr 8:64,154,945...64,205,520
G
Irf6
interferon regulatory factor 6
decreases expression
EXP
nefazodone results in decreased expression of IRF6 mRNA
CTD
PMID:24136188
NCBI chr13:107,200,876...107,220,083
Ensembl chr13:107,200,731...107,220,049
G
Irgm
immunity-related GTPase M
decreases expression
EXP
nefazodone results in decreased expression of IRGM mRNA
CTD
PMID:24136188
NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,732,961...33,743,228
G
Isoc1
isochorismatase domain containing 1
increases expression
EXP
nefazodone results in increased expression of ISOC1 mRNA
CTD
PMID:24136188
NCBI chr18:54,356,757...54,377,170
Ensembl chr18:54,356,734...54,377,170
G
Itih1
inter-alpha trypsin inhibitor, heavy chain 1
decreases expression
EXP
nefazodone results in decreased expression of ITIH1 mRNA
CTD
PMID:24136188
NCBI chr16:6,128,696...6,142,813
Ensembl chr16:6,128,698...6,142,853
G
Itih2
inter-alpha-trypsin inhibitor heavy chain 2
decreases expression
EXP
nefazodone results in decreased expression of ITIH2 mRNA
CTD
PMID:24136188
NCBI chr17:73,285,281...73,321,555
Ensembl chr17:73,285,270...73,321,547
G
Ivd
isovaleryl-CoA dehydrogenase
decreases expression
EXP
nefazodone results in decreased expression of IVD mRNA
CTD
PMID:24136188
NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:126,305,364...126,328,160
G
Iyd
iodotyrosine deiodinase
decreases expression
EXP
nefazodone results in decreased expression of IYD mRNA
CTD
PMID:24136188
NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386
G
Jade1
jade family PHD finger 1
increases expression
EXP
nefazodone results in increased expression of JADE1 mRNA
CTD
PMID:24136188
NCBI chr 2:126,471,124...126,524,252
Ensembl chr 2:126,471,124...126,524,252
G
Jagn1
jagunal homolog 1
increases expression
EXP
nefazodone results in increased expression of JAGN1 mRNA
CTD
PMID:24136188
NCBI chr 4:148,147,213...148,151,915
Ensembl chr 4:148,147,229...148,151,915
G
Jmjd1c
jumonji domain containing 1C
decreases expression
EXP
nefazodone results in decreased expression of JMJD1C mRNA
CTD
PMID:24136188
NCBI chr20:21,330,990...21,508,580
Ensembl chr20:21,330,990...21,461,916
G
Josd1
Josephin domain containing 1
increases expression
EXP
nefazodone results in increased expression of JOSD1 mRNA
CTD
PMID:24136188
NCBI chr 7:113,110,709...113,124,632
Ensembl chr 7:113,110,717...113,124,632
G
Josd2
Josephin domain containing 2
increases expression
EXP
nefazodone results in increased expression of JOSD2 mRNA
CTD
PMID:24136188
NCBI chr 1:104,097,382...104,101,271
Ensembl chr 1:104,097,376...104,101,277
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression increases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of JUN mRNA nefazodone results in increased expression of JUN mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of JUN mRNA
CTD
PMID:24136188 PMID:27288927 PMID:32152650
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression increases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of JUND mRNA nefazodone results in increased expression of JUND mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of JUND mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,764,985...18,782,148
G
Jup
junction plakoglobin
decreases expression
EXP
nefazodone results in decreased expression of JUP mRNA
CTD
PMID:24136188
NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,800,814...85,827,429
G
Kansl1
KAT8 regulatory NSL complex subunit 1
decreases expression
EXP
nefazodone results in decreased expression of KANSL1 mRNA
CTD
PMID:24136188
NCBI chr10:89,237,667...89,368,735
Ensembl chr10:89,737,637...89,868,620
G
Kansl2
KAT8 regulatory NSL complex subunit 2
increases expression
EXP
nefazodone results in increased expression of KANSL2 mRNA
CTD
PMID:24136188
NCBI chr 7:129,669,031...129,685,750
Ensembl chr 7:131,548,062...131,564,753
G
Kcmf1
potassium channel modulatory factor 1
increases expression
EXP
nefazodone results in increased expression of KCMF1 mRNA
CTD
PMID:24136188
NCBI chr 4:106,447,974...106,508,359
Ensembl chr 4:106,447,981...106,508,359
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity multiple interactions affects activity
ISO
nefazodone results in decreased activity of KCNH2 protein nefazodone binds to and results in decreased activity of KCNH2 protein nefazodone affects the activity of KCNH2 protein
CTD
PMID:24052561 PMID:24374264 PMID:26821276 PMID:28551711
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
G
Kcnj3
potassium inwardly-rectifying channel, subfamily J, member 3
multiple interactions
ISO
nefazodone affects the activity of [KCNJ3 mRNA co-treated with KCNJ5 mRNA]; nefazodone affects the activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]
CTD
PMID:22164246
NCBI chr 3:60,353,990...60,518,110
Ensembl chr 3:60,354,146...60,518,104
G
Kcnj5
potassium inwardly-rectifying channel, subfamily J, member 5
multiple interactions
ISO
nefazodone affects the activity of [KCNJ3 mRNA co-treated with KCNJ5 mRNA]
CTD
PMID:22164246
NCBI chr 8:38,981,598...39,011,197
Ensembl chr 8:38,983,034...39,011,101
G
Kcnj6
potassium inwardly-rectifying channel, subfamily J, member 6
multiple interactions
ISO
nefazodone affects the activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]
CTD
PMID:22164246
NCBI chr11:47,531,312...47,778,348
Ensembl chr11:47,531,312...47,778,348
G
Kctd5
potassium channel tetramerization domain containing 5
increases expression
EXP
nefazodone results in increased expression of KCTD5 mRNA
CTD
PMID:24136188
NCBI chr10:13,583,781...13,609,762
Ensembl chr10:13,583,781...13,610,062
G
Kctd9
potassium channel tetramerization domain containing 9
increases expression
EXP
nefazodone results in increased expression of KCTD9 mRNA
CTD
PMID:24136188
NCBI chr15:46,117,211...46,145,258
Ensembl chr15:46,117,874...46,145,266
G
Kdm5b
lysine demethylase 5B
decreases expression
EXP
nefazodone results in decreased expression of KDM5B mRNA
CTD
PMID:24136188
NCBI chr13:48,554,367...48,625,721
Ensembl chr13:48,554,420...48,626,423
G
Keap1
Kelch-like ECH-associated protein 1
increases expression
EXP
nefazodone results in increased expression of KEAP1 mRNA
CTD
PMID:24136188
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
G
Klf15
KLF transcription factor 15
increases expression
EXP
nefazodone results in increased expression of KLF15 mRNA
CTD
PMID:24136188
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:124,522,909...124,542,373
G
Klhdc2
kelch domain containing 2
increases expression
EXP
nefazodone results in increased expression of KLHDC2 mRNA
CTD
PMID:24136188
NCBI chr 6:93,512,981...93,552,809
Ensembl chr 6:93,513,017...93,577,762
G
Kmt2e
lysine methyltransferase 2E
decreases expression
EXP
nefazodone results in decreased expression of KMT2E mRNA
CTD
PMID:24136188
NCBI chr 4:12,550,570...12,655,329
Ensembl chr 4:12,550,570...12,619,721
G
Kng1
kininogen 1
decreases expression
EXP
nefazodone results in decreased expression of KNG1 mRNA
CTD
PMID:24136188
NCBI chr11:91,317,354...91,340,148
Ensembl chr11:91,317,355...91,340,148
G
Kng2
kininogen 2
decreases expression
EXP
nefazodone results in decreased expression of KNG2 mRNA
CTD
PMID:24136188
NCBI chr11:91,418,470...91,440,841
Ensembl chr11:91,414,207...91,441,259
G
Kpna1
karyopherin subunit alpha 1
increases expression
EXP
nefazodone results in increased expression of KPNA1 mRNA
CTD
PMID:24136188
NCBI chr11:78,221,165...78,279,778
Ensembl chr11:78,222,884...78,267,067
G
Krt18
keratin 18
increases expression
EXP
nefazodone results in increased expression of KRT18 mRNA
CTD
PMID:24136188
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
G
Krt8
keratin 8
increases expression
EXP
nefazodone results in increased expression of KRT8 mRNA
CTD
PMID:24136188
NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403
G
Kxd1
KxDL motif containing 1
increases expression
EXP
nefazodone results in increased expression of KXD1 mRNA
CTD
PMID:24136188
NCBI chr16:18,929,316...18,950,239
Ensembl chr16:18,936,356...18,950,237
G
Kyat1
kynurenine aminotransferase 1
increases expression
EXP
nefazodone results in increased expression of KYAT1 mRNA
CTD
PMID:24136188
NCBI chr 3:33,857,407...33,891,153
Ensembl chr 3:33,857,743...33,890,642
G
Kynu
kynureninase
decreases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of KYNU mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of KYNU mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 3:48,188,286...48,338,996
Ensembl chr 3:48,188,182...48,339,014
G
L3mbtl2
L3MBTL histone methyl-lysine binding protein 2
increases expression
EXP
nefazodone results in increased expression of L3MBTL2 mRNA
CTD
PMID:24136188
NCBI chr 7:115,066,427...115,087,625
Ensembl chr 7:115,066,486...115,087,598
G
Lactb2
lactamase, beta 2
increases expression
EXP
nefazodone results in increased expression of LACTB2 mRNA
CTD
PMID:24136188
NCBI chr 5:10,352,165...10,374,928
Ensembl chr 5:10,352,154...10,379,255
G
Lama3
laminin subunit alpha 3
increases expression
EXP
nefazodone results in increased expression of LAMA3 mRNA
CTD
PMID:24136188
NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449
G
Lamtor3
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
increases expression
EXP
nefazodone results in increased expression of LAMTOR3 mRNA
CTD
PMID:24136188
NCBI chr 2:226,411,389...226,423,612
Ensembl chr 2:229,084,858...229,099,383
G
Lamtor4
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4
increases expression
EXP
nefazodone results in increased expression of LAMTOR4 mRNA
CTD
PMID:24136188
NCBI chr12:22,372,269...22,376,090
Ensembl chr12:22,372,269...22,376,090
G
Lancl1
LanC like glutathione S-transferase 1
increases expression
EXP
nefazodone results in increased expression of LANCL1 mRNA
CTD
PMID:24136188
NCBI chr 9:75,968,284...75,998,397
Ensembl chr 9:75,968,286...76,003,475
G
Lap3
leucine aminopeptidase 3
decreases expression
EXP
nefazodone results in decreased expression of LAP3 mRNA
CTD
PMID:24136188
NCBI chr14:69,820,907...69,839,891
Ensembl chr14:69,820,908...69,839,891
G
Laptm4a
lysosomal protein transmembrane 4 alpha
increases expression
EXP
nefazodone results in increased expression of LAPTM4A mRNA
CTD
PMID:24136188
NCBI chr 6:37,438,503...37,456,238
Ensembl chr 6:37,438,121...37,456,223
G
Lbp
lipopolysaccharide binding protein
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of LBP mRNA
CTD
PMID:33819548
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518
G
Lcmt1
leucine carboxyl methyltransferase 1
decreases expression
EXP
nefazodone results in decreased expression of LCMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:177,904,119...177,960,111
Ensembl chr 1:187,327,706...187,391,516
G
Ldlr
low density lipoprotein receptor
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of LDLR mRNA
CTD
PMID:33819548
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
G
Lect2
leukocyte cell-derived chemotaxin 2
decreases expression
EXP
nefazodone results in decreased expression of LECT2 mRNA
CTD
PMID:24136188
NCBI chr17:8,050,034...8,056,256
Ensembl chr17:8,050,034...8,056,256
G
Leprotl1
leptin receptor overlapping transcript-like 1
increases expression
EXP
nefazodone results in increased expression of LEPROTL1 mRNA
CTD
PMID:24136188
NCBI chr16:64,744,148...64,756,776
Ensembl chr16:64,743,717...64,756,776
G
Lgals5
galectin 5
decreases expression
EXP
nefazodone results in decreased expression of LGALS5 mRNA
CTD
PMID:24136188
NCBI chr10:64,351,976...64,355,137
Ensembl chr10:64,351,964...64,355,180
G
Lgals8
galectin 8
increases expression
EXP
nefazodone results in increased expression of LGALS8 mRNA
CTD
PMID:24136188
NCBI chr17:62,716,368...62,744,272
Ensembl chr17:62,719,828...62,744,482
G
Lgals9
galectin 9
decreases expression
EXP
nefazodone results in decreased expression of LGALS9 mRNA
CTD
PMID:24136188
NCBI chr10:64,405,044...64,428,249
Ensembl chr10:64,405,044...64,428,070
G
Lgalsl
galectin-like
decreases expression
EXP
nefazodone results in decreased expression of LGALSL mRNA
CTD
PMID:24136188
NCBI chr14:99,198,340...99,205,846
Ensembl chr14:99,198,339...99,206,487
G
Lims2
LIM zinc finger domain containing 2
decreases expression
EXP
nefazodone results in decreased expression of LIMS2 mRNA
CTD
PMID:24136188
NCBI chr18:23,828,164...23,866,363
Ensembl chr18:23,837,686...23,867,086
G
Lin37
lin-37 DREAM MuvB core complex component
increases expression
EXP
nefazodone results in increased expression of LIN37 mRNA
CTD
PMID:24136188
NCBI chr 1:94,936,512...94,940,444
Ensembl chr 1:94,936,512...94,940,444
G
Lipa
lipase A, lysosomal acid type
increases expression
EXP
nefazodone results in increased expression of LIPA mRNA
CTD
PMID:24136188
NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:241,437,524...241,470,740
G
Lipc
lipase C, hepatic type
decreases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of LIPC mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of LIPC mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285
G
Lmbrd1
LMBR1 domain containing 1
increases expression
EXP
nefazodone results in increased expression of LMBRD1 mRNA
CTD
PMID:24136188
NCBI chr 9:34,592,723...34,674,425
Ensembl chr 9:34,577,616...34,674,428
G
Lmna
lamin A/C
increases expression
EXP
nefazodone results in increased expression of LMNA mRNA
CTD
PMID:24136188
NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072
G
Lox
lysyl oxidase
decreases expression
EXP
nefazodone results in decreased expression of LOX mRNA
CTD
PMID:24136188
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810
G
Lpin1
lipin 1
decreases expression
EXP
nefazodone results in decreased expression of LPIN1 mRNA
CTD
PMID:24136188
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991
G
Lrat
lecithin retinol acyltransferase
decreases expression
EXP
nefazodone results in decreased expression of LRAT mRNA
CTD
PMID:24136188
NCBI chr 2:170,562,148...170,571,212
Ensembl chr 2:170,565,543...170,571,148
G
Lrp1
LDL receptor related protein 1
decreases expression
EXP
nefazodone results in decreased expression of LRP1 mRNA
CTD
PMID:24136188
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:65,265,639...65,346,196
G
Lrp3
LDL receptor related protein 3
decreases expression
EXP
nefazodone results in decreased expression of LRP3 mRNA
CTD
PMID:24136188
NCBI chr 1:96,980,762...96,996,157
Ensembl chr 1:96,981,815...96,996,057
G
Lrp5
LDL receptor related protein 5
decreases expression
EXP
nefazodone results in decreased expression of LRP5 mRNA
CTD
PMID:24136188
NCBI chr 1:210,243,499...210,346,886
Ensembl chr 1:210,243,502...210,346,822
G
Lrp6
LDL receptor related protein 6
decreases expression
EXP
nefazodone results in decreased expression of LRP6 mRNA
CTD
PMID:24136188
NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:169,000,968...169,131,716
G
Lrrc59
leucine rich repeat containing 59
increases expression
EXP
nefazodone results in increased expression of LRRC59 mRNA
CTD
PMID:24136188
NCBI chr10:80,069,162...80,083,820
Ensembl chr10:80,069,120...80,084,079
G
Lrrc8b
leucine rich repeat containing 8 VRAC subunit B
decreases expression
EXP
nefazodone results in decreased expression of LRRC8B mRNA
CTD
PMID:24136188
NCBI chr14:4,655,273...4,721,648
Ensembl chr14:4,655,273...4,721,076
G
Lsm10
LSM10, U7 small nuclear RNA associated
increases expression
EXP
nefazodone results in increased expression of LSM10 mRNA
CTD
PMID:24136188
NCBI chr 5:143,649,817...143,660,391
Ensembl chr 5:143,615,360...143,663,986
G
Lta4h
leukotriene A4 hydrolase
decreases expression
EXP
nefazodone results in decreased expression of LTA4H mRNA
CTD
PMID:24136188
NCBI chr 7:29,856,846...29,888,642
Ensembl chr 7:29,856,802...29,888,641
G
Ltbr
lymphotoxin beta receptor
increases expression
EXP
nefazodone results in increased expression of LTBR mRNA
CTD
PMID:24136188
NCBI chr 4:159,795,115...159,801,571
Ensembl chr 4:159,795,115...159,807,296
G
Luc7l2
LUC7 pre-mRNA splicing factor like 2
decreases expression
EXP
nefazodone results in decreased expression of LUC7L2 mRNA
CTD
PMID:24136188
NCBI chr 4:68,251,435...68,314,861
Ensembl chr 4:68,271,414...68,314,837
G
Ly96
lymphocyte antigen 96
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of LY96 mRNA
CTD
PMID:33819548
NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:7,365,557...7,395,816
G
Lypla1
lysophospholipase 1
decreases expression
EXP
nefazodone results in decreased expression of LYPLA1 mRNA
CTD
PMID:24136188
NCBI chr 5:19,477,408...19,506,568
Ensembl chr 5:19,477,409...19,506,522
G
Lyplal1
lysophospholipase-like 1
increases expression
EXP
nefazodone results in increased expression of LYPLAL1 mRNA
CTD
PMID:24136188
NCBI chr13:100,158,060...100,189,339
Ensembl chr13:100,158,060...100,189,503
G
Lyve1
lymphatic vessel endothelial hyaluronan receptor 1
decreases expression
EXP
nefazodone results in decreased expression of LYVE1 mRNA
CTD
PMID:24136188
NCBI chr 1:174,393,387...174,410,977
G
Maco1
macoilin 1
increases expression
EXP
nefazodone results in increased expression of MACO1 mRNA
CTD
PMID:24136188
NCBI chr 5:152,296,107...152,358,684
Ensembl chr 5:152,296,558...152,358,684
G
Macrod1
mono-ADP ribosylhydrolase 1
decreases expression
EXP
nefazodone results in decreased expression of MACROD1 mRNA
CTD
PMID:24136188
NCBI chr 1:213,675,413...213,831,571
Ensembl chr 1:213,675,406...213,816,348
G
Maf
MAF bZIP transcription factor
multiple interactions
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAF mRNA
CTD
PMID:32152650
NCBI chr19:60,259,200...60,622,145
Ensembl chr19:60,269,541...60,621,378
G
Mafb
MAF bZIP transcription factor B
decreases expression
EXP
nefazodone results in decreased expression of MAFB mRNA
CTD
PMID:24136188
NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:169,416,945...169,419,975
G
Maff
MAF bZIP transcription factor F
increases expression multiple interactions
ISO
nefazodone results in increased expression of MAFF mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFF mRNA
CTD
PMID:32152650
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147
G
Mafg
MAF bZIP transcription factor G
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA nefazodone results in increased expression of MAFG mRNA
CTD
PMID:32152650
NCBI chr10:106,401,633...106,410,159
G
Mafk
MAF bZIP transcription factor K
increases expression multiple interactions
ISO
nefazodone results in increased expression of MAFK mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFK mRNA
CTD
PMID:32152650
NCBI chr12:19,948,473...19,970,351
Ensembl chr12:19,948,476...19,959,192
G
Magmas-ps1
mitochondria-associated protein involved in granulocyte-macrophage colony-stimulating factor signal transduction, pseudogene 1
increases expression
EXP
nefazodone results in increased expression of MAGMAS-PS1 mRNA
CTD
PMID:24136188
NCBI chr10:88,602,379...88,602,899
G
Magoh
mago homolog, exon junction complex subunit
increases expression
EXP
nefazodone results in increased expression of MAGOH mRNA
CTD
PMID:24136188
NCBI chr 5:127,868,044...127,875,423
Ensembl chr 5:127,868,055...127,875,384
G
Mal2
mal, T-cell differentiation protein 2
increases expression
EXP
nefazodone results in increased expression of MAL2 mRNA
CTD
PMID:24136188
NCBI chr 7:87,790,239...87,823,219
Ensembl chr 7:87,790,239...87,850,403
G
Malsu1
mitochondrial assembly of ribosomal large subunit 1
increases expression
EXP
nefazodone results in increased expression of MALSU1 mRNA
CTD
PMID:24136188
NCBI chr 4:79,381,963...79,390,786
Ensembl chr 4:79,374,393...79,411,608
G
Maoa
monoamine oxidase A
increases expression
EXP
nefazodone results in increased expression of MAOA mRNA
CTD
PMID:24136188
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of MAP1LC3B mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA; nefazodone results in increased expression of and results in increased lipidation of MAP1LC3B protein
CTD
PMID:24136188 PMID:32152650 PMID:33609687
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
G
Map2k1
mitogen activated protein kinase kinase 1
increases expression
EXP
nefazodone results in increased expression of MAP2K1 mRNA
CTD
PMID:24136188
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
G
Map2k2
mitogen activated protein kinase kinase 2
increases expression
EXP
nefazodone results in increased expression of MAP2K2 mRNA
CTD
PMID:24136188
NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940
G
Map2k3
mitogen activated protein kinase kinase 3
increases expression
EXP
nefazodone results in increased expression of MAP2K3 mRNA
CTD
PMID:24136188
NCBI chr10:46,107,639...46,128,986
Ensembl chr10:46,106,548...46,129,004
G
Map2k6
mitogen-activated protein kinase kinase 6
multiple interactions
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA
CTD
PMID:32152650
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721
G
Mapk1
mitogen activated protein kinase 1
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of MAPK1 mRNA nefazodone results in increased phosphorylation of and results in increased activity of MAPK1 protein
CTD
PMID:24136188 PMID:27613715
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
nefazodone results in increased phosphorylation of and results in increased activity of MAPK3 protein
CTD
PMID:27613715
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
G
Mapkapk2
MAPK activated protein kinase 2
decreases expression
EXP
nefazodone results in decreased expression of MAPKAPK2 mRNA
CTD
PMID:24136188
NCBI chr13:45,066,027...45,112,326
Ensembl chr13:45,066,031...45,112,326
G
Mapkapk3
MAPK activated protein kinase 3
increases expression multiple interactions
ISO
nefazodone results in increased expression of MAPKAPK3 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA
CTD
PMID:32152650
NCBI chr 8:116,808,429...116,842,228
Ensembl chr 8:116,808,429...116,842,228
G
Marchf5
membrane associated ring-CH-type finger 5
increases expression
EXP
nefazodone results in increased expression of MARCHF5 mRNA
CTD
PMID:24136188
NCBI chr 1:244,343,674...244,365,160
Ensembl chr 1:244,343,630...244,366,462
G
Marchf6
membrane associated ring-CH-type finger 6
increases expression
EXP
nefazodone results in increased expression of MARCHF6 mRNA
CTD
PMID:24136188
NCBI chr 2:84,166,570...84,243,817
Ensembl chr 2:84,166,570...84,243,792
G
Marcksl1
MARCKS-like 1
decreases expression
EXP
nefazodone results in decreased expression of MARCKSL1 mRNA
CTD
PMID:24136188
NCBI chr 5:147,135,827...147,138,150
Ensembl chr 5:147,134,514...147,138,417
G
Masp1
MBL associated serine protease 1
decreases expression
EXP
nefazodone results in decreased expression of MASP1 mRNA
CTD
PMID:24136188
NCBI chr11:90,839,081...90,909,922
Ensembl chr11:90,839,061...90,917,470
G
Mbl1
mannose binding lectin 1
decreases expression
EXP
nefazodone results in decreased expression of MBL1 mRNA
CTD
PMID:24136188
NCBI chr16:17,063,232...17,069,271
Ensembl chr16:17,060,703...17,069,271
G
Mbl2
mannose binding lectin 2
decreases expression
EXP
nefazodone results in decreased expression of MBL2 mRNA
CTD
PMID:24136188
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
G
Mbtd1
mbt domain containing 1
decreases expression
EXP
nefazodone results in decreased expression of MBTD1 mRNA
CTD
PMID:24136188
NCBI chr10:79,336,041...79,392,315
Ensembl chr10:79,335,235...79,392,315
G
Mcee
methylmalonyl CoA epimerase
decreases expression
EXP
nefazodone results in decreased expression of MCEE mRNA
CTD
PMID:24136188
NCBI chr 1:117,964,576...117,987,779
Ensembl chr 1:127,376,298...127,400,367
G
Mcoln1
mucolipin TRP cation channel 1
increases expression
EXP
nefazodone results in increased expression of MCOLN1 mRNA
CTD
PMID:24136188
NCBI chr12:6,357,851...6,372,151
Ensembl chr12:6,357,807...6,372,151
G
Mdm2
MDM2 proto-oncogene
increases expression
EXP
nefazodone results in increased expression of MDM2 mRNA
CTD
PMID:24136188
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
G
Me1
malic enzyme 1
increases expression
EXP
nefazodone results in increased expression of ME1 mRNA
CTD
PMID:24136188
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275
G
Mecr
mitochondrial trans-2-enoyl-CoA reductase
increases expression
EXP
nefazodone results in increased expression of MECR mRNA
CTD
PMID:24136188
NCBI chr 5:149,313,765...149,339,964
Ensembl chr 5:149,313,774...149,342,825
G
Med31
mediator complex subunit 31
increases expression
EXP
nefazodone results in increased expression of MED31 mRNA
CTD
PMID:24136188
NCBI chr10:57,335,507...57,338,889
Ensembl chr10:57,335,507...57,338,889
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
nefazodone results in increased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821
G
Metap2
methionyl aminopeptidase 2
increases expression
EXP
nefazodone results in increased expression of METAP2 mRNA
CTD
PMID:24136188
NCBI chr 7:30,299,433...30,327,477
Ensembl chr 7:30,299,433...30,327,521
G
Mettl5
methyltransferase 5, N6-adenosine
increases expression
EXP
nefazodone results in increased expression of METTL5 mRNA
CTD
PMID:24136188
NCBI chr 3:75,033,605...75,046,359
Ensembl chr 3:75,026,861...75,045,831
G
Mfsd1
major facilitator superfamily domain containing 1
increases expression
EXP
nefazodone results in increased expression of MFSD1 mRNA
CTD
PMID:24136188
NCBI chr 2:154,156,167...154,176,209
Ensembl chr 2:154,156,166...154,177,086
G
Mfsd4b1
major facilitator superfamily domain containing 4B1
increases expression
EXP
nefazodone results in increased expression of MFSD4B1 mRNA
CTD
PMID:24136188
NCBI chr20:43,436,857...43,450,064
Ensembl chr20:44,991,384...45,006,161
G
Mgat4b
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B
decreases expression
EXP
nefazodone results in decreased expression of MGAT4B mRNA
CTD
PMID:24136188
NCBI chr10:35,049,421...35,060,307
Ensembl chr10:35,050,512...35,060,309
G
Mgll
monoglyceride lipase
increases expression
EXP
nefazodone results in increased expression of MGLL mRNA
CTD
PMID:24136188
NCBI chr 4:122,749,436...122,851,440
Ensembl chr 4:122,749,436...122,851,440
G
Mgst2
microsomal glutathione S-transferase 2
increases expression decreases expression multiple interactions
EXP ISO
nefazodone results in increased expression of MGST2 mRNA nefazodone results in decreased expression of MGST2 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of MGST2 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MGST2 mRNA
CTD
PMID:24136188 PMID:32152650 PMID:33819548
NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661
G
Mgst3
microsomal glutathione S-transferase 3
decreases expression
EXP
nefazodone results in decreased expression of MGST3 mRNA
CTD
PMID:24136188
NCBI chr13:82,059,480...82,080,418
Ensembl chr13:82,059,480...82,080,575
G
Mid1ip1
MID1 interacting protein 1
decreases expression
EXP
nefazodone results in decreased expression of MID1IP1 mRNA
CTD
PMID:24136188
NCBI chr X:14,733,539...14,735,859
Ensembl chr X:14,732,830...14,739,079
G
Mif
macrophage migration inhibitory factor
increases expression
EXP
nefazodone results in increased expression of MIF mRNA
CTD
PMID:24136188
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
G
Mindy3
MINDY lysine 48 deubiquitinase 3
decreases expression
EXP
nefazodone results in decreased expression of MINDY3 mRNA
CTD
PMID:24136188
NCBI chr17:80,454,404...80,532,999
Ensembl chr17:80,454,405...80,532,960
G
Miox
myo-inositol oxygenase
increases expression
EXP
nefazodone results in increased expression of MIOX mRNA
CTD
PMID:24136188
NCBI chr 7:122,284,660...122,287,158
Ensembl chr 7:122,284,660...122,287,157
G
Mix23
mitochondrial matrix import factor 23
increases expression
EXP
nefazodone results in increased expression of MIX23 mRNA
CTD
PMID:24136188
NCBI chr11:78,166,038...78,186,323
Ensembl chr11:78,166,038...78,186,323
G
Mknk2
MAPK interacting serine/threonine kinase 2
decreases expression
EXP
nefazodone results in decreased expression of MKNK2 mRNA
CTD
PMID:24136188
NCBI chr 7:9,690,385...9,701,527
Ensembl chr 7:9,690,421...9,701,529
G
Mlec
malectin
increases expression
EXP
nefazodone results in increased expression of MLEC mRNA
CTD
PMID:24136188
NCBI chr12:41,458,234...41,468,710
Ensembl chr12:47,118,855...47,130,064
G
Mlkl
mixed lineage kinase domain like pseudokinase
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MLKL mRNA nefazodone results in increased expression of MLKL mRNA
CTD
PMID:32152650
NCBI chr19:56,186,860...56,213,886
Ensembl chr19:56,186,860...56,213,858
G
Mlx
MAX dimerization protein MLX
increases expression
EXP
nefazodone results in increased expression of MLX mRNA
CTD
PMID:24136188
NCBI chr10:86,519,517...86,524,607
Ensembl chr10:86,519,864...86,524,772
G
Mlxipl
MLX interacting protein-like
decreases expression
EXP
nefazodone results in decreased expression of MLXIPL mRNA
CTD
PMID:24136188
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:27,178,158...27,213,660
G
Mlycd
malonyl-CoA decarboxylase
increases expression
EXP
nefazodone results in increased expression of MLYCD mRNA
CTD
PMID:24136188
NCBI chr19:64,356,582...64,372,447
Ensembl chr19:64,356,223...64,372,446
G
Mmadhc
metabolism of cobalamin associated D
increases expression
EXP
nefazodone results in increased expression of MMADHC mRNA
CTD
PMID:24136188
NCBI chr 3:55,117,832...55,135,735
Ensembl chr 3:55,117,833...55,135,851
G
Mmgt1
membrane magnesium transporter 1
increases expression
EXP
nefazodone results in increased expression of MMGT1 mRNA
CTD
PMID:24136188
NCBI chr X:139,445,834...139,458,169
Ensembl chr X:139,445,834...139,458,169
G
Mmut
methylmalonyl-CoA mutase
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of MMUT mRNA
CTD
PMID:33819548
NCBI chr 9:27,425,935...27,454,202
Ensembl chr 9:27,425,935...27,454,342
G
Mocs2
molybdenum cofactor synthesis 2
increases expression
EXP
nefazodone results in increased expression of MOCS2 mRNA
CTD
PMID:24136188
NCBI chr 2:48,237,655...48,249,394
Ensembl chr 2:48,237,655...48,249,394
G
Morf4l2
mortality factor 4 like 2
increases expression
EXP
nefazodone results in increased expression of MORF4L2 mRNA
CTD
PMID:24136188
NCBI chr X:104,874,850...104,885,946
Ensembl chr X:104,852,693...104,892,855
G
Mospd3
motile sperm domain containing 3
decreases expression
EXP
nefazodone results in decreased expression of MOSPD3 mRNA
CTD
PMID:24136188
NCBI chr12:24,728,012...24,737,078
Ensembl chr12:24,732,008...24,736,244
G
Mpc1
mitochondrial pyruvate carrier 1
decreases expression
EXP
nefazodone results in decreased expression of MPC1 mRNA
CTD
PMID:24136188
NCBI chr 1:54,985,305...54,996,979
Ensembl chr 1:54,985,301...54,997,064
G
Mpc2
mitochondrial pyruvate carrier 2
increases expression
EXP
nefazodone results in increased expression of MPC2 mRNA
CTD
PMID:24136188
NCBI chr13:80,261,143...80,280,668
Ensembl chr13:80,259,727...80,280,668
G
Mpp1
MAGUK p55 scaffold protein 1
decreases expression
EXP
nefazodone results in decreased expression of MPP1 mRNA
CTD
PMID:24136188
G
Mpst
mercaptopyruvate sulfurtransferase
decreases expression
EXP
nefazodone results in decreased expression of MPST mRNA
CTD
PMID:24136188
NCBI chr 7:111,836,079...111,843,651
Ensembl chr 7:111,835,587...111,843,650
G
Mri1
methylthioribose-1-phosphate isomerase 1
increases expression
EXP
nefazodone results in increased expression of MRI1 mRNA
CTD
PMID:24136188
NCBI chr19:40,812,114...40,819,846
Ensembl chr19:40,812,094...40,822,607
G
Mro
maestro
decreases expression
EXP
nefazodone results in decreased expression of MRO mRNA
CTD
PMID:24136188
NCBI chr18:69,723,764...69,742,815
Ensembl chr18:69,725,798...69,743,031
G
Mrpl14
mitochondrial ribosomal protein L14
increases expression
EXP
nefazodone results in increased expression of MRPL14 mRNA
CTD
PMID:24136188
NCBI chr 9:22,800,286...22,812,711
Ensembl chr 9:22,795,744...22,812,855
G
Mrpl17
mitochondrial ribosomal protein L17
increases expression
EXP
nefazodone results in increased expression of MRPL17 mRNA
CTD
PMID:24136188
NCBI chr 1:169,574,010...169,575,699
Ensembl chr 1:169,574,010...169,575,818
G
Mrpl18
mitochondrial ribosomal protein L18
increases expression
EXP
nefazodone results in increased expression of MRPL18 mRNA
CTD
PMID:24136188
NCBI chr 1:50,384,951...50,389,769
Ensembl chr 1:50,384,367...50,389,763
G
Mrpl19
mitochondrial ribosomal protein L19
increases expression
EXP
nefazodone results in increased expression of MRPL19 mRNA
CTD
PMID:24136188
NCBI chr 4:116,079,654...116,083,883
Ensembl chr 4:116,079,654...116,083,883
G
Mrpl20
mitochondrial ribosomal protein L20
increases expression
EXP
nefazodone results in increased expression of MRPL20 mRNA
CTD
PMID:24136188
NCBI chr 5:171,690,664...171,695,728
Ensembl chr 5:171,691,198...171,695,728
G
Mrpl22
mitochondrial ribosomal protein L22
increases expression
EXP
nefazodone results in increased expression of MRPL22 mRNA
CTD
PMID:24136188
NCBI chr10:42,843,165...42,856,243
Ensembl chr10:42,843,222...42,856,227
G
Mrpl23
mitochondrial ribosomal protein L23
increases expression
EXP
nefazodone results in increased expression of MRPL23 mRNA
CTD
PMID:24136188
NCBI chr 1:207,116,930...207,124,702
Ensembl chr 1:207,116,462...207,124,699
G
Mrpl24
mitochondrial ribosomal protein L24
increases expression
EXP
nefazodone results in increased expression of MRPL24 mRNA
CTD
PMID:24136188
NCBI chr 2:175,680,872...175,687,107
Ensembl chr 2:175,681,070...175,688,660
G
Mrpl34
mitochondrial ribosomal protein L34
increases expression
EXP
nefazodone results in increased expression of MRPL34 mRNA
CTD
PMID:24136188
NCBI chr16:18,186,447...18,187,182
Ensembl chr16:18,185,306...18,187,181
G
Mrpl36
mitochondrial ribosomal protein L36
increases expression
EXP
nefazodone results in increased expression of MRPL36 mRNA
CTD
PMID:24136188
NCBI chr 1:31,794,025...31,797,446
Ensembl chr 1:31,790,887...31,797,808
G
Mrpl49
mitochondrial ribosomal protein L49
increases expression
EXP
nefazodone results in increased expression of MRPL49 mRNA
CTD
PMID:24136188
NCBI chr 1:212,775,357...212,779,364
Ensembl chr 1:212,775,357...212,779,888
G
Mrpl50
mitochondrial ribosomal protein L50
increases expression
EXP
nefazodone results in increased expression of MRPL50 mRNA
CTD
PMID:24136188
NCBI chr 5:68,662,933...68,668,087
Ensembl chr 5:68,662,939...68,669,748
G
Mrpl52
mitochondrial ribosomal protein L52
increases expression
EXP
nefazodone results in increased expression of MRPL52 mRNA
CTD
PMID:24136188
NCBI chr15:31,852,927...31,856,160
Ensembl chr15:31,852,760...31,856,162
G
Mrpl55
mitochondrial ribosomal protein L55
increases expression
EXP
nefazodone results in increased expression of MRPL55 mRNA
CTD
PMID:24136188
NCBI chr10:44,488,252...44,491,401
Ensembl chr10:44,488,244...44,491,401
G
Mrps18b
mitochondrial ribosomal protein S18B
increases expression
EXP
nefazodone results in increased expression of MRPS18B mRNA
CTD
PMID:24136188
NCBI chr20:2,842,978...2,849,065
Ensembl chr20:2,842,528...2,849,065
G
Mrps18c
mitochondrial ribosomal protein S18C
increases expression
EXP
nefazodone results in increased expression of MRPS18C mRNA
CTD
PMID:24136188
NCBI chr14:9,116,688...9,122,943
G
Mrps30
mitochondrial ribosomal protein S30
increases expression
EXP
nefazodone results in increased expression of MRPS30 mRNA
CTD
PMID:24136188
NCBI chr 2:52,189,049...52,196,136
Ensembl chr 2:52,189,058...52,195,904
G
Mrps33
mitochondrial ribosomal protein S33
increases expression
EXP
nefazodone results in increased expression of MRPS33 mRNA
CTD
PMID:24136188
NCBI chr 4:69,563,501...69,572,317
Ensembl chr 4:69,563,503...69,572,177
G
Mrps34
mitochondrial ribosomal protein S34
increases expression
EXP
nefazodone results in increased expression of MRPS34 mRNA
CTD
PMID:24136188
NCBI chr10:14,420,543...14,421,674
Ensembl chr10:14,408,136...14,421,771
G
Mrps9
mitochondrial ribosomal protein S9
increases expression
EXP
nefazodone results in increased expression of MRPS9 mRNA
CTD
PMID:24136188
NCBI chr 9:52,605,678...52,664,499
Ensembl chr 9:52,605,678...52,664,499
G
Mrto4
MRT4 homolog, ribosome maturation factor
increases expression
EXP
nefazodone results in increased expression of MRTO4 mRNA
CTD
PMID:24136188
NCBI chr 5:151,601,780...151,608,533
Ensembl chr 5:156,884,985...156,891,738
G
Msrb2
methionine sulfoxide reductase B2
increases expression
EXP
nefazodone results in increased expression of MSRB2 mRNA
CTD
PMID:24136188
NCBI chr17:86,882,750...86,908,392
Ensembl chr17:86,882,394...86,908,391
G
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
decreases expression
ISO
nefazodone results in decreased expression of ATP8 mRNA
CTD
PMID:27288927
NCBI chr MT:7,758...7,961
Ensembl chr MT:7,743...7,946
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
decreases expression
ISO
nefazodone results in decreased expression of COX1 mRNA
CTD
PMID:27288927
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853
G
Mt-nd5
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5
decreases expression
ISO
nefazodone results in decreased expression of ND5 mRNA
CTD
PMID:27288927
NCBI chr MT:11,736...13,565
Ensembl chr MT:11,721...13,553
G
Mt1a
metallothionein 1A
increases expression
EXP
nefazodone results in increased expression of MT1A mRNA
CTD
PMID:24136188
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
G
Mtarc1
mitochondrial amidoxime reducing component 1
decreases expression
EXP
nefazodone results in decreased expression of MTARC1 mRNA
CTD
PMID:24136188
NCBI chr13:98,854,235...98,894,208
Ensembl chr13:98,871,289...98,894,252
G
Mterf3
mitochondrial transcription termination factor 3
increases expression
EXP
nefazodone results in increased expression of MTERF3 mRNA
CTD
PMID:24136188
NCBI chr 7:65,711,654...65,729,926
Ensembl chr 7:65,711,662...65,729,895
G
Mthfs
methenyltetrahydrofolate synthetase
increases expression
EXP
nefazodone results in increased expression of MTHFS mRNA
CTD
PMID:24136188
NCBI chr 8:98,609,410...98,681,901
Ensembl chr 8:98,609,399...98,752,036
G
Mtmr4
myotubularin related protein 4
increases expression
EXP
nefazodone results in increased expression of MTMR4 mRNA
CTD
PMID:24136188
NCBI chr10:72,890,665...72,913,598
Ensembl chr10:72,889,827...72,913,598
G
Mtpn
myotrophin
increases expression
EXP
nefazodone results in increased expression of MTPN mRNA
CTD
PMID:24136188
NCBI chr 4:65,126,390...65,153,803
Ensembl chr 4:65,115,980...65,153,924
G
Mtss1
MTSS I-BAR domain containing 1
increases expression
EXP
nefazodone results in increased expression of MTSS1 mRNA
CTD
PMID:24136188
NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:92,378,238...92,517,303
G
Mttp
microsomal triglyceride transfer protein
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of MTTP mRNA
CTD
PMID:33819548
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:229,286,501...229,327,650
G
Mug1
murinoglobulin 1
decreases expression
EXP
nefazodone results in decreased expression of MUG1 mRNA
CTD
PMID:24136188
NCBI chr 4:156,748,351...156,802,132
G
Mug2
murinoglobulin 2
decreases expression
EXP
nefazodone results in decreased expression of PZP mRNA
CTD
PMID:24136188
NCBI chr 4:156,836,140...156,908,972
G
Mvk
mevalonate kinase
decreases expression
EXP
nefazodone results in decreased expression of MVK mRNA
CTD
PMID:24136188
NCBI chr12:47,802,002...47,819,503
Ensembl chr12:47,802,002...47,819,503
G
Mybbp1a
MYB binding protein 1a
increases expression
EXP
nefazodone results in increased expression of MYBBP1A mRNA
CTD
PMID:24136188
NCBI chr10:57,555,458...57,565,819
Ensembl chr10:57,555,452...57,566,041
G
Myh9
myosin, heavy chain 9
decreases expression
EXP
nefazodone results in decreased expression of MYH9 mRNA
CTD
PMID:24136188
NCBI chr 7:111,224,291...111,304,963
Ensembl chr 7:111,224,291...111,304,963
G
Myo1d
myosin ID
decreases expression
EXP
nefazodone results in decreased expression of MYO1D mRNA
CTD
PMID:24136188
NCBI chr10:65,986,900...66,263,538
Ensembl chr10:65,975,122...66,263,958
G
Myo1g
myosin IG
increases expression
EXP
nefazodone results in increased expression of MYO1G mRNA
CTD
PMID:24136188
NCBI chr14:85,600,619...85,615,760
Ensembl chr14:85,600,619...85,615,760
G
Myorg
myogenesis regulating glycosidase
decreases expression
EXP
nefazodone results in decreased expression of MYORG mRNA
CTD
PMID:24136188
NCBI chr 5:61,452,956...61,460,500
Ensembl chr 5:61,432,418...61,460,581
G
Naa15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
increases expression
EXP
nefazodone results in increased expression of NAA15 mRNA
CTD
PMID:24136188
NCBI chr 2:137,608,883...137,671,618
Ensembl chr 2:137,608,797...137,671,619
G
Naa20
N(alpha)-acetyltransferase 20, NatB catalytic subunit
increases expression
EXP
nefazodone results in increased expression of NAA20 mRNA
CTD
PMID:24136188
NCBI chr 3:153,775,351...153,790,129
Ensembl chr 3:153,775,338...153,790,916
G
Naa50
N(alpha)-acetyltransferase 50, NatE catalytic subunit
increases expression
EXP
nefazodone results in increased expression of NAA50 mRNA
CTD
PMID:24136188
NCBI chr11:70,044,281...70,066,754
Ensembl chr11:70,044,281...70,066,754
G
Nab1
Ngfi-A binding protein 1
increases expression
EXP
nefazodone results in increased expression of NAB1 mRNA
CTD
PMID:24136188
NCBI chr 9:56,545,547...56,585,045
Ensembl chr 9:56,545,729...56,614,210
G
Nae1
NEDD8 activating enzyme E1 subunit 1
increases expression
EXP
nefazodone results in increased expression of NAE1 mRNA
CTD
PMID:24136188
NCBI chr19:452,462...478,591
Ensembl chr19:452,432...478,831
G
Naga
alpha-N-acetylgalactosaminidase
decreases expression
EXP
nefazodone results in decreased expression of NAGA mRNA
CTD
PMID:24136188
NCBI chr 7:115,726,438...115,735,494
Ensembl chr 7:115,726,624...115,736,828
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
EXP
nefazodone results in increased expression of NAMPT mRNA
CTD
PMID:24136188
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
G
Nap1l1
nucleosome assembly protein 1-like 1
increases expression
EXP
nefazodone results in increased expression of NAP1L1 mRNA
CTD
PMID:24136188
NCBI chr 7:48,819,464...48,844,108
Ensembl chr 7:48,819,477...48,844,104
G
Napg
NSF attachment protein gamma
increases expression
EXP
nefazodone results in increased expression of NAPG mRNA
CTD
PMID:24136188
NCBI chr18:58,710,702...58,729,450
Ensembl chr18:58,708,655...58,729,450
G
Nars1
asparaginyl-tRNA synthetase 1
increases expression
EXP
nefazodone results in increased expression of NARS1 mRNA
CTD
PMID:24136188
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:60,259,516...60,275,782
G
Nat8
N-acetyltransferase 8
increases expression
EXP
nefazodone results in increased expression of NAT8 mRNA
CTD
PMID:24136188
NCBI chr 4:119,836,986...119,837,764
Ensembl chr 4:119,835,645...119,843,159
G
Ncbp1
nuclear cap binding protein subunit 1
increases expression
EXP
nefazodone results in increased expression of NCBP1 mRNA
CTD
PMID:24136188
NCBI chr 5:65,211,632...65,244,532
Ensembl chr 5:65,211,358...65,244,665
G
Nckap1
NCK-associated protein 1
increases expression
EXP
nefazodone results in increased expression of NCKAP1 mRNA
CTD
PMID:24136188
NCBI chr 3:85,824,333...85,898,748
Ensembl chr 3:85,824,336...85,898,797
G
Ncor1
nuclear receptor co-repressor 1
decreases expression
EXP
nefazodone results in decreased expression of NCOR1 mRNA
CTD
PMID:24136188
NCBI chr10:47,498,852...47,641,612
Ensembl chr10:47,498,852...47,640,350
G
Ndfip2
Nedd4 family interacting protein 2
increases expression
EXP
nefazodone results in increased expression of NDFIP2 mRNA
CTD
PMID:24136188
NCBI chr15:88,394,548...88,500,881
Ensembl chr15:88,395,032...88,503,600
G
Ndrg2
NDRG family member 2
decreases expression
EXP
nefazodone results in decreased expression of NDRG2 mRNA
CTD
PMID:24136188
NCBI chr15:27,074,481...27,087,376
Ensembl chr15:27,074,481...27,083,125
G
Ndufa5
NADH:ubiquinone oxidoreductase subunit A5
increases expression
EXP
nefazodone results in increased expression of NDUFA5 mRNA
CTD
PMID:24136188
NCBI chr 4:53,962,877...53,971,235
Ensembl chr 4:53,962,877...53,971,235
G
Ndufab1
NADH:ubiquinone oxidoreductase subunit AB1
increases expression
EXP
nefazodone results in increased expression of NDUFAB1 mRNA
CTD
PMID:24136188
NCBI chr 1:186,075,933...186,091,843
Ensembl chr 1:186,057,113...186,089,373
G
Ndufaf3
NADH:ubiquinone oxidoreductase complex assembly factor 3
increases expression
EXP
nefazodone results in increased expression of NDUFAF3 mRNA
CTD
PMID:24136188
NCBI chr 8:118,139,891...118,141,723
Ensembl chr 8:118,139,892...118,141,723
G
Ndufaf4
NADH:ubiquinone oxidoreductase complex assembly factor 4
increases expression
EXP
nefazodone results in increased expression of NDUFAF4 mRNA
CTD
PMID:24136188
NCBI chr 5:43,401,795...43,406,967
G
Ndufc2
NADH:ubiquinone oxidoreductase subunit C2
increases expression
EXP
nefazodone results in increased expression of NDUFC2 mRNA
CTD
PMID:24136188
NCBI chr 1:161,122,370...161,129,413
Ensembl chr 1:161,123,150...161,129,419
G
Ndufv3
NADH:ubiquinone oxidoreductase subunit V3
decreases expression
EXP
nefazodone results in decreased expression of NDUFV3 mRNA
CTD
PMID:24136188
NCBI chr20:9,613,786...9,622,941
Ensembl chr13:48,468,224...48,488,847 Ensembl chr20:48,468,224...48,488,847
G
Nectin3
nectin cell adhesion molecule 3
decreases expression
EXP
nefazodone results in decreased expression of NECTIN3 mRNA
CTD
PMID:24136188
NCBI chr11:67,825,296...67,931,999
Ensembl chr11:67,827,137...67,871,383
G
Net1
neuroepithelial cell transforming 1
decreases expression
EXP
nefazodone results in decreased expression of NET1 mRNA
CTD
PMID:24136188
NCBI chr17:71,251,145...71,280,345
Ensembl chr17:71,251,149...71,289,270
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression
EXP
nefazodone results in decreased expression of NFE2L2 mRNA
CTD
PMID:24136188
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
G
Nfia
nuclear factor I/A
decreases expression
EXP
nefazodone results in decreased expression of NFIA mRNA
CTD
PMID:24136188
NCBI chr 5:117,359,006...117,897,391
Ensembl chr 5:117,359,077...117,891,395
G
Nfib
nuclear factor I/B
decreases expression
EXP
nefazodone results in decreased expression of NFIB mRNA
CTD
PMID:24136188
NCBI chr 5:101,805,168...102,020,618
Ensembl chr 5:101,805,168...102,019,945
G
Nfil3
nuclear factor, interleukin 3 regulated
decreases expression
EXP
nefazodone results in decreased expression of NFIL3 mRNA
CTD
PMID:24136188
NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826
G
Nfkbib
NFKB inhibitor beta
increases expression
EXP
nefazodone results in increased expression of NFKBIB mRNA
CTD
PMID:24136188
NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:93,173,820...93,326,366
G
Nfu1
NFU1 iron-sulfur cluster scaffold
increases expression
EXP
nefazodone results in increased expression of NFU1 mRNA
CTD
PMID:24136188
NCBI chr 4:121,016,316...121,036,925
Ensembl chr 4:121,016,393...121,037,493
G
Nfx1
nuclear transcription factor, X-box binding 1
increases expression
EXP
nefazodone results in increased expression of NFX1 mRNA
CTD
PMID:24136188
NCBI chr 5:60,900,140...60,958,889
Ensembl chr 5:60,901,217...60,958,889
G
Nfxl1
nuclear transcription factor, X-box binding-like 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of NFXL1 mRNA
CTD
PMID:33819548
NCBI chr14:35,980,058...36,021,478
Ensembl chr14:35,980,057...36,023,281
G
Nhp2
NHP2 ribonucleoprotein
increases expression
EXP
nefazodone results in increased expression of NHP2 mRNA
CTD
PMID:24136188
NCBI chr10:36,378,020...36,381,362
Ensembl chr10:36,377,997...36,381,354
G
Nifk
nucleolar protein interacting with the FHA domain of MKI67
increases expression
EXP
nefazodone results in increased expression of NIFK mRNA
CTD
PMID:24136188
NCBI chr13:29,393,303...29,403,387
Ensembl chr13:31,946,108...31,959,561
G
Nipsnap3b
nipsnap homolog 3B
decreases expression
EXP
nefazodone results in decreased expression of NIPSNAP3A mRNA
CTD
PMID:24136188
NCBI chr 5:72,446,945...72,465,090
Ensembl chr 5:72,432,957...72,465,544
G
Nit1
nitrilase 1
increases expression
EXP
nefazodone results in increased expression of NIT1 mRNA
CTD
PMID:24136188
NCBI chr13:86,302,334...86,305,770
Ensembl chr13:86,298,387...86,305,770
G
Nmt1
N-myristoyltransferase 1
increases expression
EXP
nefazodone results in increased expression of NMT1 mRNA
CTD
PMID:24136188
NCBI chr10:88,488,918...88,525,496
Ensembl chr10:88,488,990...88,522,729
G
Nnmt
nicotinamide N-methyltransferase
decreases expression
EXP
nefazodone results in decreased expression of NNMT mRNA
CTD
PMID:24136188
NCBI chr 8:57,820,156...57,851,301
Ensembl chr 8:57,825,464...57,843,174
G
Nomo1
Nodal modulator 1
increases expression
EXP
nefazodone results in increased expression of NOMO1 mRNA
CTD
PMID:24136188
NCBI chr 1:105,641,867...105,692,708
Ensembl chr 1:105,641,879...105,692,707
G
Nono
non-POU domain containing, octamer-binding
increases expression
EXP
nefazodone results in increased expression of NONO mRNA
CTD
PMID:24136188
NCBI chr X:70,594,116...70,611,976
Ensembl chr X:70,593,888...70,611,979
G
Nop16
NOP16 nucleolar protein
increases expression
EXP
nefazodone results in increased expression of NOP16 mRNA
CTD
PMID:24136188
NCBI chr17:10,022,950...10,027,867
Ensembl chr17:10,028,034...10,033,038
G
Nop56
NOP56 ribonucleoprotein
increases expression
EXP
nefazodone results in increased expression of NOP56 mRNA
CTD
PMID:24136188
NCBI chr 3:137,926,187...137,934,971
Ensembl chr 3:137,929,646...137,934,959
G
Notch2
notch receptor 2
decreases expression
EXP
nefazodone results in decreased expression of NOTCH2 mRNA
CTD
PMID:24136188
NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:188,299,336...188,432,823
G
Npepl1
aminopeptidase-like 1
increases expression
EXP
nefazodone results in increased expression of NPEPL1 mRNA
CTD
PMID:24136188
NCBI chr 3:183,312,185...183,324,744
Ensembl chr 3:183,312,185...183,324,744
G
Nphp1
nephrocystin 1
increases expression
EXP
nefazodone results in increased expression of NPHP1 mRNA
CTD
PMID:24136188
NCBI chr 3:135,413,927...135,469,505
Ensembl chr 3:135,413,927...135,469,505
G
Nploc4
NPL4 homolog, ubiquitin recognition factor
increases expression
EXP
nefazodone results in increased expression of NPLOC4 mRNA
CTD
PMID:24136188
NCBI chr10:106,152,756...106,208,306
Ensembl chr10:106,153,173...106,208,264
G
Npm1
nucleophosmin 1
increases expression
EXP
nefazodone results in increased expression of NPM1 mRNA
CTD
PMID:24136188
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024 Ensembl chr X:18,245,740...18,256,024
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
nefazodone results in increased expression of NQO1 mRNA
CTD
PMID:24136188
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
decreases expression
EXP
nefazodone results in decreased expression of NQO2 mRNA
CTD
PMID:24136188
NCBI chr17:31,114,825...31,144,062
Ensembl chr17:31,114,529...31,143,662
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
increases expression
EXP
nefazodone results in increased expression of NR1D2 mRNA
CTD
PMID:24136188
NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of NR1H2 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of NR1H2 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 1:104,178,483...104,183,863
Ensembl chr 1:104,178,234...104,183,863
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of NR1H3 mRNA
CTD
PMID:33819548
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
decreases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of NR1H4 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of NR1H4 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
decreases expression
ISO
nefazodone results in decreased expression of NR1I2 mRNA
CTD
PMID:32152650
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases expression decreases expression multiple interactions
EXP ISO
nefazodone results in increased expression of NR1I3 mRNA nefazodone results in decreased expression of NR1I3 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of NR1I3 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
G
Nr2c2ap
nuclear receptor 2C2-associated protein
increases expression
EXP
nefazodone results in increased expression of NR2C2AP mRNA
CTD
PMID:24136188
NCBI chr16:19,322,395...19,324,912
Ensembl chr16:19,322,405...19,324,637
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
EXP
nefazodone results in decreased expression of NR3C1 mRNA
CTD
PMID:24136188
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
G
Nrbp2
nuclear receptor binding protein 2
decreases expression
EXP
nefazodone results in decreased expression of NRBP2 mRNA
CTD
PMID:24136188
NCBI chr 7:109,679,330...109,685,656
Ensembl chr 7:109,679,330...109,685,588
G
Nrep
neuronal regeneration related protein
decreases expression
EXP
nefazodone results in decreased expression of NREP mRNA
CTD
PMID:24136188
NCBI chr18:25,291,219...25,320,742
Ensembl chr18:25,291,219...25,320,742
G
Nsdhl
NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL
decreases expression
EXP
nefazodone results in decreased expression of NSDHL mRNA
CTD
PMID:24136188
NCBI chr X:155,817,301...155,848,224
Ensembl chr X:155,817,340...155,848,220
G
Nsfl1c
NSFL1 cofactor
increases expression
EXP
nefazodone results in increased expression of NSFL1C mRNA
CTD
PMID:24136188
NCBI chr 3:139,978,306...140,002,876
Ensembl chr 3:160,438,708...160,463,228
G
Nsmce1
NSE1 homolog, SMC5-SMC6 complex component
increases expression
EXP
nefazodone results in increased expression of NSMCE1 mRNA
CTD
PMID:24136188
NCBI chr 1:180,030,355...180,058,541
Ensembl chr 1:189,462,677...189,491,432
G
Nsun2
NOP2/Sun RNA methyltransferase 2
increases expression
EXP
nefazodone results in increased expression of NSUN2 mRNA
CTD
PMID:24136188
NCBI chr 1:35,490,583...35,514,839
Ensembl chr 1:35,490,583...35,514,306
G
Nt5e
5' nucleotidase, ecto
decreases expression
EXP
nefazodone results in decreased expression of NT5E mRNA
CTD
PMID:24136188
NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645
G
Nubp2
NUBP iron-sulfur cluster assembly factor 2
increases expression
EXP
nefazodone results in increased expression of NUBP2 mRNA
CTD
PMID:24136188
NCBI chr10:14,407,743...14,411,428
Ensembl chr10:14,407,745...14,411,600
G
Nucb2
nucleobindin 2
decreases expression
EXP
nefazodone results in decreased expression of NUCB2 mRNA
CTD
PMID:24136188
NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:180,199,551...180,230,116
G
Nucks1
nuclear casein kinase and cyclin-dependent kinase substrate 1
increases expression
EXP
nefazodone results in increased expression of NUCKS1 mRNA
CTD
PMID:24136188
NCBI chr13:45,897,275...45,926,491
Ensembl chr13:45,897,248...45,923,101
G
Nudc
nuclear distribution C, dynein complex regulator
increases expression
EXP
nefazodone results in increased expression of NUDC mRNA
CTD
PMID:24136188
NCBI chr 5:151,041,878...151,055,260
Ensembl chr 5:151,041,875...151,055,260
G
Nudt4
nudix hydrolase 4
increases expression
EXP
nefazodone results in increased expression of NUDT4 mRNA
CTD
PMID:24136188
NCBI chr 7:32,074,978...32,091,491
Ensembl chr 7:32,075,002...32,091,491
G
Nudt7
nudix hydrolase 7
increases expression
EXP
nefazodone results in increased expression of NUDT7 mRNA
CTD
PMID:24136188
NCBI chr19:59,034,808...59,049,148
Ensembl chr19:59,034,839...59,063,994
G
Nup153
nucleoporin 153
increases expression
EXP
nefazodone results in increased expression of NUP153 mRNA
CTD
PMID:24136188
NCBI chr17:18,178,434...18,231,109
Ensembl chr17:18,178,456...18,231,109
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
EXP
nefazodone results in increased expression of NUPR1 mRNA
CTD
PMID:24136188
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901
G
Nus1
NUS1 dehydrodolichyl diphosphate synthase subunit
increases expression
EXP
nefazodone results in increased expression of NUS1 mRNA
CTD
PMID:24136188
NCBI chr20:32,354,519...32,381,265
Ensembl chr20:32,354,439...32,381,264
G
Nutf2
nuclear transport factor 2
increases expression
EXP
nefazodone results in increased expression of NUTF2 mRNA
CTD
PMID:24136188
NCBI chr19:50,662,168...50,683,457
Ensembl chr19:50,662,394...50,683,454
G
Nxpe4
neurexophilin and PC-esterase domain family member 4
decreases expression
EXP
nefazodone results in decreased expression of NXPE4 mRNA
CTD
PMID:24136188
NCBI chr 8:48,502,697...48,744,101
Ensembl chr 8:57,631,895...57,644,186
G
Oaf
out at first homolog
decreases expression
EXP
nefazodone results in decreased expression of OAF mRNA
CTD
PMID:24136188
NCBI chr 8:52,491,314...52,509,285
Ensembl chr 8:52,491,315...52,509,285
G
Oat
ornithine aminotransferase
decreases expression
EXP
nefazodone results in decreased expression of OAT mRNA
CTD
PMID:24136188
NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:196,777,975...196,797,754
G
Odc1
ornithine decarboxylase 1
increases expression
EXP
nefazodone results in increased expression of ODC1 mRNA
CTD
PMID:24136188
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
decreases expression
EXP
nefazodone results in decreased expression of OGT mRNA
CTD
PMID:24136188
NCBI chr X:70,811,317...70,856,123
Ensembl chr X:70,811,319...70,856,123
G
Olr59
olfactory receptor 59
decreases expression
EXP
nefazodone results in decreased expression of OLR59 mRNA
CTD
PMID:24136188
NCBI chr 1:166,604,972...166,639,634
Ensembl chr 1:166,604,141...166,623,265
G
Onecut1
one cut homeobox 1
decreases expression
EXP
nefazodone results in decreased expression of ONECUT1 mRNA
CTD
PMID:24136188
NCBI chr 8:84,480,066...84,507,848
Ensembl chr 8:84,480,305...84,508,124
G
Onecut2
one cut homeobox 2
decreases expression
EXP
nefazodone results in decreased expression of ONECUT2 mRNA
CTD
PMID:24136188
NCBI chr18:60,101,967...60,161,095
Ensembl chr18:60,102,126...60,107,668
G
Osbp
oxysterol binding protein
increases expression
EXP
nefazodone results in increased expression of OSBP mRNA
CTD
PMID:24136188
NCBI chr 1:218,313,455...218,343,263
Ensembl chr 1:218,313,148...218,343,258
G
Osbpl11
oxysterol binding protein-like 11
increases expression
EXP
nefazodone results in increased expression of OSBPL11 mRNA
CTD
PMID:24136188
NCBI chr11:81,038,759...81,121,887
Ensembl chr11:81,038,985...81,101,299
G
Otc
ornithine transcarbamylase
decreases expression
EXP
nefazodone results in decreased expression of OTC mRNA
CTD
PMID:24136188
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:15,126,358...15,239,555
G
Otub1
OTU deubiquitinase, ubiquitin aldehyde binding 1
increases expression
EXP
nefazodone results in increased expression of OTUB1 mRNA
CTD
PMID:24136188
NCBI chr 1:213,816,400...213,824,679
Ensembl chr 1:213,816,400...213,824,679
G
Ovca2
OVCA2 serine hydrolase domain containing
increases expression
EXP
nefazodone results in increased expression of OVCA2 mRNA
CTD
PMID:24136188
NCBI chr10:60,026,048...60,029,211
Ensembl chr10:60,522,026...60,527,536
G
Oxnad1
oxidoreductase NAD-binding domain containing 1
increases expression
EXP
nefazodone results in increased expression of OXNAD1 mRNA
CTD
PMID:24136188
NCBI chr16:7,299,755...7,328,824
Ensembl chr16:7,299,755...7,328,824
G
Pa2g4
proliferation-associated 2G4
increases expression
EXP
nefazodone results in increased expression of PA2G4 mRNA
CTD
PMID:24136188
NCBI chr 7:1,569,326...1,576,794
Ensembl chr 7:1,569,327...1,576,802
G
Pabpn1
poly(A) binding protein, nuclear 1
decreases expression
EXP
nefazodone results in decreased expression of PABPN1 mRNA
CTD
PMID:24136188
NCBI chr15:32,337,955...32,342,700
Ensembl chr15:32,338,089...32,342,691
G
Pacsin2
protein kinase C and casein kinase substrate in neurons 2
increases expression
EXP
nefazodone results in increased expression of PACSIN2 mRNA
CTD
PMID:24136188
NCBI chr 7:116,385,571...116,478,609
Ensembl chr 7:116,384,190...116,478,537
G
Pafah1b1
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1
increases expression
EXP
nefazodone results in increased expression of PAFAH1B1 mRNA
CTD
PMID:24136188
NCBI chr10:60,031,441...60,090,259
Ensembl chr10:60,032,514...60,090,196
G
Pah
phenylalanine hydroxylase
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of PAH mRNA
CTD
PMID:33819548
NCBI chr 7:23,793,096...23,885,631
Ensembl chr 7:23,792,781...23,885,627
G
Paics
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
increases expression
EXP
nefazodone results in increased expression of PAICS mRNA
CTD
PMID:24136188
NCBI chr14:31,553,355...31,586,843
Ensembl chr14:31,553,357...31,587,027
G
Pald1
phosphatase domain containing, paladin 1
increases expression
EXP
nefazodone results in increased expression of PALD1 mRNA
CTD
PMID:24136188
NCBI chr20:29,812,650...29,877,733
Ensembl chr20:29,812,650...29,850,063
G
Palmd
palmdelphin
decreases expression
EXP
nefazodone results in decreased expression of PALMD mRNA
CTD
PMID:24136188
NCBI chr 2:207,574,413...207,626,239
Ensembl chr 2:207,574,249...207,626,239
G
Paox
polyamine oxidase
increases expression
EXP
nefazodone results in increased expression of PAOX mRNA
CTD
PMID:24136188
NCBI chr 1:204,349,326...204,358,140
Ensembl chr 1:204,348,987...204,358,481
G
Paqr9
progestin and adipoQ receptor family member 9
decreases expression
EXP
nefazodone results in decreased expression of PAQR9 mRNA
CTD
PMID:24136188
NCBI chr 8:104,993,884...104,996,180
Ensembl chr 8:104,993,827...104,998,285
G
Parp14
poly (ADP-ribose) polymerase family, member 14
decreases expression
EXP
nefazodone results in decreased expression of PARP14 mRNA
CTD
PMID:24136188
NCBI chr11:78,408,134...78,440,201
Ensembl chr11:78,408,058...78,440,195
G
Parp9
poly (ADP-ribose) polymerase family, member 9
decreases expression
EXP
nefazodone results in decreased expression of PARP9 mRNA
CTD
PMID:24136188
NCBI chr11:78,286,282...78,320,409
Ensembl chr11:78,286,287...78,320,608
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
increases expression
EXP
nefazodone results in increased expression of PBLD1 mRNA
CTD
PMID:24136188
NCBI chr20:25,549,974...25,565,390
Ensembl chr20:25,549,974...25,565,226
G
Pbxip1
PBX homeobox interacting protein 1
decreases expression
EXP
nefazodone results in decreased expression of PBXIP1 mRNA
CTD
PMID:24136188
NCBI chr 2:177,154,056...177,167,810
Ensembl chr 2:177,154,101...177,167,328
G
Pc
pyruvate carboxylase
decreases expression
EXP
nefazodone results in decreased expression of PC mRNA
CTD
PMID:24136188
NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:211,228,731...211,329,940
G
Pcbp1
poly(rC) binding protein 1
increases expression
EXP
nefazodone results in increased expression of PCBP1 mRNA
CTD
PMID:24136188
NCBI chr 4:120,530,100...120,532,107
Ensembl chr 4:120,529,172...120,539,111
G
Pcdh1
protocadherin 1
decreases expression
EXP
nefazodone results in decreased expression of PCDH1 mRNA
CTD
PMID:24136188
NCBI chr18:30,258,154...30,290,828
Ensembl chr18:30,258,154...30,290,436
G
Pcdhgc3
protocadherin gamma subfamily C, 3
decreases expression
EXP
nefazodone results in decreased expression of PCDHGC3 mRNA
CTD
PMID:24136188
NCBI chr18:29,884,245...29,919,095
G
Pcgf6
polycomb group ring finger 6
increases expression
EXP
nefazodone results in increased expression of PCGF6 mRNA
CTD
PMID:24136188
NCBI chr 1:255,866,709...255,886,306
Ensembl chr 1:255,866,711...255,886,266
G
Pck1
phosphoenolpyruvate carboxykinase 1
decreases expression
EXP
nefazodone results in decreased expression of PCK1 mRNA
CTD
PMID:24136188
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
G
Pcmt1
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1
increases expression
EXP
nefazodone results in increased expression of PCMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:3,932,161...3,980,751
Ensembl chr 1:3,932,161...3,964,848
G
Pcmtd1
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
decreases expression
EXP
nefazodone results in decreased expression of PCMTD1 mRNA
CTD
PMID:24136188
NCBI chr 5:17,071,629...17,143,803
Ensembl chr 5:17,071,629...17,142,010
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
nefazodone results in decreased expression of PCNA mRNA
CTD
PMID:27288927
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
G
Pcnx1
pecanex 1
decreases expression
EXP
nefazodone results in decreased expression of PCNX1 mRNA
CTD
PMID:24136188
NCBI chr 6:107,296,704...107,433,576
Ensembl chr 6:107,296,792...107,432,452
G
Pcsk6
proprotein convertase subtilisin/kexin type 6
increases expression
EXP
nefazodone results in increased expression of PCSK6 mRNA
CTD
PMID:24136188
NCBI chr 1:128,839,742...129,038,087
Ensembl chr 1:128,839,232...129,052,128
G
Pctp
phosphatidylcholine transfer protein
decreases expression
EXP
nefazodone results in decreased expression of PCTP mRNA
CTD
PMID:24136188
NCBI chr10:75,305,999...75,351,919
Ensembl chr10:75,305,999...75,326,432
G
Pdap1
PDGFA associated protein 1
increases expression
EXP
nefazodone results in increased expression of PDAP1 mRNA
CTD
PMID:24136188
NCBI chr12:14,584,414...14,594,641
Ensembl chr12:14,584,398...14,594,641
G
Pdcd11
programmed cell death 11
increases expression
EXP
nefazodone results in increased expression of PDCD11 mRNA
CTD
PMID:24136188
NCBI chr 1:255,922,198...255,963,336
Ensembl chr 1:255,922,225...255,963,336
G
Pdcd4
programmed cell death 4
decreases expression
EXP
nefazodone results in decreased expression of PDCD4 mRNA
CTD
PMID:24136188
NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:262,926,656...262,950,189
G
Pdcl3
phosducin-like 3
increases expression
EXP
nefazodone results in increased expression of PDCL3 mRNA
CTD
PMID:24136188
NCBI chr 9:48,730,083...48,738,554
Ensembl chr 9:48,723,767...48,739,529
G
Pde2a
phosphodiesterase 2A
decreases expression
EXP
nefazodone results in decreased expression of PDE2A mRNA
CTD
PMID:24136188
NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:165,235,623...165,327,466
G
Pdha1
pyruvate dehydrogenase E1 subunit alpha 1
increases expression
EXP
nefazodone results in increased expression of PDHA1 mRNA
CTD
PMID:24136188
NCBI chr X:38,509,158...38,522,986
Ensembl chr X:38,509,084...38,522,536
G
Pdhx
pyruvate dehydrogenase complex, component X
increases expression
EXP
nefazodone results in increased expression of PDHX mRNA
CTD
PMID:24136188
NCBI chr 3:109,826,579...109,886,869
Ensembl chr 3:109,827,209...109,886,905
G
Pdia5
protein disulfide isomerase family A, member 5
decreases expression
EXP
nefazodone results in decreased expression of PDIA5 mRNA
CTD
PMID:24136188
NCBI chr11:78,777,436...78,892,370
Ensembl chr11:78,777,419...78,864,329
G
Pdk2
pyruvate dehydrogenase kinase 2
decreases expression
EXP
nefazodone results in decreased expression of PDK2 mRNA
CTD
PMID:24136188
NCBI chr10:80,469,388...80,483,988
Ensembl chr10:80,469,389...80,484,355
G
Pdk4
pyruvate dehydrogenase kinase 4
decreases expression
EXP
nefazodone results in decreased expression of PDK4 mRNA
CTD
PMID:24136188
NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:34,556,330...34,568,381
G
Pdlim1
PDZ and LIM domain 1
decreases expression
EXP
nefazodone results in decreased expression of PDLIM1 mRNA
CTD
PMID:24136188
NCBI chr 1:248,991,818...249,040,409
Ensembl chr 1:248,991,818...249,047,379
G
Pdzk1
PDZ domain containing 1
increases expression
EXP
nefazodone results in increased expression of PDZK1 mRNA
CTD
PMID:24136188
NCBI chr 2:187,064,995...187,096,348
Ensembl chr 2:187,065,013...187,096,806
G
Pebp1
phosphatidylethanolamine binding protein 1
increases expression
EXP
nefazodone results in increased expression of PEBP1 mRNA
CTD
PMID:24136188
NCBI chr12:44,946,307...44,967,890
Ensembl chr12:44,963,675...44,971,780
G
Pecr
peroxisomal trans-2-enoyl-CoA reductase
increases expression
EXP
nefazodone results in increased expression of PECR mRNA
CTD
PMID:24136188
NCBI chr 9:81,347,170...81,375,809
Ensembl chr 9:81,347,173...81,375,806
G
Pef1
penta-EF hand domain containing 1
increases expression
EXP
nefazodone results in increased expression of PEF1 mRNA
CTD
PMID:24136188
NCBI chr 5:147,735,973...147,759,239
Ensembl chr 5:147,735,976...147,761,092
G
Pelo
pelota mRNA surveillance and ribosome rescue factor
increases expression
EXP
nefazodone results in increased expression of PELO mRNA
CTD
PMID:24136188
NCBI chr 2:48,530,902...48,532,670
Ensembl chr 2:48,530,907...48,532,761
G
Pex11a
peroxisomal biogenesis factor 11 alpha
increases expression
EXP
nefazodone results in increased expression of PEX11A mRNA
CTD
PMID:24136188
NCBI chr 1:143,089,410...143,096,491
Ensembl chr 1:143,089,410...143,096,645
G
Pex16
peroxisomal biogenesis factor 16
increases expression
EXP
nefazodone results in increased expression of PEX16 mRNA
CTD
PMID:24136188
NCBI chr 3:98,800,357...98,808,091
Ensembl chr 3:98,798,654...98,808,630
G
Pex2
peroxisomal biogenesis factor 2
increases expression
EXP
nefazodone results in increased expression of PEX2 mRNA
CTD
PMID:24136188
NCBI chr 2:97,957,479...97,973,767
Ensembl chr 2:97,948,443...97,981,092
G
Pex7
peroxisomal biogenesis factor 7
increases expression
EXP
nefazodone results in increased expression of PEX7 mRNA
CTD
PMID:24136188
NCBI chr 1:16,402,319...16,466,304
Ensembl chr 1:16,402,320...16,466,366
G
Pfdn6
prefoldin subunit 6
increases expression
EXP
nefazodone results in increased expression of PFDN6 mRNA
CTD
PMID:24136188
NCBI chr20:4,947,844...4,949,318
Ensembl chr20:4,947,844...4,949,318
G
Pfn1
profilin 1
increases expression
EXP
nefazodone results in increased expression of PFN1 mRNA
CTD
PMID:24136188
NCBI chr10:55,863,882...55,866,587
Ensembl chr10:55,863,881...55,868,611
G
Pgam1
phosphoglycerate mutase 1
increases expression
EXP
nefazodone results in increased expression of PGAM1 mRNA
CTD
PMID:24136188
NCBI chr 1:250,673,152...250,680,762
Ensembl chr 1:250,673,049...250,690,203
G
Pgpep1
pyroglutamyl-peptidase I
decreases expression
EXP
nefazodone results in decreased expression of PGPEP1 mRNA
CTD
PMID:24136188
NCBI chr16:18,804,408...18,817,466
Ensembl chr16:18,805,009...18,817,462
G
Pgrmc1
progesterone receptor membrane component 1
increases expression
EXP
nefazodone results in increased expression of PGRMC1 mRNA
CTD
PMID:24136188
NCBI chr X:120,698,610...120,706,805
Ensembl chr X:120,698,610...120,706,805
G
Pgrmc2
progesterone receptor membrane component 2
decreases expression
EXP
nefazodone results in decreased expression of PGRMC2 mRNA
CTD
PMID:24136188
NCBI chr 2:125,996,190...126,012,090
Ensembl chr 2:125,996,193...126,012,090
G
Phb1
prohibitin 1
increases expression
EXP
nefazodone results in increased expression of PHB1 mRNA
CTD
PMID:24136188
NCBI chr10:81,102,043...81,114,815
Ensembl chr10:81,102,028...81,116,233
G
Phf5a
PHD finger protein 5A
increases expression
EXP
nefazodone results in increased expression of PHF5A mRNA
CTD
PMID:24136188
NCBI chr 7:115,258,609...115,265,174
Ensembl chr 7:115,258,609...115,265,174
G
Phgdh
phosphoglycerate dehydrogenase
increases expression
EXP
nefazodone results in increased expression of PHGDH mRNA
CTD
PMID:24136188
NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789
G
Phldb2
pleckstrin homology-like domain, family B, member 2
decreases expression
EXP
nefazodone results in decreased expression of PHLDB2 mRNA
CTD
PMID:24136188
NCBI chr11:68,321,738...68,540,724
Ensembl chr11:68,355,959...68,540,734
G
Phtf1
putative homeodomain transcription factor 1
decreases expression
EXP
nefazodone results in decreased expression of PHTF1 mRNA
CTD
PMID:24136188
NCBI chr 2:194,161,343...194,249,925
Ensembl chr 2:194,161,000...194,219,530
G
Pi4k2b
phosphatidylinositol 4-kinase type 2 beta
increases expression
EXP
nefazodone results in increased expression of PI4K2B mRNA
CTD
PMID:24136188
NCBI chr14:62,434,589...62,461,507
Ensembl chr14:62,424,511...62,461,446
G
Pi4ka
phosphatidylinositol 4-kinase alpha
increases expression
EXP
nefazodone results in increased expression of PI4KA mRNA
CTD
PMID:24136188
NCBI chr11:97,113,390...97,234,374
Ensembl chr11:97,113,245...97,228,315
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
nefazodone results in increased expression of PID1 mRNA
CTD
PMID:32816093
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:92,734,214...92,750,070
G
Pigc
phosphatidylinositol glycan anchor biosynthesis, class C
increases expression
EXP
nefazodone results in increased expression of PIGC mRNA
CTD
PMID:24136188
NCBI chr13:76,876,894...76,879,420
Ensembl chr13:76,872,922...76,880,224
G
Pigk
phosphatidylinositol glycan anchor biosynthesis, class K
increases expression
EXP
nefazodone results in increased expression of PIGK mRNA
CTD
PMID:24136188
NCBI chr 2:244,289,928...244,375,394
Ensembl chr 2:244,250,621...244,376,030
G
Pigp
phosphatidylinositol glycan anchor biosynthesis, class P
decreases expression
EXP
nefazodone results in decreased expression of PIGP mRNA
CTD
PMID:24136188
NCBI chr11:47,152,601...47,158,766
Ensembl chr11:47,148,465...47,160,082
G
Pigx
phosphatidylinositol glycan anchor biosynthesis, class X
increases expression
EXP
nefazodone results in increased expression of PIGX mRNA
CTD
PMID:24136188
NCBI chr11:82,192,125...82,208,062
Ensembl chr11:82,192,092...82,208,061
G
Pik3c2b
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
decreases expression multiple interactions
ISO
nefazodone results in decreased expression of PIK3C2B mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA
CTD
PMID:32152650
NCBI chr13:47,046,866...47,107,733
Ensembl chr13:47,047,127...47,107,725
G
Pik3c2g
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
decreases expression multiple interactions
ISO
nefazodone results in decreased expression of PIK3C2G mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2G mRNA
CTD
PMID:32152650
NCBI chr 4:174,215,527...174,583,378
Ensembl chr 4:174,215,527...174,581,705
G
Pik3c3
phosphatidylinositol 3-kinase, catalytic subunit type 3
decreases expression multiple interactions
ISO
nefazodone results in decreased expression of PIK3C3 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C3 mRNA
CTD
PMID:32152650
NCBI chr18:22,119,677...22,203,546
Ensembl chr18:22,119,792...22,203,539
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression multiple interactions
ISO
nefazodone results in decreased expression of PIK3R1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3R1 mRNA
CTD
PMID:32152650
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
G
Pim3
Pim-3 proto-oncogene, serine/threonine kinase
increases expression
EXP
nefazodone results in increased expression of PIM3 mRNA
CTD
PMID:24136188
NCBI chr 7:121,822,076...121,836,257
Ensembl chr 7:121,832,742...121,836,259
G
Pink1
PTEN induced kinase 1
increases expression
EXP
nefazodone results in increased expression of PINK1 mRNA
CTD
PMID:24136188
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950
G
Pir
pirin
increases expression
EXP
nefazodone results in increased expression of PIR mRNA
CTD
PMID:24136188
NCBI chr X:33,740,428...33,851,049
Ensembl chr X:33,740,429...33,851,049
G
Pithd1
PITH domain containing 1
increases expression
EXP
nefazodone results in increased expression of PITHD1 mRNA
CTD
PMID:24136188
NCBI chr 5:148,205,995...148,216,490
Ensembl chr 5:153,489,529...153,500,261
G
Pkdcc
protein kinase domain containing, cytoplasmic
decreases expression
EXP
nefazodone results in decreased expression of PKDCC mRNA
CTD
PMID:24136188
NCBI chr 6:17,208,171...17,217,488
Ensembl chr 6:17,208,171...17,218,042
G
Pklr
pyruvate kinase L/R
decreases expression
EXP
nefazodone results in decreased expression of PKLR mRNA
CTD
PMID:24136188
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644
G
Pla2g12a
phospholipase A2, group XIIA
increases expression
EXP
nefazodone results in increased expression of PLA2G12A mRNA
CTD
PMID:24136188
NCBI chr 2:221,110,722...221,126,966
Ensembl chr 2:221,110,685...221,126,964
G
Plaa
phospholipase A2, activating protein
increases expression
EXP
nefazodone results in increased expression of PLAA mRNA
CTD
PMID:24136188
NCBI chr 5:114,544,327...114,576,023
Ensembl chr 5:114,544,325...114,576,109
G
Plaat3
phospholipase A and acyltransferase 3
decreases expression
EXP
nefazodone results in decreased expression of PLAAT3 mRNA
CTD
PMID:24136188
NCBI chr 1:214,211,755...214,245,551
Ensembl chr 1:214,211,791...214,246,763
G
Plbd1
phospholipase B domain containing 1
decreases expression
EXP
nefazodone results in decreased expression of PLBD1 mRNA
CTD
PMID:24136188
NCBI chr 4:171,204,198...171,260,488
Ensembl chr 4:171,204,198...171,260,488
G
Plekhb1
pleckstrin homology domain containing B1
decreases expression
EXP
nefazodone results in decreased expression of PLEKHB1 mRNA
CTD
PMID:24136188
NCBI chr 1:164,410,901...164,425,216
Ensembl chr 1:164,410,903...164,428,568
G
Plg
plasminogen
decreases expression
EXP
nefazodone results in decreased expression of PLG mRNA
CTD
PMID:24136188
NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320
G
Plod1
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1
increases expression
EXP
nefazodone results in increased expression of PLOD1 mRNA
CTD
PMID:24136188
NCBI chr 5:163,623,847...163,650,737
Ensembl chr 5:163,623,848...163,651,110
G
Plpbp
pyridoxal phosphate binding protein
increases expression
EXP
nefazodone results in increased expression of PLPBP mRNA
CTD
PMID:24136188
NCBI chr16:71,705,064...71,717,726
Ensembl chr16:71,700,028...71,717,726
G
Plpp2
phospholipid phosphatase 2
increases expression
EXP
nefazodone results in increased expression of PLPP2 mRNA
CTD
PMID:24136188
NCBI chr 7:10,826,534...10,834,628
Ensembl chr 7:10,826,549...10,834,627
G
Plpp3
phospholipid phosphatase 3
decreases expression
EXP
nefazodone results in decreased expression of PLPP3 mRNA
CTD
PMID:24136188
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667
G
Pls3
plastin 3
increases expression
EXP
nefazodone results in increased expression of PLS3 mRNA
CTD
PMID:24136188
NCBI chr X:116,401,247...116,495,898
Ensembl chr X:116,401,293...116,495,893
G
Plxna2
plexin A2
decreases expression
EXP
nefazodone results in decreased expression of PLXNA2 mRNA
CTD
PMID:24136188
NCBI chr13:108,683,155...108,888,336
Ensembl chr13:108,691,530...108,887,453
G
Plxnb2
plexin B2
decreases expression
EXP
nefazodone results in decreased expression of PLXNB2 mRNA
CTD
PMID:24136188
NCBI chr 7:122,111,917...122,138,201
Ensembl chr 7:122,111,917...122,127,746
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
ISO
nefazodone results in increased expression of PMAIP1 mRNA
CTD
PMID:27288927
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
G
Pmpca
peptidase, mitochondrial processing subunit alpha
increases expression
EXP
nefazodone results in increased expression of PMPCA mRNA
CTD
PMID:24136188
NCBI chr 3:29,605,823...29,614,936
Ensembl chr 3:29,604,232...29,614,935
G
Pmvk
phosphomevalonate kinase
decreases expression
EXP
nefazodone results in decreased expression of PMVK mRNA
CTD
PMID:24136188
NCBI chr 2:177,174,344...177,184,076
Ensembl chr 2:177,174,335...177,184,080
G
Pnisr
PNN interacting serine and arginine rich protein
decreases expression
EXP
nefazodone results in decreased expression of PNISR mRNA
CTD
PMID:24136188
NCBI chr 5:40,190,214...40,219,619
Ensembl chr 5:40,192,735...40,219,611
G
Pnn
pinin, desmosome associated protein
decreases expression
EXP
nefazodone results in decreased expression of PNN mRNA
CTD
PMID:24136188
NCBI chr 6:82,493,032...82,501,345
Ensembl chr 6:82,492,978...82,501,933
G
Pno1
partner of NOB1 homolog
increases expression
EXP
nefazodone results in increased expression of PNO1 mRNA
CTD
PMID:24136188
NCBI chr14:95,811,335...95,819,903
Ensembl chr14:95,688,125...95,905,881
G
Pnpla2
patatin-like phospholipase domain containing 2
increases expression
EXP
nefazodone results in increased expression of PNPLA2 mRNA
CTD
PMID:24136188
NCBI chr 1:205,982,279...205,987,361
Ensembl chr 1:205,982,258...205,987,359
G
Pnpla7
patatin-like phospholipase domain containing 7
increases expression
EXP
nefazodone results in increased expression of PNPLA7 mRNA
CTD
PMID:24136188
NCBI chr 3:28,180,670...28,259,673
Ensembl chr 3:28,180,751...28,259,672
G
Pnpla8
patatin-like phospholipase domain containing 8
increases expression
EXP
nefazodone results in increased expression of PNPLA8 mRNA
CTD
PMID:24136188
NCBI chr 6:67,056,783...67,118,714
Ensembl chr 6:67,056,697...67,120,512
G
Pnrc1
proline-rich nuclear receptor coactivator 1
decreases expression
EXP
nefazodone results in decreased expression of PNRC1 mRNA
CTD
PMID:24136188
NCBI chr 5:52,443,400...52,489,303
Ensembl chr 5:52,443,400...52,446,491
G
Pold4
DNA polymerase delta 4, accessory subunit
increases expression
EXP
nefazodone results in increased expression of POLD4 mRNA
CTD
PMID:24136188
NCBI chr 1:210,956,110...210,957,863
Ensembl chr 1:210,956,099...210,957,860
G
Poldip2
DNA polymerase delta interacting protein 2
increases expression
EXP
nefazodone results in increased expression of POLDIP2 mRNA
CTD
PMID:24136188
NCBI chr10:63,407,237...63,417,605
Ensembl chr10:63,904,691...63,915,655
G
Pole4
DNA polymerase epsilon 4, accessory subunit
increases expression
EXP
nefazodone results in increased expression of POLE4 mRNA
CTD
PMID:24136188
NCBI chr 4:115,165,285...115,171,097
Ensembl chr 4:116,716,719...116,728,851
G
Polg2
DNA polymerase gamma 2, accessory subunit
increases expression
EXP
nefazodone results in increased expression of POLG2 mRNA
CTD
PMID:24136188
NCBI chr10:92,212,303...92,222,849
Ensembl chr10:92,212,304...92,222,726
G
Polr1f
RNA polymerase I subunit F
increases expression
EXP
nefazodone results in increased expression of POLR1F mRNA
CTD
PMID:24136188
NCBI chr 6:55,780,706...55,797,935
Ensembl chr 6:55,780,706...55,797,935
G
Polr3d
RNA polymerase III subunit D
increases expression
EXP
nefazodone results in increased expression of POLR3D mRNA
CTD
PMID:24136188
NCBI chr15:51,921,283...51,925,952
Ensembl chr15:51,921,283...51,925,691
G
Pomp
proteasome maturation protein
increases expression
EXP
nefazodone results in increased expression of POMP mRNA
CTD
PMID:24136188
NCBI chr12:12,198,262...12,212,132
Ensembl chr12:12,198,263...12,210,880
G
Pon3
paraoxonase 3
decreases expression
EXP
nefazodone results in decreased expression of PON3 mRNA
CTD
PMID:24136188
NCBI chr 4:34,323,546...34,350,244
Ensembl chr 4:34,315,889...34,350,244
G
Pop5
POP5 homolog, ribonuclease P/MRP subunit
increases expression
EXP
nefazodone results in increased expression of POP5 mRNA
CTD
PMID:24136188
NCBI chr12:47,037,451...47,045,778
Ensembl chr12:47,029,403...47,042,032
G
Por
cytochrome p450 oxidoreductase
increases expression
EXP
nefazodone results in increased expression of POR mRNA
CTD
PMID:24136188
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
G
Ppa1
inorganic pyrophosphatase 1
increases expression
EXP
nefazodone results in increased expression of PPA1 mRNA
CTD
PMID:24136188
NCBI chr20:30,132,088...30,160,492
Ensembl chr20:30,133,504...30,160,489
G
Ppa2
inorganic pyrophosphatase 2
decreases expression
EXP
nefazodone results in decreased expression of PPA2 mRNA
CTD
PMID:24136188
NCBI chr 2:221,800,791...221,878,079
Ensembl chr 2:224,474,823...224,552,628
G
Ppan
peter pan homolog
increases expression
EXP
nefazodone results in increased expression of PPAN mRNA
CTD
PMID:24136188
NCBI chr 8:27,700,147...27,704,127
Ensembl chr 8:27,700,152...27,704,128
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of PPARA mRNA
CTD
PMID:33819548
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
G
Ppat
phosphoribosyl pyrophosphate amidotransferase
increases expression
EXP
nefazodone results in increased expression of PPAT mRNA
CTD
PMID:24136188
NCBI chr14:31,570,010...31,604,410
Ensembl chr14:31,551,388...31,604,405
G
Ppcs
phosphopantothenoylcysteine synthetase
increases expression
EXP
nefazodone results in increased expression of PPCS mRNA
CTD
PMID:24136188
NCBI chr 5:138,308,394...138,312,047
Ensembl chr 5:138,308,397...138,312,012
G
Ppdpf
pancreatic progenitor cell differentiation and proliferation factor
decreases expression
EXP
nefazodone results in decreased expression of PPDPF mRNA
CTD
PMID:24136188
NCBI chr 3:188,676,821...188,678,599
Ensembl chr 3:188,676,965...188,678,599
G
Ppfibp2
PPFIA binding protein 2
decreases expression
EXP
nefazodone results in decreased expression of PPFIBP2 mRNA
CTD
PMID:24136188
NCBI chr 1:170,916,649...171,062,096
Ensembl chr 1:170,916,649...171,065,618
G
Ppie
peptidylprolyl isomerase E
increases expression
EXP
nefazodone results in increased expression of PPIE mRNA
CTD
PMID:24136188
NCBI chr 5:140,691,285...140,704,347
Ensembl chr 5:140,683,801...140,740,767
G
Ppm1k
protein phosphatase, Mg2+/Mn2+ dependent, 1K
increases expression
EXP
nefazodone results in increased expression of PPM1K mRNA
CTD
PMID:24136188
NCBI chr 4:87,612,198...87,638,993
Ensembl chr 4:88,942,386...88,969,136
G
Ppp1cb
protein phosphatase 1 catalytic subunit beta
increases expression
EXP
nefazodone results in increased expression of PPP1CB mRNA
CTD
PMID:24136188
NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:29,681,100...29,712,924
G
Ppp1r14b
protein phosphatase 1, regulatory (inhibitor) subunit 14B
increases expression
EXP
nefazodone results in increased expression of PPP1R14B mRNA
CTD
PMID:24136188
NCBI chr 1:213,594,416...213,596,527
Ensembl chr12:21,088,517...21,101,431 Ensembl chr 1:21,088,517...21,101,431
G
Ppp1r21
protein phosphatase 1, regulatory subunit 21
decreases expression
EXP
nefazodone results in decreased expression of PPP1R21 mRNA
CTD
PMID:24136188
NCBI chr 6:5,901,518...5,970,684
Ensembl chr 6:11,655,059...11,724,219
G
Ppp1r3b
protein phosphatase 1, regulatory subunit 3B
decreases expression
EXP
nefazodone results in decreased expression of PPP1R3B mRNA
CTD
PMID:24136188
NCBI chr16:63,533,318...63,545,683
Ensembl chr16:63,532,842...63,549,997
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of PPP1R3C mRNA
CTD
PMID:33819548
NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
increases expression
EXP
nefazodone results in increased expression of PPP2CB mRNA
CTD
PMID:24136188
NCBI chr16:65,261,178...65,282,658
Ensembl chr16:65,261,181...65,282,634
G
Ppp2r1a
protein phosphatase 2 scaffold subunit A alpha
increases expression
EXP
nefazodone results in increased expression of PPP2R1A mRNA
CTD
PMID:24136188
NCBI chr 1:69,213,198...69,232,441
Ensembl chr 1:69,213,038...69,238,242
G
Ppp2r2d
protein phosphatase 2, regulatory subunit B, delta
increases expression
EXP
nefazodone results in increased expression of PPP2R2D mRNA
CTD
PMID:24136188
NCBI chr 1:203,095,536...203,129,895
Ensembl chr 1:203,095,531...203,129,893
G
Ppp2r5a
protein phosphatase 2, regulatory subunit B', alpha
decreases expression
EXP
nefazodone results in decreased expression of PPP2R5A mRNA
CTD
PMID:24136188
NCBI chr13:105,462,371...105,506,767
Ensembl chr13:105,462,371...105,506,767
G
Ppp2r5e
protein phosphatase 2 regulatory subunit B', epsilon
decreases expression
EXP
nefazodone results in decreased expression of PPP2R5E mRNA
CTD
PMID:24136188
NCBI chr 6:99,904,569...100,053,672
Ensembl chr 6:99,904,569...100,053,573
G
Ppp3cb
protein phosphatase 3 catalytic subunit beta
increases expression
EXP
nefazodone results in increased expression of PPP3CB mRNA
CTD
PMID:24136188
NCBI chr15:3,809,182...3,854,204
Ensembl chr15:3,809,262...3,854,203
G
Ppp3r1
protein phosphatase 3, regulatory subunit B, alpha
increases expression
EXP
nefazodone results in increased expression of PPP3R1 mRNA
CTD
PMID:24136188
NCBI chr14:95,758,333...95,808,015
G
Ppp6c
protein phosphatase 6, catalytic subunit
increases expression
EXP
nefazodone results in increased expression of PPP6C mRNA
CTD
PMID:24136188
NCBI chr 3:43,339,521...43,371,807
Ensembl chr 3:43,341,108...43,371,807
G
Prdx1
peroxiredoxin 1
increases expression
EXP
nefazodone results in increased expression of PRDX1 mRNA
CTD
PMID:24136188
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504
G
Prdx3
peroxiredoxin 3
increases expression
EXP
nefazodone results in increased expression of PRDX3 mRNA
CTD
PMID:24136188
NCBI chr 1:269,987,691...270,000,111
Ensembl chr 1:269,987,685...270,000,300
G
Prdx5
peroxiredoxin 5
increases expression
EXP
nefazodone results in increased expression of PRDX5 mRNA
CTD
PMID:24136188
NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:213,529,035...213,533,020
G
Prdx6
peroxiredoxin 6
increases expression
EXP
nefazodone results in increased expression of PRDX6 mRNA
CTD
PMID:24136188
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657
G
Preb
prolactin regulatory element binding
increases expression
EXP
nefazodone results in increased expression of PREB mRNA
CTD
PMID:24136188
NCBI chr 6:31,138,757...31,142,544
Ensembl chr 6:31,138,743...31,142,540
G
Prelid3b
PRELI domain containing 3B
increases expression
EXP
nefazodone results in increased expression of PRELID3B mRNA
CTD
PMID:24136188
NCBI chr 3:163,263,059...163,271,055
Ensembl chr 3:183,681,255...183,689,289
G
Prkab1
protein kinase AMP-activated non-catalytic subunit beta 1
decreases expression
EXP
nefazodone results in decreased expression of PRKAB1 mRNA
CTD
PMID:24136188
NCBI chr12:46,248,971...46,259,487
Ensembl chr12:46,249,010...46,259,482
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
decreases expression
EXP
nefazodone results in decreased expression of PRKACA mRNA
CTD
PMID:24136188
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
increases expression
EXP
nefazodone results in increased expression of PRKAR1A mRNA
CTD
PMID:24136188
NCBI chr10:95,120,537...95,139,028
Ensembl chr10:95,120,487...95,139,025
G
Prkci
protein kinase C, iota
increases expression
EXP
nefazodone results in increased expression of PRKCI mRNA
CTD
PMID:24136188
NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:114,250,398...114,310,784
G
Prmt1
protein arginine methyltransferase 1
increases expression
EXP
nefazodone results in increased expression of PRMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:104,595,339...104,605,552
Ensembl chr 1:104,595,335...104,604,827
G
Prodh
proline dehydrogenase
decreases expression
EXP
nefazodone results in decreased expression of PRODH mRNA
CTD
PMID:24136188
NCBI chr11:96,414,275...96,431,604
Ensembl chr11:96,414,224...96,433,418
G
Prpf19
pre-mRNA processing factor 19
increases expression
EXP
nefazodone results in increased expression of PRPF19 mRNA
CTD
PMID:24136188
NCBI chr 1:216,966,104...216,977,549
Ensembl chr 1:216,966,462...216,980,506
G
Prps1
phosphoribosyl pyrophosphate synthetase 1
increases expression
EXP
nefazodone results in increased expression of PRPS1 mRNA
CTD
PMID:24136188
NCBI chr X:108,920,663...108,942,713
Ensembl chr X:108,920,651...108,942,711
G
Prss23
serine protease 23
decreases expression
EXP
nefazodone results in decreased expression of PRSS23 mRNA
CTD
PMID:24136188
NCBI chr 1:152,815,301...152,835,005
Ensembl chr 1:152,813,670...152,947,871
G
Prxl2b
peroxiredoxin like 2B
decreases expression
EXP
nefazodone results in decreased expression of PRXL2B mRNA
CTD
PMID:24136188
NCBI chr 5:170,744,953...170,747,556
Ensembl chr 5:170,744,953...170,747,556
G
Psat1
phosphoserine aminotransferase 1
increases expression
EXP
nefazodone results in increased expression of PSAT1 mRNA
CTD
PMID:24136188
NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693
G
Psma1
proteasome 20S subunit alpha 1
increases expression
EXP
nefazodone results in increased expression of PSMA1 mRNA
CTD
PMID:24136188
NCBI chr 1:177,876,838...177,887,857
Ensembl chr 1:177,875,353...177,887,949
G
Psma2
proteasome 20S subunit alpha 2
increases expression
EXP
nefazodone results in increased expression of PSMA2 mRNA
CTD
PMID:24136188
NCBI chr17:55,250,054...55,260,441
Ensembl chr17:55,247,442...55,339,673
G
Psma3
proteasome 20S subunit alpha 3
increases expression
EXP
nefazodone results in increased expression of PSMA3 mRNA
CTD
PMID:24136188
NCBI chr 6:95,219,714...95,239,745
Ensembl chr 6:95,219,629...95,241,032
G
Psma4
proteasome 20S subunit alpha 4
increases expression
EXP
nefazodone results in increased expression of PSMA4 mRNA
CTD
PMID:24136188
NCBI chr 8:64,236,520...64,243,980
Ensembl chr 8:64,236,783...64,243,979
G
Psma5
proteasome 20S subunit alpha 5
increases expression
EXP
nefazodone results in increased expression of PSMA5 mRNA
CTD
PMID:24136188
NCBI chr 2:198,584,502...198,607,867
Ensembl chr 2:198,584,505...198,607,867
G
Psma6
proteasome 20S subunit alpha 6
increases expression
EXP
nefazodone results in increased expression of PSMA6 mRNA
CTD
PMID:24136188
NCBI chr 6:78,500,676...78,531,693
Ensembl chr 6:78,500,736...78,531,717
G
Psma7
proteasome 20S subunit alpha 7
increases expression
EXP
nefazodone results in increased expression of PSMA7 mRNA
CTD
PMID:24136188
NCBI chr 3:187,514,901...187,521,289
Ensembl chr 3:187,513,441...187,521,253
G
Psmb1
proteasome 20S subunit beta 1
increases expression
EXP
nefazodone results in increased expression of PSMB1 mRNA
CTD
PMID:24136188
NCBI chr 1:65,115,770...65,136,516
Ensembl chr 1:65,114,724...65,136,640
G
Psmb2
proteasome 20S subunit beta 2
increases expression
EXP
nefazodone results in increased expression of PSMB2 mRNA
CTD
PMID:24136188
NCBI chr 5:144,255,058...144,287,200
Ensembl chr 5:144,255,026...144,287,608
G
Psmb3
proteasome 20S subunit beta 3
increases expression
EXP
nefazodone results in increased expression of PSMB3 mRNA
CTD
PMID:24136188
NCBI chr10:83,193,787...83,200,883
Ensembl chr10:83,193,787...83,200,883
G
Psmb4
proteasome 20S subunit beta 4
increases expression
EXP
nefazodone results in increased expression of PSMB4 mRNA
CTD
PMID:24136188
NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:185,131,786...185,135,287
G
Psmb5
proteasome 20S subunit beta 5
increases expression
EXP
nefazodone results in increased expression of PSMB5 mRNA
CTD
PMID:24136188
NCBI chr15:32,042,784...32,047,379
Ensembl chr15:32,042,787...32,047,379
G
Psmb6
proteasome 20S subunit beta 6
increases expression
EXP
nefazodone results in increased expression of PSMB6 mRNA
CTD
PMID:24136188
NCBI chr10:55,737,852...55,740,218
Ensembl chr10:55,737,888...55,740,218
G
Psmb7
proteasome 20S subunit beta 7
increases expression
EXP
nefazodone results in increased expression of PSMB7 mRNA
CTD
PMID:24136188
NCBI chr 3:42,767,500...42,827,470
Ensembl chr 3:42,767,501...42,827,601
G
Psmb8
proteasome 20S subunit beta 8
decreases expression
EXP
nefazodone results in decreased expression of PSMB8 mRNA
CTD
PMID:24136188
NCBI chr20:4,654,068...4,657,049
Ensembl chr20:4,654,068...4,657,031
G
Psmb9
proteasome 20S subunit beta 9
decreases expression
EXP
nefazodone results in decreased expression of PSMB9 mRNA
CTD
PMID:24136188
NCBI chr20:4,668,952...4,674,421
Ensembl chr20:4,668,739...4,674,421
G
Psmc1
proteasome 26S subunit, ATPase 1
increases expression
EXP
nefazodone results in increased expression of PSMC1 mRNA
CTD
PMID:24136188
NCBI chr 6:125,122,497...125,134,859
Ensembl chr 6:125,122,490...125,134,858
G
Psmc2
proteasome 26S subunit, ATPase 2
increases expression
EXP
nefazodone results in increased expression of PSMC2 mRNA
CTD
PMID:24136188
NCBI chr 4:14,148,080...14,162,390
Ensembl chr 4:14,148,090...14,162,390
G
Psmc3
proteasome 26S subunit, ATPase 3
increases expression
EXP
nefazodone results in increased expression of PSMC3 mRNA
CTD
PMID:24136188
NCBI chr 3:97,487,643...97,493,025
Ensembl chr 3:97,487,632...97,499,176
G
Psmc4
proteasome 26S subunit, ATPase 4
increases expression
EXP
nefazodone results in increased expression of PSMC4 mRNA
CTD
PMID:24136188
NCBI chr 1:92,476,690...92,485,268
Ensembl chr 1:92,476,690...92,485,060
G
Psmc5
proteasome 26S subunit, ATPase 5
increases expression
EXP
nefazodone results in increased expression of PSMC5 mRNA
CTD
PMID:24136188
NCBI chr10:91,687,553...91,693,487
Ensembl chr10:91,686,295...91,695,921
G
Psmc6
proteasome 26S subunit, ATPase 6
increases expression
EXP
nefazodone results in increased expression of PSMC6 mRNA
CTD
PMID:24136188
NCBI chr15:21,022,314...21,043,785
Ensembl chr15:21,022,314...21,043,785
G
Psmd1
proteasome 26S subunit, non-ATPase 1
increases expression
EXP
nefazodone results in increased expression of PSMD1 mRNA
CTD
PMID:24136188
NCBI chr 9:94,157,971...94,233,218
Ensembl chr 9:94,157,971...94,233,218
G
Psmd11
proteasome 26S subunit, non-ATPase 11
increases expression
EXP
nefazodone results in increased expression of PSMD11 mRNA
CTD
PMID:24136188
NCBI chr10:65,923,669...65,977,523
Ensembl chr10:65,931,279...65,976,234
G
Psmd12
proteasome 26S subunit, non-ATPase 12
increases expression
EXP
nefazodone results in increased expression of PSMD12 mRNA
CTD
PMID:24136188
NCBI chr10:92,937,957...92,956,601
Ensembl chr10:92,901,133...92,988,964
G
Psmd13
proteasome 26S subunit, non-ATPase 13
increases expression
EXP
nefazodone results in increased expression of PSMD13 mRNA
CTD
PMID:24136188
NCBI chr 1:205,394,248...205,406,525
Ensembl chr 1:205,393,746...205,411,651
G
Psmd14
proteasome 26S subunit, non-ATPase 14
increases expression
EXP
nefazodone results in increased expression of PSMD14 mRNA
CTD
PMID:24136188
NCBI chr 3:66,662,933...66,755,666
Ensembl chr 3:66,662,900...66,755,665
G
Psmd2
proteasome 26S subunit ubiquitin receptor, non-ATPase 2
increases expression
EXP
nefazodone results in increased expression of PSMD2 mRNA
CTD
PMID:24136188
NCBI chr11:93,752,761...93,763,388
Ensembl chr11:93,752,763...93,763,388
G
Psmd3
proteasome 26S subunit, non-ATPase 3
increases expression
EXP
nefazodone results in increased expression of PSMD3 mRNA
CTD
PMID:24136188
NCBI chr10:84,139,249...84,151,879
Ensembl chr10:84,139,677...84,151,878
G
Psmd4
proteasome 26S subunit ubiquitin receptor, non-ATPase 4
increases expression
EXP
nefazodone results in increased expression of PSMD4 mRNA
CTD
PMID:24136188
NCBI chr 2:185,287,941...185,297,238
Ensembl chr 2:185,286,868...185,297,201
G
Psmd5
proteasome 26S subunit, non-ATPase 5
increases expression
EXP
nefazodone results in increased expression of PSMD5 mRNA
CTD
PMID:24136188
NCBI chr 3:38,531,206...38,552,085
Ensembl chr 3:38,530,951...38,548,490
G
Psmd6
proteasome 26S subunit, non-ATPase 6
increases expression
EXP
nefazodone results in increased expression of PSMD6 mRNA
CTD
PMID:24136188
NCBI chr15:13,532,675...13,542,682
Ensembl chr15:13,532,675...13,542,682
G
Psmd7
proteasome 26S subunit, non-ATPase 7
increases expression
EXP
nefazodone results in increased expression of PSMD7 mRNA
CTD
PMID:24136188
NCBI chr19:52,404,032...52,411,316
Ensembl chr19:52,404,032...52,417,871
G
Psmd8
proteasome 26S subunit, non-ATPase 8
increases expression
EXP
nefazodone results in increased expression of PSMD8 mRNA
CTD
PMID:24136188
NCBI chr 1:93,601,857...93,608,689
Ensembl chr 1:93,601,853...93,608,689
G
Psmd9
proteasome 26S subunit, non-ATPase 9
increases expression
EXP
nefazodone results in increased expression of PSMD9 mRNA
CTD
PMID:24136188
NCBI chr12:38,998,027...39,018,340
Ensembl chr12:38,998,030...39,018,679
G
Psme3
proteasome activator subunit 3
increases expression
EXP
nefazodone results in increased expression of PSME3 mRNA
CTD
PMID:24136188
NCBI chr10:86,757,933...86,765,719
Ensembl chr10:86,757,899...86,818,033
G
Psme4
proteasome activator subunit 4
increases expression
EXP
nefazodone results in increased expression of PSME4 mRNA
CTD
PMID:24136188
NCBI chr14:108,706,643...108,810,330
Ensembl chr14:108,706,643...108,810,328
G
Psmg2
proteasome assembly chaperone 2
increases expression
EXP
nefazodone results in increased expression of PSMG2 mRNA
CTD
PMID:24136188
NCBI chr18:61,208,669...61,227,671
G
Psmg3
proteasome assembly chaperone 3
increases expression
EXP
nefazodone results in increased expression of PSMG3 mRNA
CTD
PMID:24136188
NCBI chr12:19,923,288...19,926,205
Ensembl chr12:19,923,288...19,926,205
G
Pten
phosphatase and tensin homolog
increases expression
EXP
nefazodone results in increased expression of PTEN mRNA
CTD
PMID:24136188
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
G
Ptges3l1
prostaglandin E synthase 3-like 1
increases expression
EXP
nefazodone results in increased expression of PTGES3L1 mRNA
CTD
PMID:24136188
NCBI chr X:42,215,200...42,224,472
Ensembl chr X:46,092,206...46,107,019
G
Ptgr3
prostaglandin reductase 3
increases expression
EXP
nefazodone results in increased expression of PTGR3 mRNA
CTD
PMID:24136188
NCBI chr18:79,729,282...79,738,632
Ensembl chr18:79,729,282...79,738,632
G
Ptms
parathymosin
decreases expression
EXP
nefazodone results in decreased expression of PTMS mRNA
CTD
PMID:24136188
NCBI chr 4:159,408,647...159,412,837
Ensembl chr 4:159,408,649...159,415,212
G
Ptpmt1
protein tyrosine phosphatase, mitochondrial 1
increases expression
EXP
nefazodone results in increased expression of PTPMT1 mRNA
CTD
PMID:24136188
NCBI chr 3:97,345,752...97,355,396
Ensembl chr 3:97,345,752...97,355,254
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
increases expression
EXP
nefazodone results in increased expression of PTPN11 mRNA
CTD
PMID:24136188
NCBI chr12:41,026,079...41,085,577
Ensembl chr12:41,043,785...41,085,577
G
Ptpn21
protein tyrosine phosphatase, non-receptor type 21
increases expression
EXP
nefazodone results in increased expression of PTPN21 mRNA
CTD
PMID:24136188
NCBI chr 6:123,662,783...123,727,809
Ensembl chr 6:123,662,783...123,727,809
G
Ptprb
protein tyrosine phosphatase, receptor type, B
decreases expression
EXP
nefazodone results in decreased expression of PTPRB mRNA
CTD
PMID:24136188
NCBI chr 7:53,816,197...53,920,760
Ensembl chr 7:53,816,097...53,920,760
G
Ptprd
protein tyrosine phosphatase, receptor type, D
decreases expression
EXP
nefazodone results in decreased expression of PTPRD mRNA
CTD
PMID:24136188
NCBI chr 5:95,093,221...97,415,498
Ensembl chr 5:95,095,858...96,178,903
G
Ptprf
protein tyrosine phosphatase, receptor type, F
decreases expression
EXP
nefazodone results in decreased expression of PTPRF mRNA
CTD
PMID:24136188
NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:137,028,164...137,095,426
G
Pum3
pumilio RNA-binding family member 3
increases expression
EXP
nefazodone results in increased expression of PUM3 mRNA
CTD
PMID:24136188
NCBI chr 1:234,483,482...234,527,718
Ensembl chr 1:234,487,954...234,527,612
G
Pum3l1
pumilio RNA-binding family member 3 like 1
increases expression
EXP
nefazodone results in increased expression of PUM3L1 mRNA
CTD
PMID:24136188
NCBI chr X:149,570,869...149,572,962
Ensembl chr X:154,615,648...154,617,733
G
Pus1
pseudouridine synthase 1
increases expression
EXP
nefazodone results in increased expression of PUS1 mRNA
CTD
PMID:24136188
NCBI chr12:51,539,659...51,548,975
Ensembl chr12:51,540,212...51,548,973
G
Pygl
glycogen phosphorylase L
decreases expression
EXP
nefazodone results in decreased expression of PYGL mRNA
CTD
PMID:24136188
NCBI chr 6:94,433,558...94,476,219
Ensembl chr 6:94,426,346...94,476,269
G
R3hdm2
R3H domain containing 2
decreases expression
EXP
nefazodone results in decreased expression of R3HDM2 mRNA
CTD
PMID:24136188
NCBI chr 7:65,097,685...65,225,863
Ensembl chr 7:65,097,923...65,225,862
G
Rab11b
RAB11B, member RAS oncogene family
decreases expression
EXP
nefazodone results in decreased expression of RAB11B mRNA
CTD
PMID:24136188
NCBI chr 7:15,223,613...15,236,754
Ensembl chr 7:15,223,534...15,236,756
G
Rab21
RAB21, member RAS oncogene family
increases expression
EXP
nefazodone results in increased expression of RAB21 mRNA
CTD
PMID:24136188
NCBI chr 7:52,790,158...52,814,943
Ensembl chr 7:52,790,165...52,814,943
G
Rab28
RAB28, member RAS oncogene family
increases expression
EXP
nefazodone results in increased expression of RAB28 mRNA
CTD
PMID:24136188
NCBI chr14:69,245,846...69,322,968
Ensembl chr14:73,458,249...73,535,369
G
Rab2a
RAB2A, member RAS oncogene family
increases expression
EXP
nefazodone results in increased expression of RAB2A mRNA
CTD
PMID:24136188
NCBI chr 5:26,473,424...26,537,441
Ensembl chr 5:26,473,548...26,538,488
G
Rab30
RAB30, member RAS oncogene family
increases expression
EXP
nefazodone results in increased expression of RAB30 mRNA
CTD
PMID:24136188
NCBI chr 1:156,216,137...156,310,778
Ensembl chr 1:156,216,137...156,310,778
G
Rab34
RAB34, member RAS oncogene family
increases expression
EXP
nefazodone results in increased expression of RAB34 mRNA
CTD
PMID:24136188
NCBI chr10:63,581,542...63,585,608
Ensembl chr10:63,580,997...63,586,083
G
Rab38
RAB38, member RAS oncogene family
decreases expression
EXP
nefazodone results in decreased expression of RAB38 mRNA
CTD
PMID:24136188
NCBI chr 1:151,595,153...151,675,492
Ensembl chr 1:151,595,078...151,675,493
G
Rab5a
RAB5A, member RAS oncogene family
increases expression
EXP
nefazodone results in increased expression of RAB5A mRNA
CTD
PMID:24136188
NCBI chr 9:6,720,057...6,749,456
Ensembl chr 9:6,721,122...6,749,447
G
Rab5if
RAB5 interacting factor
increases expression
EXP
nefazodone results in increased expression of RAB5IF mRNA
CTD
PMID:24136188
NCBI chr 3:165,818,060...165,828,071
Ensembl chr 3:165,816,588...165,828,067
G
Rab6a
RAB6A, member RAS oncogene family
increases expression
EXP
nefazodone results in increased expression of RAB6A mRNA
CTD
PMID:24136188
NCBI chr 1:164,370,033...164,422,324
Ensembl chr 1:164,369,861...164,417,763
G
Rab7a
RAB7A, member RAS oncogene family
decreases expression
EXP
nefazodone results in decreased expression of RAB7A mRNA
CTD
PMID:24136188
NCBI chr 4:122,019,281...122,068,067
Ensembl chr 4:121,983,938...122,064,185
G
Rack1
receptor for activated C kinase 1
increases expression
EXP
nefazodone results in increased expression of RACK1 mRNA
CTD
PMID:24136188
NCBI chr10:33,668,560...33,676,031
Ensembl chr10:33,670,270...33,675,948
G
Rad23b
RAD23 homolog B, nucleotide excision repair protein
increases expression
EXP
nefazodone results in increased expression of RAD23B mRNA
CTD
PMID:24136188
NCBI chr 5:74,885,518...74,923,621
Ensembl chr 5:74,885,516...74,962,426
G
Rala
RAS like proto-oncogene A
increases expression multiple interactions
ISO
nefazodone results in increased expression of RALA mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RALA mRNA
CTD
PMID:32152650
NCBI chr17:51,787,682...51,840,738
Ensembl chr17:51,787,699...51,840,733
G
Ramac
RNA guanine-7 methyltransferase activating subunit
increases expression
EXP
nefazodone results in increased expression of RAMAC mRNA
CTD
PMID:24136188
NCBI chr 1:145,117,752...145,123,640
Ensembl chr 1:145,117,736...145,124,256
G
Ran
RAN, member RAS oncogene family
increases expression
EXP
nefazodone results in increased expression of RAN mRNA
CTD
PMID:24136188
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317
G
Ranbp2
RAN binding protein 2
increases expression
EXP
nefazodone results in increased expression of RANBP2 mRNA
CTD
PMID:24136188
NCBI chr20:26,984,520...27,036,573
Ensembl chr20:26,985,275...27,036,571
G
Rangap1
RAN GTPase activating protein 1
increases expression
EXP
nefazodone results in increased expression of RANGAP1 mRNA
CTD
PMID:24136188
NCBI chr 7:115,104,820...115,130,564
Ensembl chr 7:115,104,823...115,130,564
G
Rap1a
RAP1A, member of RAS oncogene family
multiple interactions decreases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of RAP1A mRNA nefazodone results in decreased expression of RAP1A mRNA
CTD
PMID:32152650
NCBI chr 2:195,896,967...195,974,851
Ensembl chr 2:195,896,971...195,974,808
G
Rarb
retinoic acid receptor, beta
decreases expression
EXP
nefazodone results in decreased expression of RARB mRNA
CTD
PMID:24136188
NCBI chr15:10,837,252...11,482,037
Ensembl chr15:11,131,358...11,482,040
G
Rarres1
retinoic acid receptor responder 1
decreases expression
EXP
nefazodone results in decreased expression of RARRES1 mRNA
CTD
PMID:24136188
NCBI chr 2:154,059,761...154,094,021
Ensembl chr 2:154,059,761...154,094,024
G
Rarres2
retinoic acid receptor responder 2
decreases expression
EXP
nefazodone results in decreased expression of RARRES2 mRNA
CTD
PMID:24136188
NCBI chr 4:78,853,450...78,856,652
Ensembl chr 4:78,853,453...78,856,457
G
Rars1
arginyl-tRNA synthetase 1
increases expression
EXP
nefazodone results in increased expression of RARS1 mRNA
CTD
PMID:24136188
NCBI chr10:20,774,804...20,799,251
Ensembl chr10:20,774,805...20,799,251
G
Rb1
RB transcriptional corepressor 1
decreases expression
EXP
nefazodone results in decreased expression of RB1 mRNA
CTD
PMID:24136188
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
G
Rbbp7
RB binding protein 7, chromatin remodeling factor
increases expression
EXP
nefazodone results in increased expression of RBBP7 mRNA
CTD
PMID:24136188
NCBI chr X:35,544,873...35,563,030
Ensembl chr X:35,544,873...35,563,030
G
Rbfa
ribosome binding factor A
decreases expression
EXP
nefazodone results in decreased expression of RBFA mRNA
CTD
PMID:24136188
NCBI chr18:75,914,247...75,923,893
Ensembl chr18:75,914,145...75,939,219
G
Rbis
ribosomal biogenesis factor
increases expression
EXP
nefazodone results in increased expression of RBIS mRNA
CTD
PMID:24136188
NCBI chr 2:88,702,599...88,718,587
Ensembl chr 2:88,702,536...88,719,527
G
Rbm26
RNA binding motif protein 26
decreases expression
EXP
nefazodone results in decreased expression of RBM26 mRNA
CTD
PMID:24136188
NCBI chr15:88,299,378...88,379,365
Ensembl chr15:88,301,436...88,378,686
G
Rbm3
RNA binding motif protein 3
increases expression
EXP
nefazodone results in increased expression of RBM3 mRNA
CTD
PMID:24136188
NCBI chr X:17,020,863...17,024,341
Ensembl chr X:17,020,864...17,024,841
G
Rbm39
RNA binding motif protein 39
decreases expression
EXP
nefazodone results in decreased expression of RBM39 mRNA
CTD
PMID:24136188
NCBI chr 3:165,123,087...165,156,453
Ensembl chr 3:165,123,095...165,149,397
G
Rbpms
RNA binding protein, mRNA processing factor
increases expression
EXP
nefazodone results in increased expression of RBPMS mRNA
CTD
PMID:24136188
NCBI chr16:64,942,159...65,098,504
Ensembl chr16:64,942,530...65,098,503
G
Rbx1
ring-box 1
increases expression
EXP
nefazodone results in increased expression of RBX1 mRNA
CTD
PMID:24136188
NCBI chr 7:114,870,893...114,881,194
Ensembl chr 7:114,870,972...114,881,191
G
Rcan1
regulator of calcineurin 1
decreases expression
EXP
nefazodone results in decreased expression of RCAN1 mRNA
CTD
PMID:24136188
NCBI chr11:45,108,123...45,188,065
Ensembl chr11:45,108,124...45,118,236
G
Rcan2
regulator of calcineurin 2
increases expression
EXP
nefazodone results in increased expression of RCAN2 mRNA
CTD
PMID:24136188
NCBI chr 9:24,456,861...24,674,234
Ensembl chr 9:24,456,861...24,672,189
G
Rcc2
regulator of chromosome condensation 2
increases expression
EXP
nefazodone results in increased expression of RCC2 mRNA
CTD
PMID:24136188
NCBI chr 5:158,277,476...158,300,294
Ensembl chr 5:158,277,476...158,300,294
G
Rchy1
ring finger and CHY zinc finger domain containing 1
increases expression
EXP
nefazodone results in increased expression of RCHY1 mRNA
CTD
PMID:24136188
NCBI chr14:16,397,533...16,413,286
Ensembl chr14:16,397,494...16,413,451
G
Rdh11
retinol dehydrogenase 11
decreases expression
EXP
nefazodone results in decreased expression of RDH11 mRNA
CTD
PMID:24136188
NCBI chr 6:103,712,373...103,728,247
Ensembl chr 6:103,712,374...103,729,741
G
Rdh16
retinol dehydrogenase 16
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of RDH16 mRNA
CTD
PMID:33819548
NCBI chr 7:65,499,763...65,510,304
G
Reep5
receptor accessory protein 5
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of REEP5 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of REEP5 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr18:26,219,528...26,257,505
Ensembl chr18:26,219,530...26,250,660
G
Reep6
receptor accessory protein 6
increases expression
EXP
nefazodone results in increased expression of REEP6 mRNA
CTD
PMID:24136188
NCBI chr 7:10,024,601...10,031,507
Ensembl chr 7:10,024,602...10,031,740
G
Reln
reelin
decreases expression
EXP
nefazodone results in decreased expression of RELN mRNA
CTD
PMID:24136188
NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:13,628,399...14,055,162
G
Retreg1
reticulophagy regulator 1
increases expression
EXP
nefazodone results in increased expression of RETREG1 mRNA
CTD
PMID:24136188
NCBI chr 2:78,045,435...78,205,316
Ensembl chr 2:78,066,031...78,225,356
G
Rex1bd
required for excision 1-B domain containing
increases expression
EXP
nefazodone results in increased expression of REX1BD mRNA
CTD
PMID:24136188
NCBI chr16:18,956,023...18,958,494
Ensembl chr16:18,955,969...18,958,494
G
Rexo2
RNA exonuclease 2
increases expression
EXP
nefazodone results in increased expression of REXO2 mRNA
CTD
PMID:24136188
NCBI chr 8:57,708,420...57,720,142
Ensembl chr 8:57,707,558...57,720,142
G
Rfk
riboflavin kinase
increases expression
EXP
nefazodone results in increased expression of RFK mRNA
CTD
PMID:24136188
NCBI chr 1:224,226,632...224,234,185
Ensembl chr 1:224,226,628...224,235,698 Ensembl chr X:224,226,628...224,235,698
G
Rfk-ps3
riboflavin kinase, pseudogene 3
increases expression
EXP
nefazodone results in increased expression of RFK-PS3 mRNA
CTD
PMID:24136188
NCBI chr 3:86,510,729...86,512,353
Ensembl chr 3:106,954,321...106,967,418
G
Rgn
regucalcin
decreases expression
EXP
nefazodone results in decreased expression of RGN mRNA
CTD
PMID:24136188
NCBI chr X:4,172,537...4,190,112
Ensembl chr X:4,172,537...4,190,251
G
Rhbdd2
rhomboid domain containing 2
increases expression
EXP
nefazodone results in increased expression of RHBDD2 mRNA
CTD
PMID:24136188
NCBI chr12:26,680,206...26,690,926
Ensembl chr12:26,680,969...26,691,080
G
Rheb
Ras homolog, mTORC1 binding
increases expression
EXP
nefazodone results in increased expression of RHEB mRNA
CTD
PMID:24136188
NCBI chr 4:11,012,173...11,053,860
Ensembl chr 4:11,012,643...11,053,931
G
Rhob
ras homolog family member B
decreases expression
EXP
nefazodone results in decreased expression of RHOB mRNA
CTD
PMID:24136188
NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772
G
Rida
reactive intermediate imine deaminase A homolog
decreases expression
EXP
nefazodone results in decreased expression of RIDA mRNA
CTD
PMID:24136188
NCBI chr 7:67,576,586...67,590,493
Ensembl chr 7:67,576,586...67,590,692
G
Rig1
RNA sensor RIG-1
decreases expression
EXP
nefazodone results in decreased expression of RIGI mRNA
CTD
PMID:24136188
NCBI chr 5:60,117,398...60,165,995
Ensembl chr 5:60,117,398...60,165,995
G
Riok3
RIO kinase 3
increases expression
EXP
nefazodone results in increased expression of RIOK3 mRNA
CTD
PMID:24136188
NCBI chr18:3,602,535...3,628,108
Ensembl chr18:3,602,535...3,628,108
G
Ripk1
receptor interacting serine/threonine kinase 1
increases expression multiple interactions
ISO
nefazodone results in increased expression of RIPK1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RIPK1 mRNA
CTD
PMID:32152650
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167
G
Rmdn2
regulator of microtubule dynamics 2
decreases expression
EXP
nefazodone results in decreased expression of RMDN2 mRNA
CTD
PMID:24136188
NCBI chr 6:21,101,383...21,195,221
Ensembl chr 6:21,119,396...21,193,684
G
Rmi1
RecQ mediated genome instability 1
decreases expression
EXP
nefazodone results in decreased expression of RMI1 mRNA
CTD
PMID:24136188
NCBI chr17:6,261,961...6,269,947
Ensembl chr17:6,260,896...6,282,052
G
Rnase4
ribonuclease A family member 4
decreases expression
EXP
nefazodone results in decreased expression of RNASE4 mRNA
CTD
PMID:24136188
NCBI chr15:26,786,287...26,803,634
Ensembl chr15:26,786,079...26,803,639
G
Rnf10
ring finger protein 10
increases expression
EXP
nefazodone results in increased expression of RNF10 mRNA
CTD
PMID:24136188
NCBI chr12:47,002,409...47,036,201
Ensembl chr12:47,002,409...47,036,201
G
Rnf113a2
ring finger protein 113A2
increases expression
EXP
nefazodone results in increased expression of RNF113A2 mRNA
CTD
PMID:24136188
NCBI chr 6:104,063,677...104,064,958
Ensembl chr 6:109,794,684...109,796,273
G
Rnf114
ring finger protein 114
increases expression
EXP
nefazodone results in increased expression of RNF114 mRNA
CTD
PMID:24136188
NCBI chr 3:176,641,456...176,653,262
Ensembl chr 3:176,641,499...176,671,960
G
Rnf115
ring finger protein 115
increases expression
EXP
nefazodone results in increased expression of RNF115 mRNA
CTD
PMID:24136188
NCBI chr 2:186,950,959...187,018,673
Ensembl chr 2:186,950,760...187,019,561
G
Rnf125
ring finger protein 125
decreases expression
EXP
nefazodone results in decreased expression of RNF125 mRNA
CTD
PMID:24136188
NCBI chr18:12,528,995...12,550,646
Ensembl chr18:12,528,838...12,554,430
G
Rnf139
ring finger protein 139
increases expression
EXP
nefazodone results in increased expression of RNF139 mRNA
CTD
PMID:24136188
NCBI chr 7:92,329,201...92,340,386
Ensembl chr 7:92,329,157...92,341,721
G
Rnf14
ring finger protein 14
increases expression
EXP
nefazodone results in increased expression of RNF14 mRNA
CTD
PMID:24136188
NCBI chr18:30,381,072...30,406,859
Ensembl chr18:30,382,857...30,406,774
G
Rnf149
ring finger protein 149
increases expression
EXP
nefazodone results in increased expression of RNF149 mRNA
CTD
PMID:24136188
NCBI chr 9:49,322,524...49,350,361
Ensembl chr 9:49,323,857...49,350,042
G
Rnf187
ring finger protein 187
increases expression
EXP
nefazodone results in increased expression of RNF187 mRNA
CTD
PMID:24136188
NCBI chr10:44,209,080...44,214,979
Ensembl chr10:44,202,332...44,215,470
G
Rnf39
ring finger protein 39
decreases expression
EXP
nefazodone results in decreased expression of RNF39 mRNA
CTD
PMID:24136188
NCBI chr20:1,610,027...1,615,516
Ensembl chr20:1,610,026...1,612,323
G
Rnf4
ring finger protein 4
increases expression
EXP
nefazodone results in increased expression of RNF4 mRNA
CTD
PMID:24136188
NCBI chr14:80,625,864...80,647,138
Ensembl chr14:80,625,866...80,647,148
G
Rnf7
ring finger protein 7
increases expression
EXP
nefazodone results in increased expression of RNF7 mRNA
CTD
PMID:24136188
NCBI chr 8:105,918,395...105,927,643
Ensembl chr 8:105,918,395...105,927,405
G
Rnh1
ribonuclease/angiogenin inhibitor 1
increases expression
EXP
nefazodone results in increased expression of RNH1 mRNA
CTD
PMID:24136188
NCBI chr 1:205,698,882...205,711,348
Ensembl chr 1:205,698,882...205,711,582
G
Rnps1
RNA binding protein with serine rich domain 1
increases expression
EXP
nefazodone results in increased expression of RNPS1 mRNA
CTD
PMID:24136188
NCBI chr10:13,950,151...13,960,396
Ensembl chr10:13,950,184...13,960,393
G
Rogdi
rogdi atypical leucine zipper
increases expression
EXP
nefazodone results in increased expression of ROGDI mRNA
CTD
PMID:24136188
NCBI chr10:11,074,288...11,078,907
Ensembl chr10:11,074,262...11,078,906
G
Rora
RAR-related orphan receptor A
decreases expression
EXP
nefazodone results in decreased expression of RORA mRNA
CTD
PMID:24136188
NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:78,182,620...78,915,730
G
Rorc
RAR-related orphan receptor C
decreases expression
EXP
nefazodone results in decreased expression of RORC mRNA
CTD
PMID:24136188
NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:184,698,818...184,724,566
G
Rpa1
replication protein A1
decreases expression
EXP
nefazodone results in decreased expression of RPA1 mRNA
CTD
PMID:24136188
NCBI chr10:60,647,185...60,698,279
Ensembl chr10:60,647,185...60,698,279
G
Rpl10a
ribosomal protein L10A
increases expression
EXP
nefazodone results in increased expression of RPL10A mRNA
CTD
PMID:24136188
NCBI chr20:6,390,533...6,393,091
Ensembl chr20:6,390,179...6,393,091
G
Rpl12a-ps1
ribosomal protein L12, pseudogene 1
increases expression
EXP
nefazodone results in increased expression of RPL12A-PS1 mRNA
CTD
PMID:24136188
NCBI chr 7:52,366,726...52,367,448
G
Rpl15
ribosomal protein L15
increases expression
EXP
nefazodone results in increased expression of RPL15 mRNA
CTD
PMID:24136188
NCBI chr15:9,934,663...9,937,946
Ensembl chr15:9,934,679...9,938,308
G
Rpl17
ribosomal protein L17
increases expression
EXP
nefazodone results in increased expression of RPL17 mRNA
CTD
PMID:24136188
NCBI chr18:70,856,275...70,859,388
Ensembl chr 3:111,722,010...111,722,638 Ensembl chr18:111,722,010...111,722,638
G
Rpl18
ribosomal protein L18
increases expression
EXP
nefazodone results in increased expression of RPL18 mRNA
CTD
PMID:24136188
NCBI chr 1:105,325,269...105,327,911
Ensembl chr 1:105,325,250...105,327,910
G
Rpl18a
ribosomal protein L18A
increases expression
EXP
nefazodone results in increased expression of RPL18A mRNA
CTD
PMID:24136188
NCBI chr16:18,576,467...18,578,653
Ensembl chr 1:70,166,729...70,167,654 Ensembl chr16:70,166,729...70,167,654
G
Rpl22l1
ribosomal protein L22 like 1
increases expression
EXP
nefazodone results in increased expression of RPL22L1 mRNA
CTD
PMID:24136188
NCBI chr 2:113,683,196...113,685,132
Ensembl chr 2:113,683,196...113,685,132
G
Rpl23
ribosomal protein L23
increases expression
EXP
nefazodone results in increased expression of RPL23 mRNA
CTD
PMID:24136188
NCBI chr10:83,268,223...83,272,184
Ensembl chr10:83,262,592...83,272,214
G
Rpl3
ribosomal protein L3
increases expression
EXP
nefazodone results in increased expression of RPL3 mRNA
CTD
PMID:24136188
NCBI chr 7:113,491,943...113,508,115
Ensembl chr 7:113,501,960...113,507,990
G
Rpl36a
ribosomal protein L36A
increases expression
EXP
nefazodone results in increased expression of RPL36A mRNA
CTD
PMID:24136188
NCBI chr X:102,058,573...102,062,162
Ensembl chr20:22,034,086...22,034,406
G
Rpl7l1
ribosomal protein L7-like 1
increases expression
EXP
nefazodone results in increased expression of RPL7L1 mRNA
CTD
PMID:24136188
NCBI chr 9:21,695,718...21,703,736
Ensembl chr 9:21,695,707...21,703,735
G
Rpl8
ribosomal protein L8
increases expression
EXP
nefazodone results in increased expression of RPL8 mRNA
CTD
PMID:24136188
NCBI chr 7:110,506,815...110,509,106
Ensembl chr 7:110,506,800...110,509,103 Ensembl chr 3:110,506,800...110,509,103
G
Rpl9
ribosomal protein L9
increases expression
EXP
nefazodone results in increased expression of RPL9 mRNA
CTD
PMID:24136188
NCBI chr14:43,247,536...43,250,784
Ensembl chr14:43,247,588...43,250,782 Ensembl chr 1:43,247,588...43,250,782
G
Rplp2
ribosomal protein lateral stalk subunit P2
increases expression
EXP
nefazodone results in increased expression of RPLP2 mRNA
CTD
PMID:24136188
NCBI chr 1:205,975,598...205,978,192
Ensembl chr 1:205,975,894...205,978,191
G
Rpp21
ribonuclease P/MRP subunit p21
decreases expression
EXP
nefazodone results in decreased expression of RPP21 mRNA
CTD
PMID:24136188
NCBI chr20:1,986,225...2,025,308
Ensembl chr20:2,023,186...2,025,308
G
Rps12
ribosomal protein S12
increases expression
EXP
nefazodone results in increased expression of RPS12 mRNA
CTD
PMID:24136188
NCBI chr 1:23,499,943...23,502,234
Ensembl chr 1:23,500,073...23,502,235
G
Rps14
ribosomal protein S14
increases expression
EXP
nefazodone results in increased expression of RPS14 mRNA
CTD
PMID:24136188
NCBI chr18:56,492,010...56,503,092
Ensembl chr18:56,498,245...56,503,091
G
Rps15
ribosomal protein S15
increases expression
EXP
nefazodone results in increased expression of RPS15 mRNA
CTD
PMID:24136188
NCBI chr 7:10,066,572...10,068,167
Ensembl chr 7:10,066,677...10,068,123
G
Rps16
ribosomal protein S16
increases expression
EXP
nefazodone results in increased expression of RPS16 mRNA
CTD
PMID:24136188
NCBI chr 1:92,770,658...92,773,603
Ensembl chr19:56,922,246...56,923,020 Ensembl chr 1:56,922,246...56,923,020
G
Rps17
ribosomal protein S17
increases expression
EXP
nefazodone results in increased expression of RPS17 mRNA
CTD
PMID:24136188
NCBI chr 1:144,705,150...144,707,736
Ensembl chr 1:144,705,149...144,707,734 Ensembl chr 8:144,705,149...144,707,734
G
Rps2
ribosomal protein S2
increases expression
EXP
nefazodone results in increased expression of RPS2 mRNA
CTD
PMID:24136188
NCBI chr10:14,251,841...14,253,697
Ensembl chr10:14,251,380...14,253,695
G
Rps2-ps38
ribosomal protein S2, pseudogene 38
increases expression
EXP
nefazodone results in increased expression of RPS2-PS38 mRNA
CTD
PMID:24136188
NCBI chr11:38,421,728...38,422,600
G
Rps20
ribosomal protein S20
increases expression
EXP
nefazodone results in increased expression of RPS20 mRNA
CTD
PMID:24136188
NCBI chr 5:21,616,687...21,618,068
Ensembl chr 3:42,839,965...43,095,621 Ensembl chr 9:42,839,965...43,095,621 Ensembl chr 5:42,839,965...43,095,621
G
Rps21-ps1
ribosomal protein S21, pseudogene 1
increases expression
EXP
nefazodone results in increased expression of RPS21 mRNA
CTD
PMID:24136188
NCBI chr 5:158,670,141...158,670,484
Ensembl chr 5:158,670,116...158,670,490
G
Rps27a
ribosomal protein S27a
increases expression
EXP
nefazodone results in increased expression of RPS27A mRNA
CTD
PMID:24136188
NCBI chr14:107,486,664...107,488,941
Ensembl chr 5:138,465,088...138,466,080 Ensembl chr14:138,465,088...138,466,080 Ensembl chr 5:138,465,088...138,466,080
G
Rps3
ribosomal protein S3
increases expression
EXP
nefazodone results in increased expression of RPS3 mRNA
CTD
PMID:24136188
NCBI chr 1:163,190,476...163,195,885
Ensembl chr 1:163,189,842...163,195,776
G
Rps5
ribosomal protein S5
increases expression
EXP
nefazodone results in increased expression of RPS5 mRNA
CTD
PMID:24136188
NCBI chr 1:82,610,965...82,615,262
Ensembl chr 1:82,610,965...82,615,262
G
Rps6
ribosomal protein S6
increases expression
EXP
nefazodone results in increased expression of RPS6 mRNA
CTD
PMID:24136188
NCBI chr 5:106,417,680...106,420,540
Ensembl chr 5:106,417,680...106,420,566
G
Rps9
ribosomal protein S9
increases expression
EXP
nefazodone results in increased expression of RPS9 mRNA
CTD
PMID:24136188
NCBI chr 1:74,427,084...74,430,513
Ensembl chr 1:74,427,087...74,430,105
G
Rpsa
ribosomal protein SA
increases expression
EXP
nefazodone results in increased expression of RPSA mRNA
CTD
PMID:24136188
NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737
G
Rragc
Ras-related GTP binding C
increases expression
EXP
nefazodone results in increased expression of RRAGC mRNA
CTD
PMID:24136188
NCBI chr 5:141,433,014...141,452,546
Ensembl chr 5:141,433,040...141,452,548
G
Rras2
RAS related 2
multiple interactions
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA
CTD
PMID:32152650
NCBI chr 1:177,668,143...177,737,551
Ensembl chr 1:177,668,144...177,737,551
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP
nefazodone results in decreased expression of RRM2 mRNA
CTD
PMID:24136188
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370
G
Rrn3
RRN3 homolog, RNA polymerase I transcription factor
increases expression
EXP
nefazodone results in increased expression of RRN3 mRNA
CTD
PMID:24136188
NCBI chr10:2,637,016...2,672,338
Ensembl chr10:2,637,016...2,672,330
G
Rsrc2
arginine and serine rich coiled-coil 2
decreases expression
EXP
nefazodone results in decreased expression of RSRC2 mRNA
CTD
PMID:24136188
NCBI chr12:38,500,709...38,520,715
Ensembl chr12:38,500,770...38,520,707
G
Rsrp1
arginine and serine rich protein 1
decreases expression
EXP
nefazodone results in decreased expression of RSRP1 mRNA
CTD
PMID:24136188
NCBI chr 5:152,431,448...152,435,202
Ensembl chr 5:152,431,478...152,435,126
G
RT1-S3
RT1 class Ib, locus S3
decreases expression
EXP
nefazodone results in decreased expression of RT1-S3 mRNA
CTD
PMID:24136188
NCBI chr20:2,675,463...2,680,229
G
Rtcb
RNA 2',3'-cyclic phosphate and 5'-OH ligase
increases expression
EXP
nefazodone results in increased expression of RTCB mRNA
CTD
PMID:24136188
NCBI chr 7:17,907,668...17,927,136
Ensembl chr 7:19,795,393...19,814,875
G
Rtl8a
retrotransposon Gag like 8A
decreases expression
EXP
nefazodone results in decreased expression of RTL8B mRNA
CTD
PMID:24136188
NCBI chr X:138,436,824...138,438,037
Ensembl chr X:138,436,605...138,470,972
G
Rup2
urinary protein 2
decreases expression
EXP
nefazodone results in decreased expression of RUP2 mRNA
CTD
PMID:24136188
NCBI chr 8:43,547,875...43,551,456
Ensembl chr 8:43,549,809...43,700,211
G
Ruvbl2
RuvB-like AAA ATPase 2
increases expression
EXP
nefazodone results in increased expression of RUVBL2 mRNA
CTD
PMID:24136188
NCBI chr 1:105,038,487...105,051,851
Ensembl chr 1:105,038,174...105,051,720
G
Rwdd4
RWD domain containing 4
increases expression
EXP
nefazodone results in increased expression of RWDD4 mRNA
CTD
PMID:24136188
NCBI chr16:44,714,698...44,733,090
Ensembl chr16:51,447,385...51,465,759
G
S1pr1
sphingosine-1-phosphate receptor 1
decreases expression
EXP
nefazodone results in decreased expression of S1PR1 mRNA
CTD
PMID:24136188
NCBI chr 2:206,309,715...206,314,070
Ensembl chr 2:205,900,836...206,328,689
G
Saa4
serum amyloid A4
decreases expression
EXP
nefazodone results in decreased expression of SAA4 mRNA
CTD
PMID:24136188
NCBI chr 1:106,383,856...106,388,158
Ensembl chr 1:106,383,856...106,387,354
G
Sall1
spalt-like transcription factor 1
increases expression
EXP
nefazodone results in increased expression of SALL1 mRNA
CTD
PMID:24136188
NCBI chr19:34,179,316...34,196,278
Ensembl chr19:34,181,078...34,196,278
G
Samm50
SAMM50 sorting and assembly machinery component
increases expression
EXP
nefazodone results in increased expression of SAMM50 mRNA
CTD
PMID:24136188
NCBI chr 7:117,197,460...117,221,668
Ensembl chr 7:117,197,381...117,224,581
G
Sap18
Sin3A associated protein 18
increases expression
EXP
nefazodone results in increased expression of SAP18 mRNA
CTD
PMID:24136188
NCBI chr15:36,058,784...36,063,089
Ensembl chr10:87,156,914...87,158,257 Ensembl chr15:87,156,914...87,158,257
G
Sap30l
SAP30-like
increases expression
EXP
nefazodone results in increased expression of SAP30L mRNA
CTD
PMID:24136188
NCBI chr10:42,480,201...42,488,139
Ensembl chr10:42,480,201...42,488,139
G
Sar1b
secretion associated, Ras related GTPase 1B
increases expression
EXP
nefazodone results in increased expression of SAR1B mRNA
CTD
PMID:24136188
NCBI chr10:36,525,365...36,555,009
Ensembl chr10:36,519,384...36,555,005
G
Sardh
sarcosine dehydrogenase
decreases expression
EXP
nefazodone results in decreased expression of SARDH mRNA
CTD
PMID:24136188
NCBI chr 3:30,908,621...30,973,409
Ensembl chr 3:30,908,621...30,972,137
G
Sars1
seryl-tRNA synthetase 1
increases expression
EXP
nefazodone results in increased expression of SARS1 mRNA
CTD
PMID:24136188
NCBI chr 2:198,753,673...198,769,411
Ensembl chr 2:198,753,675...198,769,365
G
Sat1
spermidine/spermine N1-acetyl transferase 1
decreases expression
EXP
nefazodone results in decreased expression of SAT1 mRNA
CTD
PMID:24136188
NCBI chr X:44,008,089...44,011,376
Ensembl chr X:44,006,781...44,011,374
G
Scamp1
secretory carrier membrane protein 1
increases expression
EXP
nefazodone results in increased expression of SCAMP1 mRNA
CTD
PMID:24136188
NCBI chr 2:27,168,863...27,251,637
Ensembl chr 2:27,168,864...27,251,742
G
Scamp4
secretory carrier membrane protein 4
increases expression
EXP
nefazodone results in increased expression of SCAMP4 mRNA
CTD
PMID:24136188
NCBI chr 7:9,752,193...9,764,614
Ensembl chr 7:9,752,193...9,778,736
G
Scarb1
scavenger receptor class B, member 1
multiple interactions
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of SCARB1 mRNA
CTD
PMID:32152650
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
G
Scarb2
scavenger receptor class B, member 2
increases expression
EXP
nefazodone results in increased expression of SCARB2 mRNA
CTD
PMID:24136188
NCBI chr14:15,842,583...15,894,123
Ensembl chr14:15,842,515...15,896,671
G
Sccpdh
saccharopine dehydrogenase (putative)
increases expression
EXP
nefazodone results in increased expression of SCCPDH mRNA
CTD
PMID:24136188
NCBI chr13:93,932,086...93,953,840
Ensembl chr13:93,912,395...93,954,192
G
Scd
stearoyl-CoA desaturase
decreases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of SCD1 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of SCD mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
G
Scn5a
sodium voltage-gated channel alpha subunit 5
affects activity
ISO
nefazodone affects the activity of SCN5A protein
CTD
PMID:26821276
NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:128,098,613...128,196,470
G
Scp2
sterol carrier protein 2
decreases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of SCP2 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of SCP2 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 5:128,035,714...128,110,015
Ensembl chr 5:128,008,125...128,110,043
G
Sdc2
syndecan 2
decreases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of SDC2 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of SDC2 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 7:66,012,405...66,125,101
Ensembl chr 7:66,108,853...66,126,294
G
Sdhc
succinate dehydrogenase complex subunit C
increases expression
EXP
nefazodone results in increased expression of SDHC mRNA
CTD
PMID:24136188
NCBI chr13:86,077,133...86,098,025
Ensembl chr13:86,077,134...86,098,044
G
Sdr42e1
short chain dehydrogenase/reductase family 42E, member 1
increases expression
EXP
nefazodone results in increased expression of SDR42E1 mRNA
CTD
PMID:24136188
NCBI chr19:62,624,130...62,636,652
Ensembl chr19:62,624,150...62,636,756
G
Sds
serine dehydratase
decreases expression
EXP
nefazodone results in decreased expression of SDS mRNA
CTD
PMID:24136188
NCBI chr12:41,743,796...41,751,108
Ensembl chr12:41,743,799...41,748,773
G
Sec23a
Sec23 homolog A, COPII coat complex component
increases expression
EXP
nefazodone results in increased expression of SEC23A mRNA
CTD
PMID:24136188
NCBI chr 6:82,393,699...82,442,594
Ensembl chr 6:82,394,863...82,440,904
G
Sec23b
Sec23 homolog B, COPII coat complex component
increases expression
EXP
nefazodone results in increased expression of SEC23B mRNA
CTD
PMID:24136188
NCBI chr 3:152,392,340...152,434,813
Ensembl chr 3:152,392,308...152,434,800
G
Sec24d
SEC24 homolog D, COPII coat complex component
increases expression
EXP
nefazodone results in increased expression of SEC24D mRNA
CTD
PMID:24136188
NCBI chr 2:214,103,138...214,211,155
Ensembl chr 2:214,103,190...214,211,144
G
Sec62
SEC62 homolog, preprotein translocation factor
decreases expression
EXP
nefazodone results in decreased expression of SEC62 mRNA
CTD
PMID:24136188
NCBI chr 2:114,499,317...114,526,705
Ensembl chr 2:114,499,317...114,530,321
G
Sec63
SEC63 homolog, protein translocation regulator
decreases expression
EXP
nefazodone results in decreased expression of SEC63 mRNA
CTD
PMID:24136188
NCBI chr20:47,827,291...47,896,248
Ensembl chr20:47,827,291...47,896,248
G
Sectm1b
secreted and transmembrane 1B
decreases expression
EXP
nefazodone results in decreased expression of SECTM1B mRNA
CTD
PMID:24136188
NCBI chr10:106,822,397...106,832,105
Ensembl chr10:106,822,397...106,832,104
G
Selenbp1
selenium binding protein 1
increases expression
EXP
nefazodone results in increased expression of SELENBP1 mRNA
CTD
PMID:24136188
NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:185,183,004...185,194,295
G
Serf2
small EDRK-rich factor 2
decreases expression
EXP
nefazodone results in decreased expression of SERF2 mRNA
CTD
PMID:24136188
NCBI chr 3:128,880,681...128,884,457
Ensembl chr 3:128,880,681...128,884,457
G
Serp1
stress-associated endoplasmic reticulum protein 1
increases expression
EXP
nefazodone results in increased expression of SERP1 mRNA
CTD
PMID:24136188
NCBI chr 2:144,907,204...144,911,187
Ensembl chr 2:144,907,205...144,911,187
G
Serpina11
serpin family A member 11
decreases expression
EXP
nefazodone results in decreased expression of SERPINA11 mRNA
CTD
PMID:24136188
NCBI chr 6:128,668,030...128,677,476
Ensembl chr 6:128,668,034...128,677,454
G
Serpina3c
serine (or cysteine) proteinase inhibitor, clade A, member 3C
decreases expression
EXP
nefazodone results in decreased expression of SERPINA3C mRNA
CTD
PMID:24136188
NCBI chr 6:129,007,578...129,014,988
Ensembl chr 6:128,829,577...129,014,971
G
Serpina3n
serpin family A member 3N
decreases expression
EXP
nefazodone results in decreased expression of SERPINA3N mRNA
CTD
PMID:24136188
NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:129,088,398...129,097,415
G
Serpina4
serpin family A member 4
decreases expression
EXP
nefazodone results in decreased expression of SERPINA4 mRNA
CTD
PMID:24136188
NCBI chr 6:128,764,738...128,773,858
Ensembl chr 6:128,764,769...128,776,028
G
Serpina6
serpin family A member 6
decreases expression
EXP
nefazodone results in decreased expression of SERPINA6 mRNA
CTD
PMID:24136188
NCBI chr 6:128,544,828...128,555,064
Ensembl chr 6:128,544,831...128,555,139
G
Serpinb9
serpin family B member 9
decreases expression
EXP
nefazodone results in decreased expression of SERPINB9 mRNA
CTD
PMID:24136188
NCBI chr17:31,628,887...31,652,003
Ensembl chr17:31,629,392...31,651,974
G
Serpind1
serpin family D member 1
decreases expression
EXP
nefazodone results in decreased expression of SERPIND1 mRNA
CTD
PMID:24136188
NCBI chr11:97,168,753...97,179,830
Ensembl chr11:97,168,754...97,179,755
G
Serpine1
serpin family E member 1
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SERPINE1 mRNA nefazodone results in increased expression of SERPINE1 mRNA
CTD
PMID:32152650
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
G
Serpinf2
serpin family F member 2
decreases expression
EXP
nefazodone results in decreased expression of SERPINF2 mRNA
CTD
PMID:24136188
NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,770,698...60,778,996
G
Serping1
serpin family G member 1
decreases expression
EXP
nefazodone results in decreased expression of SERPING1 mRNA
CTD
PMID:24136188
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717
G
Sesn2
sestrin 2
decreases expression
EXP
nefazodone results in decreased expression of SESN2 mRNA
CTD
PMID:24136188
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
G
Set
Set nuclear proto-oncogene
increases expression
EXP
nefazodone results in increased expression of SET mRNA
CTD
PMID:24136188
NCBI chr 3:33,732,319...33,743,433
G
Setd4
SET domain containing 4
increases expression
EXP
nefazodone results in increased expression of SETD4 mRNA
CTD
PMID:24136188
NCBI chr11:46,315,340...46,344,024
Ensembl chr11:46,323,895...46,344,024
G
Setd6
SET domain containing 6, protein lysine methyltransferase
increases expression
EXP
nefazodone results in increased expression of SETD6 mRNA
CTD
PMID:24136188
NCBI chr19:9,349,011...9,356,515
Ensembl chr19:9,353,520...9,356,515
G
Sez6
seizure related 6 homolog
decreases expression
EXP
nefazodone results in decreased expression of SEZ6 mRNA
CTD
PMID:24136188
NCBI chr10:63,317,065...63,366,733
Ensembl chr10:63,316,953...63,366,723
G
Sf3b4
splicing factor 3B subunit 4
increases expression
EXP
nefazodone results in increased expression of SF3B4 mRNA
CTD
PMID:24136188
NCBI chr 2:186,421,667...186,426,419
Ensembl chr 2:186,421,636...186,426,833
G
Sf3b5
splicing factor 3b, subunit 5
increases expression
EXP
nefazodone results in increased expression of SF3B5 mRNA
CTD
PMID:24136188
NCBI chr 1:9,177,189...9,177,901
Ensembl chr 1:9,177,098...9,177,900
G
Sfpq
splicing factor proline and glutamine rich
increases expression
EXP
nefazodone results in increased expression of SFPQ mRNA
CTD
PMID:24136188
NCBI chr 5:144,621,678...144,637,930
Ensembl chr 5:144,622,476...144,637,926
G
Sfxn1
sideroflexin 1
increases expression
EXP
nefazodone results in increased expression of SFXN1 mRNA
CTD
PMID:24136188
NCBI chr17:10,491,315...10,527,793
Ensembl chr17:10,491,344...10,527,456
G
Sgf29
SAGA complex associated factor 29
increases expression
EXP
nefazodone results in increased expression of SGF29 mRNA
CTD
PMID:24136188
NCBI chr 1:190,668,803...190,702,500
Ensembl chr 1:190,669,028...190,717,906
G
Sgk1
serum/glucocorticoid regulated kinase 1
decreases expression
EXP
nefazodone results in decreased expression of SGK1 mRNA
CTD
PMID:24136188
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231
G
Sgpp1
sphingosine-1-phosphate phosphatase 1
increases expression
EXP
nefazodone results in increased expression of SGPP1 mRNA
CTD
PMID:24136188
NCBI chr 6:100,161,024...100,182,214
Ensembl chr 6:100,161,024...100,182,259
G
Sh2d4a
SH2 domain containing 4A
decreases expression
EXP
nefazodone results in decreased expression of SH2D4A mRNA
CTD
PMID:24136188
NCBI chr16:26,106,721...26,176,069
Ensembl chr16:26,106,730...26,175,974
G
Sh3bgrl
SH3 domain binding glutamate rich protein like
decreases expression
EXP
nefazodone results in decreased expression of SH3BGRL mRNA
CTD
PMID:24136188
NCBI chr X:78,242,704...78,343,633
Ensembl chr X:78,242,405...78,343,634
G
Sh3glb1
SH3 domain -containing GRB2-like endophilin B1
multiple interactions increases expression
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA nefazodone results in increased expression of SH3GLB1 mRNA
CTD
PMID:32152650
NCBI chr 2:236,411,194...236,445,225
Ensembl chr 2:236,410,436...236,445,140
G
Shc1
SHC adaptor protein 1
increases expression
EXP
nefazodone results in increased expression of SHC1 mRNA
CTD
PMID:24136188
NCBI chr 2:177,135,649...177,147,257
Ensembl chr 2:177,135,659...177,147,914
G
Shmt1
serine hydroxymethyltransferase 1
increases expression
EXP
nefazodone results in increased expression of SHMT1 mRNA
CTD
PMID:24136188
NCBI chr10:45,968,959...45,990,341
Ensembl chr10:45,960,434...45,997,326
G
Sin3b
SIN3 transcription regulator family member B
increases expression
EXP
nefazodone results in increased expression of SIN3B mRNA
CTD
PMID:24136188
NCBI chr16:17,157,352...17,194,051
Ensembl chr16:17,157,352...17,270,664
G
Skic8
SKI8 subunit of superkiller complex
increases expression
EXP
nefazodone results in increased expression of SKIC8 mRNA
CTD
PMID:24136188
NCBI chr 8:63,999,669...64,016,959
Ensembl chr 8:63,999,671...64,016,846
G
Skp1
S-phase kinase-associated protein 1
increases expression
EXP
nefazodone results in increased expression of SKP1 mRNA
CTD
PMID:24136188
NCBI chr10:36,898,670...36,917,828
Ensembl chr10:36,903,078...36,918,308
G
Slc10a1
solute carrier family 10 member 1
decreases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of SLC10A1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of SLC10A1 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944
G
Slc10a7
solute carrier family 10, member 7
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of SLC10A7 mRNA
CTD
PMID:33819548
NCBI chr19:46,087,440...46,311,753
Ensembl chr19:46,049,631...46,311,753
G
Slc12a2
solute carrier family 12 member 2
increases expression
EXP
nefazodone results in increased expression of SLC12A2 mRNA
CTD
PMID:24136188
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470
G
Slc16a7
solute carrier family 16 member 7
increases expression
EXP
nefazodone results in increased expression of SLC16A7 mRNA
CTD
PMID:24136188
NCBI chr 7:62,929,067...63,096,995
Ensembl chr 7:62,936,567...63,040,386
G
Slc17a1
solute carrier family 17 member 1
increases expression
EXP
nefazodone results in increased expression of SLC17A1 mRNA
CTD
PMID:24136188
NCBI chr17:41,647,332...41,683,078
Ensembl chr17:41,649,919...41,681,174
G
Slc17a2
solute carrier family 17, member 2
decreases expression
EXP
nefazodone results in decreased expression of SLC17A2 mRNA
CTD
PMID:24136188
NCBI chr17:41,748,195...41,767,601
Ensembl chr17:41,748,195...41,764,180
G
Slc17a3
solute carrier family 17 member 3
increases expression
EXP
nefazodone results in increased expression of SLC17A3 mRNA
CTD
PMID:24136188
NCBI chr17:41,698,679...41,729,057
Ensembl chr17:41,698,680...41,723,329
G
Slc18b1
solute carrier family 18 member B1
increases expression
EXP
nefazodone results in increased expression of SLC18B1 mRNA
CTD
PMID:24136188
NCBI chr 1:23,447,462...23,490,043
Ensembl chr 1:23,447,462...23,489,962
G
Slc19a2
solute carrier family 19 member 2
decreases expression
EXP
nefazodone results in decreased expression of SLC19A2 mRNA
CTD
PMID:24136188
NCBI chr13:79,135,118...79,149,316
Ensembl chr13:79,135,059...79,149,315
G
Slc20a1
solute carrier family 20 member 1
increases expression
EXP
nefazodone results in increased expression of SLC20A1 mRNA
CTD
PMID:24136188
NCBI chr 3:136,880,360...136,894,255
Ensembl chr 3:136,880,290...136,894,249
G
Slc22a1
solute carrier family 22 member 1
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of SLC22A1 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of SLC22A1 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:50,624,377...50,651,436
G
Slc22a18
solute carrier family 22, member 18
increases expression
EXP
nefazodone results in increased expression of SLC22A18 mRNA
CTD
PMID:24136188
NCBI chr 1:208,100,032...208,124,382
Ensembl chr 1:208,101,136...208,124,380
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
nefazodone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Slc22a5
solute carrier family 22 member 5
increases expression
EXP
nefazodone results in increased expression of SLC22A5 mRNA
CTD
PMID:24136188
NCBI chr10:38,509,072...38,536,240
Ensembl chr10:38,509,072...38,536,077
G
Slc22a7
solute carrier family 22 member 7
decreases expression
EXP
nefazodone results in decreased expression of SLC22A7 mRNA
CTD
PMID:24136188
NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:22,045,435...22,051,681
G
Slc22a8
solute carrier family 22 member 8
decreases expression
EXP
nefazodone results in decreased expression of SLC22A8 mRNA
CTD
PMID:24136188
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
G
Slc25a1
solute carrier family 25 member 1
decreases expression
EXP
nefazodone results in decreased expression of SLC25A1 mRNA
CTD
PMID:24136188
NCBI chr11:96,560,054...96,563,071
Ensembl chr11:96,560,041...96,565,052
G
Slc25a17
solute carrier family 25 member 17
increases expression
EXP
nefazodone results in increased expression of SLC25A17 mRNA
CTD
PMID:24136188
NCBI chr 7:114,724,533...114,767,163
Ensembl chr 7:114,724,533...114,767,345
G
Slc25a20
solute carrier family 25 member 20
increases expression
EXP
nefazodone results in increased expression of SLC25A20 mRNA
CTD
PMID:24136188
NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:118,243,519...118,265,027
G
Slc25a23
solute carrier family 25 member 23
decreases expression
EXP
nefazodone results in decreased expression of SLC25A23 mRNA
CTD
PMID:24136188
NCBI chr 9:1,969,633...1,985,365
Ensembl chr 9:1,969,357...1,985,365
G
Slc25a25
solute carrier family 25 member 25
decreases expression
EXP
nefazodone results in decreased expression of SLC25A25 mRNA
CTD
PMID:24136188
NCBI chr 3:36,106,448...36,139,812
Ensembl chr 3:36,106,449...36,140,011
G
Slc25a3
solute carrier family 25 member 3
increases expression
EXP
nefazodone results in increased expression of SLC25A3 mRNA
CTD
PMID:24136188
NCBI chr 7:27,499,164...27,506,685
Ensembl chr 7:27,499,165...27,506,309
G
Slc25a30
solute carrier family 25, member 30
decreases expression
EXP
nefazodone results in decreased expression of SLC25A30 mRNA
CTD
PMID:24136188
NCBI chr15:57,486,346...57,508,981
Ensembl chr15:57,486,350...57,502,690
G
Slc25a39
solute carrier family 25, member 39
increases expression
EXP
nefazodone results in increased expression of SLC25A39 mRNA
CTD
PMID:24136188
NCBI chr10:87,862,630...87,867,626
Ensembl chr10:87,862,631...87,866,973
G
Slc26a8
solute carrier family 26 member 8
increases expression
EXP
nefazodone results in increased expression of SLC26A8 mRNA
CTD
PMID:24136188
NCBI chr20:6,687,207...6,751,184
Ensembl chr20:6,699,445...6,751,184
G
Slc28a2
solute carrier family 28 member 2
decreases expression
EXP
nefazodone results in decreased expression of SLC28A2 mRNA
CTD
PMID:24136188
NCBI chr 3:129,778,425...129,841,292
Ensembl chr 3:129,807,537...129,841,291
G
Slc29a1
solute carrier family 29 member 1
decreases expression
EXP
nefazodone results in decreased expression of SLC29A1 mRNA
CTD
PMID:24136188
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:22,902,471...22,914,620
G
Slc2a2
solute carrier family 2 member 2
decreases expression
EXP
nefazodone results in decreased expression of SLC2A2 mRNA
CTD
PMID:24136188
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
G
Slc30a1
solute carrier family 30 member 1
increases expression
EXP
nefazodone results in increased expression of SLC30A1 mRNA
CTD
PMID:24136188
NCBI chr13:106,022,019...106,025,892
Ensembl chr13:106,022,019...106,025,892
G
Slc30a5
solute carrier family 30 member 5
increases expression
EXP
nefazodone results in increased expression of SLC30A5 mRNA
CTD
PMID:24136188
NCBI chr 2:33,679,800...33,710,025
Ensembl chr 2:33,679,800...33,712,596
G
Slc33a1
solute carrier family 33 member 1
increases expression
EXP
nefazodone results in increased expression of SLC33A1 mRNA
CTD
PMID:24136188
NCBI chr 2:150,565,327...150,587,700
Ensembl chr 2:150,565,328...150,587,416
G
Slc34a1
solute carrier family 34 member 1
increases expression
EXP
nefazodone results in increased expression of SLC34A1 mRNA
CTD
PMID:24136188
NCBI chr17:9,224,010...9,238,983
Ensembl chr17:9,224,010...9,238,983
G
Slc34a2
solute carrier family 34 member 2
decreases expression
EXP
nefazodone results in decreased expression of SLC34A2 mRNA
CTD
PMID:24136188
NCBI chr14:62,123,313...62,153,020
Ensembl chr14:62,123,316...62,143,360
G
Slc35b1
solute carrier family 35, member B1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of SLC35B1 mRNA
CTD
PMID:33819548
NCBI chr10:80,327,921...80,335,279
Ensembl chr10:80,824,696...80,832,045
G
Slc35e3
solute carrier family 35, member E3
increases expression
EXP
nefazodone results in increased expression of SLC35E3 mRNA
CTD
PMID:24136188
NCBI chr 7:53,337,091...53,350,152
Ensembl chr 7:55,219,998...55,236,035
G
Slc39a8
solute carrier family 39 member 8
decreases expression
EXP
nefazodone results in decreased expression of SLC39A8 mRNA
CTD
PMID:24136188
NCBI chr 2:226,845,686...226,992,668
Ensembl chr 2:226,929,644...226,992,667
G
Slc3a2
solute carrier family 3 member 2
increases expression
EXP
nefazodone results in increased expression of SLC3A2 mRNA
CTD
PMID:24136188
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064
G
Slc40a1
solute carrier family 40 member 1
increases expression
EXP
nefazodone results in increased expression of SLC40A1 mRNA
CTD
PMID:24136188
NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:55,525,532...55,543,460
G
Slc43a1
solute carrier family 43 member 1
decreases expression
EXP
nefazodone results in decreased expression of SLC43A1 mRNA
CTD
PMID:24136188
NCBI chr 3:90,327,250...90,353,438
Ensembl chr 3:90,327,149...90,353,438
G
Slc46a1
solute carrier family 46 member 1
decreases expression
EXP
nefazodone results in decreased expression of SLC46A1 mRNA
CTD
PMID:24136188
NCBI chr10:63,859,551...63,865,987
Ensembl chr10:63,859,504...63,866,869
G
Slc48a1
solute carrier family 48 member 1
increases expression
EXP
nefazodone results in increased expression of SLC48A1 mRNA
CTD
PMID:24136188
NCBI chr 7:130,794,233...130,802,119
Ensembl chr 7:130,794,245...130,803,022
G
Slc4a2
solute carrier family 4 member 2
increases expression
EXP
nefazodone results in increased expression of SLC4A2 mRNA
CTD
PMID:24136188
NCBI chr 4:11,628,860...11,646,961
Ensembl chr 4:11,628,862...11,645,402
G
Slc51b
SLC51 subunit beta
multiple interactions
ISO
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA
CTD
PMID:32152650
NCBI chr 8:74,827,047...74,835,109
Ensembl chr 8:74,827,047...74,835,109
G
Slc66a2
solute carrier family 66 member 2
decreases expression
EXP
nefazodone results in decreased expression of SLC66A2 mRNA
CTD
PMID:24136188
NCBI chr18:75,976,000...76,014,651
Ensembl chr18:75,977,458...76,014,651
G
Slc6a12
solute carrier family 6 member 12
decreases expression
EXP
nefazodone results in decreased expression of SLC6A12 mRNA
CTD
PMID:24136188
NCBI chr 4:156,257,518...156,275,870
Ensembl chr 4:156,254,208...156,275,879
G
Slc6a6
solute carrier family 6 member 6
decreases expression
EXP
nefazodone results in decreased expression of SLC6A6 mRNA
CTD
PMID:24136188
NCBI chr 4:125,752,340...125,826,033
Ensembl chr 4:125,752,372...125,826,032
G
Slc6a9
solute carrier family 6 member 9
increases expression
EXP
nefazodone results in increased expression of SLC6A9 mRNA
CTD
PMID:24136188
NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:136,659,948...136,694,172
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
increases expression
EXP
nefazodone results in increased expression of SLCO1A2 mRNA
CTD
PMID:24136188
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816
G
Slco2a1
solute carrier organic anion transporter family, member 2a1
decreases expression
EXP
nefazodone results in decreased expression of SLCO2A1 mRNA
CTD
PMID:24136188
NCBI chr 8:112,467,739...112,551,923
Ensembl chr 8:112,467,160...112,551,921
G
Slfn3
schlafen 3
decreases expression
EXP
nefazodone results in decreased expression of SLFN3 mRNA
CTD
PMID:24136188
NCBI chr10:68,020,482...68,060,248
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
ISO
nefazodone results in increased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822
G
Sltm
SAFB-like, transcription modulator
increases expression
EXP
nefazodone results in increased expression of SLTM mRNA
CTD
PMID:24136188
NCBI chr 8:80,096,555...80,142,668
Ensembl chr 8:80,097,652...80,142,671
G
Smagp
small cell adhesion glycoprotein
decreases expression
EXP
nefazodone results in decreased expression of SMAGP mRNA
CTD
PMID:24136188
NCBI chr 7:133,599,043...133,617,492
Ensembl chr 7:133,599,043...133,616,642
G
Smarcb1
SWI/SNF related BAF chromatin remodeling complex subunit B1
increases expression
EXP
nefazodone results in increased expression of SMARCB1 mRNA
CTD
PMID:24136188
NCBI chr20:12,740,105...12,763,054
Ensembl chr20:12,740,943...12,763,055
G
Smc6
structural maintenance of chromosomes 6
decreases expression
EXP
nefazodone results in decreased expression of SMC6 mRNA
CTD
PMID:24136188
NCBI chr 6:39,697,810...39,752,275
Ensembl chr 6:39,697,811...39,752,279
G
Smim26
small integral membrane protein 26
increases expression
EXP
nefazodone results in increased expression of SMIM26 mRNA
CTD
PMID:24136188
NCBI chr 3:152,443,397...152,445,102
Ensembl chr 3:152,443,579...152,445,447
G
Smoc1
SPARC related modular calcium binding 1
decreases expression
EXP
nefazodone results in decreased expression of SMOC1 mRNA
CTD
PMID:24136188
NCBI chr 6:106,432,592...106,593,956
Ensembl chr 6:106,432,603...106,593,956
G
Snap29
synaptosome associated protein 29
increases expression
EXP
nefazodone results in increased expression of SNAP29 mRNA
CTD
PMID:24136188
NCBI chr11:97,082,721...97,113,195
Ensembl chr11:97,082,739...97,113,195
G
Snrnp25
small nuclear ribonucleoprotein U11/U12 subunit 25
increases expression
EXP
nefazodone results in increased expression of SNRNP25 mRNA
CTD
PMID:24136188
NCBI chr10:15,924,932...15,928,279
Ensembl chr10:15,924,940...15,928,252
G
Snrnp70
small nuclear ribonucleoprotein U1 subunit 70
decreases expression
EXP
nefazodone results in decreased expression of SNRNP70 mRNA
CTD
PMID:24136188
NCBI chr 1:104,992,518...105,012,851
Ensembl chr 1:104,992,442...105,012,851
G
Snrpb
small nuclear ribonucleoprotein polypeptides B and B1
increases expression
EXP
nefazodone results in increased expression of SNRPB mRNA
CTD
PMID:24136188
NCBI chr 3:137,824,870...137,832,479
Ensembl chr 3:137,824,683...137,832,515
G
Snrpc
small nuclear ribonucleoprotein polypeptide C
increases expression
EXP
nefazodone results in increased expression of SNRPC mRNA
CTD
PMID:24136188
NCBI chr20:5,890,229...5,908,410
Ensembl chr20:5,890,229...5,908,410
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
increases expression
EXP
nefazodone results in increased expression of SNRPD3 mRNA
CTD
PMID:24136188
NCBI chr20:13,129,555...13,145,100
Ensembl chr20:13,109,294...13,145,763
G
Snrpg
small nuclear ribonucleoprotein polypeptide G
increases expression
EXP
nefazodone results in increased expression of SNRPG mRNA
CTD
PMID:24136188
NCBI chr 4:120,369,676...120,377,263
Ensembl chr 4:120,369,685...120,377,261 Ensembl chr X:120,369,685...120,377,261
G
Snu13
small nuclear ribonucleoprotein 13
increases expression
EXP
nefazodone results in increased expression of SNU13 mRNA
CTD
PMID:24136188
NCBI chr 7:115,445,415...115,451,008
Ensembl chr 1:269,702,002...269,703,004 Ensembl chr 7:269,702,002...269,703,004
G
Snx2
sorting nexin 2
increases expression
EXP
nefazodone results in increased expression of SNX2 mRNA
CTD
PMID:24136188
NCBI chr18:48,800,594...48,842,158
Ensembl chr18:48,800,583...48,842,474
G
Snx24
sorting nexin 24
decreases expression
EXP
nefazodone results in decreased expression of SNX24 mRNA
CTD
PMID:24136188
NCBI chr18:48,869,804...49,024,352
Ensembl chr18:48,869,882...49,024,350
G
Socs2
suppressor of cytokine signaling 2
decreases expression
EXP
nefazodone results in decreased expression of SOCS2 mRNA
CTD
PMID:24136188
NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:31,874,463...31,930,423
G
Sod2
superoxide dismutase 2
increases expression decreases expression multiple interactions
EXP ISO
nefazodone results in increased expression of SOD2 mRNA nefazodone results in decreased expression of SOD2 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SOD2 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
G
Sord
sorbitol dehydrogenase
increases expression
EXP
nefazodone results in increased expression of SORD mRNA
CTD
PMID:24136188
NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:129,638,302...129,686,100
G
Sorl1
sortilin related receptor 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of SORL1 mRNA
CTD
PMID:33819548
NCBI chr 8:51,238,713...51,401,458
Ensembl chr 8:51,238,722...51,401,446
G
Sparc
secreted protein acidic and cysteine rich
decreases expression
EXP
nefazodone results in decreased expression of SPARC mRNA
CTD
PMID:24136188
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268
G
Spg21
SPG21 abhydrolase domain containing, maspardin
increases expression
EXP
nefazodone results in increased expression of SPG21 mRNA
CTD
PMID:24136188
NCBI chr 8:74,876,136...74,903,676
Ensembl chr 8:74,876,136...74,903,676
G
Sphk2
sphingosine kinase 2
increases expression
EXP
nefazodone results in increased expression of SPHK2 mRNA
CTD
PMID:24136188
NCBI chr 1:105,317,332...105,324,985
Ensembl chr 1:105,317,333...105,321,637
G
Spink1
serine peptidase inhibitor, Kazal type 1
decreases expression
EXP
nefazodone results in decreased expression of SPINK1 mRNA
CTD
PMID:24136188
NCBI chr18:36,121,626...36,133,596
Ensembl chr18:36,076,399...36,133,545
G
Spryd4
SPRY domain containing 4
increases expression
EXP
nefazodone results in increased expression of SPRYD4 mRNA
CTD
PMID:24136188
NCBI chr 7:1,217,984...1,222,231
Ensembl chr 7:1,218,122...1,219,942
G
Spryd7
SPRY domain containing 7
increases expression
EXP
nefazodone results in increased expression of SPRYD7 mRNA
CTD
PMID:24136188
NCBI chr15:39,883,237...39,903,770
Ensembl chr15:39,883,238...39,903,674
G
Sptan1
spectrin, alpha, non-erythrocytic 1
increases expression
EXP
nefazodone results in increased expression of SPTAN1 mRNA
CTD
PMID:24136188
NCBI chr 3:33,639,020...33,703,890
Ensembl chr 3:33,607,210...33,703,889
G
Sptssa
serine palmitoyltransferase, small subunit A
decreases expression
EXP
nefazodone results in decreased expression of SPTSSA mRNA
CTD
PMID:24136188
NCBI chr 6:77,879,931...77,891,344
Ensembl chr 6:77,879,941...77,891,403
G
Sqstm1
sequestosome 1
increases expression multiple interactions
EXP ISO
nefazodone results in increased expression of SQSTM1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SQSTM1 mRNA
CTD
PMID:24136188 PMID:32152650
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
G
Srd5a1
steroid 5 alpha-reductase 1
decreases expression
EXP
nefazodone results in decreased expression of SRD5A1 mRNA
CTD
PMID:24136188
NCBI chr 1:35,514,914...35,548,898
Ensembl chr 1:35,514,846...35,548,903
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression multiple interactions
EXP ISO
nefazodone results in decreased expression of SREBF1 mRNA [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of SREBF1 mRNA
CTD
PMID:24136188 PMID:33819548
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
G
Srgn
serglycin
decreases expression
EXP
nefazodone results in decreased expression of SRGN mRNA
CTD
PMID:24136188
NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,985,508...31,000,327
G
Srm
spermidine synthase
increases expression
EXP
nefazodone results in increased expression of SRM mRNA
CTD
PMID:24136188
NCBI chr 5:164,309,002...164,312,203
Ensembl chr 5:164,308,991...164,332,705
G
Srp72
signal recognition particle 72
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of SRP72 mRNA
CTD
PMID:33819548
NCBI chr14:31,522,424...31,549,978
Ensembl chr14:31,522,963...31,550,151
G
Srr
serine racemase
decreases expression
EXP
nefazodone results in decreased expression of SRR mRNA
CTD
PMID:24136188
NCBI chr10:60,267,936...60,285,094
Ensembl chr10:60,268,859...60,285,100
G
Srrt
serrate, RNA effector molecule
increases expression
EXP
nefazodone results in increased expression of SRRT mRNA
CTD
PMID:24136188
NCBI chr12:25,027,883...25,042,847
Ensembl chr12:25,029,334...25,042,845
G
Srsf11
serine and arginine rich splicing factor 11
decreases expression
EXP
nefazodone results in decreased expression of SRSF11 mRNA
CTD
PMID:24136188
NCBI chr 2:249,733,464...249,760,296
Ensembl chr 2:249,733,464...249,760,499
G
Srsf4
serine and arginine rich splicing factor 4
increases expression
EXP
nefazodone results in increased expression of SRSF4 mRNA
CTD
PMID:24136188
NCBI chr 5:149,345,538...149,373,309
Ensembl chr 5:149,345,422...149,374,609
G
Srxn1
sulfiredoxin 1
increases expression
EXP
nefazodone results in increased expression of SRXN1 mRNA
CTD
PMID:24136188
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765
G
Ssbp1
single stranded DNA binding protein 1
increases expression
EXP
nefazodone results in increased expression of SSBP1 mRNA
CTD
PMID:24136188
NCBI chr 4:70,232,740...70,242,824
Ensembl chr 4:70,232,794...70,243,700
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
EXP
nefazodone results in decreased expression of SSX2IP mRNA
CTD
PMID:24136188
NCBI chr 2:237,958,286...237,991,026
Ensembl chr 2:237,958,465...237,991,017
G
St13
ST13, Hsp70 interacting protein
increases expression
EXP
nefazodone results in increased expression of ST13 mRNA
CTD
PMID:24136188
NCBI chr 7:114,769,758...114,805,877
Ensembl chr 7:114,769,759...114,805,941
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
decreases expression
EXP
nefazodone results in decreased expression of ST6GAL1 mRNA
CTD
PMID:24136188
NCBI chr11:91,031,481...91,158,111
Ensembl chr11:91,032,450...91,040,415
G
Stac3
SH3 and cysteine rich domain 3
decreases expression
EXP
nefazodone results in decreased expression of STAC3 mRNA
CTD
PMID:24136188
NCBI chr 7:65,227,151...65,235,884
Ensembl chr 7:65,228,352...65,235,878
G
Stag1
STAG1 cohesin complex component
decreases expression
EXP
nefazodone results in decreased expression of STAG1 mRNA
CTD
PMID:24136188
NCBI chr 8:110,057,981...110,443,666
Ensembl chr 8:110,058,056...110,443,665
G
Stard3nl
STARD3 N-terminal like
increases expression
EXP
nefazodone results in increased expression of STARD3NL mRNA
CTD
PMID:24136188
NCBI chr17:50,278,859...50,312,864
Ensembl chr17:50,278,894...50,312,866
G
Stat2
signal transducer and activator of transcription 2
decreases expression
EXP
nefazodone results in decreased expression of STAT2 mRNA
CTD
PMID:24136188
NCBI chr 7:1,287,025...1,302,858
Ensembl chr 7:1,287,024...1,303,459
G
Stbd1
starch binding domain 1
increases expression
EXP
nefazodone results in increased expression of STBD1 mRNA
CTD
PMID:24136188
NCBI chr14:15,754,769...15,758,174
Ensembl chr14:15,754,644...15,761,659
G
Steap3
STEAP3 metalloreductase
decreases expression
EXP
nefazodone results in decreased expression of STEAP3 mRNA
CTD
PMID:24136188
NCBI chr13:33,904,710...33,950,100
Ensembl chr13:33,904,710...33,950,080
G
Steap4
STEAP4 metalloreductase
decreases expression
EXP
nefazodone results in decreased expression of STEAP4 mRNA
CTD
PMID:24136188
NCBI chr 4:27,032,096...27,054,769
Ensembl chr 4:27,009,584...27,067,105
G
Stip1
stress-induced phosphoprotein 1
increases expression
EXP
nefazodone results in increased expression of STIP1 mRNA
CTD
PMID:24136188
NCBI chr 1:213,638,641...213,657,654
Ensembl chr 1:213,638,641...213,657,654
G
Stk24
serine/threonine kinase 24
increases expression
EXP
nefazodone results in increased expression of STK24 mRNA
CTD
PMID:24136188
NCBI chr15:104,770,556...104,866,524
Ensembl chr15:104,773,569...104,865,975
G
Stoml2
stomatin like 2
increases expression
EXP
nefazodone results in increased expression of STOML2 mRNA
CTD
PMID:24136188
NCBI chr 5:62,052,042...62,055,639
Ensembl chr 5:62,052,045...62,055,670
G
Strap
serine/threonine kinase receptor associated protein
increases expression
EXP
nefazodone results in increased expression of STRAP mRNA
CTD
PMID:24136188
NCBI chr 4:172,377,325...172,391,573
Ensembl chr 4:172,377,305...172,392,436
G
Stx12
syntaxin 12
increases expression
EXP
nefazodone results in increased expression of STX12 mRNA
CTD
PMID:24136188
NCBI chr 5:150,347,554...150,376,426
Ensembl chr 5:150,334,836...150,376,346
G
Stx7
syntaxin 7
decreases expression
EXP
nefazodone results in decreased expression of STX7 mRNA
CTD
PMID:24136188
NCBI chr 1:23,016,330...23,056,579
Ensembl chr 1:23,016,336...23,056,465
G
Sulf2
sulfatase 2
decreases expression
EXP
nefazodone results in decreased expression of SULF2 mRNA
CTD
PMID:24136188
NCBI chr 3:175,241,322...175,323,808
Ensembl chr 3:175,241,322...175,323,651
G
Sult1b1
sulfotransferase family 1B member 1
increases expression
EXP
nefazodone results in increased expression of SULT1B1 mRNA
CTD
PMID:24136188
NCBI chr14:20,771,917...20,784,665
Ensembl chr14:20,771,868...20,785,549
G
Sult1c2a
sulfotransferase family 1C member 2A
decreases expression
EXP
nefazodone results in decreased expression of SULT1C2A mRNA
CTD
PMID:24136188
NCBI chr 9:7,075,873...7,103,316
Ensembl chr 9:7,066,905...7,244,132
G
Sult1c3
sulfotransferase family 1C member 3
decreases expression
EXP
nefazodone results in decreased expression of SULT1C3 mRNA
CTD
PMID:24136188
NCBI chr 9:7,548,839...7,594,299
Ensembl chr 9:7,548,622...7,594,295
G
Sult2a1
sulfotransferase family 2A member 1
decreases expression multiple interactions
ISO
nefazodone results in decreased expression of SULT2A1 mRNA [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of SULT2A1 mRNA
CTD
PMID:32152650
NCBI chr 1:84,582,011...84,639,001
G
Sult2a6
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6
increases expression
EXP
nefazodone results in increased expression of SULT2A6 mRNA
CTD
PMID:24136188
NCBI chr 1:84,046,685...84,097,808
Ensembl chr 1:84,046,685...84,097,808
G
Sumf2
sulfatase modifying factor 2
increases expression
EXP
nefazodone results in increased expression of SUMF2 mRNA
CTD
PMID:24136188
NCBI chr12:32,489,671...32,507,941
Ensembl chr12:32,489,671...32,507,928
G
Sun2
Sad1 and UNC84 domain containing 2
increases expression
EXP
nefazodone results in increased expression of SUN2 mRNA
CTD
PMID:24136188
NCBI chr 7:113,155,766...113,172,950
Ensembl chr 7:113,155,766...113,172,940
G
Suox
sulfite oxidase
decreases expression
EXP
nefazodone results in decreased expression of SUOX mRNA
CTD
PMID:24136188
NCBI chr 7:1,687,666...1,691,759
Ensembl chr 7:1,687,666...1,690,235
G
Svil
supervillin
decreases expression
EXP
nefazodone results in decreased expression of SVIL mRNA
CTD
PMID:24136188
NCBI chr17:57,343,910...57,539,508
Ensembl chr17:57,343,910...57,462,660
G
Swi5
SWI5 homologous recombination repair protein
increases expression
EXP
nefazodone results in increased expression of SWI5 mRNA
CTD
PMID:24136188
NCBI chr 3:35,972,436...35,981,658
Ensembl chr 3:35,972,436...35,981,554
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
increases expression
EXP
nefazodone results in increased expression of SYNCRIP mRNA
CTD
PMID:24136188
NCBI chr 8:98,282,358...98,315,412
Ensembl chr 8:98,282,358...98,315,386
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
EXP
nefazodone results in decreased expression of SYNE2 mRNA
CTD
PMID:24136188
NCBI chr 6:100,272,729...100,586,364
Ensembl chr 6:100,272,729...100,583,723
G
Syngr2
synaptogyrin 2
increases expression
EXP
nefazodone results in increased expression of SYNGR2 mRNA
CTD
PMID:24136188
NCBI chr10:103,528,599...103,533,167
Ensembl chr10:103,528,607...103,533,162
G
Synj2bp
synaptojanin 2 binding protein
decreases expression
EXP
nefazodone results in decreased expression of SYNJ2BP mRNA
CTD
PMID:24136188
NCBI chr 6:106,920,970...106,958,653
Ensembl chr 6:106,920,970...106,966,543
G
Synrg
synergin, gamma
decreases expression
EXP
nefazodone results in decreased expression of SYNRG mRNA
CTD
PMID:24136188
NCBI chr10:69,346,154...69,428,714
Ensembl chr10:69,322,114...69,428,714
G
Taf9
TATA-box binding protein associated factor 9
increases expression
EXP
nefazodone results in increased expression of TAF9 mRNA
CTD
PMID:24136188
NCBI chr 2:33,528,388...33,532,395
Ensembl chr 2:33,531,368...33,536,078
G
Tardbp
TAR DNA binding protein
increases expression
EXP
nefazodone results in increased expression of TARDBP mRNA
CTD
PMID:24136188
NCBI chr 5:164,330,452...164,348,435
Ensembl chr 5:164,334,924...164,345,204
G
Tatdn2
TatD DNase domain containing 2
increases expression
EXP
nefazodone results in increased expression of TATDN2 mRNA
CTD
PMID:24136188
NCBI chr 4:148,400,454...148,416,501
Ensembl chr 4:148,400,492...148,416,501
G
Tbc1d15
TBC1 domain family, member 15
increases expression
EXP
nefazodone results in increased expression of TBC1D15 mRNA
CTD
PMID:24136188
NCBI chr 7:52,690,770...52,746,309
Ensembl chr 7:52,690,770...52,746,303
G
Tbc1d17
TBC1 domain family, member 17
increases expression
EXP
nefazodone results in increased expression of TBC1D17 mRNA
CTD
PMID:24136188
NCBI chr 1:104,461,266...104,469,615
Ensembl chr 1:104,461,267...104,469,489
G
Tbc1d8
TBC1 domain family, member 8
decreases expression
EXP
nefazodone results in decreased expression of TBC1D8 mRNA
CTD
PMID:24136188
NCBI chr 9:49,147,109...49,257,140
Ensembl chr 9:49,147,109...49,257,118
G
Tbcb
tubulin folding cofactor B
increases expression
EXP
nefazodone results in increased expression of TBCB mRNA
CTD
PMID:24136188
NCBI chr 1:94,605,100...94,610,949
Ensembl chr 1:94,605,101...94,610,949
G
Tbce
tubulin folding cofactor E
increases expression
EXP
nefazodone results in increased expression of TBCE mRNA
CTD
PMID:24136188
NCBI chr17:55,983,627...56,031,578
Ensembl chr17:55,985,707...56,032,302
G
Tbk1
TANK-binding kinase 1
increases expression
EXP
nefazodone results in increased expression of TBK1 mRNA
CTD
PMID:24136188
NCBI chr 7:58,963,319...58,996,357
Ensembl chr 7:58,963,325...58,996,357
G
Tcea1
transcription elongation factor A1
increases expression
EXP
nefazodone results in increased expression of TCEA1 mRNA
CTD
PMID:24136188
NCBI chr 5:19,414,351...19,466,629
Ensembl chr15:12,831,339...12,834,156 Ensembl chr 5:12,831,339...12,834,156
G
Tcp1
t-complex 1
increases expression
EXP
nefazodone results in increased expression of TCP1 mRNA
CTD
PMID:24136188
NCBI chr 1:50,376,848...50,384,527
Ensembl chr 1:50,376,848...50,384,527
G
Tdg
thymine-DNA glycosylase
increases expression
EXP
nefazodone results in increased expression of TDG mRNA
CTD
PMID:24136188
NCBI chr 7:22,965,388...22,990,311
Ensembl chr 7:22,965,388...22,985,100
G
Tef
TEF transcription factor, PAR bZIP family member
increases expression
EXP
nefazodone results in increased expression of TEF mRNA
CTD
PMID:24136188
NCBI chr 7:115,197,180...115,221,930
Ensembl chr 7:115,193,282...115,221,928
G
Tefm
transcription elongation factor, mitochondrial
increases expression
EXP
nefazodone results in increased expression of TEFM mRNA
CTD
PMID:24136188
NCBI chr10:65,617,547...65,622,042
Ensembl chr10:65,617,550...65,622,042
G
Tent2
terminal nucleotidyltransferase 2
decreases expression
EXP
nefazodone results in decreased expression of TENT2 mRNA
CTD
PMID:24136188
NCBI chr 2:26,115,150...26,167,465
Ensembl chr 2:26,115,240...26,167,113
G
Tent4b
terminal nucleotidyltransferase 4B
increases expression
EXP
nefazodone results in increased expression of TENT4B mRNA
CTD
PMID:24136188
NCBI chr19:34,984,244...35,042,423
Ensembl chr19:34,980,296...35,042,399
G
Tent5a
terminal nucleotidyltransferase 5A
decreases expression
EXP
nefazodone results in decreased expression of TENT5A mRNA
CTD
PMID:24136188
NCBI chr 8:95,102,349...95,109,100
Ensembl chr 8:95,105,412...95,109,100
G
Tex261
testis expressed 261
increases expression
EXP
nefazodone results in increased expression of TEX261 mRNA
CTD
PMID:24136188
NCBI chr 4:117,813,050...117,818,408
Ensembl chr 4:117,811,176...117,819,180
G
Tex264
testis expressed 264
increases expression
EXP
nefazodone results in increased expression of TEX264 mRNA
CTD
PMID:24136188
NCBI chr 8:107,295,806...107,322,858
Ensembl chr 8:116,174,518...116,201,667
G
Tf
transferrin
decreases expression
EXP
nefazodone results in decreased expression of TF mRNA
CTD
PMID:24136188
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400
G
Tfam
transcription factor A, mitochondrial
increases expression
EXP
nefazodone results in increased expression of TFAM mRNA
CTD
PMID:24136188
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877
G
Tfb2m
transcription factor B2, mitochondrial
increases expression
EXP
nefazodone results in increased expression of TFB2M mRNA
CTD
PMID:24136188
NCBI chr13:93,810,859...93,828,678
Ensembl chr13:93,810,731...93,828,594
G
Tfe3
transcription factor binding to IGHM enhancer 3
increases expression
EXP
nefazodone results in increased expression of TFE3 mRNA
CTD
PMID:24136188
NCBI chr X:17,401,466...17,414,829
Ensembl chr X:17,401,466...17,414,685
G
Tfpi
tissue factor pathway inhibitor
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of TFPI mRNA
CTD
PMID:33819548
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:89,939,868...89,980,742
G
Tfrc
transferrin receptor
increases expression
EXP
nefazodone results in increased expression of TFRC mRNA
CTD
PMID:24136188
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
G
Tgfbi
transforming growth factor, beta induced
decreases expression
EXP
nefazodone results in decreased expression of TGFBI mRNA
CTD
PMID:24136188
NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,960,516...7,990,471
G
Tgm2
transglutaminase 2
decreases expression
EXP
nefazodone results in decreased expression of TGM2 mRNA
CTD
PMID:24136188
NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240
G
Thnsl2
threonine synthase-like 2
decreases expression
EXP
nefazodone results in decreased expression of THNSL2 mRNA
CTD
PMID:24136188
NCBI chr 4:104,671,305...104,691,084
Ensembl chr 4:104,670,925...104,691,959
G
Thrsp
thyroid hormone responsive
decreases expression
EXP
nefazodone results in decreased expression of THRSP mRNA
CTD
PMID:24136188
NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:161,133,453...161,139,827
G
Thumpd3
THUMP domain containing 3
increases expression
EXP
nefazodone results in increased expression of THUMPD3 mRNA
CTD
PMID:24136188
NCBI chr 4:147,741,288...147,764,254
Ensembl chr 4:147,741,309...147,765,579
G
Timm10
translocase of inner mitochondrial membrane 10
increases expression
EXP
nefazodone results in increased expression of TIMM10 mRNA
CTD
PMID:24136188
NCBI chr 3:90,315,048...90,318,613
Ensembl chr 3:90,315,092...90,318,614
G
Timm10b
translocase of inner mitochondrial membrane 10B
increases expression
EXP
nefazodone results in increased expression of TIMM10B mRNA
CTD
PMID:24136188
NCBI chr 1:169,392,355...169,395,201
Ensembl chr 1:169,392,177...169,395,205
G
Timm13
translocase of inner mitochondrial membrane 13
increases expression
EXP
nefazodone results in increased expression of TIMM13 mRNA
CTD
PMID:24136188
NCBI chr 7:9,459,490...9,460,849
Ensembl chr 7:9,459,582...9,460,862
G
Timm17a
translocase of inner mitochondrial membrane 17A
increases expression
EXP
nefazodone results in increased expression of TIMM17A mRNA
CTD
PMID:24136188
NCBI chr13:49,282,918...49,296,363
Ensembl chr13:49,282,918...49,307,904
G
Timm29
translocase of inner mitochondrial membrane 29
increases expression
EXP
nefazodone results in increased expression of TIMM29 mRNA
CTD
PMID:24136188
NCBI chr 8:28,421,370...28,424,339
Ensembl chr 8:28,421,370...28,424,339
G
Timm8a1
translocase of inner mitochondrial membrane 8A1
increases expression
EXP
nefazodone results in increased expression of TIMM8A1 mRNA
CTD
PMID:24136188
NCBI chr X:102,011,206...102,015,444
Ensembl chr X:102,011,206...102,015,444
G
Timm8b
translocase of inner mitochondrial membrane 8 homolog B
increases expression
EXP
nefazodone results in increased expression of TIMM8B mRNA
CTD
PMID:24136188
NCBI chr 8:59,850,737...59,852,117
Ensembl chr 8:59,850,728...59,852,962
G
Timm9
translocase of inner mitochondrial membrane 9
increases expression
EXP
nefazodone results in increased expression of TIMM9 mRNA
CTD
PMID:24136188
NCBI chr 6:95,346,065...95,358,895
Ensembl chr 6:95,346,065...95,358,895
G
Tjp2
tight junction protein 2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of TJP2 mRNA
CTD
PMID:33819548
NCBI chr 1:231,136,218...231,264,750
Ensembl chr 1:231,136,243...231,264,750
G
Tkt
transketolase
increases expression
EXP
nefazodone results in increased expression of TKT mRNA
CTD
PMID:24136188
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431
G
Tle5
TLE family member 5, transcriptional modulator
decreases expression
EXP
nefazodone results in decreased expression of TLE5 mRNA
CTD
PMID:24136188
NCBI chr 7:8,794,123...8,801,056
Ensembl chr 7:8,793,796...8,801,054
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of TLR4 mRNA
CTD
PMID:33819548
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
G
Tm2d1
TM2 domain containing 1
increases expression
EXP
nefazodone results in increased expression of TM2D1 mRNA
CTD
PMID:24136188
NCBI chr 5:118,136,299...118,177,639
Ensembl chr 5:118,136,299...118,170,283
G
Tm2d3
TM2 domain containing 3
increases expression
EXP
nefazodone results in increased expression of TM2D3 mRNA
CTD
PMID:24136188
NCBI chr 1:119,267,194...119,277,094
Ensembl chr 1:128,677,629...128,687,580
G
Tm9sf3
transmembrane 9 superfamily member 3
increases expression
EXP
nefazodone results in increased expression of TM9SF3 mRNA
CTD
PMID:24136188
NCBI chr 1:249,981,458...250,034,247
Ensembl chr 1:249,981,458...250,034,247
G
Tmcc2
transmembrane and coiled-coil domain family 2
decreases expression
EXP
nefazodone results in decreased expression of TMCC2 mRNA
CTD
PMID:24136188
NCBI chr13:43,794,029...43,831,716
Ensembl chr13:46,346,177...46,383,862
G
Tmco1
transmembrane and coiled-coil domains 1
increases expression
EXP
nefazodone results in increased expression of TMCO1 mRNA
CTD
PMID:24136188
NCBI chr13:81,993,172...82,016,496
Ensembl chr13:81,993,097...82,017,201
G
Tmed2
transmembrane p24 trafficking protein 2
increases expression
EXP
nefazodone results in increased expression of TMED2 mRNA
CTD
PMID:24136188
NCBI chr12:37,713,522...37,722,606
Ensembl chr12:37,713,529...37,722,606
G
Tmed9
transmembrane p24 trafficking protein 9
increases expression
EXP
nefazodone results in increased expression of TMED9 mRNA
CTD
PMID:24136188
NCBI chr17:9,034,797...9,039,311
Ensembl chr17:9,034,823...9,039,319
G
Tmem106b
transmembrane protein 106B
increases expression
EXP
nefazodone results in increased expression of TMEM106B mRNA
CTD
PMID:24136188
NCBI chr 4:42,294,074...42,313,426
Ensembl chr 4:42,294,101...42,313,407
G
Tmem11
transmembrane protein 11
increases expression
EXP
nefazodone results in increased expression of TMEM11 mRNA
CTD
PMID:24136188
NCBI chr10:45,542,753...45,557,570
Ensembl chr 6:125,690,543...125,691,404 Ensembl chr10:125,690,543...125,691,404
G
Tmem126a
transmembrane protein 126A
increases expression
EXP
nefazodone results in increased expression of TMEM126A mRNA
CTD
PMID:24136188
NCBI chr 1:153,837,015...153,843,192
Ensembl chr 1:153,835,236...153,843,160
G
Tmem134
transmembrane protein 134
increases expression
EXP
nefazodone results in increased expression of TMEM134 mRNA
CTD
PMID:24136188
NCBI chr 1:210,848,761...210,857,735
Ensembl chr 1:210,848,578...210,858,861
G
Tmem140
transmembrane protein 140
decreases expression
EXP
nefazodone results in decreased expression of TMEM140 mRNA
CTD
PMID:24136188
NCBI chr 4:64,503,621...64,514,620
Ensembl chr 4:64,500,439...64,521,990
G
Tmem147
transmembrane protein 147
increases expression
EXP
nefazodone results in increased expression of TMEM147 mRNA
CTD
PMID:24136188
NCBI chr 1:95,104,448...95,106,268
Ensembl chr 1:95,104,452...95,106,283
G
Tmem14c
transmembrane protein 14C
increases expression
EXP
nefazodone results in increased expression of TMEM14C mRNA
CTD
PMID:24136188
NCBI chr17:23,939,501...23,945,622
Ensembl chr17:23,939,509...23,959,055
G
Tmem176a
transmembrane protein 176A
decreases expression
EXP
nefazodone results in decreased expression of TMEM176A mRNA
CTD
PMID:24136188
NCBI chr 4:79,101,946...79,109,499
Ensembl chr 4:79,101,857...79,111,175
G
Tmem205
transmembrane protein 205
increases expression
EXP
nefazodone results in increased expression of TMEM205 mRNA
CTD
PMID:24136188
NCBI chr 8:28,728,172...28,733,908
Ensembl chr 8:28,728,172...28,733,908
G
Tmem208
transmembrane protein 208
increases expression
EXP
nefazodone results in increased expression of TMEM208 mRNA
CTD
PMID:24136188
NCBI chr19:33,203,587...33,206,287
Ensembl chr19:50,113,510...50,124,153
G
Tmem259
transmembrane protein 259
increases expression
EXP
nefazodone results in increased expression of TMEM259 mRNA
CTD
PMID:24136188
NCBI chr 7:9,724,196...9,730,932
Ensembl chr 7:10,373,119...10,381,566
G
Tmem33
transmembrane protein 33
increases expression
EXP
nefazodone results in increased expression of TMEM33 mRNA
CTD
PMID:24136188
NCBI chr14:41,242,358...41,264,586
Ensembl chr14:41,242,358...41,264,586
G
Tmem38b
transmembrane protein 38B
increases expression
EXP
nefazodone results in increased expression of TMEM38B mRNA
CTD
PMID:24136188
NCBI chr 5:73,255,662...73,291,383
Ensembl chr 5:73,255,632...73,292,384
G
Tmem41a
transmembrane protein 41a
increases expression
EXP
nefazodone results in increased expression of TMEM41A mRNA
CTD
PMID:24136188
NCBI chr11:79,084,005...79,090,613
Ensembl chr11:92,588,489...92,595,715
G
Tmem60
transmembrane protein 60
increases expression
EXP
nefazodone results in increased expression of TMEM60 mRNA
CTD
PMID:24136188
NCBI chr 4:15,102,168...15,107,023
Ensembl chr 4:15,100,348...15,107,139
G
Tmem62
transmembrane protein 62
increases expression
EXP
nefazodone results in increased expression of TMEM62 mRNA
CTD
PMID:24136188
NCBI chr 3:128,380,366...128,415,583
Ensembl chr 3:128,375,500...128,415,583
G
Tmem69
transmembrane protein 69
increases expression
EXP
nefazodone results in increased expression of TMEM69 mRNA
CTD
PMID:24136188
NCBI chr 5:135,241,557...135,247,323
Ensembl chr 5:135,241,560...135,247,215
G
Tmem9b
TMEM9 domain family, member B
increases expression
EXP
nefazodone results in increased expression of TMEM9B mRNA
CTD
PMID:24136188
NCBI chr 1:163,755,307...163,783,880
Ensembl chr 1:173,200,869...173,218,053
G
Tmsb4x
thymosin beta 4, X-linked
decreases expression
EXP
nefazodone results in decreased expression of TMSB4X mRNA
CTD
PMID:24136188
NCBI chr X:30,761,611...30,763,612
Ensembl chr X:30,761,612...30,763,613
G
Tmx1
thioredoxin-related transmembrane protein 1
increases expression
EXP
nefazodone results in increased expression of TMX1 mRNA
CTD
PMID:24136188
NCBI chr 6:94,696,699...94,707,751
Ensembl chr 6:94,696,358...94,708,618
G
Tmx2
thioredoxin-related transmembrane protein 2
increases expression
EXP
nefazodone results in increased expression of TMX2 mRNA
CTD
PMID:24136188
NCBI chr 3:90,161,628...90,169,278
Ensembl chr 3:90,160,930...90,169,278
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
[IFNG protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to nefazodone
CTD
PMID:19362101
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Tnfrsf10b
TNF receptor superfamily member 10b
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of TNFRSF10A mRNA
CTD
PMID:33819548
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:51,250,112...51,278,082
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
EXP
nefazodone results in increased expression of TNFRSF1A mRNA
CTD
PMID:24136188
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of TNFSF10 mRNA
CTD
PMID:33819548
NCBI chr 2:112,136,550...112,155,903
G
Tnfsf11
TNF superfamily member 11
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of TNFSF11 mRNA
CTD
PMID:33819548
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
G
Tomm20
translocase of outer mitochondrial membrane 20
increases expression
EXP
nefazodone results in increased expression of TOMM20 mRNA
CTD
PMID:24136188
NCBI chr19:71,822,429...71,832,420
Ensembl chr19:71,822,411...71,832,510
G
Tomm5
translocase of outer mitochondrial membrane 5
increases expression
EXP
nefazodone results in increased expression of TOMM5 mRNA
CTD
PMID:24136188
NCBI chr 5:64,158,026...64,160,857
G
Tomm70
translocase of outer mitochondrial membrane 70
increases expression
EXP
nefazodone results in increased expression of TOMM70A mRNA
CTD
PMID:24136188
NCBI chr11:56,847,837...56,886,302
Ensembl chr11:56,846,334...56,886,320
G
Tor1a
torsin family 1, member A
increases expression
EXP
nefazodone results in increased expression of TOR1A mRNA
CTD
PMID:24136188
NCBI chr 3:34,648,421...34,655,453
Ensembl chr 3:34,648,422...34,655,417
G
Tp53i3
tumor protein p53 inducible protein 3
decreases expression
EXP
nefazodone results in decreased expression of TP53I3 mRNA
CTD
PMID:24136188
NCBI chr 6:33,537,779...33,545,204
G
Tp53inp2
tumor protein p53 inducible nuclear protein 2
decreases expression
EXP
nefazodone results in decreased expression of TP53INP2 mRNA
CTD
PMID:24136188
NCBI chr 3:164,341,618...164,350,270
Ensembl chr 3:164,343,205...164,350,225
G
Tpcn1
two pore segment channel 1
decreases expression
EXP
nefazodone results in decreased expression of TPCN1 mRNA
CTD
PMID:24136188
NCBI chr12:41,633,399...41,690,200
Ensembl chr12:41,633,398...41,690,200
G
Tpm1
tropomyosin 1
increases expression
EXP
nefazodone results in increased expression of TPM1 mRNA
CTD
PMID:24136188
NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:76,511,871...76,543,468
G
Tpm3
tropomyosin 3
increases expression
EXP
nefazodone results in increased expression of TPM3 mRNA
CTD
PMID:24136188
NCBI chr 2:177,812,534...177,842,661
Ensembl chr 2:177,814,883...177,842,660
G
Tpm4
tropomyosin 4
decreases expression
EXP
nefazodone results in decreased expression of TPM4 mRNA
CTD
PMID:24136188
NCBI chr16:17,718,442...17,732,483
Ensembl chr16:17,717,230...17,732,494
G
Tprg1l
tumor protein p63 regulated 1-like
increases expression
EXP
nefazodone results in increased expression of TPRG1L mRNA
CTD
PMID:24136188
NCBI chr 5:170,004,577...170,007,784
Ensembl chr 5:170,004,577...170,007,983
G
Tpst1
tyrosylprotein sulfotransferase 1
decreases expression
EXP
nefazodone results in decreased expression of TPST1 mRNA
CTD
PMID:24136188
NCBI chr12:32,180,688...32,247,478
Ensembl chr12:32,180,936...32,241,821
G
Trabd
TraB domain containing
increases expression
EXP
nefazodone results in increased expression of TRABD mRNA
CTD
PMID:24136188
NCBI chr 7:122,034,685...122,045,657
Ensembl chr 7:122,038,553...122,045,657
G
Trak1
trafficking kinesin protein 1
decreases expression
EXP
nefazodone results in decreased expression of TRAK1 mRNA
CTD
PMID:24136188
NCBI chr 8:129,861,967...130,016,870
Ensembl chr 8:129,861,977...130,016,870
G
Trappc13
trafficking protein particle complex subunit 13
increases expression
EXP
nefazodone results in increased expression of TRAPPC13 mRNA
CTD
PMID:24136188
NCBI chr 2:37,004,288...37,035,837
Ensembl chr 2:37,002,976...37,035,820
G
Trib3
tribbles pseudokinase 3
increases expression
EXP
nefazodone results in increased expression of TRIB3 mRNA
CTD
PMID:24136188
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
G
Trim26
tripartite motif-containing 26
decreases expression
EXP
nefazodone results in decreased expression of TRIM26 mRNA
CTD
PMID:24136188
NCBI chr20:1,711,564...1,736,389
Ensembl chr20:1,715,005...1,736,623
G
Trim5
tripartite motif-containing 5
decreases expression
EXP
nefazodone results in decreased expression of TRIM5 mRNA
CTD
PMID:24136188
NCBI chr 1:168,132,277...168,149,263
Ensembl chr 1:168,132,308...168,141,657
G
Trmt1
tRNA methyltransferase 1
increases expression
EXP
nefazodone results in increased expression of TRMT1 mRNA
CTD
PMID:24136188
NCBI chr19:40,361,583...40,374,971
Ensembl chr19:40,361,583...40,374,622
G
Tsfm
Ts translation elongation factor, mitochondrial
increases expression
EXP
nefazodone results in increased expression of TSFM mRNA
CTD
PMID:24136188
NCBI chr 7:64,714,330...64,750,106
Ensembl chr 7:64,714,036...64,750,171
G
Tsku
tsukushi, small leucine rich proteoglycan
increases expression
EXP
nefazodone results in increased expression of TSKU mRNA
CTD
PMID:24136188
NCBI chr 1:162,071,459...162,082,972
Ensembl chr 1:162,064,126...162,089,272
G
Tsnax
translin-associated factor X
increases expression
EXP
nefazodone results in increased expression of TSNAX mRNA
CTD
PMID:24136188
NCBI chr19:69,873,210...69,887,244
Ensembl chr19:69,872,987...69,887,224
G
Ttc1
tetratricopeptide repeat domain 1
increases expression
EXP
nefazodone results in increased expression of TTC1 mRNA
CTD
PMID:24136188
NCBI chr10:28,703,763...28,728,910
Ensembl chr10:28,703,769...28,728,882
G
Ttc13
tetratricopeptide repeat domain 13
decreases expression
EXP
nefazodone results in decreased expression of TTC13 mRNA
CTD
PMID:24136188
NCBI chr19:69,534,989...69,589,590
Ensembl chr19:69,534,989...69,589,563
G
Ttc3
tetratricopeptide repeat domain 3
decreases expression
EXP
nefazodone results in decreased expression of TTC3 mRNA
CTD
PMID:24136188
NCBI chr11:47,158,766...47,258,612
Ensembl chr11:47,158,792...47,258,418
G
Ttyh2
tweety family member 2
decreases expression
EXP
nefazodone results in decreased expression of TTYH2 mRNA
CTD
PMID:24136188
NCBI chr10:100,208,129...100,252,505
Ensembl chr10:100,207,860...100,253,521
G
Ttyh3
tweety family member 3
decreases expression
EXP
nefazodone results in decreased expression of TTYH3 mRNA
CTD
PMID:24136188
NCBI chr12:19,110,973...19,139,379
Ensembl chr12:19,110,824...19,139,371
G
Tuba1c
tubulin, alpha 1C
increases expression
EXP
nefazodone results in increased expression of TUBA1C mRNA
CTD
PMID:24136188
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
EXP
nefazodone results in decreased expression of TUBB2A mRNA
CTD
PMID:24136188
NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,983,387...31,006,838
G
Tut7
terminal uridylyl transferase 7
decreases expression
EXP
nefazodone results in decreased expression of TUT7 mRNA
CTD
PMID:24136188
NCBI chr17:4,854,553...4,908,758
Ensembl chr17:4,855,936...4,909,070
G
Txn1
thioredoxin 1
increases expression
EXP
nefazodone results in increased expression of TXN1 mRNA
CTD
PMID:24136188
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
G
Txnl1
thioredoxin-like 1
increases expression
EXP
nefazodone results in increased expression of TXNL1 mRNA
CTD
PMID:24136188
NCBI chr18:59,397,275...59,428,072
Ensembl chr18:59,398,535...59,435,518
G
Txnrd1
thioredoxin reductase 1
increases expression
EXP
nefazodone results in increased expression of TXNRD1 mRNA
CTD
PMID:24136188
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
G
Tysnd1
trypsin like peroxisomal matrix peptidase 1
increases expression
EXP
nefazodone results in increased expression of TYSND1 mRNA
CTD
PMID:24136188
NCBI chr20:30,180,878...30,188,239
Ensembl chr20:30,181,090...30,188,236
G
U2af1
U2 small nuclear RNA auxiliary factor 1
increases expression
EXP
nefazodone results in increased expression of U2AF1 mRNA
CTD
PMID:24136188
NCBI chr20:9,744,206...9,755,146
Ensembl chr20:9,744,207...9,755,094
G
Uba3
ubiquitin-like modifier activating enzyme 3
increases expression
EXP
nefazodone results in increased expression of UBA3 mRNA
CTD
PMID:24136188
NCBI chr 4:131,346,219...131,367,378
Ensembl chr 4:131,346,224...131,367,277
G
Uba5
ubiquitin-like modifier activating enzyme 5
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of UBA5 mRNA
CTD
PMID:33819548
NCBI chr 8:113,544,037...113,559,711
Ensembl chr 8:113,544,037...113,559,711
G
Ube2d3
ubiquitin-conjugating enzyme E2D 3
increases expression
EXP
nefazodone results in increased expression of UBE2D3 mRNA
CTD
PMID:24136188
NCBI chr 2:226,543,194...226,571,001
Ensembl chr 2:226,540,531...226,573,144
G
Ube2f
ubiquitin-conjugating enzyme E2F (putative)
increases expression
EXP
nefazodone results in increased expression of UBE2F mRNA
CTD
PMID:24136188
NCBI chr 9:99,293,506...99,328,690
Ensembl chr 9:99,293,515...99,330,479
G
Ube2k
ubiquitin-conjugating enzyme E2K
increases expression
EXP
nefazodone results in increased expression of UBE2K mRNA
CTD
PMID:24136188
NCBI chr14:43,011,681...43,077,825
Ensembl chr14:43,011,681...43,072,462
G
Ube2l3
ubiquitin-conjugating enzyme E2L 3
increases expression
EXP
nefazodone results in increased expression of UBE2L3 mRNA
CTD
PMID:24136188
NCBI chr11:97,300,584...97,343,084
Ensembl chr11:97,301,945...97,343,084
G
Ube2m
ubiquitin-conjugating enzyme E2M
increases expression
EXP
nefazodone results in increased expression of UBE2M mRNA
CTD
PMID:24136188
NCBI chr 1:73,662,576...73,666,113
G
Ube2n
ubiquitin-conjugating enzyme E2N
increases expression
EXP
nefazodone results in increased expression of UBE2N mRNA
CTD
PMID:24136188
NCBI chr 7:32,041,190...32,071,252
G
Ube2q2
ubiquitin conjugating enzyme E2 Q2
increases expression
EXP
nefazodone results in increased expression of UBE2Q2 mRNA
CTD
PMID:24136188
NCBI chr 8:64,414,502...64,474,425
Ensembl chr 8:64,414,301...64,474,418
G
Ube2v2
ubiquitin conjugating enzyme E2 V2
increases expression
EXP
nefazodone results in increased expression of UBE2V2 mRNA
CTD
PMID:24136188
NCBI chr11:98,808,681...98,842,583
Ensembl chr11:98,807,538...98,843,211
G
Ube2z
ubiquitin-conjugating enzyme E2Z
increases expression
EXP
nefazodone results in increased expression of UBE2Z mRNA
CTD
PMID:24136188
NCBI chr10:80,997,816...81,016,936
Ensembl chr10:81,494,523...81,513,641
G
Ube3a
ubiquitin protein ligase E3A
increases expression
EXP
nefazodone results in increased expression of UBE3A mRNA
CTD
PMID:24136188
NCBI chr 1:119,204,244...119,297,097
Ensembl chr 1:119,206,148...119,297,097
G
Ube3c
ubiquitin protein ligase E3C
increases expression
EXP
nefazodone results in increased expression of UBE3C mRNA
CTD
PMID:24136188
NCBI chr 4:6,323,831...6,425,085
Ensembl chr 4:6,323,831...6,424,845
G
Ube4a
ubiquitination factor E4A
increases expression
EXP
nefazodone results in increased expression of UBE4A mRNA
CTD
PMID:24136188
NCBI chr 8:54,132,799...54,174,921
Ensembl chr 8:54,132,801...54,174,835
G
Ube4b
ubiquitination factor E4B
increases expression
EXP
nefazodone results in increased expression of UBE4B mRNA
CTD
PMID:24136188
NCBI chr 5:165,049,897...165,153,572
Ensembl chr 5:165,049,897...165,153,572
G
Ubfd1
ubiquitin family domain containing 1
increases expression
EXP
nefazodone results in increased expression of UBFD1 mRNA
CTD
PMID:24136188
NCBI chr 1:176,626,003...176,640,993
Ensembl chr 1:186,057,123...186,066,103
G
Ubl3
ubiquitin-like 3
increases expression
EXP
nefazodone results in increased expression of UBL3 mRNA
CTD
PMID:24136188
NCBI chr12:6,473,684...6,518,331
Ensembl chr12:11,509,848...11,554,547
G
Ubqln1
ubiquilin 1
increases expression
EXP
nefazodone results in increased expression of UBQLN1 mRNA
CTD
PMID:24136188
NCBI chr17:6,438,456...6,482,498
Ensembl chr17:6,444,124...6,482,499
G
Ubqln2
ubiquilin 2
increases expression
EXP
nefazodone results in increased expression of UBQLN2 mRNA
CTD
PMID:24136188
NCBI chr X:21,228,809...21,232,228
Ensembl chr X:21,229,197...21,232,268
G
Ubr4
ubiquitin protein ligase E3 component n-recognin 4
increases expression
EXP
nefazodone results in increased expression of UBR4 mRNA
CTD
PMID:24136188
NCBI chr 5:156,919,029...157,027,127
Ensembl chr 5:156,919,085...157,027,127
G
Ubxn1
UBX domain protein 1
increases expression
EXP
nefazodone results in increased expression of UBXN1 mRNA
CTD
PMID:24136188
NCBI chr 1:215,194,418...215,198,343
Ensembl chr 1:215,174,216...215,198,343
G
Ubxn4
UBX domain protein 4
increases expression
EXP
nefazodone results in increased expression of UBXN4 mRNA
CTD
PMID:24136188
NCBI chr13:39,740,064...39,772,493
Ensembl chr13:42,292,528...42,326,143
G
Uchl3-ps1
ubiquitin C-terminal hydrolase L3, pseudogene 1
increases expression
EXP
nefazodone results in increased expression of UCHL3-PS1 mRNA
CTD
PMID:24136188
NCBI chr 3:161,856,954...161,857,835
G
Uchl5
ubiquitin C-terminal hydrolase L5
increases expression
EXP
nefazodone results in increased expression of UCHL5 mRNA
CTD
PMID:24136188
NCBI chr13:58,070,947...58,106,825
Ensembl chr13:58,042,029...58,107,441
G
Ufd1
ubiquitin recognition factor in ER associated degradation 1
increases expression
EXP
nefazodone results in increased expression of UFD1 mRNA
CTD
PMID:24136188
NCBI chr11:95,665,971...95,689,423
Ensembl chr11:95,665,972...95,689,434
G
Ufl1
Ufm1-specific ligase 1
increases expression
EXP
nefazodone results in increased expression of UFL1 mRNA
CTD
PMID:24136188
NCBI chr 5:43,759,271...43,791,682
Ensembl chr 5:43,758,098...43,791,682
G
Ugdh
UDP-glucose 6-dehydrogenase
increases expression
EXP
nefazodone results in increased expression of UGDH mRNA
CTD
PMID:24136188
NCBI chr14:43,202,480...43,226,002
Ensembl chr14:43,202,356...43,226,629
G
Uggt1
UDP-glucose glycoprotein glucosyltransferase 1
increases expression
EXP
nefazodone results in increased expression of UGGT1 mRNA
CTD
PMID:24136188
NCBI chr 9:45,851,127...45,964,454
Ensembl chr 9:45,854,985...45,964,455
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
increases expression
EXP
nefazodone results in increased expression of UGT1A6 mRNA
CTD
PMID:24136188
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases expression
EXP
nefazodone results in increased expression of UGT2B17 mRNA
CTD
PMID:24136188
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,378,853...21,392,331
G
Ulk2
unc-51 like autophagy activating kinase 2
decreases expression
EXP
nefazodone results in decreased expression of ULK2 mRNA
CTD
PMID:24136188
NCBI chr10:46,951,038...47,029,844
Ensembl chr10:46,951,038...47,029,844
G
Umps
uridine monophosphate synthetase
increases expression
EXP
nefazodone results in increased expression of UMPS mRNA
CTD
PMID:24136188
NCBI chr11:80,311,269...80,321,678
Ensembl chr11:80,311,214...80,327,828
G
Ung
uracil-DNA glycosylase
increases expression
EXP
nefazodone results in increased expression of UNG mRNA
CTD
PMID:24136188
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:48,145,838...48,155,257
G
Unkl
unk like zinc finger
increases expression
EXP
nefazodone results in increased expression of UNKL mRNA
CTD
PMID:24136188
NCBI chr10:14,710,627...14,756,725
Ensembl chr10:14,710,563...14,756,724
G
Uqcrc1
ubiquinol-cytochrome c reductase core protein 1
increases expression
EXP
nefazodone results in increased expression of UQCRC1 mRNA
CTD
PMID:24136188
NCBI chr 8:118,468,223...118,479,968
Ensembl chr 8:118,468,200...118,479,964
G
Uqcrc2
ubiquinol cytochrome c reductase core protein 2
increases expression
EXP
nefazodone results in increased expression of UQCRC2 mRNA
CTD
PMID:24136188
NCBI chr 1:184,599,240...184,629,804
Ensembl chr 1:184,599,212...184,630,946
G
Uri1
URI1, prefoldin-like chaperone
increases expression
EXP
nefazodone results in increased expression of URI1 mRNA
CTD
PMID:24136188
NCBI chr 1:99,783,157...99,845,787
Ensembl chr 1:99,783,158...99,853,906
G
Use1
unconventional SNARE in the ER 1
increases expression
EXP
nefazodone results in increased expression of USE1 mRNA
CTD
PMID:24136188
NCBI chr16:18,038,284...18,041,826
Ensembl chr16:18,070,793...18,075,814
G
Usp10
ubiquitin specific peptidase 10
increases expression
EXP
nefazodone results in increased expression of USP10 mRNA
CTD
PMID:24136188
NCBI chr19:64,881,255...64,923,522
Ensembl chr19:64,881,315...64,923,519
G
Usp14
ubiquitin specific peptidase 14
increases expression
EXP
nefazodone results in increased expression of USP14 mRNA
CTD
PMID:24136188
NCBI chr18:1,292,745...1,330,867
Ensembl chr18:1,292,745...1,330,336
G
Usp3
ubiquitin specific peptidase 3
increases expression
EXP
nefazodone results in increased expression of USP3 mRNA
CTD
PMID:24136188
NCBI chr 8:75,973,278...76,049,151
Ensembl chr 8:75,974,615...76,049,153
G
Usp39
ubiquitin specific peptidase 39
increases expression
EXP
nefazodone results in increased expression of USP39 mRNA
CTD
PMID:24136188
NCBI chr 4:105,932,140...105,964,551
Ensembl chr 4:105,932,140...105,964,551
G
Usp47
ubiquitin specific peptidase 47
increases expression
EXP
nefazodone results in increased expression of USP47 mRNA
CTD
PMID:24136188
NCBI chr 1:175,586,758...175,669,904
Ensembl chr 1:175,586,723...175,669,904
G
Usp5
ubiquitin specific peptidase 5
increases expression
EXP
nefazodone results in increased expression of USP5 mRNA
CTD
PMID:24136188
NCBI chr 4:159,305,927...159,321,345
Ensembl chr 4:159,305,938...159,320,956
G
Usp7
ubiquitin specific peptidase 7
increases expression
EXP
nefazodone results in increased expression of USP7 mRNA
CTD
PMID:24136188
NCBI chr10:7,335,508...7,432,018
Ensembl chr10:7,367,604...7,432,013
G
Ust4r
integral membrane transport protein UST4r
increases expression
EXP
nefazodone results in increased expression of UST4R mRNA
CTD
PMID:24136188
NCBI chr 1:205,072,204...205,142,718
Ensembl chr 1:214,501,347...214,571,832
G
Ust5r
integral membrane transport protein UST5r
decreases expression
EXP
nefazodone results in decreased expression of UST5R mRNA
CTD
PMID:24136188
NCBI chr 1:214,640,172...214,716,024
Ensembl chr 1:214,640,172...214,715,861
G
Vat1
vesicle amine transport 1
increases expression
EXP
nefazodone results in increased expression of VAT1 mRNA
CTD
PMID:24136188
NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,889,793...86,897,411
G
Vcp
valosin-containing protein
increases expression
EXP
nefazodone results in increased expression of VCP mRNA
CTD
PMID:24136188
NCBI chr 5:62,005,984...62,025,387
Ensembl chr 5:62,005,985...62,025,387
G
Vdac1
voltage-dependent anion channel 1
increases expression
EXP
nefazodone results in increased expression of VDAC1 mRNA
CTD
PMID:24136188
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541
G
Vdac3
voltage-dependent anion channel 3
increases expression
EXP
nefazodone results in increased expression of VDAC3 mRNA
CTD
PMID:24136188
NCBI chr16:76,137,489...76,153,933
Ensembl chr16:76,137,504...76,155,304
G
Vim
vimentin
decreases expression
EXP
nefazodone results in decreased expression of VIM mRNA
CTD
PMID:24136188
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
G
Vkorc1
vitamin K epoxide reductase complex, subunit 1
decreases expression
EXP
nefazodone results in decreased expression of VKORC1 mRNA
CTD
PMID:24136188
NCBI chr 1:191,932,969...191,935,490
G
Vkorc1l1
vitamin K epoxide reductase complex, subunit 1-like 1
increases expression
EXP
nefazodone results in increased expression of VKORC1L1 mRNA
CTD
PMID:24136188
NCBI chr12:32,354,078...32,404,327
G
Vnn1
vanin 1
increases expression
EXP
nefazodone results in increased expression of VNN1 mRNA
CTD
PMID:24136188
NCBI chr 1:23,356,324...23,366,629
Ensembl chr 1:23,356,330...23,366,629
G
Vps26a
VPS26 retromer complex component A
increases expression
EXP
nefazodone results in increased expression of VPS26A mRNA
CTD
PMID:24136188
NCBI chr20:30,947,018...30,976,964
Ensembl chr20:30,947,023...30,976,827
G
Vps29
VPS29 retromer complex component
increases expression
EXP
nefazodone results in increased expression of VPS29 mRNA
CTD
PMID:24136188
NCBI chr12:39,869,688...39,878,732
Ensembl chr12:39,869,688...39,878,848
G
Vps35
VPS35 retromer complex component
increases expression
EXP
nefazodone results in increased expression of VPS35 mRNA
CTD
PMID:24136188
NCBI chr19:37,938,989...37,974,887
Ensembl chr19:37,938,720...37,974,886
G
Vwa8
von Willebrand factor A domain containing 8
increases expression
EXP
nefazodone results in increased expression of VWA8 mRNA
CTD
PMID:24136188
NCBI chr15:60,661,764...60,985,971
Ensembl chr15:60,661,877...60,985,971
G
Wapl
WAPL cohesin release factor
increases expression
EXP
nefazodone results in increased expression of WAPL mRNA
CTD
PMID:24136188
NCBI chr16:10,011,741...10,081,472
Ensembl chr16:10,012,110...10,081,472
G
Wasl
WASP like actin nucleation promoting factor
increases expression
EXP
nefazodone results in increased expression of WASL mRNA
CTD
PMID:24136188
NCBI chr 4:54,049,081...54,097,653
Ensembl chr 4:54,049,082...54,097,570
G
Wdr36
WD repeat domain 36
increases expression
EXP
nefazodone results in increased expression of WDR36 mRNA
CTD
PMID:24136188
NCBI chr18:24,747,812...24,783,704
Ensembl chr18:24,747,832...24,783,110
G
Wdr45
WD repeat domain 45
increases expression
EXP
nefazodone results in increased expression of WDR45 mRNA
CTD
PMID:24136188
NCBI chr X:17,448,195...17,454,117
Ensembl chr X:17,448,207...17,454,117
G
Wdr77
WD repeat domain 77
increases expression
EXP
nefazodone results in increased expression of WDR77 mRNA
CTD
PMID:24136188
NCBI chr 2:196,123,882...196,133,853
Ensembl chr 2:196,123,848...196,134,567
G
Wsb1
WD repeat and SOCS box-containing 1
decreases expression
EXP
nefazodone results in decreased expression of WSB1 mRNA
CTD
PMID:24136188
NCBI chr10:64,700,752...64,717,038
Ensembl chr10:64,700,762...64,716,832
G
Wwc3
WWC family member 3
increases expression
EXP
nefazodone results in increased expression of WWC3 mRNA
CTD
PMID:24136188
NCBI chr X:27,146,018...27,263,446
Ensembl chr X:27,145,812...27,263,446
G
Xbp1
X-box binding protein 1
increases splicing
ISO
nefazodone results in increased splicing of XBP1 mRNA
CTD
PMID:27613715
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
G
Xdh
xanthine dehydrogenase
decreases expression
EXP
nefazodone results in decreased expression of XDH mRNA
CTD
PMID:24136188
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
decreases expression
EXP
nefazodone results in decreased expression of XPC mRNA
CTD
PMID:24136188
NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:125,550,833...125,578,305
G
Xpnpep2
X-prolyl aminopeptidase 2
decreases expression
EXP
nefazodone results in decreased expression of XPNPEP2 mRNA
CTD
PMID:24136188
NCBI chr X:132,165,696...132,194,937
Ensembl chr X:132,165,701...132,195,126
G
Xpo1
exportin 1
increases expression
EXP
nefazodone results in increased expression of XPO1 mRNA
CTD
PMID:24136188
NCBI chr14:101,434,450...101,476,705
Ensembl chr14:101,434,517...101,476,714
G
Xpot
exportin for tRNA
increases expression
EXP
nefazodone results in increased expression of XPOT mRNA
CTD
PMID:24136188
NCBI chr 7:58,997,025...59,037,506
Ensembl chr 7:58,997,025...59,037,502
G
Yars1
tyrosyl-tRNA synthetase 1
increases expression
EXP
nefazodone results in increased expression of YARS1 mRNA
CTD
PMID:24136188
NCBI chr 5:146,820,163...146,848,377
Ensembl chr 5:146,819,358...146,848,377
G
Yif1a
Yip1 interacting factor homolog A, membrane trafficking protein
increases expression
EXP
nefazodone results in increased expression of YIF1A mRNA
CTD
PMID:24136188
NCBI chr 1:202,394,923...202,399,125
Ensembl chr 1:211,824,273...211,828,802
G
Yipf1
Yip1 domain family, member 1
decreases expression
EXP
nefazodone results in decreased expression of YIPF1 mRNA
CTD
PMID:24136188
NCBI chr 5:122,112,144...122,147,729
Ensembl chr 5:127,340,953...127,376,538
G
Yipf4
Yip1 domain family, member 4
increases expression
EXP
nefazodone results in increased expression of YIPF4 mRNA
CTD
PMID:24136188
NCBI chr 6:26,702,647...26,714,066
Ensembl chr 6:26,682,488...26,714,066
G
Ypel3
yippee-like 3
decreases expression
EXP
nefazodone results in decreased expression of YPEL3 mRNA
CTD
PMID:24136188
NCBI chr 1:190,814,920...190,818,248
Ensembl chr 1:190,814,512...190,818,251
G
Ypel5
yippee-like 5
increases expression
EXP
nefazodone results in increased expression of YPEL5 mRNA
CTD
PMID:24136188
NCBI chr 6:28,408,079...28,423,536
Ensembl chr 6:28,408,080...28,412,385
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
increases expression
EXP
nefazodone results in increased expression of YWHAB mRNA
CTD
PMID:24136188
NCBI chr 3:173,078,904...173,101,508
Ensembl chr 3:173,079,041...173,101,854
G
Ywhag
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
increases expression
EXP
nefazodone results in increased expression of YWHAG mRNA
CTD
PMID:24136188
NCBI chr12:26,381,106...26,409,466
Ensembl chr12:26,380,816...26,409,465
G
Ywhaq
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
increases expression
EXP
nefazodone results in increased expression of YWHAQ mRNA
CTD
PMID:24136188
NCBI chr 6:46,664,358...46,694,875
Ensembl chr 6:46,664,358...46,694,875
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
increases expression
EXP
nefazodone results in increased expression of YWHAZ mRNA
CTD
PMID:24136188
NCBI chr 7:69,826,404...69,848,702
Ensembl chr 7:69,826,404...69,849,007
G
Zbtb20
zinc finger and BTB domain containing 20
decreases expression
EXP
nefazodone results in decreased expression of ZBTB20 mRNA
CTD
PMID:24136188
NCBI chr11:70,558,010...71,297,039
Ensembl chr11:70,580,930...70,736,237
G
Zdhhc7
zinc finger DHHC-type palmitoyltransferase 7
increases expression
EXP
nefazodone results in increased expression of ZDHHC7 mRNA
CTD
PMID:24136188
NCBI chr19:65,048,140...65,065,286
Ensembl chr19:65,037,310...65,065,286
G
Zfand2a
zinc finger AN1-type containing 2A
increases expression
EXP
nefazodone results in increased expression of ZFAND2A mRNA
CTD
PMID:24136188
NCBI chr12:20,275,435...20,286,513
Ensembl chr12:20,275,450...20,286,513
G
Zfp110
zinc finger protein 110
decreases expression
EXP
nefazodone results in decreased expression of ZFP110 mRNA
CTD
PMID:24136188
NCBI chr 1:82,509,563...82,533,294
Ensembl chr 1:82,517,769...82,533,292
G
Zfp260
zinc finger protein 260
decreases expression
EXP
nefazodone results in decreased expression of ZFP260 mRNA
CTD
PMID:24136188
NCBI chr 1:94,469,861...94,477,377
Ensembl chr 1:94,460,733...94,478,217
G
Zfp36l1
zinc finger protein 36, C3H type-like 1
decreases expression
EXP
nefazodone results in decreased expression of ZFP36L1 mRNA
CTD
PMID:24136188
NCBI chr 6:104,663,396...104,669,815
Ensembl chr 6:104,663,399...104,687,979
G
Zfp386
zinc finger protein 386 (Kruppel-like)
decreases expression
EXP
nefazodone results in decreased expression of ZFP386 mRNA
CTD
PMID:24136188
NCBI chr 6:143,109,563...143,124,266
Ensembl chr 6:143,109,610...143,127,027
G
Zfp598
zinc finger protein 598
increases expression
EXP
nefazodone results in increased expression of ZFP598 mRNA
CTD
PMID:24136188
NCBI chr10:14,198,763...14,210,773
Ensembl chr10:14,185,611...14,210,772
G
Zfp706
zinc finger protein 706
increases expression
EXP
nefazodone results in increased expression of ZFP706 mRNA
CTD
PMID:24136188
NCBI chr 7:70,050,960...70,059,588
Ensembl chr 7:70,052,534...70,059,159
G
Zfyve21
zinc finger FYVE-type containing 21
decreases expression
EXP
nefazodone results in decreased expression of ZFYVE21 mRNA
CTD
PMID:24136188
NCBI chr 6:136,695,132...136,715,601
Ensembl chr 6:136,694,908...136,715,601
G
Zkscan3
zinc finger with KRAB and SCAN domains 3
decreases expression
EXP
nefazodone results in decreased expression of ZKSCAN3 mRNA
CTD
PMID:24136188
NCBI chr17:47,912,816...47,928,553
Ensembl chr17:47,912,912...47,928,551
G
Zmiz2
zinc finger, MIZ-type containing 2
decreases expression
EXP
nefazodone results in decreased expression of ZMIZ2 mRNA
CTD
PMID:24136188
NCBI chr14:85,465,323...85,481,860
Ensembl chr14:85,465,373...85,481,860
G
Zpr1
ZPR1 zinc finger
increases expression
EXP
nefazodone results in increased expression of ZPR1 mRNA
CTD
PMID:24136188
NCBI chr 8:55,461,839...55,471,413
Ensembl chr 8:55,461,839...55,471,413
G
Zwint
ZW10 interacting kinetochore protein
increases expression
EXP
nefazodone results in increased expression of ZWINT mRNA
CTD
PMID:24136188
NCBI chr20:15,502,559...15,953,701
Ensembl chr20:15,937,396...15,953,203
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all